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TOPIC 01 – Atherosclerosis, hemostasis,
inflammation, AGE – A
0409
Trans-radial Approach for Coronary Angiography in patients recei-
ving long term oral anticoagulation: Safety and Feasibility of an
“uninterrupted” strategy in selected patients
Laurent Bali, Thomas Cuisset, Raphael Poyet, Jacques Quilici, Marc Lam-
bert, Jean-Louis Bonnet
CHU TIMONE, Cardiologie interventionelle, Marseille, France
Introduction: Patient receiving oral anticoagulation (OAC) with vitamin K
Antagonists (VKA) are patients with higher risk of both ischemic and bleeding
complications when bridging therapy is performed. Trans-radial approach has
been shown to dramatically decrease the rate of bleeding complications after
coronary angiography. We, therefore, designed a study to assess the safety and
feasibility of trans-radial coronary angiography with uninterrupted strategy
with VKA in selected patients eligible for radial approach. 
Methods and results: Consecutive patients receiving OAC and scheduled
for coronary angiography were prospectively included between December
2008 and September 2009. Patients were eligible and included if the Allen’s
Test Manoeuvre was positive and the radial pulse suitable according to an
experienced operator, and coronary angiography was performed by radial
approach with uninterrupted oral anticoagulantion.100 consecutive patients
were included. Major and Minor bleeding according to the TIMI classification
and ischemic Cardiovascular events (death, myocardial infarction, target
vessel revascularization, and stent thrombosis) were recorded. Among the 100
patients included, trans-radial Coronary angiography was feasible in 95
patients, and femoral access was used in 5 patients. Among the 95 patients, we
did not observe any major and minor bleeding or ischemic CV events. Among
the 5 “femoral access” patients, closure device was used in all patients and no
patients suffered from major bleeding.
Conclusion: In patient receiving OAC, screening of patients suitable for
radial approach is an effective tool to identify patients eligible for a strategy
of uninterrupted therapy with VKA. This strategy is feasible and safe in a
large majority of patients with good probability of radial access if performed
by trained operator from a “radial group”.
0403
In vivo detection of non-occlusive thrombi in drug-eluting stents by
scintigraphy and radio-labelled Annexin V in a rabbit model
Francis Blackwell (1), Anne Meddahi-Pellé (2), Graciella Pavon-
Djavid (3), François Rouzet (1), Liliane Louedec (2), Laure Sarda (1),
Alain Meulemans (1), Christophe Hélary (4), Didier Letourneur (5), Lau-
rent Feldman (6), Jean-Baptiste Michel (2), Dominique Le Guludec (1),
Fabien Hyafil (1)
(1) Hôpital Bichat, Université Paris 7 Denis-Diderot, Service de médecine
nucléaire et INSERM 698, Paris, France – (2) INSERM 698, Paris,
France – (3) Université Paris 13, Institut Galilée, Villetaneuse, France –
(4) Université Pierre et Marie Curie, UMR7574 Chimie de la Matière
Condensée de Paris, Paris, France – (5) INSERM 698 et Université paris
13, Paris, France – (6) Hôpital Bichat, Université Paris 7 Denis-Diderot,
Service de cardiologie et INSERM 698, Paris, France
Introduction: Thrombi in contact with non re-endothelialized stent struts
are associated with drug-eluting stents (DES) thrombosis. Hence, detection of
thrombi in DES could help to evaluate the risk of DES thrombosis. Annexin
V radio-labelled with 99mTechnetium (99mTc) is a radiotracer with a high
affinity for activated platelets.
Objectives: Our objectives were: 1) to develop an animal model of non-
occlusive thrombosis of stents, 2) to evaluate the ability of annexin V 99mTc for
the detection of in-stent thrombi using scintigraphy. 
Methods: Right carotid arteries of NZW rabbits (n=14) fed a high choles-
terol diet were implanted with overlapping DES (n=7) or bare-metal stents
(BMS; n=7). Four weeks after stent implantation, rabbits underwent a first
scintigraphy 3 hours after injection of 200 MBq of radio-labelled annexin
V 99mTc. At the end of the first scintigraphy, a suture was placed surgically
proximal to the injured carotid arteries in order to induce a thrombus-prone
flow limiting stenosis. Four days later, a second scintigraphy was performed.
After the second scintigraphy, stents were excised and fixed for histological
examination and scanning electron microscopy (SEM). 
Results: Activities measured in vivo in the stented carotid arteries after
injection of annexin V 99mTc increased on the second scintigraphy after cre-
ation of a surgical stenosis as compared to the first scintigraphy (0.24 vs. 0.15
counts/pixel/ MBq, respectively; p<0.05). On the second scintigraphy, activi-
ties were higher in DES vs. BMS (0.26 vs. 0.19 counts/pixel/ MBq, respec-
tively; p<0.005). High activities measured in stents were associated with the
detection of thrombi on corresponding histological sections and SEM.
Conclusions: In this study, we developed a rabbit model of non-occlusive
thrombosis of stents in carotid arteries. In this model, in-stent thrombi could
be detected using annexin V 99mTc scintigraphy. 
0244
Rosiglitazone increases PGE2 level released by cultured peritoneal
macrophages by activating PPARgamma
Xavier Lanciaux, Jean-Etienne Fabre
IGBMC, Illkirch, France
Myocardial infarctions or strokes are due to atherothrombosis, i.e. throm-
bosis occurring at the surface of atherosclerotic plaques. Atherosclerotic
plaques are chronic inflammatory lesions of the vascular wall, but the role of
inflammation in atherothrombosis is not clear. Our lab has been the first to
clearly show a link between the inflammatory mediator prostaglandin E2
(PGE2) produced in plaques and atherothrombosis, due to the ability of PGE2
to activate its EP3 receptor on platelets. Our current project is to find whether
PGE2 production is under the control of a pathway that modulates the plaque
thrombogenicity. PTGS-2 is the gene coding for cyclooxygenase 2, needed for
PGE2 biosynthesis, and contains a peroxisome proliferator activated receptor
(PPAR) responsive element. Macrophages are predominant into the plaque,
and express PPARγ. Therefore, PPARγ might modulate the PGE2 production
in atherosclerotic plaques. To test this hypothesis, we stimulated freshly iso-
lated peritoneal macrophages in vitro with agonists for PPARs. We show that
PGE2 production by cultured macrophages was increased only by rosiglita-
zone, a PPARγ agonist. Using a specific inhibitor for PPARγ, we showed that
the stimulating effect of rosiglitazone on PGE2 production is indeed due to its
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effect on PPARγ. We then confirmed that PPARγ mRNA and protein level are
clearly up regulated in ApoE-/- vascular wall. These data strongly suggest that
PPARγ modulate the plaque PGE2 production. We are currently investigating
the mechanism involved: PPARγ could modulate the level of one of the dif-
ferent enzyme of the arachidonic acid cascade leading to PGE2. In vivo
studies are currently under way to test whether rosiglitazone impacts the PGE2
production in vivo and thereby modulates atherothrombosis. Our results could
unveil a mechanism explaining the cardiovascular toxicity of rosiglitazone evi-
denced by clinical trials in patients treated for mellitus diabetes.
0466
The Outcome of PCI in the Elderly is Mostly Related to the Clinical
Presentation at Admission: Insights from a Registry Study
Anne-Céline Martin, Stéphane Manzo-Silberman, Christian Spaulding
Cochin, cardiologie, Paris, France
Optimal management of coronary artery disease in very old patients – over
eighty years of age – remains unclear due to the absence of large randomized
trials in this high-risk subgroup and the benefit/risk ratio of percutaneous cor-
onary intervention (PCI) is difficult to assess in clinical practice. Data from
registries are therefore valuable to assess the benefit/risk ratio of reperfusion
strategies.
Aim: The aim of our study was to evaluate the in-hospital and two year
outcome of PCI in elderly patients aged ≥ 80 years old in a prospective reg-
istry including patients with clinical presentation ranging from stable angina to
cardiogenic shock. 
Methodes and Results: Between 2004 and 2009, a coronary angiogram
was performed in 554 patients aged ≥ 80 years of age. PCI was performed in
232 patients. Mean age was 82 ± 2.6 and 38% were women. The procedures
were unplanned due to ST elevation myocardial infarction (STEMI) 32.8%),
cardiogenic shock complicating STEMI (9%), and non ST segment elevation
myocardial infarction (NSTEMI) (30.6%). 36.6% of procedures were per-
formed for stable angina refractory to optimal medical therapy. Radial access
was used in 87% of cases. One vessel disease was found in 32%. Primary suc-
cess rate was 93%. Stents were implanted in 99% of lesions, with only 1% use
of drug eluting stent). Rates of in hospital mortality were respectively 12.5%
in all patients; 85.7% in those presenting with cardiogenic shock, 14.5% in
those with STEMI without shock, 2.8% in patients with NSTEMI and 2.35%
in patients with stable angina. The overall two year mortality rate is 20%.
Conclusion: In very old patients over 80 years of age, in hospital outcome
is strongly related to the clinical presentation at admission. The prognosis of
cardiogenic shock remains poor in this subgroup despite revascularization. In
contrast, the in-hospital outcome of PCI in patients admitted with STEMI,
NSTEMI and stable angina is encouraging. However, long term mortality
remains high. 
0247
Cardiovascular mortality in chronic kidney disease patients under-
going percutaneous coronary intervention is mainly related to impai-
red P2Y12 inhibition by clopidogrel
Olivier Morel (1), Soraya El-Ghannudi (1), Bogdan Radulescu (1), Lau-
rence Jesel (2), Nicolas Meyer (3), Marie-Louise Wiesel (4), Sophie
Caillard (5), Bruno Moulin (5), Christian Gachet (4), Patrick Ohlmann (2)
(1) Pôle d’activité médico-chirurgicale cardiovasculaire, NHC, Stras-
bourg, France – (2) Hopitaux Universitaires de Strasbourg, Federation de
Cardiologie, Strasbourg, France – (3) Département de Biostatistique,
Hôpitaux Universitaires de Strasbourg, Strasbourg, France – (4) EFS,
Strasbourg, France – (5) Service de Nephrologie, NHC, Strasbourg,
France
 Objectives: To determine whether low platelet response to the P2Y12
receptor antagonist clopidogrel as assessed by VAsodilator Stimulated Phos-
phoprotein flow cytometry test (VASP- FCT) predicts cardiovascular events in
patients with chronic kidney disease (CKD) undergoing percutaneous coronary
intervention (PCI).
Background: Whilst both CKD and impaired platelet responsiveness to
clopidogrel are strong predictors of unfavourable outcome after PCI, the dele-
terious impact of their association is unknown. The platelet VASP-FCT is a
new assay specific of the P2Y12 ADP receptor-pathway. In this test, platelet
activation is expressed as Platelet Reactivity Index (PRI).
Methods: 440 unselected patients (CKD: 126 (CrCl < 60 ml/min), Normal
renal function: 314 (CrCl > 60 ml/min)) undergoing urgent (n=336) or planned
(n=104) PCI were prospectively enrolled. In each sub-group, patients were
classified as low-responders (LR: PRI≥61%) and responders (R: PRI<61%) to
clopidogrel 
Results: At follow-up (9±2 months), total, cardiac mortality, probable and
possible stent thrombosis rates were higher in CKD patients. In this sub-group,
cardiac death, total stent thrombosis and MACE were dramatically increased
in LR patients. Conversely, in patients with normal renal function, LR was not
associated with an adverse cardiovascular outcome. In CKD patients, multi-
variate analysis identified LR to clopidogrel (HR 4.00 [1.08-14.80]; p=0.025)
and BNP > 400 ng/L (HR 9.55 [1.18-77.11]; p=0.034) as independent predic-
tors of cardiac death. 
Conclusions: In CKD patients undergoing PCI, LR to clopidogrel assessed
by VASP-FCT is an independent predictor of cardiovascular death at the PRI
cut-off value of ≥61%. 
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0059
Coronary thrombectomy: Technical comparison of two systems on a
laboratory bench. Impact of bends, angles and thrombus age
Luc Lorgis (1), Virginie Pioud (2), Carole Richard (1), Bertrand Collin (3),
Aurélie Gudjoncik (1), Marie-Hélène Guignard (2), Luc Rochette (3), Yves
Cottin (1)
(1) CHU du BOCAGE, cardiologie, Dijon, France – (2) CHU du
BOCAGE, Pharmacie, Dijon, France – (3) Faculté de Médecine et de
Pharmacie, LPPCE, Dijon, France
Background: Despite the results of recent randomized studies, the system-
atic use of aspiration techniques in ST-elevation myocardial infarction has not
been included in the new guidelines. To date, there have been very few bench
tests of the different systems and the aim of our study was to test two catheters
on different models of arteries with thrombi at 6 and 12 hours.
Methods: The test apparatus consisted of 3-mm diameter glass tubes of
150 mm in length. The thrombi were left for either 6 or 12 hours and ten
models of tubes were used: straight, with a single bend and with two bends.
Two types of catheter were tested: the Export® aspiration catheter (EAC) and
the Proxis® embolic protection system (PES). The main assessment criterion
was total thrombectomy. 
Results: Total thrombectomy was achieved in only 55.3% of the tests and
no difference appeared between the two systems. Total thrombectomy was
achieved more frequently with 6-h thrombi than 12-h thrombi for the two tech-
niques, 62.5% vs. 42.5% (p=0.018) and 67.5% vs. 48.7% (p=0.025) for EAC
and PES catheter, respectively. In contrast, total thrombectomy were more fre-
quent in straight tubes and in tubes with a single bend than in tubes with
double bends, respectively for EAC (64% vs. 44.8%, p=0.028) and for PES
(85.9% vs. 35.4%, p<0.001). 
Conclusion: The use of thrombectomy in the invasive management of
acute coronary syndromes is growing. Our work on a “laboratory bench”
reveals important technical differences. In consequence, in clinical practice,
we speculate that the catheter system must be chosen according to both the
artery anatomy and the delay between chest pain and PCI. 
0123
In-hospital complications after PCI for non ST-segment elevation
myocardial infarction in old women as compared to young men
Gerald Roul, Caroline Berthillot, Dominique Stephan, Michel Chauvin
Pôle Cardiologie, USI Cardiologie, Strasbourg, France
Background: To analyze the in-hospital complication rate in women suf-
fering from NSTEMI treated with PCI compared to men. Methods: 479 con-
secutive patients (133 women and 346 men) suffering from a NSTEMI
between January 1st 2006 and March 21st 2009 were retrospectively analyzed.
Data were analyzed using nonparametric tests and reported as median unless
otherwise specified. 
Results: As compared to men, women were significantly older (p<.005).
All cardiovascular risk factors but tobacco and hypertension were similar
between the groups. No difference was noticed for pre-hospital cardiovascular
drug treatment. However women were slightly more severe at entry (more
Killip class IV; p=.0023; higher GRACE score for in-hospital death – p=.008
and CRUSADE score for bleeding – p < .0001). All the patients underwent
PCI of the infarct-related artery after 24 or 48 hrs post admission without any
sex-related difference. During hospitalization, 130 complications were
recorded. Though the event rate was slightly higher in women (30% vs. 26%
– p=NS), no single event was significantly gender related. The logistic regres-
sion identified age and CRP concentration as the only predictive variables in
the whole group. After splitting for genders, these parameters were still pre-
dictive of events in men. In women however, CRP was the only one with a
borderline p value. 
Conclusions: Our study does not support any gender difference for in-hos-
pital adverse events in patients treated invasively for a Non-STEMI. 
0444
Shear stress induced-endothelial microparticles release: 
role of MAPK and NF-κB pathways.
Anne-Clémence Vion, Bhama Ramkhelawon, Alain Tedgui, Chantal Bou-
langer
INSERM, unité U970, Paris, France
Endothelial Microparticles (EMPs) are bioactive submicron membrane ves-
icles released upon cell activation and may contribute to the pathogenesis of
atherosclerosis. Laminar shear stress is known to protect against plaque forma-
tion contrarily to oscillatory and low shear stress. We thus investigated
whether shear stress could modulate the release of EMPs and whether these
effects would be mediated by the MAPK and NF-κB pathways.
Endothelial cells (HUVECs, Passage 2-3) were subjected to low (1.5dyn/
cm2), high (15dyn/cm2, physiologic) laminar shear stress or maintained under
static conditions for 24 hours. EMPs were isolated from the cell culture
medium by centrifugation, and characterized by annexinV labelling using flow
cytometry.
Endothelial exposure to low shear stress stimulated EMP release by 4-fold
as compared to physiologic shear stress conditions ; TNFα or IL1β (10nM),
also increased EMP release by 50% over static conditions. The effects of low
shear stress was decreased by 40% by ERK1/2 and JNK inhibitor (PD98059
and SP600125, 10-5M) and was only impared by 5% following exposure to
NF-κB inhibitor (PDTC, 10-5M). However, NF-κB inhibition by PDTC
decreased both actin filaments polymerization (F-actin), known to determine
EMP formation at the plasma membrane, and subsequent EMP release (40%
decrease) following endothelial stimulation with TNFα or IL1β.
Altogether, these findings indicate that multiple mechanisms can lead to
EMP release among which, NF-κB seems to play an important role by acting
on actin polymerization. The MAPK pathway seems to further participate in
vesiculation under low shear stress. Our results might help to explain the
proatherogenic effects of low shear stress patterns mediated by EMPs.
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Endothelial estrogen receptor-alpha plays a crucial role in the athero-
protective action of 17beta-estradiol in low-density lipoprotein recep-
tor-deficient mice.
Audrey Billon-Galés (1), Coralie Fontaine (1), Victorine Douin-
Echinard (1), Anne Abot (1), Laurent Delpy (2), Hortense Bergès (1), Ber-
trand Calippe (1), Henrik Laurell (1), Jean-Charles Guery (2), Pierre
Gourdy (1), Jean-François Arnal (1)
(1) I2MR, Equipe 9, U858, Toulouse, France – (2) Centre de Physiopa-
thologie de Toulouse Purpan, INSERM U563, Toulouse, France
Background: The atheroprotective properties of estrogens have been
clearly demonstrated in all animal models, and appear to be mediated through
a direct action on the arterial wall rather than through an effect on the lipopro-
tein profile. The goal of the present study was to evaluate which cellular target
is crucial in this beneficial action of estradiol (E2).
Methods and Results: We first confirmed the key role of estrogen
receptor α (ERα) in the atheroprotective effect of E2 as this action was com-
pletely abolished in mice deficient both in Low Density Lipoprotein receptor
(LDLr) and in ERα. Second, using chimeric mice ERα- deficient in the
hematopoietic lineage, we showed the persistence of the protective action of
E2, suggesting the involvement of extra-hematopoetic ERα. Third, we showed
that ERα- floxed mice (ERαflox/flox) bred with the Tie2-Cre+ mice on the
LDLr-/- background had a complete inactivation of ERα in most of hemato-
poietic and in all endothelial cells. Remarkably, in this mouse model, the E2
atheroprotection was completely abolished. Fourth, the atheroprotective effect
of E2 remained abolished in Tie2-Cre+ ERαflox/flox LDLr-/- mice trans-
planted with either Tie2-Cre+ ERαflox/flox or ERα-/- bone marrow, whereas
it was present in analogous chimeric Tie2-Cre- ERα flox/flox LDLr-/-
receivers expressing endothelial ERα.
Conclusions: We demonstrate directly and for the first time that endothe-
lial ERα represents a key target of the E2 atheroprotective effect, whereas the
hematopoietic ERα is dispensable. Selective estrogen receptor modulators
that mimic the E2 endothelial action should now be considered in atheropro-
tection. 
0126
The transactivating function 1 of estrogen receptor alpha is dispensa-
ble for the vasculoprotective actions of 17beta-estradiol.
Audrey Billon-Galés (1), Coralie Fontaine (1), Cedric Filipe (1), Victorine
Douin-Echinard (1), Anne Abot (1), Marie-José Fouque (1), Gilles Flou-
riot (2), Pierre Gourdy (1), Francoise Lenfant (1), Henrik Laurell (1),
Andrée Krust (3), Pierre Chambon (3), Jean-François Arnal (1)
(1) INSERM U858, Toulouse Cedex 4, France – (2) CNRS UMR 6026,
Équipe Récepteur des Oestrogènes et Destinée Cellulaire, Rennes Cedex,
France – (3) CNRS et INSERM, IGBMC, Illkirch Cedex, France
Full-length 66-kDa estrogen receptor alpha (ERalpha) stimulates target
gene transcription through two activation functions (AFs), AF-1 in the N-ter-
minal domain and AF-2 in the ligand binding domain. Another physiologi-
cally expressed 46-kDa ERalpha isoform lacks the N-terminal A/B domains
and is consequently devoid of AF-1. Previous studies in cultured endothelial
cells showed that the N-terminal A/B domain might not be required for
estradiol (E2)-elicited NO production. To evaluate the involvement of
ERalpha AF-1 in the vasculoprotective actions of E2, we generated a tar-
geted deletion of the ERalpha A/B domain in the mouse. In these ERal-
phaAF-1(0) mice, both basal endothelial NO production and
reendothelialization process were increased by E2 administration to a similar
extent than in control mice. Furthermore, exogenous E2 similarly decreased
fatty streak deposits at the aortic root from both ovariectomized 18-week-old
ERalphaAF-1(+/+) LDLr (-/-) (low-density lipoprotein receptor) and ERal-
phaAF-1(0) LDLr (-/-) mice fed with a hypercholesterolemic diet. In addi-
tion, quantification of lesion size on en face preparations of the aortic tree
of 8-month-old ovariectomized or intact female mice revealed that ERalpha
AF-1 is dispensable for the atheroprotective action of endogenous estrogens.
We conclude that ERalpha AF-1 is not required for three major vasculopro-
tective actions of E2, whereas it is necessary for the effects of E2 on its
reproductive targets. Thus, selective ER modulators stimulating ERalpha
with minimal activation of ERalpha AF-1 could retain beneficial vascular
actions, while minimizing the sexual effects.
0486
Impact of screening for abdominal aortic aneurysm by the cardiolo-
gist among patients with acute myocardial infarction.
Caroline Cueff De Monchy (1), Niall Keenan (1), Claire Cimadevilla (1),
Yves Castier (2), Gabriel Steg (1), Alec Vahanian (1), David Messika-Zei-
toun (1)
(1) Hôpital Bichat – Claude Bernard, cardiologie, Paris Cedex 18,
France – (2) Hôpital Bichat Claude-Bernard, Chirurgie thoracique et vas-
culaire, Paris, France
Background: Abdominal aortic aneurysms (AAA) is the 4th localisation of
atherosclerosis, occurs in 1 of 19 older men (5.5% of men over 65 years),
remains asymptomatic for many years and is the 14th cause of world death,
almost from inaugural rupture. Its prevalence in general population implies
specific target population screening. 
Material and Methods: Using small portable cardiac ultrasonography
(TTE) equipment we prospectively evaluated the prevalence of AAA (trans-
verse diameter ≥30 mm) in consecutive patients admitted for acute myocadial
infarction (AMI) in our intensive care unit. 
Results: One hundred and fifty two patients were enrolled (mean age
65±14 years old, 78% of male). Feasibility was 93% (10 patients were
anechogen) and time duration was 3±1min. Interoobserver variability between
cardiologists was good (1.7±1mm). Height patients had an AAA (5.2%). Its
prevalence increases with aging and was 8.7% among the people over 60 years
old and 10.3% among the people over 65 years old. None patient under 50
years old had AAA.
Conclusion: Small TTE is a reliable, quick and simple screening test for
AAA. Prevalence of AAA does not seem to be higher in patients with AMI
than in general population and increases with aging. Analyse of abdominal
aorta should be performed by echocardiographer during the standard echocar-
diographic exam (“one cardiovascular shot”).
0462
Impact of high fat diet on cardiovascular function and atherosclerosis
in female low density lipoprotein receptor deficient mice
Stéphanie Delemasure-Chalumeau (1), Carole Richard (2), Ségolène Gam-
bert (3), Laurence Duvillard (3), Catherine Vergely (2), Luc Rochette (1),
Patrick Dutartre (1), Jean-Louis Connat (1)
(1) COHIRO Cardiovascular Biotechnology, LPPCE, Dijon, France –
(2) LPPCE, IFR 100 Santé STIC, Dijon, France – (3) Laboratoire de Biochi-
mie Médicale, plateau technique de biologie IFR Santé STIC, Dijon, France
Hypercholesterolemia is an important risk factor involved in atheroscle-
rosis. This chronic inflammatory disease is characterized by the development
of atherosclerotic plaque in the vessel wall leading to stenosis. Genetically
modified mice lacking the Low Density Lipoprotein receptor (LDLR-/-) sub-
jected to high fat diet (HFD) are well documented in the literature as a model
of atherosclerosis. The aim of the present study was to evaluate, in these mice,
the usefulness of in vivo imaging with echocardiography for the study of car-
diac function and atherosclerotic plaque visualization.
Thirteen-week-old female C57BL/6 LDLR-/- mice were fed with either
normal chow (ND; n=3) or high fat diet (1.25% cholesterol, HFD; n=7) for
17 weeks. Transthoracic micro-echocardiography was performed using the
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VEVO 770® (Visualsonics) with a transducer frequency of 30 MHz. Left ven-
tricular (LV) function was assessed from parasternal short and long axis views.
The aortic arch was visualized in right parasternal view; the wall and plaque
thickness were measured.
After 17 weeks of diet, body weight was increased in HFD compared to
ND mice (+9.64%, p=0.019). LV function can be equally measured in the
short and long axis views. No difference among groups was measured for
LV diastolic and systolic diameters, fractional shortening and ejection frac-
tion. Thickening of LV anterior wall (p<0.05), intra-ventricular septum
(p<0.05) and dilatation of LV outflow tract (p=0.030) were significantly
observed in HFD mice. In brachiocephalic arteria, atherosclerotic plaques
were found in 6 out of 7 HFD mice. The upper wall thickness was 1.8 fold
more important in HFD than in ND mice (0.29 ± 0.03 mm vs. 0.16 ± 0.00
mm, p=0.012). 
Our result showed that LV function was modestly altered in LDLR-/- mice
after 17 weeks of HFD. We demonstrated that atherosclerotic plaques can be
detected and measured in LDLR-/- HFD mice by a noninvasive imaging tech-
nique of
0173
Atherosclerotic lesion-derived lipids initiate plaque angiogenesis by
triggering a pro-angiogenic phenotype in human vascular smooth
muscle cells
Julien Le Dall, Delphine Gomez, Olivier Meilhac, Liliane Louedec, Jean-
Baptiste Michel, Benoît Ho-Tin-Noé
INSERM, U698, Paris, France
Rationale: Neovascularization is a prominent feature of atherosclerotic
lesions that contribute to their progression and complications by promoting
intraplaque hemorrhage and leukocyte infiltration. The initiating factors and
mechanisms of plaque angiogenesis remain unclear. 
Objective: We aimed to identify the mediators of angiogenesis at early
stages of human aortic atherosclerosis. 
Methods and results: Human aortic segments were classified as normal
aorta or as aorta bearing early atherosclerotic lesions including intimal thick-
ening, fatty streak and fibrolipid preatheroma, according to their histological
features. The distribution, amount and mural cell coverage of vessels in these
samples were studied by immunostaining for endothelial cells and alpha-
smooth muscle actin. Even when lesions were devoid of vessels, the density
of vessels was increased in the media of aortic segments bearing atheroscle-
rotic lesions, indicating that atherosclerosis-associated angiogenesis is an
early event that first occurs in the tunica media. The pericyte coverage index
of neovessels was low, suggesting an inherent fragility of these vessels.
Immunostaining and ELISA analysis of expression of angiogenic factors
revealed that vascular endothelial growth factor (VEGF) mostly originated
from vascular smooth muscle cells (VSMC) of the tunica media subjacent to
atherosclerotic lesions. VEGF levels were indeed significantly higher in
media of aortas with early atherosclerotic lesions than in lesions and media
of normal aortas. Furthermore, we show that lesion-derived lipids but not pro-
teins, dramatically increased the production of VEGF by VSMC in culture
and their ability to promote angiogenesis when incorporated in Matrigel
implants in mice. 
Conclusion: Our results show that plaque-derived lipids trigger a pro-
angiogenic switch in the phenotype of human VSMC that may contribute to
the initiation of intraplaque angiogenesis. 
0501
Pre-hospital mortality from coronary heart disease in adults from 35
to 74 years in the Bas-Rhin County during year 2006
Alexandre Buscal, Patrick Ohlmann, Bogdan Radulescu, Olivier Morel,
Dominique Arveiler, Pierre Bareiss
Hôpitaux Universitaires de Strasbourg, Pôle cardiovasculaire, Stras-
bourg, France
Background: pre-hospital mortality accounts for more than half of death
in coronary heart disease (CHD). Few is known about the clinical charac-
teristics and circumstances of death in patient dead in a pre-hospital set-
ting. 
Aim: to describe the clinical circumstances of pre-hospital death at the
level of a whole French county (Bas-Rhin) that occurred during the year 2006.
Methods: among 1537 registered CHD events during 2006, we focused on
patients with definite coronary death, probable coronary death and possible
coronary death.
Results: in this registry, 343 among 487 (70%) death occurred pre-hos-
pital. Mean age was 61,3 ± 10 years old. 35% of the patients had an his-
tory of hypertension, 21% were diabetics, 18% had dyslipidemia, 28%
were smokers, 16% had an history of CHD. 18% of the patients presented
chest pain, 16% a dyspnoea. Symptoms lasted less than one hour in 43%
of the cases. 14% of the patients had symptoms less than 5 minutes before
death. Among the patients who receive cardio-pulmonary resuscitation
(CPR) median duration of the symptom was less than 60 minutes. Death
occurred in a private place in 88% and in a public place in only 10%. CPR
was more commonly performed in a public (67%) than in a private (39%)
place. In the presence of a witness CPR was achieved in 74% vs 15% in
the absence.
Conclusion: a great proportion of death from CHD occurs pre-hospital.
Risk factors and symptoms are a frequent in those patients. The observation
that death occurs in a private place in the absence of a witness reinforces the
paramount importance of population information campaigns to sensitise on
primary prevention measures and emergency call in case of symptoms onset in
patients with risk factors.
0109
Visceral white adipose tissue is involved in the dyslipidemia and athe-
rogenesis induced by intermittent hypoxia.
Laureline Poulain (1), Patrick Lévy (2), Maurice Dematteis (1), Claire
Arnaud (1)
(1) INSERM, Laboratoire HP2, La Tronche, France – (2) CHU, Labora-
toire EFCR, Grenoble, France
Obstructive sleep apnea (OSA) syndrome is a highly prevalent disease,
affecting 5 to 20% of middle aged men. OSA is characterized by repetitive
upper airway collapses during sleep resulting in intermittent hypoxia (IH).
IH induces numerous consequences including cardiovascular and metabolic
complications such as atherosclerosis and dyslipidemia, respectively. How-
ever, the pathophysiological link is unclear. Since abdominal fat is recog-
nized as an endocrine and paracrine organ with an important role in
inflammation and atherogenesis, we postulate that the inflammatory and
atherogenic role of IH could be mediated at least in part through the IH
effects on visceral adipose tissue. Twenty weeks old male dyslipidemic and
atherosclerosis-prone apolipoprotein E-deficient mice were exposed to
either IH (1 min cycle, FiO2 21-5%, 8 h/day) or air (normoxic mice, N)
during 6 weeks. Three days before exposure, IH and N mice were lipecto-
mized or sham operated. After exposure, mice were sacrificed and analyzed
for atherosclerosis development and AT alterations. IH increased the dys-
lipidemia (triglycerides and LDL-cholesterol) and the development of ath-
erosclerotic plaques in thoraco-abdominal aorta and aortic roots. IH also
induced structural and functional remodeling of visceral white fat (epid-
idymal fat pads) characterized by macrophage infiltration, and decreased
size of adipocytes with overexpression of the uncoupling protein-1. The
epididymal lipectomy reduced the IH-induced dyslipidemia and atherogen-
esis. Our results confirm the dyslipidemic and pro-atherogenic role of IH
that involves morphological and inflammatory alterations of visceral adi-
pose tissue. The functional meaning of this adipose tissue plasticity needs
to be determined, as well as the involvement of the other adipose compart-
ments. Our preliminary results bring new insight into the pathophysiology
of OSA-related atherosclerosis, opening novel treatment strategies of OSA-
associated complications.
© Elsevier Masson SAS. All rights reserved.
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Impact of ozone air pollution on ischemic cerebral and cardiac events
in Dijon, France
Yannick Bejot (1), Jean -Bernard Henrotin (1), Guy-Victor Osseby (1),
Luc Lorgis (2), Carole Richard (2), Marianne Zeller (2), Yves Cottin (2),
Maurice Giroud (1), Aurélie Gudjoncik (2)
(1) Hôpital Général, neurologie, Dijon, France – (2) Hôpital du Bocage,
cardiologie, Dijon, France
Background: There is strong evidence that short-term exposure to ozone
(O3) is associated with respiratory disease and death, but the effects of short-
term exposure to ozone on ischemic heart and cerebrovascular disease have
not been clearly established.
Methods: Daily levels of urban O3 pollution, the incidence of first-ever,
recurrent, fatal and non-fatal ischemic cerebro-vascular events (ICVE) and
myocardial infarction (MI) were correlated using a bi-directional case-cross-
over design analysis. We analysed 1 574 ICVE and 913 MI that occurred in
Dijon, France from 2001 to 2007. Sulphur dioxide (SO2), nitrogen dioxide
(NO2), carbon monoxide (CO), particulate matter with an aerodiameter of
≤ 10µg/m3 (PM10) were used to create bi-pollutant models. Using the
adjusted Odd Ratios (OR), the effects of O3 exposure were calculated for
every 10 µg/m3 increase in pollutants in multivariate logistic models adjusted
for all possible confounders. 
Results: We found a statistically significant association between low-level
of O3 and recurrent ICVE with a 3-day lag (OR=1.115; 95%CI: 1.027-1.209).
The association was marginally significant for recurrent MI with 1–day lag
(OR=1.147; 95% CI: 0.999-1.318). For incident events, we detected no sig-
nificant association. In stratified analysis by vascular risk factors, we
observed for ICVE an association with each vascular risk factor (OR=1.523;
95% CI: 1.149-2.018) while for MI, an association with O3 was found when
hypercholesterolemia was present (OR=1.111; 95%: 1.020-1.211). Moreover,
we noted an increase of the strength of association with the number of com-
bined factors.
Conclusion: From this population-based study, recurrent ICVE and MI
could be triggered by short-term exposure to low levels of O3, especially
among subjects with severe vascular risk factors. As a result, preventive strat-
egies could be designed for such subjects.
0394
In the acute phase of myocardial infarction, the length of leukocyte
telomeres depends on the patient’s cardiological history and determi-
nes their future
Sébastien Saliques (1), Julie Lorin (1), Pierre Sicard (1), Anne Donzel-
Javouhey (2), Catherine Vergely (1), Marianne Zeller (1), Jean-Raymond
Teyssier (2), Yves Cottin (3), Luc Rochette (1)
(1) LPPCE, Dijon, France – (2) CHU de Dijon, Laboratoire de génétique
moléculaire, Dijon, France – (3) CHU de Dijon, Cardiologie, Dijon,
France
Objectives: The study of leukocyte telomere length (LTL) in a context of
cardiovascular disease is generating more and more interest. However, even
though certain studies have shown an association between LTL and heart
failure or atherosclerosis, none has yet shown how this parameter evolves
during acute myocardial infarction (MI) in men. The aim of our study was
therefore to shed light on the relationship between LTL and other factors in
heart disease.
Methods: The biological and clinical (left ventricular ejection fraction
(LVEF), KILLIP class on admission, cardiovascular history) characteristics of
a cohort of 174 patients recorded in the RICO database (obseRvatoire des Inf-
arctus de Côte-d’Or) were collected. The LTL was evaluated by qPCR from
leukocyte DNA from venous blood samples max 48h after symptom onset.
Results: Our results show a strong correlation between LTL and age
(r=0.222, p=0.003). Age adjusted-LTL is positively associated with LVEF (r=
+0.248, p=0.001). Moreover, negative associations were found between LTL
and plasma levels of C-reactive protein (r=-0.312, p<0.001) and homocysteine
(r=-0.178, p=0.034), arterial hypertension (1.271 vs. 1.289 T/S-1 ratio,
p<0.001), a family history of cardiovascular disease (1.275 vs. 1.287 T/S-1
ratio, p=0 .050), KILLIP class on admission (1.267 vs. 1.282 T/S-1 ratio,
p=0.002), anterior location of the MI (1.272 vs. 1.281 T/S-1 ratio, p=0.017)
and smoking (1.270 vs. 1.295 T/S-1 ratio, p<0.001).
Conclusion: These results suggest that LTL is closely associated with the
patient’s cardiovascular history and genetic profile. Functional manifestations
of the heart disease such as reduced LVEF, or even the location of the MI
could be influenced by LTL. Investigations that explore the mechanisms
involved, namely the impact of the level of oxidative stress on LTL in such
patients, are now under way. These must be continued in order to identify new
markers that may help to orient the management of these high risk patients.
© Elsevier Masson SAS. All rights reserved.
 
Archives of Cardiovascular Diseases Supplements (2010) 2, 1-90 7
TOPIC 03 – Atherosclerosis, hemostasis,
inflammation, AGE – C
0411
Still a place for DES for PCI of short coronary lesions (≤18 mm) in
large vessels (≥3.0 mm) in patients with Diabetes Mellitus?
Olivier Barthelemy (1), G. Helft (1), Anne Bellemain-Appaix (1),
J. Silvain (1), F. Beygui (1), R. Choussat (1), E. Berman (1), Jean Philippe
Collet (2), G. Montalescot (1), Jean Philippe Metzger (3), Claude Le Feu-
vre (3)
(1) CHU Pitié Salpêtrière, Département de Cardiologie Médicale, Paris
Cedex 13, France – (2) CHU Pitié-Salpétrière, Etablissement Français du
Sang, Paris, France – (3) CHU Pitié-Salpêtrière, Département de cardio-
logie, Paris, France
Aim: Compare the effectiveness and safety of drug-eluting stent (DES) vs
bare metal stent (BMS) in diabetic patients treated by percutaneous coronary
intervention (PCI) for short lesions in large vessels (stent diameter ≥ 3.0 mm
AND stent length ≤ 18 mm). 
Methods: Consecutive patients treated with at least one large (≥ 3.0 mm)
and short (≤ 18 mm) stent were included over one year. Clinical and angio-
graphic data were prospectively entered into the « Middle-Care » database and
outcomes obtained at one year. We compare the occurrence of 1) cardiovas-
cular (CV) death, 2) MACCE (CV death, Myocardial Infarction (MI) and
stroke), 3) TVF (CV death, Target vessel MI, Target Vessel Revascularization
(TVR)), 4) TVR and 5) Target Lesion Revascularization (TLR) as 6) Stent
Thrombosis (ST) in the diabetic population according to the type of stent used
(DES vs BMS). 
Results: Three hundred ninety nine patients fulfilled inclusion criteria.
Among the 108 (27%) diabetic patients, 58% (n=63) underwent PCI with
BMS and 42% (n=45) with DES. Mean age was 65 ± 11 years, 82% (n=89)
were male, 32% (n=35) had acute coronary syndrome, 16% acute MI. Clinical
characteristics were well matched between the two groups, except for prior
PCI, acute MI and multivessel disease (19% vs 49%, 24% vs 4% and 49% vs
73%, for BMS vs DES respectively, p<0.05 for all). One year follow-up was
completed for 100% of the patients. Four (3.7%) patients died from CV cause,
8 (7.4%) had MACCE, 14 (13.0%) had TVF. Event rates in diabetics were
similar whatever the stent used (Figure). TVF rates were similar in diabetic
and non diabetic patients.
Conclusions: Diabetes does not increase the risk of TVF after PCI with
short stents in large vessels. At one year, no additional benefit was found with
the use of DES among diabetic patients in this setting. 
0264
Effect of red wine polyphenols on calcium and NO production in
T lymphocytes
Matthieu Chalopin, Ramaroson Andriantsitohaina
UMR INSERM 771 CNRS 6214, Faculté de Médecine, Angers, France
Red wine polyphenols (RWP) have been reported to possess beneficial
effects against processes leading to atherosclerosis, pathology with a strong
inflammatory component. Both RWP and the peroxysome proliferator-acti-
vated receptor alpha (PPARα) agonist, fenofibrate, improve endothelial NO
vasodilatation. This study was designed to investigate capacity of RWP to acti-
vate T lymphocytes and the role of PPARα in these effects. A T cell lineage
(CEM) was stimulated, either by ProvinolsTM (10-2g/L), the total extract of
RWP, or delphinidin (10-3g/L), an anthocyanin supporting similar pharmaco-
logical properties of RWP, in presence or not of MK886 (20µM), a PPARα
antagonist. Changes in cytosolic calcium level ([Ca2+]i) either by intracellular
stores release or by Ca2+ entry through the capacitative pathway, were assessed
using the calcium probe, fluo-3 (3µM). Then, NO production induced by RWP
was evaluated by electron paramagnetic resonance technique. In Ca2+ free
medium, both ProvinolsTM and delphinidin, elicited a transient increase in
[Ca2+]i. Addition of exogenous CaCl2 (2.5mM) produced large and sustained
increase of the calcium signal. Blocking of PPARα only increased Ca2+ entry
induced by delphinidin. Besides, both ProvinolsTM and delphinidin were able
to stimulate a transient NO production in T lymphocytes; the maximal effects
achieved within 20 and 10 min respectively. These data provide evidence that
RWP are able to release Ca2+ from intracellular stores and to induce Ca2+ entry
through the capacitative pathway in T lymphocytes, PPARα exerting a nega-
tive feedback on the later. These effects were associated to NO production.
These data underscore the ability of RWP to modulate immuno-inflammatory
cells, T lymphocytes, in releasing NO, which may participate in its anti-
inflammatory and anti-atherosclerotic properties.
0221
CD31 driven expansion of regulatory T cells prevents angiotensin II-
induced inflammation and atherosclerotic complications
Giulia Fornasa, Marc Clement, Emilie Groyer, Anh-Thu Gaston, Aditi
Varthaman, Jamila Khallou-Laschet, Stephanie Graff-Dubois, Antonino
Nicoletti, Giuseppina Caligiuri
INSERM U698, Paris, France
Angiotensin II is a strong pro-inflammatory mediator in vitro and in vivo.
Chronic perfusion with angiotensin II in apolipoproteinE knock out (ApoE°) mice
results in acceleration of atherosclerotic plaque growth and formation of abdom-
inal aortic aneurysm. Disease aggravation occurs in association with an increase
of IL-6 plasma levels and with activation of downstream STAT3 signaling. 
Since IL-6/STAT3 signaling drives the differentiation of pro-inflammatory
T IL-17A producing cells at the expenses of regulatory T-cells (Tregs), we
reasoned that interventional tool able to uncouple IL-6/STAT3 signaling could
restore the Treg compartment and protect from the pro-inflammatory/athero-
sclerotic effect of Angiotensin II. SHP2 is known to block the IL-6/STAT3
pathway and is typically induced by the CD31-ITIM signaling.
We therefore wanted to evaluate whether a peptide, able to trigger the CD31/
ITIM/SHP2 cascade, can redirect T-cell differentiation towards the regulatory
phenotype at the expense of the Angiotensin II-induced IL-6/STAT3 pathway.
Daily peptide (50 µg, sc) treatment reduced atherosclerotic lesions size and
aneurysm formation (80% less than controls, p<0.001) in ApoE° mice sub-
jected to the Angiotensin II model.
Protection was associated with an increased proportion of circulating Tregs
and with a decreased IL-17A intracellular content in Th17 cells. We also found
that, in vitro, the peptide induces phosphoSHP2 and decreases phosphoSTAT3
upon angiotensin II stimulation. Our data suggest that CD31 signaling redirect
T-cell differentiation towards the regulatory phenotype and prevents angio-
tensin II-induced inflammation and atherosclerotic complications.
0290
Relationship between demographic, elevated HDL-Cholesterol,
inflammation and metabolic syndrome in Brazzaville Banks
Thierry Gombet (1), Bertrand Ellenga-Mbola (1), Stephane Meo
Ikama (1), Gisèle Kimbally-Kaky (1), Jean-Louis Nkoua (1), Benjamin
Longo-Mbenza (2)
(1) CHU de Brazzaville, Brazzaville, Congo – (2) Walter Sisulu Univer-
sity, Mthatha, Afrique du Sud
Objective: The main objective of this study was to compare the IDF for
Europe, IDF for Central Africa, the WHO and the NCEP-ATPIII criteria to
diagnose metabolic syndrome (MS) among urbanised Bank employees. It also
determined the correlates of MS and effective cut-off values of these compo-
nents to detect employees at higher cardiovascular disease risk.
Methods: This cross-sectional included a simple random of 126 bank
employees from Brazzaville (70 men and 56 women). The effective values of
components were tested by ROC curves and agreement between definitions
was defined by Kappa statistic. The prevalence of MS was found to be 4.8%
(WHO criteria), 8.7% (NECP-ATPIII), 14.3% (IDF Europe criteria),15.9%
(IDF criteria modified for Central Africa). 
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Results: The prevalence of MS varied from 4.8% (n=6) using WHO cri-
teria to 15.9% (n=20) when IDF for Central Africa (waist≥94cm for both men
and women) definition was used. There was a significant U-shaped relation-
ship between MS and HDL-C. Erythrocyte sedimentation rate at 1st hour
≥13mm and ≥30mm at 2nd hour were the optimal and effective cut-off points
to diagnose MS (sensitive=91%), whereas no effective cut-points for HDL-C,
triglycerides, total cholesterol and LDL-C were obtained. Age≥45 years was
the only significant and independent determinant of MS defined by IDF defi-
nitions (OR=45 95%CI 1.5-14; P=0.009) using IDF for defined by IDF for
Central Africa (OR=4.5 95%CI 1.4-11; P<0.0001). The risk of sub-clinical
atherosclerosis conferred by MS higher than that conferred by MS/IDF for
Central Africa (OR=3.8 95%CI 1.6-42.7; P=0.004). However, the risk of
T2DM conferred by MS/IDF for Central Africa (OR=85.1 95%CI 9.9-174.2;
P<0.0001), MS/NCEP-ATPIII (OR=18.3 95%CI 4.1-81; P<0.0001) and MS/
WHO OR=0.9 95%CI 0.7-1.3; P=0.841). The best agreement to classify MS
was obtained between MS/IDF for Central Africa and MS/IDF for Europe
(Kappa=0.938; P<0.0001) in comparison with the good agreement between
MS/IDF and MS/NCEP-ATPIII (Kappa=0.729; P<0.0001 for IDF Europe and
Kappa = 0.673; P<0.0001 for IDF/Central Africa). The worst agreement was
between MS/WHO and MS/IDF (Kappa=0.419; P<0.0001 for IDF/Central
Africa and Kappa=0.462; P<0.0001 for IDF/Europe).
0263
Low molecular weight fucoidan prevents intimal hyperplasia in rat
injured thoracic aorta through the modulation of matrix metallopro-
teinase-2 expression
Hanna Hlawaty, Nadine Suffee, Angela Sutton, Olivier Oudar, Oualid Had-
dad, Christelle Laguiller-Morizot, Didier Letourneur, Nathalie Charnaux
INSERM U698, Bobigny, France
Objective: The intimal hyperplasia is a principal mechanism of re-stenosis
after balloon injury with intimal damage and media overstretch, leading to
increased matrix metalloproteinase (MMP) expression and vascular smooth
muscle cell (VSMC) migration. The aim of this work was to evaluate the
ability of low molecular weight fucoidan (LMWF), a sulfated polysaccharide
extracted from brown seaweed, to inhibit VSMC- and stimulate HUV-EC-C
migration in vitro and in vivo to decrease intimal hyperplasia in rat aorta after
balloon injury. 
Results: Sprague-Dawley rats were subjected to balloon injury in thoracic
aorta followed by intramuscular injection of either LMWF (5 mg/kg/day) or
vehicle. Morphological analysis at day 14 indicated that LMWF prevented
intimal hyperplasia in rat thoracic aorta by 40.0±5.0% (P<0.01 vs. vehicle). In
addition, in situ zymography showed that LMWF significantly decreased
MMP activities in the neo-intimal layer (Figure 1). Our in vitro study revealed
that, in the scrape wound assay, LMWF at 10 µg/mL increased by 45.0±5.0%
HUV-EC-C migration (P<0.01), but reduced by 40.0±3.0% VSMC migration
(P<0.01). Total MMP-2 level was 5.4-fold higher in HUV-EC-C- but 6-fold
lower in VSMC conditioned media upon LMWF treatment. Moreover, LMWF
increased pro-MMP-2 expression by 20.0±3.0% in HUV-EC-C, but decreased
it by 30.0±4.0% in VSMC (P<0.05). 
Conclusions: Our results show that LMWF not only increased HUV-EC-C
migration and proliferation, but also decreased VSMC migration in vitro, as
well as reduced the intimal hyperplasia in rat injured aorta in vivo, suggesting
that LMWF is a promising approach for the treatment of intimal hyperplasia. 
0024
Cathepsins: link between periodontal diseases and atherosclerosis 
Olivier Huck (1), René Elkaïm (2), Henri Tenenbaum (1)
(1) Faculté chirurgie dentaire strasbourg, parodontologie, Strasbourg,
France – (2) Parogène, Strasbourg, France
Numerous studies consider periodontal diseases, which are inflammatory
diseases initiated by anaerobic bacteria such as Porphyromonas gingivalis
(P.g.), as a potential risk factor for systemic diseases such as diabetes or ath-
erosclerosis, through dissemination of these periopathogenic bacteria in the
blood flow. Therefore, considering a link between periodontal diseases and
atherosclerosis, the aim of the present study was to test if P.g. can stimulate in
human endothelial cells (HUVEC) the expression of cathepsins B, S and L,
enzymes involved in the destruction of gingival tissues but also having a major
role in the atheromatous plaque formation where they are over-expressed.
Cells were stimulated by the purified lipopolysaccharide (LPS) of P.g. during
24h, 48h and 72h. The effect of the stimulation on the production of cathepsins
B, S and L was analyzed by reverse transcription- quantitative PCR (RT-
qPCR) and enzymatic assays. Similarly, cells were also infected by whole bac-
teria and the same assays were performed. Our results showed that LPS
induced an increase of the enzymatic activity of cathepsin B, without modifi-
cation of the level of mRNA encoding for this enzyme. No effect was
observed on the expression of mRNAs or the enzymatic activity of cathepsins
S and L. Using the whole bacteria, we observed an increase of the enzymatic
activity of cathepsins B, S and L, without any modification of the levels of
mRNAs encoding for cathepsins B and L. However, a significant increase of
the mRNA encoding for cathepsin S was measured, although observed at the
end of the time-course infection. These results may contribute to propose a
possible model explaining the link between periodontal diseases and athero-
sclerosis.
0112
Telomere length in tissues from patients with atherosclerotic disease
Rosine Nzietchueng (1), Mazen El Farra (2), Joseph Nloga (2), Carlos
Labat (1), Jean-Pierre Carteaux (2), Pablo Maureira (2), Patrick
Lacolley (1), Jean-Pierre Villemot (2), Athanase Benetos (3)
(1) INSERM U961, Faculté de Médecine, Vandoeuvre Les Nancy,
France – (2) CHU de Nancy, Service de Chirurgie cardiovasculaire, Van-
doeuvre Les Nancy, France – (3) CHU de Nancy, Service de Gériatrie,
Vandoeuvre Les Nancy, France
Objectives: The present study was aimed at evaluating telomere length in
blood and in different vascular tissues with or without atheroma, in 3 groups
of subjects: a group of atherosclerotic subjects who underwent surgery (Ath-
erosclerosis-Surgery), a second group of subjects with asymptomatic athero-
sclerotic carotid plaques but who did not undergo cardiovascular surgery
(Atherosclerosis-No surgery), and a third group of subjects without atheroscle-
rotic disease (Controls). The main objective was to determine if there is in
vivo regulation of telomere length in situ by atherosclerotic lesions.
Research design and methods: A total of 84 subjects (mean age 69±8
years) were studied. Blood and arterial tissue telomere lengths were deter-
mined by Southern blotting. Personal medical history (diabetes, hypertension,
cardiovascular disease, dyslipidemia), family medical history, drug intake, and
lifestyle were evaluated in the entire population through the use of a question-
naire.
Results and Conclusion: Arterial segments which did not develop athero-
sclerosis such as the saphenous vein and internal mammary artery, had longer
telomere length than aortic segments. On the other hand, telomere length was
shorter in aortic tissues which presented atherosclerotic lesions compared to
corresponding tissues without atherosclerotic lesions. There was a negative
correlation between pulse pressure and telomere length only in atherosclerotic
tissues. In conclusion, the present data suggest an in situ regulation of
telomere length in different arterial tissues with or without atheroma. These
results also suggest tissue regulation of telomere size by local factors likely
related to oxidative stress responses.MMPs expression in the neo-intima layer
© Elsevier Masson SAS. All rights reserved.
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Percutaneous coronary interventions for unprotected left main coro-
nary artery bifurcation lesions: characteristics and long term outco-
mes
Sofiene Rekik , Jerome Brunet, Francois Xavier Hager, Gilles Bayet, Lau-
rent Meille, Jean Michel Quatre, Joel Sainsous
Clinique Rhône Durance, cardiologie, Avignon, France
Aims: we sought to evaluate the clinical characteristics and long term out-
comes after Percutaneous coronary intervention (PCI) in patients with unpro-
tected left main coronary artery (ULMCA) bifurcation lesions.
Methods: 136 consecutive patients who underwent PCI for distal bifur-
cated lesions of ULMCA between January 2004 and December 2008 were
included. The Cox proportional hazards regression model was used to analyse
long term predictors of Major adverse cardiac events (MACE). P values <0.05
were considered significant.
Results: Mean age was 73.26±10.9 years. 91 patients (75.5%) were males;
33 (24.3%) had diabetes mellitus, 94 (69%) had hypertension and 35 (25.7%)
had peripheral artery disease. 24 (17.6%) patients presented with STEMI, 54
(40%) with NSTEMI/UA, 38 (28%) with stable angina, 26 (19%) with silent
ischemia and 5 (3.7%) with syncope. Mean additive EuroSCORE value was
7.29±4.8 and mean predicted surgical mortality by logistic EuroSCORE was
14%. Associated 2 or 3 vessel-diseases were noted in 115 (84.7%) patients.
The provisional side-branch T-stenting approach was used in 92.3% of cases
and final kissing balloon inflation in 92.3%. GpIIbIIIa inhibitors were used in
22 (16%) cases and rotationnal atherectomy in 17 cases (12.5%) Angiographic
success was achieved in 99.3%. Drug eluting stents (Paclitaxel elution in all
cases) were implanted 62 (45%) patients.
After a mean follow up of 30.8 months, 14 (10.3%) cardiac deaths were
recorded, 23 (17%) patients had target lesion revascularisation. Combined
major cardiac events (cardiac death, non fatal Q wave MI, or TLR) occurred
in 37 patients (27.2%).
By multivariate analysis, EuroSCORE risk assessment system was the only
independent predictor of long term MACE (p=0.029; HR=1.14, 95% CI [1.04-
1.22])
Conclusion: In an unselected population of patients with ULMCA distal
lesions, PCI proved to be a feasible and safe procedure associated with accept-
able short and long term outcomes. EuroSCORE was the only predictor of
major cardiac events.
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Trimetazidine in the treatment of stable angina pectoris: a meta-ana-
lysis of randomized, controlled clinical trials
Nicolas Danchin (1), M. Marzilli (2), A. Parkhomenko (3), Nadia
Aissaoui (1), J. Ribeiro (4)
(1) HEGP, cardiologie, Paris, France – (2) département cardiothoracique
et vasculaire, Pisa, Italie – (3) Institut Ukrainien de cardiologie, Kiev,
Ukraine – (4) Hospital de Clinicas de Porto Alegre, Porto Alegre, Brésil
Introduction: Stable angina pectoris (SAP) is the clinical correlate of
myocardial ischemia, being the most frequent clinical presentation of chronic
ischaemic heart disease. 
Trimetazidine (TMZ) is a metabolic anti-anginal agent which provides a
significant anti-ischemic efficacy when used as monotherapyand totally addi-
tional benefits when used in combination with other agents.
Objective: To assess the treatment effect of TMZ on symptoms and exer-
cice response in patients with SAP. 
All relevant clinical trials conducted with TMZ vs placebo in the treatment of
angina pectoris from 1967 up to 2008 have systematically been reviewed and
critically assessed. The objective of the present review was to compile and
analyse the full data with the Cochrane methodology.
Data from randomized, placebo controlled, parallel-group (n=18) or cross-over
studies (n=4) on SAP were complied for efficacy (N=2786).
Safety data from 24 studies vs placebo were available and compiled to assess
the number of adverse event (AE) or the number of patients withdrawn for AE
(N=2961). 
Exercise test end-points analysed were: total exercice duration (TED) and time
to 1-mm ST segment depression (T1). The clinical evaluation was based on
the: weekly mean number of anginal attacks (AA), short-acting nitrates con-
sumption (SAN).
Results: Treatment with TMZ showed a significant benefit of both exercise
test and clinical end-points increasing TED by 23.3s (95% CI [2.7; 44.0]), T1
by 34.0s (95% CI [15.9; 51.8]) and decreasing the clinical symptoms by 1.4
for AA (95% CI [-2.1; -0.8]) and 1.3 for SAN(95% CI [-1.9; -0.7]). When
cross-over studies were added, the significant benefit is confirmed.
153 AE were reported in both the TMZ (N=1484) and the placebo (N=1477)
groups, 0R=0.97, 95%CI [0.76; 1.24].
Conclusion: The overall treatment effect of TMZ estimated by the meta-
analysis of efficacy data in the 18 parallel-group studies vs placebo was in
favour of TMZ treatment and clinically relevant for the 4 assessed criteria.
0480
Periodontal diseases and cardiovascular diseases: a meta analysis 
Thomas Dufour, Sylvie Jeanne
Faculté d’odontologie de Rennes, service de Parodontologie, Rennes,
France
Introduction: Periodontitis is an infectious disease occuring in mouth and
leading to tooth loss. It is characterized by an inflammatory syndrom and a
burden of inflammatory molecules in systemic circulation. Numerous studies
showed a link between periodontal diseases and cardio-vascular diseases. The
aim of this study was to assess the relationship between this two pathologies
with a meta-analysis.
Method: Multiple database search was done (Pubmed database and
Cochrane library database). Cardiovascular case definition was: acute myocar-
dial infarction fatal or not, coronary artery diseases and stroke. Severe peri-
odontitis was the periodontal case definition. Selected articles were included
in a meta-analysis.
Results: 273 articles were identified, 73 abstracts were readed and 49 arti-
cles were included in 3 meta analysis wether they were cohort, case/control
or transversal studies. RR associated with cohort studies was 1,259 [1,565-
2,043], RR associated with transversal studies was 1,126 [1,041-1,527], OR
associated with case control studies was 1,78 [1,490-1,951].
Conclusion: Linking this results to the last periodontal health survey in
France, about 14000 death could be due to the excess of cardio-vascular risk
in relation with periodontal diseases. It seems necessary to build periodontal
prevention action in order to reduce cardiovascular surmortality due to peri-
odontal diseases.
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Inflammation, coronary heart disease, metabolic syndrome and phy-
sical inactivity among bank employees of Brazzaville
Thierry Gombet (1), Benjamin Longo-Mbenza (2), Bertrand Ellenga-
Mbola (1), Gisèle Kimbally-Kaky (1), Stephane Meo Ikama (1), Jean-
Louis Nkoua (1)
(1) CHU de Brazzaville, Brazzaville, Congo – (2) Walter Sisulu Univer-
sity, Mthatha, Afrique du Sud
Background: In this paper, we determine the cardiometabolic causes and
consequences of elevated erythrocyte sedimentation rate (ESR) among healthy
bank employees from Brazzaville, Central-Africa. We also aimed at deter-
mining the optimal cut-points for ESR associated with higher cardiometabolic
risk using ROC analysis.
Methods: This cross-sectional survey used data from participants exam-
ined from 1 to 30 December, 2008. A simple random of 126 bank employees,
42±9 years old, completed an interviewer administered questionnaire and had
anthropometric, QTc, cardiac index and blood pressure measurements per-
formed by trained nurses using standardized procedures. Fasting glucose,
lipids, ESR and creatinin were measured using a venous blood sample. Cardi-
ometabolic risk was defined by obesity, physical inactivity, low energy expen-
diture, long QTc, dyslipidaemia, hypertension, metabolic syndrome, type2
diabetes, coronary heart disease(CHD) and decline of estimated glomerular fil-
tration rate(EGFR).
Results: The population was defined by epidemic rates of physical inactivity,
hypertension, obesity, excessive alcohol intake and CHD. This higher cardiomet-
abolic risk and the ESR values were more frequent in females than males. There
was a significant (P<0.05) association between age (r=0.292), QTc (r=0.245),
BMI (r=0.263), waist (r=0.520), body fat mas s (r=0.534), systolic blood pressure
(r=0.244), diastolic blood pressure (r=0.279), total cholesterol (r=0.318), LDL-
cholesterol (r=0.281), eGFR (r=-0.311), and ESR at second hour. Abdominal fat
distribution, reduced energy expenditure, decline in body total water, total obe-
sity, hypertension, type 2 diabetes, metabolic syndrome and CHD were signifi-
cantly associated with elevated ESR, respectively. ESR≥13mm at 1sthour and
ESR≥30mm at second hour were identified as significant and optimal cut-points
to detect hypertension, type2 diabetes and metabolic syndrome.
Conclusions: Aging, female sex, physical inactivity, low energy expendi-
ture, reduced body total water and obesities are considered as the causes of
elevated ESR. Dyslipidaemia, hypertension, type 2 diabetes, renal function
decline and coronary heart disease are associated to elevated ESR. 
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Implication of Adenylyl Cyclase 8 in pathological smooth muscle cell
migration occurring in rat and human vascular remodelling
Marie Gueguen (1), Larissa Lipskaia (2), Zela Keuylian (1), Anne-Marie
Lompré (3), Jean-Baptiste Michel (4), Olivier Meilhac (5), Isabelle Limon (1)
(1) University of Pierre and Marie Curie, batiment A 5ème étage, Paris,
France – (2) Mount Sinai School of Medicine, New York City, Etats-Unis –
(3) Pierre et Marie Curie University, INSERM UMR 956, Paris, France –
(4) Paris 7 Denis Diderot University, Bichat-Claude Bernard Hospital,
INSERM U698, Paris, France – (5) Paris 7 Denis Diderot University
Bichat-Claude Bernard Hospital, Paris, France
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Recently, we discovered on primary cell cultures that Adenylyl Cyclase
type 8 (AC8) was involved in rat vascular smooth muscle cell (VSMC) tran-
sition toward an inflammatory phenotype. The present paper further demon-
strates in human vessels displaying early or advanced atherosclerotic lesions
that i) only intimal VSMCs strongly express AC8, ii) very few AC8 positive
VSMCs were detected in the medial layer either in atherosclerotic or healthy
arteries. Furthermore, over-expressing AC8 in primary rat VSMC cultures
triggered the re-colonization of a wounded zone and similar results were
obtained in presence of mitomycin, a potent inhibitor of proliferation. This
phenomenon was prevented by silencing AC8. Indeed, in IL-1β-treated cells
AC8 silencing halted migration and decreased the matrix-metalloproteinases
2/9 secretion, known to be involved in VSMC migration. In vivo, we show i)
a pronounced up-regulation of AC8 expression in highly migrating VSMC of
the rat injured carotid artery , ii) an undetectable AC8 labelling in re-endot-
helized vessels where neo-intimal thickening had stopped. From this study,
we conclude that AC8 expression appears closely linked to the properties
developed by VSMCs in atherosclerosis and postangioplasty neo-intima for-
mation leading to restenosis. In addition, it reinforces the idea as to whether
VSMC responses to cell environment greatly depend on expressed AC iso-
forms and attributes a new role to AC8 in these pathological vascular pro-
cesses.
0262
The cannabinoid receptor CB2 protects against balloon-induced vas-
cular remodelling in atherosclerosis-prone mice
Filippo Molica (1), Fabienne Burger (2), Pal Pacher (3), Christian M. Mat-
ter (4), Andreas Zimmer (5), Sabine Steffens (2)
(1) Fondation pour Recherches Médiclaes, cardiologie, Genève, Suisse –
(2) Fondations pour Recherches Médicales, Cardiologie, Genève, Suisse –
(3) National Institutes of Health, Section on Oxidative Stress Tissue
Injury, Laboratory of Physiological Studies, Bethesda, Etats-Unis –
(4) Institute of Physiology, University of Zurich and University Hospital,
Zurich, Cardiovascular Research, Zurich, Suisse – (5) Institute of Molecu-
lar Psychiatry, University of Bonn, Bonn, Allemagne
Vascular inflammation and smooth muscle cell proliferation contribute
to vascular remodelling and obstructive vasculopathies such as atheroscle-
rosis and restenosis following acute vascular injury. Cannabinoids are
known for their immunomodulatory properties, due mainly to cannabinoid
type 2 (CB2) receptors. It is known that CB2 activation with selective CB2
receptor agonists inhibited the TNF-α-induced proliferation and migration
of human coronary artery smooth muscle cells. The potential in vivo rele-
vance of these findings and putative effects on endothelial cells after acute
vascular injury, however, remain unclear. The aim of our study was to test
the role of CB2 receptors in an experimental mouse model mimicking
human angioplasty.
We performed carotid balloon distension injury in male WT and CB2-/-
mice under normal diet which induced an endothelial and medial cell loss one
day after injury. Four weeks after injury, we found significantly increased
numbers of medial nuclei in CB2-/- mice (WT: 145.1 ± 8.46, n=6; CB2: 184.6
± 10.07, n=5; p=0.0143), suggesting enhanced smooth muscle cell prolifera-
tion; cell type was confirmed by immunohistochemical analysis for smooth
muscle α-actin. In addition, we found significantly higher numbers of circu-
lating leukocytes in CB2-/- mice 4 weeks post-operation, indicating an
enhanced systemic inflammatory state.
Moreover, ApoE-/- mice were fed on high cholesterol diet for two weeks
before performing left common carotid distension. These mice develop
enhanced inflammation, proliferation and neointima formation in response to
balloon injury. Mice were randomly assigned to receive daily i.p. injection of
either the CB2-selective synthetic cannabinoid JWH-133 (5 mg/kg) or vehicle
control, with the first injection given 30 min before balloon injury. After 7
days, we found significantly reduced numbers of total intimal nuclei in injured
vessels of JWH-133-treated mice (vehicle: 57.09 ± 1.985, n=9; JWH: 43.26 ±
5.44, n=7; p=0.0199), suggesting beneficial effects of CB2 activation on neoin-
tima formation.
Our data indicate that CB2 receptors play a role in vascular remodelling in
response to acute arterial injury. Thus, selective targeting of CB2 receptors
may offer a new therapeutic strategy for reducing restenosis in response to bal-
loon angioplasty in humans. 
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Patients in secondary prevention: all equal? New data of the French
arm of the international propective registry REACH
Pierre Sabouret (1), Jean Dallongeville (2), Ph. Gabriel Steg (3), Patrice
Cacoub (4), Michel Krempf (5), Jean Louis Mas (6), Jean François
Pinel (7), Pascal Priollet (8), Denis Taminau (9), Gilles Montalescot (1)
(1) Heart Institute – Pitié Salpétrière , Department of cardiology, Paris,
France – (2) Institut Pasteur, Lille, France – (3) Bichat Hospital, Depart-
ment of cardiology, Paris, France – (4) Pitie Salpetriere, Department of
Internal Medicine, Paris, France – (5) Nantes University Hospital,
Department of diabetology, Nantes, France – (6) Sainte-Anne Hospital,
Department of neurology, Paris, France – (7) Rennes University Hospital,
Department of neurology, Rennes, France – (8) Saint-Joseph Hospital,
Department of vascular medicine, Paris, France – (9) General Medical
Office, Egletons, France
Objectives: To evaluate the control of cardiovascular risk factors at 1 year
follow-up in French patients, recruited in the REACH international registry
and to compare the rates of control between patients with coronary artery dis-
ease (CAD), with cerebrovascular disease (CVD), and patients with lower
limb peripheral arterial occlusive disease (PAD).
Methods: The REACH registry has included patients, aged at least 45
years, and suffering from established atherothrombotic disease (EAD), or with
several cardiovascular risk factors (CVRF) (> 3). In France, 713 investigators
selected 4740 patients, with either CVRF (n=1226) or with EAD (n=3514)
between December 2003 and June 2004. After exclusion of patients with
missing data, 2916 patients were available for statistical analyses.
Results: Among the 2916 french patients of the REACH registry, 1169
(40.1%) suffered from CAD, 317 (10.9%) had documented CVD, 257 (8.8%)
suffered from PAD, and 13.8% had symptomatic polyvascular disease. We
found important differences for the rate of control of major CV risk between
groups: target goals are obtained for 24.89% for patients with CAD, 14.20%
for patients with CVD, and only 11.28% for symptomatic PAD.
Table 1: Rate of patients at targets (No smoking, Glycemia < 1.26 g/l, SBP/
DBP < 140/90-130/80 mmHg if diabetes, Total Cholesterol < 2.0 g/l).
Conclusion: The rate of patients treated and controlled is globally poor,
with significant differences between patients according to symptomatic
arterial bed. These results underline the need for more widespread use of
medications, and for optimize therapeutic education to induce lifestyle
changes.
 
Tobacco=0 BP control Diab TC<2g/l All CVRF
CAD only 91.62% 45.51% 22.16% 61.51% 24.89%
CVD only 93.69% 34.70% 20.50%  43.22% 14.20%
PAD only 79.38% 29.95% 21.40% 46.69% 11.28%
P Chi-Square <0.0001 <0.0001 0.81 NS <0.0001 <0.0001
Chi-Square:  
Chi-Square  
analysis ; SBP:  
systolic blood  
pressure, DBP:  
diastolic blood  
pressure ; BP:  
blood pressure ;  
TC total  
cholestérol, 
CVRF:  
cardiovascular 
risk  factors.
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Protein tyrosine phosphatase 1B is involved in endoplasmic reticulum
stress response in both hepatocytes and adipocytes
Abdelali Agouni, Mirela Delibegovic
University of Aberdeen, Institute of Biological Sciences, Aberdeen,
Royaume-Uni
Protein tyrosine phosphatase 1B (PTP1B) is a widely expressed non receptor
tyrosine phosphatase which is considered as a potential therapeutic target of type
2 diabetes because of its negative regulation of insulin and leptin signalling. It is
located on the cytosolic surface of endoplasmic reticulum (ER), a multifunc-
tional organelle which co-ordinates protein folding, lipid biosynthesis, calcium
storage and release. Perturbations that disrupt ER homeostasis lead to ER stress
and upregulation of a signalling pathway called the unfolded protein response
(UPR). Chronic and prolonged UPR activation leads to cell death and insulin
resistance (ER stress response). The aim of our study was to analyze the role of
PTP1B in ER stress response in liver and fat by using human and mouse hepa-
tocytes and adipocytes as our models. Intestingly, we found that the pharmaco-
logical induction of ER stress response by itself increased PTP1B mRNA levels
in both HepG2 hepatocytes and 3T3-L1 adipocytes. In addition, silencing of
PTP1B in these cell lines using small interfering RNA (siRNA) or small hairpin
RNA (shRNA) prevented tunicamycin-induced increase of several markers of
ER stress response regulated through PERK/eIF2-α and IRE1-α sensors. More-
over, ER stress response is also shown to be associated with an increase in oxi-
dative stress. Here, we show that PTP1B downregulation potentiates the
antioxidant capacity of the cells after ER stress stimulation, by inducing expres-
sion of heme oxygenase 1 (HO-1). 
In conclusion, PTP1B seems to be an important player in ER stress
response signalling pathway in both hepatocytes and adipocytes, two main tar-
gets of insulin action, and its inhibition may alleviate consequences of obesity-
induced ER stress response and insulin resistance, type 2 diabetes and cardio-
vascular risk.
0267
ERK inhibition restores insulin sensitivity in adult rat cardiomyocytes
through microtubules stabilisation
Mohamed Asrih, Corinne Pellieux, Irene Papageorgiou, Christophe Mon-
tessuit
Fondation pour la recherche Medicale, cardiologie, Genève, Suisse
Microtubules polymerisation is involved in several cellular processes
including insulin induced glucose uptake. After three days of culture, adult rat
cardiomyocytes (ARC) develop insulin resistance, which is reversed by 9-cis
retinoic acid treatment. Such transient insulin unresponsiveness is associated
with structurally altered microtubules. Disruption of microtubules also reduced
phosphorylation of AS160, a major regulator of glucose transporter transloca-
tion (GLUT4). The mechanisms underlying microtubules disruption in cul-
tured cardiomyocytes are unclear. The extracellular signal-regulated kinases 1
and 2 (ERK1/2) signalling pathway is reactivated in isolated rat cardiomyo-
cytes. Given the role of this pathway in decreasing microtubule stability in
other cells types, we investigated whether ERK inactivation might improve
microtubule stabilisation and restore insulin stimulated glucose uptake in cul-
tured adult rat cardiomyocytes. Cardiomyocytes exposed to MEK 1/2 inhibitor
U0126 had increased insulin- and metabolic stress-stimulated glucose trans-
port, associated with stable microtubules and activation of several key proteins
within insulin activated pathway, thus reproducing the effect of 9-cis retinoic
acid. Double immunofluorescence staining showed that p-ERK was perinu-
cleare in addition to nuclear p-ERK, thus colocalized with the microtubules
organising centre (MTOC) in untreated cells, whereas MOTOC colocalization
of p-ERK was lost in 9cRA treated cells. Taken together these results suggest
that ERK could destabilises microtubules by acting on MTOC.Thus, in direct
support of the microtubule hypothesis, we show here that ERK-mediated
microtubules disarray contribute to cardiac insulino-resistance.
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Paclitaxel Eluting Stent use in everyday practice: low revascularisa-
tion rate at 3 years, but higher stent thrombosis rate in diabetic
patients
Gilles Barone-Rochette (1), Gérald Vanzetto (1), Alison Foote (2), Que-
sada Jean-Louis (2), Grollier Gilles (3), Jacques Machecourt (4)
(1) CHU de Grenoble, unité de soins intensifs cardiologiques, Grenoble,
France – (2) Centre d’Investigation Clinique, Grenoble, France – (3) Ser-
vice de cardiologie, Caen, France – (4) Clinique universitaire de cardio-
logie, Grenoble, France
We sought to assess the efficacy and safety of the PES used in everyday
practice in diabetic patients (DP) with single or multiple vessel disease com-
pared to non-diabetic patients (NDP) over at least 3 years. Safety concerns
about PES have been raised, particularly when used in less highly selected
patients than those included in randomized trials and especially among DP. 
Methods: The EVASTENT-Tax study is a multicenter matched cohort reg-
istry of 502 patients (pts) revascularised exclusively with paclitaxel stents
(Taxus®). For each DP included a NDP patient was subsequently included.
Patients were followed for at least 3 years (follow-up at 1 yr 98%, at ≥3 yrs
92%). The safety primary end point was a composite of cardiac death and non-
fatal myocardial infarction (with or without stent thrombosis, according to
Academic Research Consortium definitions), and for efficacy target lesion
revascularisation (TLR). Target vessel revascularisation excluding TLR (TVR)
and non TVR were also assessed. 
Results: We included 502 patients (mean age 70 years) presenting with
ACS (52%) or a stable condition (48%), but not acute MI, of who 233 were
diabetic and 381 (76%) were male. During follow-up 28 pts (6%) died, with
cardiac death in 14 pts (3%). Nonfatal myocardial infarction occurred in 10 pts
(2%). Stent thrombosis was noted in 15 pts (3%): 4 definite (3 acute), 6 prob-
able (1 sub-acute), and 5 possible; 4 acute or sub acute, 4 late and 7 very late
ST. At 3-years, the safety endpoint rate was significantly higher in diabetic
than in non-diabetic patients (8% vs.1%, p≤0.001), whereas TLR was not sig-
nificantly different. Over half the patients (52%) were still on dual antiplatelet
therapy 3 years after stent implantation. 
Conclusions: In everyday practice the PES has a good efficacy with com-
parable clinical parameters for restenosis in DP and NDP at 3 years. PES are
clinically safe, however the risk of paclitaxel stent thrombosis, including very
late ST, is higher for DP. 
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Altered surface marker expression and function of circulating neutro-
phils in a fructose-induced rat model of metabolic syndrome
Madjid Tagzirt, Joke Breyne, Delphine Corseaux, Sophie Susen, Alexan-
dre Ung, Victorien Grard, Matthieu Barthelemy, Ahmed Elkalioubie, Fré-
déric Mouquet, Brigitte Jude, Annabelle Dupont
Univ Lille Nord de France, UDSL, IFR 114, EA 2693, faculté de Méde-
cine pole recherche, Lille Cedex, France
Metabolic syndrome (MetS) is a complex disorder combining obesity, dys-
lipidemia, hypertension and insulin resistance in association with a chronic
inflammation. This common disorder represents a major risk factor for athero-
sclerotic cardiovascular disease. Polymorphonuclear neutrophils (PMN) are
crucially involved in inflammation, but their implication in MetS remains
unclear. The aim of this study was to evaluate the surface marker expression
and functions of circulating PMN on fructose-induced MetS in a rat model. 
Male Sprague Dawley rats (n=54) were on a regular (Control rats [CR]) or
a fructose-enriched (60%) (Fructose-fed rats [FFR]) diet, during 6 weeks. In
whole blood samples, the surface expression of markers (CD11b, CD18, mye-
loid lineage and CD62l), phagocytic activity and NADPH-dependant reactive
oxygen species (ROS) production, by resting and phorbol myristate acetate
(PMA, 1 µM)-stimulated PMN, were assessed by flow cytometry. 
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FFR showed insulin resistance, hyperinsulinemia, hypertriglyceridemia
and hypertension. Compared to resting PMN from CR, those from FFR pre-
sented significant modification of both CD11b and myeloid lineage expres-
sion (-3%, p=0.01, +37%, p<0.01, respectively), as well as an increased
ROS production (+14%, p<0.01). After PMA-stimulation, PMN showed
increased phagocytic activity and ROS production and elevated surface
marker expression, except for the myeloid lineage marker. Interestingly,
increased ROS production was more important in PMN from FFR as com-
pared to PMN from CR (454% vs. 377%, p<0.01), indicating that PMN from
FFR are more sensitive to PMA activation and subsequent ROS production
by NADPH-oxydase. 
In conclusion, the results of this study provide evidence that fructose-
induced MetS affects function of circulating PMN. These alterations could
play a key role in the induction of inflammation, characterizing the MetS.
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Silent epidemics of diabetes mellitus, type 2 diabetes, pre-diabetes,
metabolic syndrome and coronary heart disease at bank site of Braz-
zaville
Thierry Gombet (1), Bertrand Ellenga-Mbola (1), Stephane Meo
Ikama (1), Gisèle Kimbally-Kaky (1), Benjamin Longo-Mbenza (2), Jean-
Louis Nkoua (1)
(1) CHU de Brazzaville, Brazzaville, Congo – (2) Walter Sisulu Univer-
sity, Mthatha, Afrique du Sud
Background: Bank employees, mostly sedentary are at higher risk of DM,
pre-diabetes and other cardiovascular risk factors. The objectives of this study
were to test this hypothesis, to assess the prevalence of DM types and pre-dia-
betes and to identify the determinants of type 2 diabetes (T2DM) and pre-dia-
betes among bank employees.
Methods: This cross-sectional study assessed the prevalence of diabetes
mellitus (DM), type 2 diabetes mellitus (T2DM) and pre-diabetes while asso-
ciated risk factors of T2DM were identified among representative 126 bank
employees from Brazzaville, Congo, Central Africa. Overweight/total obesity,
DM, T2DM and pre-diabetes were defined along WHO criteria. Abdominal
obesity, dyslipidemia and metabolic syndrome (MetS) were defined by IDF
for Europe, NCEP-ATPIII and IDF criteria modified for Central Africa. Pro-
jected high 10-year total risk of coronary heart disease (CHD) ≥20% was cal-
culated using Framingham scores. 
Results: Out of the employees, 16% and 21.4% had DM and pre-diabetes,
respectively. The rate of T2DM among diabetics was estimated 90%. Aging,
high HDL-C, high total cholesterol, high LDL-cholesterol, high conicity index
and longer urban residence after migration were significantly associated with
pre-diabetes. Physical inactivity, smoking, excessive alcohol intake, abdominal
obesity, female gender, low HDL-C, very high HDL-C, hypertension, CHD,
projected high 10-year total CHD risk, age≥55 years, urban residence,
Southern area residence, high socioeconomic status, non married status
(OR=32.6 95%CI 6-39; P<0.0001), MetS/NCEP (OR=18.3 95%CI 4.1-81.1;
P<0.00001), MetS/IDF for Europe (OR=42.4 95%CI 7.9-127.4; P<0.0001) and
MetS/IDF for Africa (OR=85.1 95%CI 9.9-174.2; P<0.0001) were signifi-
cantly associated with T2DM.MetS/IDF for Africa (OR=56.8 95%CI 6.4-
103;P<0.037), and both younger age <45 years (OR=6 95%CI 1.2-27;
P=0.027) and elevated HDL-C were the independent determinants of T2DM in
3 successive different logistic regression models. 
Conclusion: Urgent prevention and intervention programme are needed to
curb the alarming increase in DM, T2DM, pre-diabetes and other CHD risk
factors related to lifestyle changes and urbanization.
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Metabolic and cardiovascular consequences of postnatal overfeeding
in mice
A. Habbout, S. Delemasure-Chalumeau, C. Richard, L. Rochette, C. Vergely
LPPCE, Faculties of Medicine and Pharmacy, IFR SANTE-STIC, Dijon,
France
Cardiovascular and metabolic consequences of overweight are a growing
concern in both western and developing countries. Several studies in mice
have shown that postnatal overfeeding (OF) induces permanent moderate
increase of body weight in the adult life; however, the metabolic and cardio-
vascular repercussions of postnatal OF are less known.
Immediately after birth, and during 3 weeks, litters of C57BL/6 mice were
either maintained at 10 (normal-fed group, NF), or reduced to 3 in order to
induce a OF situation. At weaning, mice of both groups received a standard
diet. Measurements of body weight, food intake, but also of metabolic param-
eters (cholesterol, leptin and insulin) were performed in the plasma at 7
months. Cardiac function was assessed by echocardiography and the suscepti-
bility to myocardial ischemia and reperfusion was assessed ex vivo in isolated
perfused heart.
OF led to an increase in body weight (+30%) and an overconsumption of
food as compared to NF group. Significant increases of plasma cholesterol,
insulin and leptin levels were observed in OF mice as compared to NF mice.
In vivo, LV shortening and ejection fraction were decreased in OF mice. Ex
vivo, after 30 minutes of ischemia, hearts isolated from mice that underwent
postnatal OF showed lower recovery of coronary flow (35% vs 55%, p<0.05),
of developed ventricular pressure, of +dP/dt and -dP/dt. Moreover, infarct size
evaluated after 2 hours of reperfusion was increased in OF group (+74%,
p<0.05) as compared to NF.
These results show that OF induces metabolic disturbances but also a
higher susceptibility to cardiac functional damage after ischemia. Complemen-
tary data are required to understand the cellular pathways implicated in these
modifications of cardiovascular parameters.
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Modulation by sodium intake of cardiorenal and metabolic changes
induced by high fructose diet in rats
Carole Oudot (1), Cyril Reboul (2), Bernard Jover (1), Caroline Rugale (1)
(1) Université Montpellier, Groupe Rein & Hypertension, Montpellier,
France – (2) Université Avignon, Physiologie des adaptions cardiovascu-
laires à l’exercice, Avignon, France
High fructose (HF) diet is a well known model of insulin resistance in rats,
associated with slightly increase in blood pressure, cardiac hypertrophy and
renal damages. The aim of this study was to evaluate the influence of sodium
intake on cardiorenal and metabolic changes associated with HF diet in
Sprague-Dawley rats. At the age of 6 weeks, rats fed 4 types of diet for 12
weeks: normal salt control (NSC, 0.64% NaCl), normal salt-60% fructose
(NSF), low salt-60% fructose (DSF, <0.01% NaCl), or high salt-60% fructose
(HSF, 8% NaCl) diet. At the end of the diet, tail-cuff pressure (TCP) was mea-
sured. Glucose metabolism was assessed by intra-peritoneal glucose and
insulin tolerance tests. Cardiac morphology and function were evaluated by
echocardiography. Urinary albumin excretion (UAE) was measured by ELISA
test. Heart weight index (HWI) was determined.
Group TCP HWI RWT UAE Créat Insulin sensitivity KITT
N=8 mmHg mg/gBW% mg/24h mg/dl index 
NSC 136±1 2.52±0.05 30±2 0.34±0.07 0.41±0.05 1.20±0.08 0.40±0.04
NSF 137±3 2.76±0.04* 35±1 1.25±0.38* 0.53±0.06 0.81±0.08*
0.30±0.02*
LSF 137±3 2.64±0.05 30±1 0.27±0.06§ 0.50±0.04 0.97±0.14 0.29±0.02*
HSF 141±3 2.96±0.12*§ 46±3*§ 1.73±0.33* 0.73±0.16* 1.06±0.07
0.33±0.02
Fructose diet induced insulin resistance, cardiac hypertrophy and albumin-
uria, and these damages were amplified by high sodium intake independently
of blood pressure. Low sodium intake prevented albuminuria without change
of blood pressure but had no significant effect on cardiac hypertrophy. Sodium
intake did not influence insulin resistance associated with high fructose diet. 
Effects of sodium intake on cardiac and renal changes induced by high
fructose diet were independent of blood pressure and glucose metabolism. The
role of oxidative stress should be assessed. 
© Elsevier Masson SAS. All rights reserved.
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Effect of NADPH oxydase inhibition in an experimental model of
Metabolic syndrome
Isabelle Remy-Jouet, Cathy Dehaudt, Aurélia Vergeade, Paul Mulder,
Ghislain Gangwe Nana, Brigitte Dautreaux, Christelle Monteil, Christian
Thuillez
INSERM Unité 644 université de Rouen, Faculté Médecine&Pharmacie,
Rouen Cedex 1, France
Metabolic syndrome predisposes to the development of various cardio-
vascular diseases associated with an impairment of endothelium-dependent
vasodilatation in a variety of vascular beds induced by an increase in oxi-
dative stress. NADPH oxidase is the major source of superoxide anion (O2-
) production in the vasculature. The aim of the present study was to
examin the effects of administration of a NADPH oxidase antagonist, Apo-
cynin, on metabolic and cardiovascular parameters in fructose-fed rats
(FFR), an experimental model of insulin resistance implicated in metabolic
syndrome. Wistar rats received water (control group) or fructose (FFR) in
drinking water 10% (w/v) during an experimental period of 8 weeks. FFR
rats had elevated blood pressure, a myocardial dysfunction associated with
an elevation of reactive oxygen species (ROS) in the heart and a decreased
level of nitric oxide (NO) production in the endothelium of thoracic aortas,
as mesured by Electron Paramagnetic Resonance (EPR) Spectroscopy. The
apocynin (APO) chronic administration (50mg/kg per day for 8 weeks)
reversed the increment in systolic blood pressure (FFR 122±4 mmHg, APO
98±2 mmHg) and the diastolic dysfunction (lvedp, p=0.052 vs FFR),
reduced the cardiac (p=0.049 vs FFR) and the interfibrilar mitochondrial
(p=0.0 vs FFR) ROS production. Further APO restored moderately the NO
production in thoracic aortic segments. These results indicate that the car-
diac dysfunction induced by chronic administration of fructose resulting
in, the production of ROS by the mitochondria is controled by NADPH
oxidase. Moreover inhition of NADPH oxidase and the associated reduc-
tion of O2- production improved the vascular NO production. We conclude
that NADPH oxidase plays a key role and may represent a novel thera-
peutic target for cardiovascular diseases associated with metabolic syn-
drome. 
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Propionyl-l-carnitine prevents metabolic and cardiovascular altera-
tions in a model of diet-induced obesity
Carmina Mingorance (1), Matthieu Chalopin (2), Gilles Simard (3), Pierre-
Henri Ducluzeau (3), Yves Malthiéry (3), Maria Dolores Herrera (1), Maria
Alvarez De Sotomayor (1), Ramaroson Andriantsitohaina (2)
(1) University of Sevilla, Department of Pharmacology, School of Phar-
macy, Sevilla, Espagne – (2) UMR INSERM 771 CNRS 6214, Faculté de
Médecine, Angers, France – (3) UMR INSERM 694, Mitochondrie: régu-
lations et pathologie, Angers, France
Obesity is pointed out as a primary contributor to acquired insulin resis-
tance leading to the development of type 2 diabetes that is often associated
with cardiovascular alterations. Propionyl-L-carnitine (PLC) is a short chain
fatty acid esterified to carnitine that is transformed into free carnitine and pro-
pionyl coenzyme A in the cellular mitochondria, both playing a role in the
control of energy. The aim of this study was to evaluate the metabolic and the
cardiovascular effects of oral treatment with PLC in an experimental model of
diet-induced obesity (DIO). C57BL/6 mice -6 week old- were fed with a high
fat diet (42% kcal from fat) for 8 weeks. Next, animals were divided into two
groups receiving either water (vehicle-HF) or PLC (200 mg kg-1 day-1, PLC-
HF) during 4 weeks. A group of animals receiving a standard diet ad libitum
was used as a lean control group (vehicle-ST). Body weight evolution and
daily food intake were periodically measured. Glucose tolerance test (GTT)
and echocardiography examination were performed the last week of treatment.
Finally, endothelial function was assessed using myography. Vehicle-HF mice
displayed a greater increase of body weight compared to the lean group. Inter-
estingly, PLC treatment induced a decrease of body weight in HF mice. HF
diet led to a similar decrease of daily food intake in mice treated or not with
PLC compared to the vehicle-ST. The GTT revealed the presence of impaired
response to glucose overload in the vehicle-HF group that was partially
improved by PLC. Vehicle-HF animals exhibited reduced cardiac index com-
pared to vehicle-ST that was partially reversed upon treatment with PLC.
Besides, PLC corrected the endothelial dysfunction in aorta from HF animals
as shown by the reversal of reduced relaxation to Ach towards that of vehicle-
ST mice. Use of PLC may be a potential mechanism for prevention of cardio-
vascular and metabolic alterations associated with obesity.
0163
N-terminal pro-brain natriuretic peptide levels and obesity in patients
with acute myocardial infarction. Data from the RICO survey
Luc Lorgis (1), Yves Cottin (1), Alexandre Cochet (2), Pierre Sicard (3),
Philippe Buffet (1), Isabelle L’Huillier (1), Jean Claude Beer (1), Michel
Vincent-Martin (4), Hamid Makki (5), Philippe Gambert (6), Marianne
Zeller (7), Aurélie Gudjoncik (1,3)
(1) Service de cardiologie, CHU Dijon, Dijon, France – (2) CGFL,
Nuclear Medicine Department, Dijon, France – (3) LPPCE, IFR Sante-
STIC, Dijon, France – (4) Service de cardiologie, CH, Beaune, France –
(5) centre hospitalier, cardiologie, Chatillon Sur Seine, France – (6) Ser-
vice de Biochimie, CHU Dijon, Dijon, France – (7) LPPCE, IFR sante-
stic, Dijon, France
Objective: Recent findings reported intriguing relationships between obe-
sity and natriuretic peptides. In patients with acute myocardial infarction (MI),
we aimed to investigate the relation between body mass index (BMI) and N-
Terminal pro Brain Natriuretic Peptide (NT-proBNP) level. 
Patients and methods: From a French regional survey for acute MI, we
formed 739 triplets of patients (n=2217) with an acute MI, matched with
respect to age, gender, and renal function (MDRD, modification of diet in
renal disease), each classified for BMI groups as obese (BMI> 30 kg/m2),
overweight (BMI 25-29.9 kg/m2) and normal (BMI 20-24.9 kg/m2). Blood
samples were taken on admission to assess NT-proBNP levels.
Results: Among the 2217 participants, mean age was 68±12 years, 80%
were male and MDRD was 75±26 ml/min/1.73m2. Higher prevalence of CV
risk factors (hypertension, diabetes and dyslipidemia) was found across the
overweight and obese groups. Admission CRP levels were increased in obese
patients. Clinical heart failure on admission and LVEF were similar for the 3
groups. When compared with normal BMI, median NT-proBNP levels dramat-
ically decreased by about 20% in overweight and 60% in obese (1046 vs 839
and 444 pg/ml, respectively, p<0.001). An inverse relationship was found
between the propeptide values and BMI (r=-0.20, p<0.0001). By multivariable
linear regression, BMI as a continuous variable remained a predictor of
logNT-proBNP level, even when adjusted for potential confounders. CV mor-
tality at 1-Y follow-up was similar for the 3 BMI groups (p=0.691). By mul-
tivariate logistic regression analysis, logNT-proBNP predicted CV mortality in
normal (OR(95%CI), 2.24(1.29-3.89)) and overweight (OR(95%CI):
6.11(2.75-13.60)) patients, even when adjusted for confounders (GRACE risk
score, LVEF, and prior MI). However, in obese patients, the propeptide levels
failed to retain its prognostic capacity (OR(95%CI): 1.44(0.88-2.35)). 
Conclusions: In this large contemporary non-selected cohort of MI
patients, NT-proBNP levels were dramatically reduced in obese patients even
matched for age, renal function and gender. Moreover, in obese patients with
acute MI, the significance of the propeptide level as an independent prognostic
factor remains to be determined.
0464
Leptin stimulates proliferation and can both stimulate and inhibit
chemotaxis of human vascular smooth muscle cells
Ahmed El Kalioubie, Francis Juthier, André Vincentelli, Delphine Cor-
seaux, Madjid Tagzirt, Sophie Susen, Frédéric Mouquet, Eric Van Belle,
Brigitte Jude, Annabelle Dupont
Univ Lille Nord de France, UDSL, IFR 114, EA2693, Faculté de Méde-
cine Pôle Recherche, Lille, France
Leptin is an adipocyte – derived hormone and cytokine that regulates
energy balance. Increased circulating leptin is associated with metabolic syn-
drome and cardiovascular disease. Current knowledge on effects of leptin on
growth of human vascular smooth muscle cells (HVSMC) is contradictory. We
hypothesize that leptin effects on proliferation and migration by chemotaxis of
HVSMC is biphasic, thus helping development of the atherosclerotic plaque.
Methods: HVSMC were obtained from the media of internal mammary arteries
out of patients undergoing coronary artery bypass graft surgery. Identification
of the cells (n=113 cultures between P3 and P6) was done by microscopic
morphology and immunocytochemical analysis using anti a-actin antibodies.
After weaning of the cells at 0% Foetal Calf Serum for 48 hours, cells were
exposed to different concentrations of leptin. After 72 hours, proliferation was
assessed by the MTT test (Promega). After 6 hours, chemotaxis was assessed
in Boyden’ chambers under fluorescent microscopy. 
Results: Leptin, at 100 ng/ml, induced significant proliferation of HVSMC
(n=9), compared to untreated cells (p<0.05). From 0 to 20 ng/ml, leptin
increased chemotaxis of HVSMC, while from 20 to 100 ng/ml, leptin reduced
chemotaxis of HVSMC, compared to untreated cells. In conclusion, the initial
signal given at low leptin concentrations (0 to 20 ng/ml) is one of migration
of HVSMC, followed by a signal of proliferation at higher concentrations (20
to 100 ng/ml). By this biphasic response, leptin participates in development
and progression of atherosclerosis.
0012
Influence of dietary n-3 PUFA on the sympathetic activity in two
acquired or innate hyperinsulinic and insulin resistant models in rats
Delphine Rousseau-Ralliard, Vanessa Robbez Masson, Marine Guinot,
Alain Grynberg
INRA, UMR 1154 INRA-Paris 11, Châtenay-Malabry, France
Introduction: Hypertension plays a rising role in the NCEP-ATPIII cri-
teria and the question of its link with insulin-resistance (IR) is still addressed.
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Hyperinsulinemia (hyperINS) has been suspected in the pathophysiology of
several hypertensions, because of the antinatriuretic and sympathetic-like
effects (sympathetic hyperactivity) of insulin that also exhibits a vasodilation
activity. An umbalance of these effects could explain the progressive appari-
tion of hypertension. Factors able to induce a resensitization to insulin could
help to understand the suspected relationship between hyperINS and hyperten-
sion. The sympathetic hyperactivity is known to decrease the baroreflex
activity while hyperINS induces baroreceptor dysfunctions. A daily intake of
n-3 long-chain polyunsaturated fatty acids (n-3 LCPUFA) is known to
improve the insulin sensitivity in IR and to decrease significantly the sym-
pathovagal balance of diabetic patients. 
Methods: Two IR model, innate (SHR) and acquired (fructose in drinking
water of WKY rats) are known to exhibit a sympathetic hyperactivity com-
pared with control rats (WKY rats). Each group was divided in two dietary
groups providing different qualitative PUFA (only N-6 PUFA or including n-
3 LCPUFA). The effect of n-3 LCPUFA on the sympa- /parasympathetic sys-
tems was evaluated by injecting propranolol (beta-adrenergic antagonist), fol-
lowed by atropin (cholinergic receptor inhibitor). The baroreflex was studied
by injecting sodium nitroprussiate to induce a NO-dependent peripheral
vasodilation that increases heart rate (HR) through peripheral baroreceptor
activation. 
Results: N-3 LCPFA improved insulin sensitivity and reduced plasma
triacylglycerol and insulin, and blood pressure. Propranolol erased the n-3
LCPUFA HR- and BP-lowering effects, without additional effect of atropin.
In WKY+fructose, the sodium nitroprussiate failed to change BP, indicating
a NO-dependent vasodilation deficiency. Without BP change, the baroreflex
was not evaluated, but might be using a phenylephrine injection-induced BP
rise. In SHR, as expected, the baroreflex collapsed as comared to WKY
rats. 
Conclusions: N-3 LCPUFA opposed to the abnormalities observed in the
metabolic syndrome and act on the BP regulation by involving the sympathetic
system, without any significant effect on the baroreflex in our experimental
conditions.

© Elsevier Masson SAS. All rights reserved.
 
Archives of Cardiovascular Diseases Supplements (2010) 2, 1-90 17
TOPIC 07 – Oxidative stress
0345
Pronostic value of genotype polymorphism of superoxide dismutase 2
in patients with acute heart failure
Jean-Christophe Charniot (1), Angala Sutton (2), Dominique Bonnefont-
Rousselot (3), Claudine Cosson (4), Randa Bittar (5), Philippe Giral (3),
Nathalie Charnaux (2), Jean-Paul Albertini (6)
(1) Hôpital Avicenne, Cardiologie, Bobigny, France – (2) INSERM U698,
Cardiovascular Bioengineering, UFR SMBH Paris 13 University, Bobigny,
France – (3) Pitie Salpetriere Hospital, Paris, France – (4) Hôpital Bicetre,
Kremlin Bicetre, France – (5) Pitié, Paris, France – (6) Hôpital Avicenne,
biochimie, Bobigny, France
Aim: Prospective study to assess patients with a cardiogenic shock (CS)
due to cardiomyopathy without acute coronary syndrome: – determination of
the allelic frequency and phenotype of a common Pro-Leu polymorphism in
glutathione peroxidase (GPx1); – Ala-16Val Mn-SOD (superoxide dismutase)
dimorphisms; and – role of CM etiologies.
Methods: Patients hospitalized with a de novo CS due to a dilated (DCM)
or ischemic (ICM) cardiomyopathy. OS was evaluated: plasma and erythro-
cyte malondialdehyde (MDA), carbonylated proteins (CP) and oxidized LDL
(oxLDL); erythrocyte Cu,Zn-SOD, GPx and catalase activities. We studied the
Ala16Val-SOD2 (dbSNP: rs 4880), Pro198Leu-GPx1 (dbSNP: rs 1050450)
polymorphisms by allelic discrimination using fluorogenic probes and the 5’
nuclease (TaqMan) assay.
Results: 24 consecutive patients with ICM (n=8) or DCM (n=16) (59±11y,
LVEF 25.3 ± 8.5%, proBNP levels 8540 ng/mL) were included with a 15 month
follow-up. Erythrocyte and plasma MDA, oxLDL and CP levels were signifi-
cantly higher in both groups of CM than in controls (p=0.02, p=0.01, p=0.01 and
p=0.02, respectively). Distribution of MnSOD genotypes was 47.0% Val/Val,
29.5% Ala/Val and 23.5% Ala/Val. The severity of CS was significantly more
important in patients with Val/Val variant and can be paralleled with NT
proBNP levels (p=0.04) and hemodynamic support duration (p<0.05). We found
a positive correlation between Val/Val variant and inotrope treatment duration
(Spearman ?=0.72, p=0.045). Val/Val variant positively influenced the mortality
(Spearman ?=0.67, p=0.01), but not the morbidity (p=0.3). Distribution of GPx
genotypes was 64% Pro/Pro, 18% Pro/Leu and 18% Leu/Leu and did not influ-
ence GPx activities nor major adverse cardiac events (p=0.33). 
Conclusion: CS was associated with markers of increased OS. GPx poly-
morphism did not influence glutathione peroxidase activity. Only the Val-
encoding MnSOD allele was significantly correlated with the severity and
prognosis 
0349 
Imaging for detection of superoxide generation during ischemia and
reperfusion in a cardiac cellular model
Geoffrey Teixeira, Abdallah Gharib, Yves Tourneur, Michel Ovize
INSERM U886 Cardioprotection, Lyon, France
Background: The production of reactive oxygen species (ROS) is consid-
ered as a major component of normal cellular function. But, it is also involved
in the myocardial injury during ischemia and reperfusion. Studies have demon-
strated that a burst of oxidant stress is generated upon reperfusion of ischemic
cardiac cellular model. However, events occurring during ischemia that prime
this burst within the first few minutes of reperfusion are not well defined. 
Aim: Our goal was to measure the rate of mitochondrial superoxide (O2.-)
generation, in living cells and in different context. Kinetic study by imaging
allowed separating intracellular physiological processes involved and gave us
information about location and time.
Methods: Mitochondrial O2.- generation of a cardiac beating cell-line
(HL-1 B) was followed in time lapse fluorescence microscopy using a
MitoSOX Red probe. From a control condition in glucose-free Tyrode’s for
10 min, HL-1 B was assigned (n=4 or 5/group) to one of the 5 experimental
groups. Group I remained in the same solution throughout the experiment.
Group II and Group III received glucose (respectively 5 and 10 mM). Group
IV underwent 30 minutes of simulated ischemia (oxygen-free glucose-free
Tyrode’s) followed by 1h of reoxygenation. Group V underwent 30 minutes
of simulated ischemia followed by 1h of reperfusion with normal PO2
10 mM glucose Tyrode’s.
Results: The rate of O2.- generation was similar in solutions containing
from 0 to 10 mM glucose (Groups I, II, III). Ischemia and reoxygenation
didn’t result in an increase of O2.- production rate (Group IV). Finally, we
showed an increase of O2.- production rate during the reperfusion (0,820
±0,130 vs 0,310 ±0,040; p<0,01; Group V). O2.- production rate only increased
when oxygen is in presence of nutriment. 
Conclusion: Our data suggest that it is important to associate the oxygen
and nutriment effects when we study ROS generation. In our cellular model
this real-time experimental approach allows us to better understand the mech-
anisms involved in O2.- production during conditions which mime an infarct.
Further studies will investigate the incidence of cardio-protective therapies like
pre-conditioning and post-conditioning on ROS production. Finally, all this
methodology will be applied to cardiomyocytes of adult mice.
0249
Circulating microparticles from pulmonary hypertensive rats are vec-
tors of oxidative stress
Simon Tual-Chalot (1), Christelle Guibert (2), Bernard Muller (2), Jean-
Pierre Savineau (2), Ramaroson Andriantsitohaina (1), Maria Carmen
Martinez (1)
(1) INSERM U694, faculté de médecine, Angers, France – (2) INSERM
855, Bordeaux, France
Pulmonary arterial hypertension (PAH) is a rare and severe disease charac-
terized by an increase of pulmonary vascular resistance, which is accompanied
by functional and structural changes in pulmonary arteries. Also, oxidative stress
plays a major role in both abnormal vasomotor responses and remodelling of
pulmonary arteries during PAH. Among biological hallmark of this disease,
level of circulating microparticles (MPs), small vesicles of plasma membrane
released during cell activation and apoptosis, is increased in PAH patients.
Although MPs can act as biological vectors of oxidative stress, their roles in
PAH are not elucidated yet. The purpose of this work is to study circulating MPs
effects on oxidative stress during hypoxic PAH. Male Wistar rats were exposed
or not to chronic hypoxia (3 weeks, 0.5 atmosphere), and normoxic or hypoxic
MPs from blood were characterized by flow cytometer to determine their phe-
notype and circulating concentration. Circulating levels of MPs from hypoxic
rats were twice that of MPs from normoxic rats. In vitro treatment of endothelial
cells from aorta with MPs from either normoxic or hypoxic rats did not modify
the superoxide anion (O2-) production. By contrast, MPs from hypoxic rats
increased O2- production in endothelial cells from pulmonary arteries. In order
to study the sources of O2-, pulmonary endothelial cells were incubated with
inhibitors of either NADPH oxidase (apocynin, 100 µM), xanthine oxidase
(allopurinol, 50 µM) or mitochondrial complex I (rotenone, 5 µM). Both allopu-
rinol and rotenone reduced (28% and 17%, respectively) O2- production induced
by MPs. In addition, expression of NADPH oxidase subunits (gp91phox and
p67phox) was not modified by MP treatment. Here we have elucidated the ori-
gins of pulmonary enhanced oxidative stress evoked by MPs and found xanthine
oxidase and mitochondrial implications. These data provide evidence that
hypoxic circulating MPs display tissue-specificity with respect to increased oxi-
dative stress. Supported by ANR-06-PHYSIO-015-02.
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Cyclooxygenase-2 reduces inward remodeling induced by a chronic
blood flow reduction in old obese zucker rats resistance arteries
Emilie Vessieres, Eric Belin De Chantemèle, Anne-Laure Guihot, Ber-
trand Toutain, Daniel Henrion
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Resistance arteries have a key role in the control of local blood flow.
Changes in resistance arteries structure and function are the hallmark of most
cardiovascular diseases such as hypertension, obesity or metabolic syndrome.
Under chronic reduction in blood flow, resistance arteries undergo inward
remodeling associated with reduced endothelium function. Remodeling requires
an inflammatory process and the metabolic syndrome is associated with
cyclooxygenase-2 (COX-2) expression. Thus, we hypothesized that COX2
might affect remodeling in obese Zucker rats (OZR), a model of metabolic syn-
drome. In 3- and 12-month old obese and lean Zucker rats, second order mesen-
teric resistance arteries were ligatured in vivo and thus submitted to low flow
(LF), compared to equivalent normal flow (NF) arteries located at distance. 
After 21 days, inward remodeling occurred in LF arteries (31%
decrease in diameter in lean rats). In OZR diameter reduction in LF
arteries reached only 10%. Endothelium-dependent (acetylcholine)-relax-
ation, altered in obese rats arteries, was reduced by NO-synthesis blockade
(L-NAME) in all groups but eNOS expression decreased in LF arteries (no
difference between lean and obese rats). Indomethacin further reduced
relaxation in LF arteries in 12-month old OZR rats only. COX-2 was
detected in old OZR arteries. In old OZR 6-keto-PGF1alpha, the metabo-
lite of prostacyclin, was elevated. Acute blockade of COX-2 with NS398
also reduced endothelium-dependent relaxation. Thus, we treated OZR rats
chronically with NS398. In this group inward remodeling in LF arteries
was restored to the level found in lean rats (not affected by NS398) and
suppressed the acute effect of indomethacin on endothelium-dependent
relaxation. 
Thus, in 12-month old OZR COX-2-derived prostacyclin prevented the
diameter reduction induced by a chronic decrease in blood flow. This adapta-
tion might be in favor of a better tissue perfusion. 
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HIV Protease Inhibitor Induce Endothelial dysfunction and Prema-
ture Senescence in Cultured Human Coronary Artery Endothelial
Cells 
Chloé Lefèvre (1), Martine Auclair (1), Corinne Vigouroux (1), Emilie
Capel (1), Jacqueline Capeau (1), Franck Boccara (2), Martine Caron-
Debarle (1)
(1) INSERM UMRS 938, Paris, France – (2) CHU Saint Antoine, Cardio-
logie, Paris, France
Background: In vitro studies demonstrated that short-term treatment with
some HIV-protease inhibitors (PIs) could directly alter endothelial function.
However, the long-term effect of PIs on endothelial function and senescence
has not been evaluated. 
Methods: We studied the sequential impact on endothelial function and
senescence of a chronic incubation of human coronary artery endothelial cells
with ritonavir (RTV, 7.5 µM) or lopinavir (10 µM) plus ritonavir (2 µM)
(RTV/r). Endothelial cell dysfunction was assessed at 0, 10, 20 and 30 days,
by nitric oxide (NO) production (DAF fluorescence), level of oxidative stress
(CM-H2DCFDA oxidation, NBT reduction), inflammation (IL-6, IL-8, MCP-1,
PAI-1 secretion) and production of adhesion proteins (VCAM, ICAM). Prolif-
eration, replication and senescence were measured by the population doubling
level (PDL), BrdU incorporation, senescence-associated ß-galactosidase
activity (SA-ß-gal) and altered cell morphology. The level of the senescence
marker prelamin A was also determined
Results: Long-term treatment with RTV and LPV/r resulted in progressive
endothelial cell dysfunction with increased oxidative stress (3-12 fold) and
decreased NO production (2-3 fold) and protein expression of NO synthase 3
(2.5 fold). The secretion of IL-6, IL-8 and MCP-1 was markedly increased
after chronic PI treatment, as well as the secretion of PAI-1 (2-3.5 fold),
ICAM and VCAM (2-7 fold). The two PIs decreased cell proliferation (by 2-
3 fold) and replication (4-5 fold). They also progressively induced cellular
senescence with increased SA-ß-galactosidase activity (5-7-fold), altered cell
morphology, and increased prelamin A accumulation (10-12-fold).
Conclusions: Our results suggest that RTV and LPV/r-induced endothelial
dysfunction might result in stress-induced premature cell senescence. This could
participate to early cardiovascular diseases and aging occurring in some PI-
0310
Protective effect of a plants infusion with a potential of NO donor
during hypoxia and reperfusion
Céline François, Mourad Fares, Aurore Danigo, Jean-Michel Maixent
INSERM, U927, Poitiers, France
Background: Nitric oxide (NO) influences the functioning of the lungs,
liver, kidney, stomach and heart. Our vascular system uses nitric oxide to con-
trol the blood flow in each body part and causes vasodilation ensuring oxygen-
ation of these organs and tissues. Plants infusion’s intake has been studied for
their effects in human like theanine from tea.
Objective: to observe the protective effect of plants infusion with a poten-
tial of NO donor, during an ischemia/reperfusion sequence, on kidney epithe-
lial cells LLC PK1. 
Procedure: Preparations of infusions were obtained by incubation of 2g of
plants with hot water (95°C) during 5min. Dilutions of plants infusions (I) have
been used at a range of concentrations from 5% to 50%. LLCPK1 cells were
subjected to a test assessing cell death (Lactate Dehydrogenase assay) and a
measure of the breakdown product of NO (the NaNO2) after 24h of incubation
with different concentrations of plants infusion. These measures have been car-
ried out after 24h of hypoxia, 24h of hypoxia + 4h of reperfusion.
Results: it was observed an increase of NaNO2, and thus of NO,
depending on concentrations of infusion and a relative decrease of the cell
death depending also on concentration. Similar results were observed after
hypoxia followed by 4 hours of reperfusion (data not shown). This decrease is
maximal at a concentration of 50% of infusion. 
Conclusion: The plants infusion causes a dose-dependent increase of NO
and has a protective effect against the cellular stress caused by hypoxia and
reperfusion. Since it has been demonstrated that there is a NO-dependent
mechanism allowing the reduction of apoptosis, such a mechanism could be
involved in our conditions.
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Nitric oxide synthase 3 deficiency prevents cardiac dysfunction in
insulin resistance and pressure-overload
Baptiste Kurtz (1), Hélène Thibault (2), Michael Raher (1), John R. Popo-
vich (3), Emmanuel Buys (3), Sharon Cawley (3), Kenneth D. Bloch (3),
Marielle Scherrer-Crosbie (2)
(1) Massachusetts General Hospital, Cardiovascular Research Center, Bos-
ton, Etats-Unis – (2) Massachusetts General Hospital, Ultrasound Labora-
tory in the Cardiology Division of the Department of Medicine, Boston,
Etats-Unis – (3) Massachusetts General Hospital, Anesthesia Center for
Critical Care Research, Department of Anesthesia, Boston, Etats-Unis
Background: Insulin resistance (IR) and systemic hypertension are inde-
pendently associated with heart failure. Endothelial nitric oxide synthase
(NOS3) has a beneficial effect on cardiac function after pressure-overload in
mice. The aim of our study was to investigate the role of NOS3 in the modu-
lation of pressure-overload-induced LV remodeling and dysfunction in IR.
Methods: Wild type (WT) mice and NOS3-deficient (NOS3-/-) mice were
fed either a standard diet (SD) or a high-fat diet (HFD) that induces insulin
resistance. After 9 days of diet, mice underwent transverse aortic constriction
(TAC). LV structure and function were assessed serially using echocardio-
graphy. Oxidative stress level was evaluated on isolated cardiomyocytes using
DCF-DA in a subgroup of mice at 7 days after TAC, as well as mitochondrial
respiration and ATP production in isolated mitochondria.
Results: The TAC-induced decrease in LV function was greater in SD-fed
NOS3-/- mice compared with SD-fed WT mice. However, the decrease in LV
function was smaller in HFD-fed NOS3-/- than in HFD-fed WT mice. The sur-
vival of HFD-fed WT mice 28 days after TAC was decreased compared to that
of NOS3-/-. Cardiomyocytes oxidative stress level was significantly lower in
HFD-fed NOS3-/- compared to WT mice at 7 days. LNAME as well as mito-
chondria inhibitors decreased oxidative stress level in cardiomyocytes isolated
from HF-fed WT mice. In contrast with WT mice, mitochondrial uncoupling
did not worsen after HFD and TAC in NOS3-/- mice.
Conclusion: In contrast to its protective role in SD, NOS3 increases LV
adverse remodeling and cardiac dysfunction in HFD after pressure overload in
mice. The interaction of NOS3 and mitochondria is mainly responsible for an
increased oxidative stress environment in WT mice. 
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Cardiac-specific over-expression of H11 kinase regulates mitochon-
drial oxidative phosphorylation by a nitric oxide-dependent mecha-
nism
Lydie Laure (1), Romain Long (1), Roland Zini (1), Christophe Depre (2),
Alain Berdeaux (1), Didier Morin (1)
(1) IMRB, INSERM U955EQ03, Creteil, France – (2) UMDNJ, Newark, Nj,
Etats-Unis
H11 kinase/Hsp22 (H11K) is a small heat shock protein upregulated by
ischemia/reperfusion, which provides cardioprotection equal to ischemic pre-
conditioning (IPC) through a nitric oxide (NO)-dependent mechanism. A main
target of NO-mediated IPC is the mitochondria, where NO reduces oxygen
consumption and reactive oxygen species (ROS) production during ischemia.
Here, we investigated the effect of H11K over-expression in fresh isolated car-
diac mitochondria and tested the hypothesis that H11K modulates mitochon-
drial function through an NO-sensitive mechanism. Over-expression of H11K
increased both oxygen consumption (substrate-dependent oxygen consumption
state 2: 139±11% in H11K transgenic mice vs wild-type (wt) mice) and ATP
synthesis (ADP-dependent oxygen consumption state 3: 119±8% in H11K
mice vs wt) when mitochondrial respiratory chain (MRC) was fed either with
glucidic or lipidic substrates. These effects were not due to changes in the con-
centration of mitochondria (constant PGC1α quantity and citrate synthase
activity in H11K and wt mice) but were related to an increase in MRC
activity. Indeed, MRC activity in H11K mice could be highly enhanced
(127±10% in H11K mice vs wt) when the demand in oxygen was increased by
the uncoupling agent carbonyl cyanide 4-trifluoromethoxyphenylhydrazone.
Moreover, H2O2 production in presence of succinate showed that ROS release
was lower in H11K mice as compared to wt (54±7% in H11K mice vs wt),
confirming improved efficiency of the MRC in transgenic mice. This differ-
ence was abolished by rotenone (113±16% in H11K mice vs wt) suggesting
that complex 1 is involved in the decrease in ROS production in H11K mice.
Interestingly, pretreatment of H11K mice with L-NG-Nitroarginine methyl
ester (L-NAME) for 3 days abolished the H11K-induced increase in oxygen
consumption. These characteristics replicate those of IPC, thereby placing
H11K as a potential target for the prophylactic treatment of ischemia/reperfu-
sion injuries.
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Interest of studying telomere length and the expression of c-Fos and
OGG1 in patients during the acute phase of myocardial infarction
Julie Lorin (1), Sébastien Saliques (1), Anne Donzel-Javouhey (2), Cathe-
rine Vergely (1), Marianne Zeller (1), Jean-Raymond Teyssier (2), Yves
Cottin (3), Luc Rochette (1)
(1) LPPCE, Dijon, France – (2) CHU de Dijon, Laboratoire de génétique
moléculaire, Dijon, France – (3) CHU de Dijon, Cardiologie, Dijon,
France
Objectives: Work done by our team has shown a relationship between leu-
kocyte telomere length (LTL) and various clinical parameters such as left ven-
tricular ejection fraction (LVEF) and the cardiological history of patients. The
aim of this study was to evaluate the interest of measuring LTL in the analysis
of the expression of genes involved in the modulation of oxidative stress in
patients presenting with myocardial infarction (MI).
Methods: Studies were conducted in 174 patients with acute MI who were
registered in the RICO (l’obseRvatoire des Infarctus de Côte-d’Or) database,
which collects clinical and biological data. LTL, as well as the level of expres-
sion of 2 genes, one involved in the adaptation of cells to inflammatory pro-
cesses (c-Fos), and the second in DNA repair following oxidative damage
(OGG1), were determined by qPCR on the DNA in leukocytes taken from the
patients’ blood.
Results: After adjustment for age (which correlates strongly with LTL
(r=+0.222, p=0.003), our results show that LTL was also negatively associated
not only with expression levels of the c-Fos gene (r=-0.320, p<0.001) but also
with plasma levels of C-reactive protein (CRP) (r=-0.312, p<0.001) and
homocysteine (r=-0.178, p=0.034). A positive association was found between
LTL and LVEF (r=+0.248, p<0.001) and creatinine clearance (r=+0.693,
p<0.001). The LTL of current smokers was significantly shorter than that of
ex-smokers (1.270 vs. 1.277 T/S-1 ratio, p=0.002), and the LTL of the latter
was significantly shorter than that of patients who had never smoked (1.277
vs. 1.295 T/S-1 ratio, p=0.002). No correlation was found between LTL and
expression levels of OGG1 (p=0.643).
Conclusion: These results suggest that, in patients in the acute phase of
MI, LTL is in part determined by prior «oxidative» components. Indeed, a his-
tory of smoking, an increase in the level of c-Fos gene expression and a high
level of CRP, come together to make LTL a marker of a patient’s «oxidative
history».
0214
Mitochondrial impairment contributes to the cocaine-induced LV
diastolic dysfunction: prevention by the targeted antioxidant MitoQ
Aurélia Vergeade (1), Paul Mulder (1), Cathy Vendeville-Dehaudt (1),
François Estour (2), Dominique Fortin (3), Renée Ventura-Clapier (3),
Christian Thuillez (1), Christelle Monteil (1)
(1) INSERM U644, Rouen , France – (2) UMR 6014 CNRS – IRCOF ,
Mont St-Aignan, France – (3) INSERM U769, Châtenay-Malabry, France
Aims: Reactive oxygen species (ROS) have been implicated in cocaine-
induced cardiac dysfunction. Although mitochondrial oxidative damage has
been described in a variety of physiopathological models, the role of mito-
chondria as trigger or target of cardiac dysfunction remains unclear. We inves-
tigated the role of mitochondria in a model of cocaine-induced oxidative stress
and cardiac dysfunction. 
Methods and Results: Seven days of cocaine administration to rats led to
a diastolic dysfunction characterized by an increase of Tau, an index of left
ventricular (LV) relaxation, and of the end-diastolic pressure volume relation.
An increased oxygen consumption was detected in cardiac fibers, specifically
through complex I and complex III. ROS levels were found to be increased,
specifically in interfibrillar mitochondria (IFM). In parallel there was a
decrease in ATP synthesis, whereas no difference was obtained in subsar-
colemmal mitochondria (SSM). This uncoupling effect on oxidative phospho-
rylation was not detectable after short-term exposure to cocaine which did not
lead to cardiac dysfunction. Finally, the cardiotoxic effects of cocaine were
completely prevented by the use of MitoQ, a mitochondrial targeted antioxi-
dant. 
Conclusions: These data suggested that cocaine-induced oxidative stress
alters cardiac mitochondrial function by an uncoupling effect resulting in an
increase in ROS production selectively in IFM, and leads to LV dysfunction. 
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TOPIC 09 – Angiogenesis, growth factors,
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Paradoxical effects of the topoisomerase inhibitor ethoxidine in the
cellular processes leading to angiogenesis on endothelial cells
Nicolas Clere (1), Sébastien Faure (1), Jean-Jacques Helesbeux (2), Oli-
vier Duval (2), Ramaroson Andriantsitohaina (1)
(1)UMR INSERM U694, Angers Cedex, France – (2) UPRES EA 921 –
SONAS, Angers Cedex, France
Topoisomerase I (TopI) generates transient single-stranded breaks in
DNA and have the capacity to fragment the genome. TopI is the target for
some of the most successful anticancer drugs. Ethoxidine, a
benzo[c]phenanthridines derivative, was identified as a potent inhibitor of
TopI in various cancer cell lines. As angiogenesis is a critical step in tumor-
igenesis, the present study was designed to Maladies coronaires the potential
effect of ethoxidine on different processes leading to neovascularisation on
EaHy926 human endothelial cells including proliferation, adhesion and
migration. Ethoxidine was tested for 24h at 0.1 µM and 10 µM and VEGF
(10ng/mL) was used as positive control. Proliferation was analysed using
CyQUANT Cell Proliferation Assay Kit. Evaluation of adhesion was per-
formed using crystal violet staining. Cell migration was evaluated using a
model of wound healing. Both superoxide anion (O2-) and nitric oxide (NO)
productions were assessed using electronic paramagnetic resonance tech-
nique. Low concentration of ethoxidine promoted migration and enhanced
Eahy cell adhesion to the same extent as that produced by VEGF. These
effects were associated with increased of both O2- and NO productions. In
contrast, high concentration of ethoxidine inhibited migration, did not affect
Eahy cell adhesion, O2- and NO productions. Taken together, the present
study highlights paradoxical effects of ethoxidine on processes leading to
angiogenesis depending on the concentration used. This dual effect of ethox-
idine offers perspectives for the treatment and preventions of ischemic dis-
eases in relation to the generation of vascular network (low concentration),
in addition to its antiproliferative properties to fight against cancer growth
(high concentration). 
0132
Differential control of monocyte subsets mobilization and recruitment
by CCL2/CCR2, CX3CL1/CX3CR1 and CCL5/CCR5: role in postis-
chemic neovascularization
Clément Cochain (1), Mathieu P. Rodero (2), José Vilar (1), Alice
Recalde (1), Yasmine Zouggari (1), Adèle Richart (1), Céline Loinard (1),
Béhazine Combadière (2), Lucie Poupel (2), Bernard Lévy (1), Ziad Mal-
lat (1), Christophe Combadière (2), Jean-Sébastien Silvestre (1)
(1) INSERM U970, Paris, France – (2) INSERM UMR-S945, Paris, France
Arteriogenesis and angiogenesis are critical processes involved in the
response of the organism to ischemic injury, and contribute to tissue revascu-
larization and organ preservation. Serveral types of inflammatory cells, and
notably monocytes/macrophages, are known to promote neovascularization.
However, the respective role of different monocyte subsets -Ly6Chi and
Ly6Clo- and the mechanisms mediating their mobilization into the blood and
recruitment to ischemic tissues are not clearly understood. We sought to deter-
mine the contribution of each monocyte subset to postischemic vessel growth,
and focused on the role of the major chemokine/chemokine receptor pathways
CCL2/CCR2, CX3CL1/CX3CR1 and CCL5/CCR5 in their mobilization and
recruitment to ischemic tissues. 
In a model of murine unilateral limb ischemia, Ly6Chi monocytes were
rapidly mobilized from the bone marrow to the blood in a CCL2/CCR2 depen-
dent manner. CCL2 overexpression enhanced mobilization into the blood-
stream and infiltration of Ly6Chi and Ly6Clo monocyte subsets into ischemic
areas by 5-(p<0.05) and 3-fold (p<0.01), respectively, leading to a strong
increase of blood perfusion in the ischemic limb (140% of Control, p<0.01).
The opposite effect was seen in mice with CCL2 or CCR2 deficiency.
CX3CL1/CX3CR1 modulation seemed to preferentially impact circulating and
infiltrating Ly6Clo monocytes, but did not affect neovascularization. CCL5/
CCR5 had no major role in monocytes trafficking or neovascularization.
Adoptively transfered Ly6Chi monocytes promoted arteriogenesis and angio-
genesis, while Ly6Clo only enhanced arteriogenesis.
In conclusion, Ly6Chi monocytes appear as crucial modulators of postis-
chemic neovascularization, with CCL2/CCR2 and CX3CL1/CX3CR1 differ-
entially impacting Ly6Chi and Ly6Clo circulating and infiltrating monocytes
after ischemia. However, only CCL2/CCR2 affects postischemic vessel
growth and may be a suitable therapeutic target to control neovascularization.
0176
Inhibition of HIF-prolyl hydroxylases promotes post-ischemic neovas-
cularization in diabetic mice
Céline Loinard (1), Yasmine Zouggari (1), José Vilar (1), Clément
Cochain (1), Alice Récalde (1), Adèle Richart (1), Micheline Duriez (1),
Bernard Lévy (1), Edurne Berra (2), Jacques Pouysségur (3), Jean-Sébas-
tien Silvestre (4)
(1) PARCC HEGP INSERM U970 , Paris, France – (2) Cell Biology &
Stem Cells Unit, Derio, Espagne – (3) University of Nice, CNRS-UMR
6543, Institute of Developmental Biology and Cancer Research, Nice,
France – (4) Centre de Recherche Cardiovasculaire de Lariboisière,
UMR S689, Paris, France
The Hypoxia-Inducible transcription Factor (HIF) is a master regulator
controlling genes involved in processes that promote neovascularization,
making modulation of HIF activity an attractive approach for the treatment of
ischemic disease. HIF is hydroxylated by Prolyl hydroxylases (PHD) 1, 2 and
3, leading to proteasome degradation. We hypothesized that HIF upregulation
after PHD inhibition might promote post-ischemic neovascularization in the
diabetic pathological setting. Diabetic mice (n=8 per group, streptozotocine:
60mg/Kg) with right femoral artery ligation were treated, by in vivo elec-
trotransfer, with plasmids encoding for scramble shRNA (shCON) or shRNA
directed against HIF-1α(shHIF), PHD1(shPHD1), PHD2(shPHD2) or
PHD3(shPHD3). PHD silencing induced a specific transient downregulation of
their respective mRNA and protein levels at day 2 after ischemia. Inhibition of
each specific PHD upregulated HIF-1α mRNA and protein levels. This was
associated with an increase in VEGF-A and eNOS mRNA and protein levels,
two key HIF-inducible pro-angiogenic genes. Major chemoattractant chemok-
ines including MCP-1, Fractalkine, Rantes and SDF-1 mRNA levels as well as
the number of MAC-3-positive macrophages were enhanced in ischemic leg of
diabetic mice treated with shPHD. Activation of HIF related pathways was
associated with changes in post-ischemic neovascularization. At day 14,
silencing of PHD2 increased angiographic score, capillary density and foot
perfusion by 5, 4 and 2.6-fold, respectively when compared to diabetic mice
treated with shCON (p<0.001). Similar results were observed after shPHD1
and shPHD3 administration. Of interest, co-administration of shHIF with
shPHD2 abrogated shPHD2-related effects suggesting that activation of HIF
dependent pathways mediated the pro-angiogenic and pro-arteriogenic effects
of PHD silencing. Inhibition of PHD re-activated endogenous HIF-1α sig-
naling and subsequently promoted post-ischemic neovascularization in dia-
betes.
0211
The novel CXCL12γ isoform is a major determinant of post-ischemic
vessel growth
Adèle Richart (1), Alice Récalde (1), Patricia Rueda (2), José Vilar (1),
Clément Cochain (1), Yasmine Zouggari (1), Céline Loinard (1), Bernard
Lévy (1), Fernando Arenzana-Seisdedos (2), Jean-Sébastien Silvestre (1)
(1) INSERM U970, Paris, Etats-Unis – (2) Institut Pasteur, Paris, Etats-
Unis
Beyond the binding to its cognate receptor CXCR4, the interaction of
CXCL12 with the glycanic moiety of heparan sulfate (HS), is supposed to con-
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trol its biological activity, including homing and survival of circulating pro-
genitors and inflammatory cells and, subsequently tissue regeneration. The
novel isoform CXCL12γ binds HS with the highest affinity among chemok-
ines and has been shown to promote in vivo leukocyte attraction with much
higher efficiency than CXCL12α. We therefore analysed the therapeutic
potential of CXCL12 isoforms differing by their capacity to interact with HS
in mice with surgically-induced hindlimb ischemia.
In the ischemic muscle, CXCL12α, CXCL12γ and CXCR4 mRNA levels
peaked at day 3 after the onset of ischemia and returned to basal levels at day
14. In vivo electrotransfer of plasmid encoding for CXCL12γ enhanced by
44%, 54% and 65% the ischemic to non-ischemic angiographic score, paw
perfusion and capillary density ratios, respectively when compared to admin-
istration of empty plasmid (p<0.001, n=10). Of interest, these effects were sig-
nificantly higher than that of CXCL12α and was fully blunted by
administration of mutated CXCL12γ, selectively devoid of HS-binding
capacity. To investigate the effect of CXCL12γ on stem/progenitor cells-
regenerative capacity, we locally injected CXCL12γ into ischemic hindlimb
muscle of nude mice combined with intravenous administration of human
endothelial progenitor cells (hEPC) transplantation. At day 14 after treatment,
the ischemic to non-ischemic angiographic score and capillary density ratios
were increased by around 50% when compared to mice treated with hEPC
alone or CXL12γ alone (P<0.001, n=8). 
This study unravels, for the first time, the major contribution of CXCL12
interactions with HS/proteoglycans to its biological activity in vivo and high-
lights the key role of CXCL12γ in the regulation of post-ischemic neovascu-
larization. 
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Indoxyl Sulfate inhibits angiogenic process
Roger Ourouda (1), Laurie Aynard (1), Haifa Rahabi (1), Sabrina Kellou-
che (2), Agnès Boullier (2), Carole Amant (2)
(1) INSERM ERI-12, UPJV, Faculté de médecine d’Amiens, Amiens,
France – (2) INSERM ERI-12, UPJV et CHU d’Amiens, Faculté de méde-
cine d’Amiens, Amiens, France
Introduction: Cardiovascular diseases are the major causes of mortality in
uremic patients. Uremic solutes retained in these patients could be involved in
endothelial dysfunction. Little is known as to whether angiogenesis process is
altered in renal disease. Indoxyl Sulfate (IS) is an important representative of
the protein-bound uremic retention solutes linked to cardiovascular outcomes.
We hypothesized that IS is involved in angiogenesis dysfunction by studying
endothelial cell proliferation, differentiation and migration.
Methods and results: For each experiment, IS doses were used at physio-
logic concentrations (PC): 2µM, uremic concentration (UC): 211 µM and max-
imal concentration (MC): 940 µM. Cell proliferation test performed on Human
Umbilical Endothelial Cells (HUVEC), shows that at UC and MC, IS reduces
endothelial cell proliferation respectively by 28% (p<0.01) and 29% (p<0.05)
vs control. At UC and MC, IS reduces endothelial cell viability respectively by
25% (p<0.04) and 34% (p<0.01) vs control. At both UC and MC, IS inhibits
tube formation in matrigel assay and endothelial wound repair (an in vitro
endothelial cell proliferation model).
Conclusion: Chronic kidney diseases has been recognized as a markedly
increased risk for developing clinically apparent peripheral vascular disease. In
this study, we determine that Indoxyl Sulfate, one of the uremic toxin strongly
implicated in cardiovascular diseases, inhibits endothelial cell viability and
angiogenic process. Indoxyl Sulfate may be one of the strongest risk factor for
peripheral ischemia.
0304
Inhibition of angiogenesis by two uremic toxins: uric acid and inorga-
nic phosphate
Haifa Rahabi (1), Roger Ourouda (1), Laurie Aynard (1), Sabrina Kellou-
che (2), Carole Amant (2), Agnès Boullier (2)
(1) INSERM ERI-12, UPJV, Faculté de médecine d’Amiens, Amiens,
France – (2) INSERM ERI-12, UPJV et CHU d’Amiens , Faculté de méde-
cine d’Amiens, Amiens, France
Introduction: Chronic kidney disease (CKD) is associated with increased
cardiovascular morbidity. CKD has been recognized as a markedly increased
risk for developing clinically apparent peripheral vascular disease, but under-
lying mechanisms are poorly understood. In this study, we tried to identify
uremic toxins implicated in this mechanism. Accordingly, we tested the
hypothesis that two well-known uremic toxins, inorganic phosphate and uric
acid, impair endothelial cell proliferation, viability, migration and cell differ-
entiation.
Methods and results: For each experiment, uric acid was used at
0.87µmol/mL and inorganic phosphate (Pi) was used at 2mM, 3mM and 4mM.
Tests performed on Human Umbilical Endothelial Cells (HUVEC) showed
that Pi decreased not only cell proliferation by 53% and 59% respectively at
3mM and 4mM (p<0.001, vs control) but also cell viability by 51% and
60% (p<0.001, vs control) respectively at 3mM and 4mM. No effect was
observed with 2mM of Pi. Furthermore, we showed that uric acid decreased
cell proliferation and viability by 44% and 41% respectively (p<0.01, vs con-
trol). Uric acid also inhibits significantly tube formation in matrigel assay and
endothelial wound repair (an in vitro endothelial cell proliferation model).
Conclusion: Uric acid and inorganic phosphate reduce significantly endot-
helial cell proliferation and migration. Moreover, uric acid inhibits endothelial
cell migration and differentiation. Thus, we here showed that these two uremic
toxins are strongly implicated in inhibiting angiogenesis process and might
contribute to the poor prognosis of patients with renal failure suffering from
peripheral arterial disease. Further experiments are necessary to investigate
molecular mechanisms implicated.
0031
Endothelial osteopontin and mural cell recruitment on neovessels
Qin-Yu Yao, Marie-Ange Renault, Fanny Robbesyn, Isabelle Belloc,
Cécile Allières, Danièle Daret, Alain-Pierre Gadeau, Claude Desgranges
INSERM U828, Pessac, France
The maturation of nascent vasculature in adult requires the recruitment of
mural cells (smooth muscle cells [SMC] for large vessels and pericytes for
small vessels) on the newly formed endothelial tubes, assuring the stability and
the functionality of the vasculature. 
Our aim is to identify endothelial cell (EC)-produced chemotactic factors
involved in the mural cell recruitment. In a first time we focused our attention
on the extracellular matrix protein osteopontin (OPN) known for its role in
SMC migration. Our hypothesis is that the locally secreted OPN by EC partic-
ipates in the SMC cell recruitment on neovessels. With this aim, we developed
both in vitro (chemotaxis of cultured SMC by a Transwell approach) and in
vivo (recruitment of mural cells on ischemia-induced neovessels) models to
define the endothelial OPN function.
In vitro, the rat aortic SMC migration is strongly increased (x9.5) by the
conditioned medium (CM) of human umbilical vein EC (HUVEC) in compar-
ison with control medium, demonstrating that chemotactic factors are secreted
by cultured EC. This augmentation is even stronger (x11.2) with the CM of
lentivirus-OPN transduced HUVEC and is completely blocked by a specific
OPN antibody. These experiments show that the endothelial-secreted OPN
directly increases the chemotactic capacity of these cells towards SMC.
In vivo, we created a Tie2-OPN mouse overexpressing OPN specifically in
EC and we studied neovessel formation in tibial muscles after iliac artery lig-
ature, by double immunostaining for EC (CD31+) and SMC (α-SM actin+).
After acute hindlimb ischemia, the ratio of muscularized against total vessels
significantly increases in Tie2-OPN mice (n=6) in comparison with control
C57BL/6 mice (n=5), demonstrating that EC-produced OPN promotes, even in
vivo, an increase of SMC recruitment on neovessels.
Together, these data demonstrate that the EC-secreted OPN participates in
the SMC migration and recruitment both in vitro and in vivo. However, precise
mechanisms of SMC recruitment by endothelial OPN remain to be defined.
0336
Effects of organoschlorine pesticides on endothelial cell adhesion, pro-
liferation, nitric oxide and superoxide anion productions
Sébastien Faure, Nicolas Clere, Yves Malthiery, Ramaroson Andriantsito-
haina
UMR INSERM U694, Angers Cedex, France
Organochlorine pesticides present in the environment including agricultural
and industrial compounds are potentially harmful to human and animal health.
Indeed, these pesticides have been reported to play a role in the course of cardio-
vascular and metabolic diseases such as hypertension, metabolic syndrome or
acute coronary syndrome. One way to fight against these pathologies is to
improve the transport of fluid, nutrients, oxygen in the injured tissues by pro-
moting angiogenesis via the activation of endothelial cells. Therefore, the present
study was designed to test the potential effect of organochlorines on different pro-
cesses leading to angiogenesis on EaHy926 human endothelial cells. Toxics were
tested for 24h at concentrations similar to that found in plasma of exposed indi-
viduals or present in the environment (DEET: 10 µM and 10 mM, chlordecone:
16 pM and 50 nM, lindane: 7 pM and 50 nM). VEGF (10 ng/mL) was used as
positive control. Proliferation was analyzed by using CyQUANT® Cell Prolifera-
tion Assay Kit. Evaluation of adhesion was performed using crystal violet
staining. Analysis of both superoxide anion (O2-) and nitric oxide (NO) produc-
tions were performed using electronic paramagnetic resonance technique. All
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organochlorines tested (whatever the concentration used) induced an increase of
EaHy cell adhesion with no effect on endothelial cell proliferation. None of the
organochlotine tested modified O2- production. With regard to NO, chlordecone,
lindane and low concentration of DEET increased NO release from endothelial
cells. Altogether, these data highlight the fact that circulating concentrations of
organochlorines modulate angiogenesis processes, namely adhesion and increased
production of NO without inducing oxidative stress. The ongoing studies will help
to elucidate the mechanisms by which environmental toxics affect angiogenesis. 
0407
Signals from the sympathetic nervous system control post-ischemic ves-
sel growth through the regulation of bone marrow-derived cells egress
Alice Recalde, Adèle Richart, Clément Cochain, Yasmine Zouggari,
Céline Loinard, José Vilar, Bernard Levy, Jean-Sébastien Silvestre
INSERM, U970, Paris, France
Mobilization and recruitment of bone marrow (BM) derived endothelial
progenitor cells and monocytes play a predominant role in the tissue regener-
ation after ischemia. Recently, catecholamines have been shown to control
stem/progenitor cells egress from bone marrow (BM) niches, at least in part
through the control of G-CSF-induced osteoblast suppression and CXCL12
downregulation. We therefore hypothesized that catecholamines might have a
regulatory role in mobilization of BM-derived endothelial and inflammatory
cells and subsequently, in post-ischemic vessel growth.
In mice with right femoral artery ligation, dopamine (DA) and noradrenaline
(NE) treatment for 21 days increased angiographic score, capillary density and
arteriole density by 40% and 45% (p<0.001), by 25% and 25% (p<0.01), and by
26% and 27% (p<0.01), respectively. Using chimeric mice lethally irradiated
and transplanted with BM mononuclear cells isolated from GFP animals, we
showed that DA and NE enhanced the number of GFP/BS-1 lectin positive cells
in ischemic tissue by 82%(p<0.01) and 115% (p<0.001), respectively and that of
GFP/Mac3 positive cells by 114% (p<0.01) and 122% (p<0.01), respectively,
suggesting that catecholamines promoted the homing and recruitment of BM-
derived endothelial cells and macrophages. Of interest, both DA and NE
increased the in vitro differentiation of cultured BMC into cells with endothelial
phenotype, as revealed by BS-1 lectin/Dil-LDL or BS-1lectin/eNOS-double pos-
itive stainings. Further, administration of clenbuterol, a β2 adrenergic agonist,
enhanced mobilization and recruitement of BM-derived cells and subsequently
post-ischemic vessel growth. These effects were blunted by pharmacological
sympathectomy using 6-hydroxidopamine administration and were raised by
administration of etichlopride a specific DA D2 receptor antagonist.
These results unravel a major role of the sympathetic nervous system in the
control of BM-derived cells-induced post-ischemic neovascularization
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The hedgehog transcription factor Gli3 regulates angiogenesis
Marie-Ange Renault (1), Fanny Robbesyn (1), Qinyu Yao (1), Annabel
Reynaud (1), Béatrice Vinassa (1), Isabelle Belloc (1), Douglas Losordo
(2), Claude Desgranges (1), Alain-Pierre Gadeau (1)
(1) INSERM U828, Pessac, France – (2) Feinberg Cardiovascular
Research Institute, Northwestern University, Chicago, Etats-Unis
The Hedgehog (Hh) embryonic pathway has been shown to be reactivated
in the adult cardiovascular system under ischemic conditions and to promote
ischemia-induced angiogenesis and tissue repair. Nevertheless, molecular
mechanisms involved have been poorly studied. 
Methods and Results: We recently showed that Gli3, a key transcription
factor downstream of Hh, is strongly upregulated in ischemic tissues. We
investigated its possible role in ischemia-induced angiogenesis by using Gli3+/
-
 (Gli3+/XtJ) mice which display a reduced Gli3 expression. Hind-limb ischemia
(HLI) was induced by resection of the left femoral artery. Capillary density
was reduced up to 48.40±12.08% in Gli3+/- mice 14 days after HLI. Myocar-
dial infarction (MI) was induced by permanent ligation of the left anterior cor-
onary artery. Left ventricular function was assessed by echocardiography,
Gli3+/- shows decreased ejection fraction (-25.65±11.95%) 28 days after MI.
Histological assessment shows an increase fibrosis area in Gli3+/- mice
(+69.82±49.13%) and a decrease capillary density in the ischemic and border
zones of the infracted heart. Altogether those results demonstrate that Gli3
deficiency leads to impaired angiogenesis which is associated with a worse
cardiac function after MI. The mechanism of action of Gli3 was investigated
in vitro in cultured HUVECs. Overexpression of Gli3 promotes HUVECs
migration and consistently down regulation of Gli3 delayed tube formation on
Matrigel which confirms a role of Gli3 in angiogenesis. Real time RT-PCR
experiments revealed that Gli3 overexpression increases the pro-angiogenic
factor thymidine phosphorylase (TYMP) expression while it does not modu-
late Gli-dependent transcription. To investigate molecular mechanisms
involved in Gli3-induced TYMP expression, we are currently performing a
systematic analysis of its promoter. 
Conclusion: These studies provide the first evidence that the Gli3 tran-
scription factor regulates angiogenesis and EC phenotype. 
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Effect of Frizzled 4/6 double deletion in developmental vascularisation
and post-ischemic angiogenesis
Benjamin Seguy (1), Remi Chauvel (1), Cécile Allieres (2), J.-M. Daniel
Lamaziere (2), Cécile Duplaa (2), Thierry Couffinhal (1)
(1) Hôpital Haut-Lévèque Bordeaux, cepta pr couffinhal, Pessac, France –
(2) Unité inserm U 828, Pessac, France
sFRP-1, a Wnt/Frizzled modulator, is known for its in vivo pro-angio-
genic potential and was shown to be a ligand for Frizzled 4 (Fzd 4) and 6
(Fzd 6) receptors. Fzd 4-/- mice exhibit severe defects in retinal vascularisa-
tion. Fzd 6 -/- mice have no known vascular phenotype.
Aim: To explore Fzd 4 -/- and 6 -/- mice developmental and post-ischemic
vascularization and, because of possible redundancy, the double deletion 4 / 6 -
/-. Method: 3-D vessels analysis using a microscanner (μCT) (Oses ATVB
2009). Adult mice were injected with a radio-opaque agent and we compared
kidney, heart, normal and ischemic muscle vascular network after μCT image
reconstructions. Fzd 4 -/-, 6 -/- and Fzd 4/6-/- mice (n=5/group) were compared
to littermates (n=10) using the following parameters: connectivity/volume,
density, mean vessel diameter.
Results: All transgenic mice were viable. Compared to littermates, deleted
mice showed a drastic reduction of vessels density and connectivity of kid-
neys, heart and normal muscle vascularization. I.e.: average littermate kidney
connectivity was 800/mm3 +/-40, Fzd 6 -/- 352/mm3 +/-32, Fzd 4 -/- 327/mm3
+/-22, Fzd 4/6 -/- 310/mm3 +/-18. Double deletion was not synergistic in alter-
ation of physiologic vascularization. 
In hindlimb ischemic model, at D15, clinical or blood flow parameters
were not altered in Fzd 6-/- , whereas Fzd 4-/- displayed a strong alteration, even
stronger in Fzd 4/6 -/-. As _nalysed by microCT, Fzd 6-/- have little but signifi-
cant alteration of parameters of neo angiogenesis, whereas Fzd 4-/- exhibit a
strong decrease in vessel density and connectivity. Double deletion 4/6
induced a major defect in post-ischemic angiogenesis.
Conclusion: For the first time, we showed that Fzd 4 and 6 played a role
in vessel development and angiogenesis. . A confocal microscopic analysis is
actually realized to further characterize those aspects.
Kidneys Microscanner
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Circulating endothelial microparticles: a novel biomarker for predic-
tion of subsequent global and cardiovascular mortality in End-Stage
Renal Disease
Nicolas Amabile (1), Chantal M. Boulanger (1), Alain P. Guerin (2), Alain
Tedgui (1), Gerard London (2)
(1) INSERM U970, Paris Cardiovascular Research Center, Paris, France –
(2) Nephrology Department, Centre Hospitalier Manhes, Fleury-Merogis,
France
Background: Endothelial dysfunction is closely associated with increased
circulating levels of endothelial microparticles (EMPs) in patients with end-
stage renal disease (ESRD). As arterial damage is a major contributor to car-
diovascular mortality, we examined whether or not circulating levels of EMPs
could predict outcome in ESRD.
Methods: This prospective study included 81 stable hemodialyzed patients
with ESRD (age 59±14 yr; 63% male; follow-up 57 months). Baseline plasma
microparticles (MPs) levels and cell origin were analyzed by flow cytometry.
End-points included the occurrence of any death and cardiovascular death
(fatal myocardial infarction, stroke, congestive heart failure or sudden cardiac
death).
Results: Non-survivors (n=21) were older (69.9±9.2, vs. 54.9±13.2 y,
p<0.001) and were characterized by lower diastolic blood pressure (71.4±10.5
vs. 79.8±12.4 mmHg, p<0.01), higher values of Framingham score (15.7±3.4
vs. 12.4±4.7, p<0.01), levels of hsCRP (6.9±4.4 vs. 4.9±4.3 mg/L, p<0.05) and
endothelial CD31+CD41- EMPs (2027±2015 vs. 1026±896 ev/μL, p<0.001),
whereas other MPs subtypes were not different. Mutivariate Cox analysis
demonstrated that baseline EMPs levels independently predicted all-cause
death (HR=6.8 [2.15–21.6] per log unit, p=0.02) and cardiovascular mortality
(HR=21.4 [5.3–87.4], p<0.001) after adjustment for age, cardiovascular risk
factors, medications and biological parameters. ROC curve analysis showed
that baseline EMPs levels correctly predicted all-causes and cardiovascular
mortality (AUC: 0.77±0.07 and 0.88±0.06 respectively, p<0.001). Kaplan-
Meier analysis revealed that survival of patients with EMPs levels above
median was worse than other patients (p<0.01, log rank analysis), whereas
platelet MPs levels did not affect outcome.
Conclusions: Increased circulating levels of endothelial microparticles is a
robust independent predictor of all-causes and mainly cardiovascular mortality
in patients with ESRD and could help identify asymptomatic patients at higher
risk of developing cardiovascular diseases.
0314
Role of cardiac aldosterone on cardiac phenotype in arterial high
blood pressure
Feriel Azibani (1), François Tournoux (1), Loubina Fazal (1), Regine Mer-
val (1), Evelyne Polidano (1), Christos Chatziantoniou (2), Jane Lise
Samuel (1), Claude Delcayre (1)
(1) U 942 INSERM, Paris, France – (2) U702 INSERM, Paris, France
Our purpose was to determine 1) the role of intracardiac aldosterone in the
development of cardiac fibrosis in a context of arterial hypertension, and 2) the
involved signaling pathways. 
Thus, we created AS-RenTgKC mice by crossing strains of mice overex-
pressing the aldosterone synthase (AS) gene in cardiomyocytes with
RenTgKC mice overexpressing the renin gene in liver. AS mice have an
increase (x 2) of intracardiac aldosterone and an altered coronary function;
RenTgKC mice have an 8-fold increase of plasmatic renin and AngII, and sus-
tained hypertension.
Results: The heterozygous RenTgKC (Ren +/-) mice were hypertensive
(139±5 mmHg) compared to WT controls (98 ± 7 mm Hg, P<0.05). The asso-
ciation with the cardiac hyperaldosteronism did not modify this parameter.
The echocardiography did not reveal major changes of cardiac function what-
ever the groups. At the anatomical level, the hypertension-induced cardiac
hypertrophy (HW / BW), which developed in Ren +/- mice, was enhanced in
AS-Ren +/- mice (+114% and +128% P<0.05). Regarding the fetal gene pro-
gram, as expected, ßMyHC mRNAs, BNP or ANP mRNAs were upregulated
(x 3 fold, P<0.01, x 2.5, P<0.01, respectively) in left ventricles of Ren +/-
mice compared to controls. Conversely in AS-Ren+/- mice, these transcripts
were not or moderately up-regulated. Interestingly, a short treatment with
eplerenone (1week) reversed the AS-Ren+/- mouse phenotype towards clas-
sical fetal phenotype with up-regulation of BNP, ANP and ßMyHC mRNAs.
Regarding the fibrosis development, the respective expressions of genes like
CTGF and TGFß-1 increased significantly and similarly in Ren +/- and AS-
Ren +/- mice when compared to WT and AS mice, respectively. Conversely,
whereas BMP 7 mRNAs and BMP 4 mRNAs increased in Ren+/- comparing
to WT mice (x 2, p<0.05, x 1.7, p<0.001, respectively), the BMP4 mRNA in
AS-REN +/- mice was lower (x 0.7, p<0.01) than that of Ren +/- group. The
Sirius red staining indicated that the cardiac interstitial fibrosis, which develop
in Ren +/- was enhanced in AS-Ren +/- mice (x2, p<0.05).
Conclusion: The data indicated that in a context of arterial hypertension, a
cardiac hyperaldosteronism altered the expression of the cardiac fetal gene
program and that of antifibrotic factors (BMP4) through a MR specific path-
ways.
0162
Circulating Microparticles: A new predictive factor of severe Micro-
vascular Obstruction
Loïc Bière (1), Carmen Martinez (2), Ramaroson Andriantsitohaina (2),
Julien Jeanneteau (1), Frédéric Treguer (1), Wissam Abi-Khalil (1), Stéphane
Delépine (1), Thomas Bénard (1), Alain Furber (1), Fabrice Prunier (1)
(1) UPRES 3860, Cardiologie CHU Angers, Angers, France – (2) UMR
CNRS 6214-INSERM U771, université d’Angers, Angers, France
Objectives: We sought to elucidate whether circulating microparticles
(MPs) on admission were related to the “no-reflow” phenomenon, in patients
presenting an acute ST-elevation myocardial infarction (STEMI).
Background: Microvascular injury is a consequence of a complex endot-
helial-platelet-leukocyte interaction, mediated by adhesion molecules and
inflammation during ischemia. Microparticles have been described as pro-
coagulant, pro-angiogenic and vasoactive vectors. It is still unknown if this
local vector is significally relevant in a clinical setting.
No-reflow phenomenon can be easily assessed by contrast-enhanced mag-
netic resonance imaging (ce-MRI).
Method: Circulating microparticles before reperfusion were isolated and
cellular origins were characterized in 54 patients with acute STEMI who
underwent primary coronary angioplasty. Ce-MRI was performed on day
5,5±2,8 in 32 patients.
Results: We found higher platelet-derived MPs (PMPs) count in patients
presenting duration of ischemia less than 6 hours and higher leukocyte-derived
MPs (LMPs) count in those with duration of ischemia superior than 6 hours.
There was a positive linear relation between CD11a+leukocyte-derived MPs
and the extent of transmural infarction (r=0.701 p0.008). Remarkably,
CD146+ endothelial-derived MPs (EMPs) were higher in patients with severe
no reflow phenomenon (>3grams). Multivariate linear regression analysis
showed peak creatin kinase and EMPs to be the only independent predictor of
severe microvascular obstruction. Severe no-reflow phenomenon was associ-
ated to worse functional prognosis.
Conclusions: CD146+EMPs are shown to be independent markers of
severe no-reflow phenomenon. Beyond the supporting of the platelet-leuko-
cyte-endothelial interaction, these results suggest a potential pro-angiogenic
effect of EMPs during STEMI. Further studies should explore their biological
effect. 
April 15th, Thursday 2010
© Elsevier Masson SAS. All rights reserved.
 
26 Archives of Cardiovascular Diseases Supplements (2010) 2, 1-90
0370
SERCA2a controls Store Operated Calcium Entry dependent trans-
cription factor NFAT activation and vascular smooth muscle cell pro-
liferation
Regis Bobe (1), Alain Coulombe (2), Lahouaria Hadri (3), Jose Lopez (1),
Yassine Sassi (2), Lifan Liang (3), Ioannis Karakikes (3), Fabrice
Atassi (2), Stephane N Hatem (2), Roger J. Hajjar (3), Anne-Marie Lom-
pré (2), Larissa Lipskaia (3)
(1) INSERM, U770, Le Kremlin-Bicetre, France – (2) UPMC-Paris6,
INSERM UMR956, Paris, France – (3) Mount Sinai School of medecine,
New York, Etats-Unis
Store Operated Calcium Entry (SOCE) is involved in activation of tran-
scription factor NFAT required for proliferation in vascular smooth muscle
cells (SMC). Here, we demonstrate that in human coronary arteries SMC
(hCASMC), expression of the cardiac isoform of the sarco/endoplasmic
reticulum calcium ATPase type 2a, (SERCA2a) steers the signalling
pathway involved in the cell calcium homeostasis including basal calcium
influx that controls NFAT activity and proliferation. SERCA2a expression
was lost from proliferating hCASMCs and from neointima of atherosclerotic
vessels. In cultured hCASMC, SERCA2a gene transfer inhibited prolifera-
tion and migration through inhibition of NFAT. Single-channel patch-clamp
recording showed that spontaneous basal voltage-independent Ca2+ influx,
detected in proliferating SMC and coupled to NFAT activation was com-
pletely blunted by SERCA2a gene transfer. SERCA2a expression increased
SR calcium content measured in FURA-2 loaded cells using calcium pumps
inhibitor thapsigargin (Tg). Thapsigargin treatment also increased store-
operated calcium entry (SOCE) in SERCA2a expressing hCASMC. How-
ever, SOCE was missing in SERCA2a-expressing hCASMC stimulated with
physiological agonist thrombin. Faster recording revealed that in prolifer-
ating hCASMC, expressing mainly SERCA2b, thrombin induces long lasting
increase in cytosolic Ca2+, whereas in SERCA2a-expressing cells, thrombin
induces rapid cytosolic Ca2+ oscillations suggesting that SR calcium
refilling capacity are less dependent of calcium influx. Furthermore,
SERCA2a reduces interaction STIM1/Orai2. In conclusion, SERCA2a mod-
ulates the pattern of agonist induced Ca2+ transient that becomes less depen-
dent of extracellular Ca2+ entry and thereby represses the SOCE dependent
NFAT activation. 
0224
Increase in circulating microparticles in inflammatory bowel disease
patients induces vascular alterations by a subtle unbalance between
nitrosative and oxidative stresses and metabolites from COX-2
Daniela Leonetti (1), Angela Tesse (1), Matthieu Chalopin (1), Maria Car-
men Martinez (1), Anne-Laure Bretagne (2), Jean Marie Reimund (2),
Ramaroson Andriantsitohaina (1)
(1) CNRS 6214 inserm771, faculté de medicine, Angers, France – (2) EA
3919, IFR 146 ICORE, Université de Caen – Basse Normandie, Service
d’Hépato-Gastro-Entérologie et Nutrition, Pôle Reins-Digestif-Nutrition,
Caen, France
Microparticles (MPs) are membrane vesicles released during cell activa-
tion and apoptosis whose circulating levels have been shown to be increased
in patients with inflammatory bowel disease (IBD). We have previously
reported the release of inflammation-related vasoactive factors in small
mesenteric arteries from Crohn’s disease patients. Here, we investigated
whether MPs from IBD patients (IBD-MPs) play a role in the regulation of
endothelial function and vascular reactivity in IBD. Male Swiss mice were
injected i.v. with IBD-MPs, MPs from healthy subjects (HS-MPs) or saline
solution and sacrificed 24 h after. Endothelial function and vascular reactivity
were studied on aortic rings by myography. The involvement of nitric oxide
(NO), cyclooxygenase (COX-2) metabolites and superoxide anion (O2-) was
also assessed using the inhibitor of either NO-synthase (NG-L-Nitro-arginine)
or COX-2 (NS-398), and the superoxide dismutase (SOD) mimetic (MnT-
MPyP), respectively. In aorta, IBD-MPs significantly reduced relaxations
induced by acetylcholine and by the NO donor, sodium nitroprusside. IBD-
MPs decreased the contraction to serotonin (5-HT) compared to saline and
HS-MPs that was completely prevented in the presence of L-NA. Moreover,
aorta from mice treated with IBD-MPs displayed increased NO production.
The ability of NS-398 to reduce 5-HT-induced contraction in control and HS-
MPs-treated mice was abolished in vessels taken from mice treated with IBD-
MPs suggesting the release of COX-2 metabolites. Although in the aorta,
IBD-MPs decreased O2- production, the SOD mimetic, MnTMPyP, reduced
the contraction to 5-HT in an identical manner from three groups. The present
study shows of the capacity of IBD-MPs to induce endothelial dysfunction
and vascular hyporeactivity by a subtle alteration of the balance between the
production of NO, metabolites from COX-2 and reactive oxygen species.
These results underscore the participation of MPs in the course of vascular
alterations in IBD.
0297
Differential Regulation of Heme Oxygenase-1 Induction in Flow
(shear stress)-dependent Remodelling of Rat Resistance Arteries
Mohamed Lamine Freidja, Diane Lambert, Bertrand Toutain, Daniel Henrion
UMR CNRS 6214 / INSERM 771, Angers, France
Heme oxygenase (HO-1) is induced by hemodynamic forces in VSM and
endothelial cells, in vitro. We hypothesized that HO-1 may be induced in
resistance arteries submitted to a chronic blood-flow increase, in vivo. Thus,
we investigated the mechanism regulating HO-1 induction in flow (shear
stress)-dependent remodelling in rat mesenteric resistance arteries (MRA). In
3-months old Wistar rats, 2nd order MRA were alternatively ligated so that they
were submitted to high (HF), low (LF) or normal flow (NF). 2 or 14 days later,
arteries were isolated and mounted in an arteriograph. 
Results: I) Outward hypertrophic and inward eutrophic remodelling
occurred respectively in HF and LF arteries, 14 days after ligation. II) 2 days
after arterial ligation, HO-1 mRNA was increased in both HF and LF, com-
pared to NF vessels, and was significantly decreased, 14 days later. III) The
competitive HO inhibitor, Sn-protoporphyrin (SnPP, 50 µmol/kg, per day,
i.p.), significantly inhibited diameter enlargement in HF arteries. However,
arterial narrowing was accentuated in LF arteries by SnPP. IV) Inhibition of
macrophage infiltration (Clodronate, i.p.), inhibited HO-1 induction in LF
but not in HF arteries, 2 days after ligation. V) Similarly, NADPHox activity
inhibition (Apocynin, 5 mM), abolished HO-1 induction in LF but not in HF
arteries, 2 days after ligation. VI) Conversely, the SOD mimetic, TEMPOL
(20 mg/kg per day), significantly increased HO-1 mRNA in HF but not in
LF arteries, 2 days after ligation. VII) Finally, in MRA cannulated in an arte-
riograph, HO-1 mRNA was induced by flow in a shear stress-dependent
manner.
Conclusion: I) HO-1 is involved differentially in HF (positively) and LF
remodelling (negatively). II) In LF arteries, HO-1 induction needs mac-
rophage infiltration and it is mediated by NADPHox-derived superoxide
anion. III) In HF arteries, HO-1 induction occurs independently from mac-
rophage-mediated inflammation, and it is rather dependent on shear stress-
generated H2O2.
0131
Cardiotrophin-1 is a determinant of arterial stiffness and thickness in
rodents
Natalia Lopez-Andres (1), Laurent Calvier (1), Ma Fortuno (2), Carlos
Labat (1), Natacha Sloboda (1), Ginny Simon (1), Py Marie (1), Javier
Diez (2), Faiez Zannad (1), Patrick Lacolley (1), Patrick Rossignol (1)
(1) INSERM U961, Vandoeuvre-Les-Nancy, France – (2) CIMA. Univer-
sité de Navarre, Pampelune, Espagne
Background & aims: Besides its known cardiac effects, cardiotrophin-1
(CT-1), a cytokine belonging to the interleukin-6 family, exerts proliferative
and secretory effects in vascular smooth muscle cells. We aimed to investigate
the functional and morphological vascular changes induced by chronic CT-1
administration in rats and its involvement in the arterial phenotype of CT-1-
null mice in vivo. 
Methods: A) Recombinant rat CT-1 (20 μg/Kg, IP) was administrated to
Wistar rats for six weeks (n=10/group). Blood pressure (BP) and heart rate
were recorded by telemetry. Cardiac function was assessed using PET-scan. B)
2 year-old wild-type (WT) (n=8) and CT-1-null mice (n=3) were studied. Vas-
© Elsevier Masson SAS. All rights reserved.
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cular structure and function were evaluated by an echo-tracking device. Cir-
cumferential wall stress, incremental elastic modulus (Einc), media cross-
sectional area and pulse wave velocity (PWV) were measured. Aortic wall col-
lagen and elastin contents were determined using immunohistochemistry, and
the expression of collagen type I and III, elastin and fibronectin was quantified
by RT-PCR and Western blot in aortic extracts. 
Results: A) Neither vehicle nor CT-1 treatment modified BP. CT-1-treated
rats displayed decreased cardiac output (p<0.01) as well as wall stress
(p<0.01), Einc (p<0.01) and PWV (p<0.05) as compared with vehicle group.
CT-1-treated rats also showed increased media cross sectional area (p<0.01)
and collagen content (p<0.01). CT-1-overloaded rats displayed increased
expression of collagen type I (p<0.05) and III (p<0.01) and fibronectin
(p<0.01). B) CT-1-null mice presented an increased wall stress (p<0.05) and
Einc (p<0.05) as compared with WT mice. Media cross sectional area and col-
lagen content were reduced (p<0.05) in mice lacking CT-1. 
Conclusions: Normotensive rats subjected to CT-1 overloading developed
impaired cardiac and vascular functions, characterized by an increment in arte-
rial stiffness accompanied by an augmented media thickness and extracellular
matrix production. Accordingly, CT-1-null mice presented a reduced arterial
stiffness and a reduced media thickness and collagen content. Our data show
that CT-1 is a key player in arterial thickness and stiffness and in the cardio-
vascular coupling.
0268
Sonic hedgehog carried by microparticles prevents angiotensin II-
induced hypertension and endothelial dysfunction in mice
Maria Letizia Mastronardi, Vannina Marracchelli Gonzales, Mamadou Sarr,
Matthieu Chalopin, Maria Carmen Martinez, Ramaroson Andriantsitohaina
CNRS 6214 INSERM U771, Laboratoire de Biologie Neuro-Vasculaire,
Angers, France
Microparticles (MPs) are small fragments generated from the plasma
membrane after cell stimulation. We recently showed that morphogen Sonic
hedgehog (Shh) is present in MPs generated from activated/apoptotic human
T lymphocytes and corrects endothelial injury through nitric oxide (NO)
release. This study investigates whether MPs bearing Shh prevent angio-
tensin II (Ang II)-induced hypertension and endothelial dysfunction in mice.
Male Swiss mice (6-8 week old) were implanted with osmotic minipumps
delivering Ang II (0.5 mg/kg/day) or NaCl (0.9%). Systolic blood pressure
and heart rate were measured daily during 21 consecutive days using tail
cuff plethysmography. Mice were trained for 7 days. After 7 day of
minipump implantation, mice received i.v. injections of MPs (10 µg/ml) or
i.p. Shh receptor antagonist cyclopamine (10mg/kg/2 days) during one week
prior sacrifice. Thoracic aorta was mounted in a myograph for vascular reac-
tivity. Ang II induced a significant rise in systolic blood pressure without
affecting heart rate. MPs alone did not modify both parameters but reversed
Ang II-induced hypertension. Inhibiting Shh by cyclopamine prevented the
effects of MPs on Ang II-induced hypertension. MPs alone slightly increased
the sensitivity of endothelium-dependent relaxation to acetylcholine and
completely reversed the impairment of acetylcholine-induced relaxation in
aorta from Ang II-infused mice. The improvement of endothelial function
induced by MPs was completely prevented by cyclopamine treatment. More-
over, measurement of NO production showed that MPs alone did not modify
NO production in aorta, but significantly restored its decrease in Ang II-
treated mice. Altogether, these results show that MPs bearing Shh prevent
Ang II-induced hypertension and endothelial dysfunction in aorta through a
mechanism associated with Shh-induced NO production. These MPs may
represent a new therapeutic approach in cardiovascular diseases associated
with decreased NO production. 
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Influence of Kinins on Cardio and reno-Vascular effects in a chronic
treatment by Cyclosporine A in mice
Loubina Fazal, Georges Zadigue, Maud Clemessy, Patrick Bruneval,
François Alhenc-Gelas, Anne Pizard
UMRS 872, équipe 2, Paris, France
The Kallikrein Kinin System (KKS) is a vasodilatator system, with well
documented cardio and nephroprotective properties during the vascular or
metabolic diseases. Observations made in clinic and animal, especially
during cardiac ischemia and diabetes, have suggested that vascular KKS
plays a protective role in diseases where excessive vasoconstriction is dele-
terious. A typical episode of ischemia-reperfusion is the removal and trans-
plantation of an organ. All of the transplanted patients are then treated with
immunosuppressive drugs like Cyclosporine A (CsA) that have side effects
including the development of hypertension in 80% of the treated patients.
Studies in rat have reported an induction of gene expression of KKS compo-
nents during CsA treatment. This activation of KKS by CsA has been sug-
gested to limit the magnitude of hypertension induced by the drug. We
therefore evaluated the influence of KKS on cardio and reno-vascular effects
during the chronic treatment by CsA of mice inactivated for tissue kallikrein
(TK).
Minipumps were implanted for 7 weeks in female mice TK deficient
(TK- / -, n=16), and controls (TK+ / +, n=16) to treat them by CsA (30μg/
g/day) or solvent. Blood pressure (phlethysmography) and renal function
were monitored regularly during the experiment. At sacrifice, changes in
gene (real-time PCR) and protein (Western blot) expression were studied for
a few candidate genes in heart and kidney.
On the 28th day of CsA treatment, a significant increase of 15 mmHg is
observed only in TK-/-CsA mice. The TK+/+ mice did not alter their blood
pressure. However, at sacrifice, no histological pathological phenotype
(fibrosis or remodeling) and no impairment of renal function are observed.
Nevertheless, CsA treatment alters the expression of several genes in the heart
and the kidney differently depending on the genotype. 
Our data suggest that the level of KKS activity is able to influence the
effect of a chronic treatment by CsA in mice. 
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Engineered microparticles bearing the morphogen Sonic Hedgehog
protect endothelial cells against actinomycin D-induced apoptosis
Raffaella Soleti, Ramaroson Andriantsitohaina, Carmen Martinez
CNRS 6214, INSERM 771, Angers, France
It has been shown that microparticles generated from T lymphocytes
undergoing activation and apoptosis, bear the morphogen Sonic Hedgehog
(MPsShh+), and possessed the dual ability to increase NO and reduce ROS
productions. We investigated whether MPsShh+ protected human umbical vein
endothelial cells (HUVECs) against actinomycin D (ActD)-induced apop-
tosis. MPsShh+ were obtained by activation of human lymphocyte with phyto-
hemagglutinin and then, by stimulation with phorbol-12myristate-13acetate
and ActD. HUVECs were grown for 24h in absence or presence of ActD
and/or MPsShh+. Apoptosis evaluation was based on flow cytometry, TUNEL
labeling and cytochrome c release. We showed that MPsShh+ treatment pre-
vented HUVECs apoptosis evoked by ActD. Also, caspases inhibitor z-
vad.fmk reduced cell death either in presence or in absence of MPsShh+, indi-
cating the implication of caspases in ActD-induced apoptosis. Shh agonist,
SAG reduced apoptosis in a dose-dependent manner; by itself, Shh antago-
nist, CUR61414 had no effect but abolished the antiapoptotic effect of
MPsShh+, revealing a contribution of Shh pathway. Besides, we explored
changes in ROS production at different times, by electronic paramagnetic
resonance. ROS levels were increased in ActD-treated cells at 2h and 10h.
This elevation was prevented by MPsShh+ only at 2h. When sources of ROS,
xanthine oxidase, NADPH oxidase and respiratory chain complex I, were
inhibited using allopurinol, apocynin and rotenone, respectively, we found
that only rotenone reduced ActD-induced apoptosis. Also, the superoxide
dismutase (SOD) mimetic, MnTMPyP, reduced ActD-evoked cell death and
the protective effect of MPsShh+. These results indicate that MPsShh+ may act
in the early phase of apoptosis at mitochondrial level and behave as a SOD
mimetic. These findings provide further mechanisms by which MPsShh+ exert
their vasculoprotective effects, preserving integrity of endothelial mono-
layer.
Supported by ANR-07-PHYSIO-010-01.
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TOPIC 12 – Myocardial hypoxia, reperfu-
sion, stroke – A
0160
MGluR1 identified as a candidate gene of cardioprotection
Catherine Sportouch-Dukhan (1), Tom Moore-Morris (2), Aurélie Covin-
hes (2), Christelle Dantec (3), Brigitte Couette (2), Christophe Piot (1),
Joël Nargeot (2), Stéphanie Barrère-Lemaire (2)
(1) Institut de Génomique Fonctionnelle- CNRS UMR 5203-INSERM
U661- UM1 et UM2, Departement de cardiologie- CHU A de Villeneuve,
Montpellier, France – (2) UMR5203, U661, UM1 & 2, Institut de Géno-
mique Fonctionnelle, departement de physiologie, Montpellier, France –
(3) Institut de Génomique Fonctionnelle- CNRS UMR 5203-INSERM
U661- UM1 et UM2, GenomiX platform, Montpellier, France
Acute myocardial infarction remains a frequent disease leading to heart
failure. Postconditioning (PostC) appears to be a potent cardioprotective
strategy but there is still a need to find new treatments to protect the myocar-
dium against ischemia-reperfusion injuries. The aim of our study was first to
identify candidate genes for cardioprotection and second to investigate the role
and action mechanisms of mGluR1, specifically regulated by PostC, in the
mouse heart in vivo. 
Methods: C57Bl6 mice underwent an IR (40 min. ischemia/60 min.reper-
fusion) protocol. Mice were assigned to the IR or PostC (a stimulus of 3 cycles
of 1-min. reperfusion-reocclusion applied at the onset of reperfusion) groups.
At the end of surgery, RNA extraction was performed on left ventricles.
Mouse oligo microarrays were used for gene expression profiling. +/-, -/-
mGluR1 KO and wildtype mice were subjected to 30 min. of ischemia and 60
min. of reperfusion. Determination of area at risk (AR) and infarct size was
assessed by TTC staining. Calcium transients were recorded using Fura-2
spectrofluorimetry on ventricular myocytes isolated on a Langendorff system
with collagenase. µ
Results: mGluR1 was significantly up-regulated at the transcriptional
levels upon PostC. Application of extracellular glutamate (10 micromol) or
specific agonist DHPG on fura-2 loaded cardiomyocytes elicited non-oscilla-
tory calcium transients. Increases in infarct size were measured in +/- and -/-
GluR1 KO versus wild-type mice subjected to myocardial IR. 
Conclusion: Our study showed that mGluR1 was up-regulated at the tran-
scriptional upon Postconditioning versus IR. Cardioprotection against IR was
lost in mGluR1 KO mice. Interestingly, glutamate was able to induce intracel-
lular calcium mobilization in isolated mouse ventricular cardiomyocytes sug-
gesting that glutamate-induced cardioprotective effects could be related to the
activation of mGluR1 receptors and non exclusively to a metabolic effect. 
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Alteration of RISK/GSK-3β signaling in diabetic hearts abrogates
erythropoietin-induced myocardial protection
Nehmat Ghaboura (1), Sophie Tamareille (1), Pierre-Henri Ducluzeau (2),
Anne Croué (3), Yves Tourmen (4), Daniel Henrion (5), Alain Furber (6),
Fabrice Prunier (6)
(1) UPRES EA 3860, Protection et Remodelage du Myocarde, Université
Angers , Angers, France – (2) INSERM U694, Université Angers, Faculté
de Médecine, Angers, France – (3) CHU d’Angers , Laboratoire d’anato-
mie pathologique, Angers, France – (4) Laboratoire de biochimie, CHU
d’Angers, Angers, France – (5) INSERM U771, CNRS UMR 6214, Uni-
versité Angers, Faculté de Médecine, Angers, France – (6) UPRES 3860,
Université d’Angers et CHU d’Angers service de Cardiologie, Angers,
France
Aim: We sought to examine whether the cardioprotective effects of eryth-
ropoietin (EPO) against ischemic-reperfusion (I/R) injury is maintained in
presence of diabetes mellitus or insulin resistance.
Methods: Isolated hearts were obtained from 3 cohorts of rats: healthy
adults; animals injected 4 weeks (wks) earlier with streptozotocin (STZ) to
induce diabetes and rats fed with a high fat diet (HFD) for 4 wks to induce
insulin resistance. All hearts underwent 25min ischemia and were assigned to
receive either 2h reperfusion with no intervention or with one dose of EPO
injected at the onset of reperfusion.
Results: In hearts from healthy rats: 1) EPO was cardioprotective: infarct
size was 14.4±0.6% vs 36.2±4.2% of the left ventricle in EPO-treated vs
untreated hearts (p<0.05); 2) EPO-induced cardioprotection was associated
with significant increase in phosphorylated forms of Akt, ERK1/2 and their
downstream target GSK-3β, at 30min reperfusion. At 4 wks post-STZ injec-
tion, rats displayed: 1) inhibition of EPO-induced cardioprotection: infarct size
was 32.1±2.4% vs 31.9±1.9% in EPO-treated vs untreated diabetic rat hearts;
2) no up-regulation of PI3K/Akt, ERK1/2 and GSK-3β signaling in response
to EPO. In contrast, at 4 wks post-HFD, rats showed: 1) cardioprotective effect
of EPO: infarct size was 18.7±1.9% vs 34.6±3.4% in EPO-treated vs untreated
HFD rat hearts (p<0.05); 2) up-regulation in PI3K/Akt, ERK1/2 and GSK-3β
signaling in response to EPO, at 30min reperfusion. Furthermore, administra-
tion of the GSK-3β inhibitor SB216367 was cardioprotective in both healthy
and diabetic rat hearts: infarct size was 18.9±2.3% and 20.3±3.9% vs
36.2±4.2% and 31.9±1.9% in treated vs untreated healthy and diabetic hearts
respectively (p<0.05).
Conclusion: Diabetic rat hearts are refractory to EPO-induced cardiopro-
tection because of the disruption of GSK-3β signaling upstream. Thus, direct
inhibition of GSK-3β may provide a novel strategy to protect diabetic hearts
against I/R injury.
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Importance of phosphocreatine overshoot resulting from ischemic
postconditioning in the isolated mouse heart
Sandrine Lemoine (1), Guillaume Calmettes (2), Béatrice Jaspard-
Vinassa (1), Cécile Duplaa (1), Thierry Couffinhal (1), Philippe Diolez (2),
Pierre Dos Santos (1)
(1) INSERM U.828, Pessac, France – (2) UMR 5536-CNRS, Bordeaux,
France
Introduction: Experimental and clinical evidences indicate that modula-
tions of reperfusion or postconditioning (PostC) during the onset of reperfu-
sion reduce cardiac ischemia-reperfusion injury. Mitochondrial permeability
transition pore (mPTP) inhibition plays a relevant role in PostC. However, the
dynamics of energetic metabolism in response to PostC has never been inves-
tigated. Here, we examined the kinetics of alterations in high energy phos-
phates (ATP, PCr, ΔGp), using 31P-NMR in isolated mouse hearts submitted
either to ischemic PostC (IPostC) or administration of cyclosporin A (CsA), an
inhibitor of mPTP. 
Methods-Results: The hearts isolated from C57BL/6J mice were subjected
to no flow ischemia for 40 min followed by 2 hours of reperfusion (Control,
n=8). IPostC was performed by 10 cycles of 5s reperfusion/5s ischemia at the
onset of reperfusion (n=8), CsA was administered during the first 10 min of
reperfusion (n=8). IPostC and CsA significantly enhanced postischemic
recovery of phosphocreatine levels (PCr) as compared to Control, and IPostC
was associated with an overshoot of PCr (at 20 min reperfusion, PCr:
147±13% of baseline in IPostC, 98±20% in CsA vs. 59±14% in Control,
P<0.05). At the end of reperfusion, PCr: 107±28% of baseline in IPostC and
84±37% in CsA, vs. in Control 52±8%, P<0.05). The pHi, Pi, ΔGp and ATP
levels were not statistically different between the 3 groups. At the end of rep-
erfusion, IPostC and CsA significantly reduced myocardial infarct size
(27±3% and 37±4% of area vs. 56±3% in Control, P<0.05), and induced a sig-
nificantly better recovery of contractile function (57± 8% in IPostC, 41±12%
in CsA vs. in Control 18±5% of initial rate pressure product, P<0.05). 
Conclusions: Our results show that IPostC and CsA induced-cardioprotec-
tion are linked to an overshoot of PCr in early reperfusion. Nevertheless, car-
dioprotective effect induced by inhibition of mPTP opening was less important
than IPostC effect.
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Pravastatin but not simvastatin, administered during reperfusion,
protects the human myocardium, in vitro: mechanisms involved
Sandrine Lemoine (1), Clément Buléon (2), Pierre Dos Santos (1), Jean-
Louis Gérard (2), Jean-Luc Hanouz (2)
(1) INSERM U.828, Pessac, France – (2) CHU de Caen, Pole Anesthesie
Réanimation chirurgicale, Caen, France
Introduction: Reperfusion following a myocardial infarction is a double-
edged sword and can induce severe damage to the myocardium. New thera-
peutic approach will need to be focused on limiting reperfusion-induced
injury. Statins have been reported to have pleiotropic effects on the cardiovas-
cular system. Here, we investigated the effect of pravastatin and simvastatin
when administered at the point of reoxygenation following hypoxia, in human
myocardium, in vitro. 
Methods: After the approval of CPPB, human right atrial appendages were
obtained during cannulation for cardiopulmonary bypass. The force of contrac-
tion (34°C, 1Hz) of right atrial trabeculae was recorded during 30-min hypoxia
followed by 60-min reoxygenation (Control, n=10). In statins groups (n=6 in
each group), after a 30-min hypoxic period, pravastatin (5µM, 10µM, 50µM,
75µM) and simvastatin (1µM, 10µM, 100µM) were administered during the
reoxygenation. In additional groups, Pravastatin 50µM was administered in
presence of L-NAME, a Nitric Oxyde Synthase inhibitor, and atractyloside,
the mPTP opener. The force of contraction at the end of 60-min reoxygenation
period (FoC60) was compared (mean ± SD) between the groups by a variance
analysis.
Results: Pravastatin 5µM (FoC60: 49±10% of baseline) did not modify the
FoC60 as compared to control group (50±9%; P>0.05). Pravastatin 10µM
(77±5%), 50µM (86±6%) and 75µM (88±13%) induced a significant increase
of FoC60 (P<0.0001 vs. Control). L-NAME and atractyloside abolished the
enhanced recovery of FoC60 induced by pravastatin 50µM (51±6% and
54±4%; P<0.0001 vs. Pravastatin). Simvastatin 1µM, 10µM and 100µM did
not modify the recovery of FoC60 (respectively 58±9%, 54±10%, 56±9%;
P>0.05 vs. Control).
Discussion: In vitro, simvastatin, unlike pravastatin, was not cardioprotec-
tive when administered at reperfusion. Our data demonstrate that pravastatin,
administered at reperfusion, induced cardioprotection through NOS activation,
and inhibition of mPTP opening.
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Simulated urban carbon monoxide pollution alters myocardial perfu-
sion reserve: Implications for coronary endothelial dysfunction
Cyril Reboul (1), Gregory Meyer (1), Julien Boissiere (2), Caroline
Rugale (3), Sandrine Gayrard (1), Philippe Obert (1), Bernard Jover (3),
Stephane Tanguy (1)
(1) EA4278- Université d’Avignon, Pôle sportif et de recherche, Avignon,
France – (2) Université de Lille 2, Lille, France – (3) GRH Université
Montpellier I, Montpellier, France
Carbon monoxide (CO) is an environmental pollutant present in automobile
emissions as well as cigarette smoke. Chronic CO exposure has been reported
to be correlated with hospital admissions and mortality related to cardiovas-
cular diseases. Despite the potential implication of myocardial perfusion in the
pathophysiology of CO pollution, the mechanisms are still unknown. There-
fore, the aim of this work is to evaluate the effects of prolonged exposure to
CO pollution on myocardial perfusion regulation. An assessment of myocar-
dial perfusion and hemodynamics parameters was performed, in-vivo, under
basal conditions, and during the infusion of a β-Adrenergic agonist. In a
second trial, the effects of CO exposure on capillary density, coronary vasodi-
latation, eNOS expression and eNOS monomerization were evaluated. Our
principal results were that prolonged CO exposure markedly altered myocar-
dial perfusion reserve (-24%) and that this phenomenon can be explained by
the specific effects of CO on the regulation of coronary endothelium-depen-
dent vasorelaxation (-45%). Although no effect of CO on eNOS expression
was observed, CO exposure significantly increased monomerized eNOS, sug-
gesting uncoupling of eNOS in CO rats. Therefore, this work highlights that
chronic exposure to low level of CO is associated with reduced myocardial
perfusion reserve and that the deleterious effects of CO exposure on NO
pathway could be mainly implicated in this phenomenon. 
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Post-conditioning in Daxx-DN mice: involvement of the PI3K/Akt
pathway
Christelle Redt (1), Alicia Franck-Miclo (1), François Roubille (2), Anne
Vincent (1), Catherine Sportouch-Dukhan (2), Joël Nargeot (2), Christo-
phe Piot (2), Stéphanie Barrere-Lemaire (1)
(1) Institut de Génomique Fonctionnelle- CNRS UMR 5203-INSERM
U661- UM1 et UM2, departement de Physiologie, Montpellier, France –
(2) IGF, UMR5203, U661, UM1 & 2 , Departement de cardiologie- CHU
A de Villeneuve, Montpellier, France
In a previous work using transgenic Daxx-DN mice, we showed that inhi-
bition of the Daxx-apoptotic pathway decreases infarct size and attenuates
apoptosis. Western blot analysis revealed that the ERK1/2 survival pathway
was over-activated in ischemic Daxx-DN hearts. Postconditioning, a potent
cardioprotective strategy against ischemia-reperfusion injuries, involves the
PI3K/Akt survival pathway. The aim of our study here was to investigate if
the PI3-kinase-Akt survival pathway was activated in Daxx-DN hearts sub-
jected to ischemia-reperfusion and postconditioning.
Methods: Daxx-DN mice and wild type (WT) littermates were randomly
assigned to three surgical groups: IR, 40 min.ischemia/60 min.reperfusion;
PreC: IR protocol with 3 repeted cycles of ischemia-reperfusion applied
5 min.before the severe ischemia as preconditioning stimulus; PostC: IR with
a same algorithm but applied 5 min. before reperfusion. At the end of surgery,
left ventricles were harvested and dedicated to infarct size analysis after dual
staining by phtalocyanine blue and TTC or western blot analysis after total
protein extraction or mitochondrial protein specific extraction.
Results: Daxx-DN hearts were sensitive to both cardioprotective strategies
PreC and PostC. Decrease in Infarct size upon PostC seemed to be more pro-
nounced in DN hearts than in WT. Our preliminary results showed a higher
level of Akt in mitochondrial protein fractions from Daxx-DN versus WT
hearts after both IR and PostC protocols. Phosphorylated mitochondrial Akt
was detected in Daxx-DN but not in WT hearts. Akt was reported to mediate
protection in cardiomyocytes through phosphorylation of mitochondrial hex-
okinase-II (HK-II) able to inhibit the opening of the mitochondrial perme-
ability transition pore. We are currently investigating the level of HK-II in
mutant mice.
In conclusion, our results showed that PostC and PreC offered an addi-
tional cardioprotection in Daxx-DN mutant mice lacking the Fas-Daxx apop-
totic pathway. Moreover, the protection offered by PostC seemed to be more
efficient in Daxx-DN mice than in WT animals. These effects are correlated
with an increase of Akt level and phosphorylation in mitochondrias which
could favour activation of HK-II and inhibition in turn of the opening of the
mitochondrial permeability transition pore. 
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Mitochondrial permeability transition pore opening and oxidative
stress during hypoxia-reoxygenation in adult cardiomyocytes
Rana Assaly, Clément Mompied, Alexandra D’Anglemont De Tassigny,
Alain Berdeaux, Didier Morin
INSERM U955 Equipe 03, Faculté de Médecine ,Université Paris Est Cré-
teil, Creteil, France
Background: Reactive oxygen species (ROS) participate to myocardial
Ischemia/Reperfusion injury. While many studies report close association
between this injury and mitochondrial permeability transition pore (mPTP)
opening, few reports have presented direct evidence of ROS acting as a medi-
ator of this opening. Here, we (i) designed an in-vitro model of Hypoxia/Reox-
ygenation (HYP/REOX) in order (ii) to evaluate mPTP opening and (iii) to
investigate the role of oxidative stress in this effect.
Methods: Freshly isolated adult rat cardiomyocytes were submitted to a
sequence of HYP/REOX (30, 60 or 120min of 1% HYP) to evaluate mPTP
opening by the calcein-loading Co2+quenching technique and to simulta-
neously assess cell death by propidium iodide using an inverted microscope
for fluorescence recordings. Cyclosporine A (CsA 1µM) was introduced
15min before the onset and during the first 10min of the REOX. To study the
role of ROS, an antioxidant cocktail (phenanthroline 10µM and 2-mercapto-
propionyl glycine 400µM) was introduced either like CsA or just before HYP.
ROS production was detected using dihydroethidium bromide.
Results: The percentage of cardiomyocytes exhibiting mPTP opening
during REOX was dependent on the duration of HYP (42, 85, 98% at 30, 60,
120min respectively). CsA delayed both the time to mPTP opening (from
29.6±2.6 to 63.1±6.3min; p<0.01 vs. control) and cell death following REOX
which validates the model. Antioxidants significantly increased the time to
mPTP opening (from 29.6±2.6 to 78.7±6.5min; p<0.01 vs. control) when intro-
duced just before HYP but not when introduced just before REOX and this
increase was closely associated with a drop in ROS production during HYP.
Conclusion: If it is well known that ROS highly contribute to ischemia/
reperfusion injury at the onset of reperfusion, the present data indicate that
ROS production throughout HYP is also of major importance for mPTP
opening and this phenomenon is dependent on HYP duration. 
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Pro-apoptotic role of Zac1 in the mouse myocardium during ische-
mia-reperfusion
Anne Vincent (1), Gérald Gahide (1), Catherine Sportouch-Dukhan (2),
Alicia Franck-Miclo (1), Aurélie Covinhes (1), Christelle Dantec (3), Lau-
rent Journot (3), Joël Nargeot (1), Christophe Piot (2), Stéphanie Barrère-
Lemaire (1)
(1) UMR5203, U661, UM1 & 2, Institut de Génomique Fonctionnelle,
departement de physiologie, Montpellier, France – (2) Institut de Génomi-
que Fonctionnelle- CNRS UMR 5203-INSERM U661- UM1 et UM2,
Departement de cardiologie- CHU A de Villeneuve, Montpellier, France –
(3) Institut de Génomique Fonctionnelle- CNRS UMR 5203-INSERM
U661- UM1 et UM2, GenomiX platform, Montpellier, France
Zac1, known as a tumor suppressor gene, was jointly down-regulated at the
transcriptional level upon Preconditioning and postconditioning versus
ischemia-reperfusion (IR) (pangenomic microarrays). The aim of our study
was to study the role of Zac1 during myocardial IR in mice in vivo. 
Methods: C57Bl6, Zac1 KO and wildtype mice underwent an IR (40 min.
ischemia/60 min.reperfusion) protocol. C57Bl6 mice were assigned to: IR,
PostC (postconditioning: a stimulus of 3 cycles of 1-min. reperfusion-reocclu-
sion applied at the onset of reperfusion); and PreC (preconditioning, same
algorithm applied but before ischemia). At the end of surgery, left ventricles
were assigned to RNA extraction, infarct size assessment or immunohis-
tochemistry using TUNEL staining and anti-Zac1 antibodies. Mouse oligo
microarrays were used for gene expression profiling. Determination of area at
risk (AR) and infarct size was assessed by TTC staining. 
Results: Zac1 was jointly down-regulated at the transcriptional levels upon
PreC and PostC. Zac1 protein levels were decrease by the same extent in
PostC and PreC hearts. 8% of the Zac 1-positive nuclei were positive to the
TUNEL staining. Furthermore, infarct size/AR was decreased in +/-pat and -/-
Zac1 KO mice subjected to myocardial IR. 
Conclusion: Our study showed that downregulation both at the transcrip-
tional and protein levels of Zac1 leads to cardioprotection against IR and sug-
gests that Zac1 plays a key role in ischemia-reperfusion injuries in the mouse
myocardium. 
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BH4 peptide attenuates ischemia/reperfusion injury in mouse hearts
Prisca Boisguerin (1), Alicia Franck (2), Aurélie Covinhes (2), Stéphanie
Barrère-Lemaire (2), Bernard Lebleu (1)
(1) UMR5235 CNRS, Dynamique des Interactions Membranaires Norma-
les et Pathologiques, Montpellier, France – (2) Institut de Génomique
Fonctionnelle, , UMR 5203, U661, Université Montpellier 1, 2, Montpel-
lier, France
Acute myocardial infarction (AMI) is a frequent and disabling disease, and
infarct size is a major determinant of myocardial functional recovery and mor-
tality after AMI. Lethal reperfusion injury is caused by restoration of coronary
blood flow after an ischemic episode. This phenomenon culminates in apop-
totic death of cardiac cells that were viable immediately before myocardial
reperfusion. The involvement of a highly regulated form of cell death during
myocardial ischemia/reperfusion (I/R) may lead to novel therapeutic interven-
tions in the reperfusion phase.
Recently, Ono and co-worker [1] showed that a BH4-peptide (derived from
the BH4 domain of the Bclx-L protein) prevents apoptosis when coupled to the
TAT [2] cell penetrating peptide (CPP). CPP are short peptides, able to pene-
trate cell membranes and to translocate different cargoes into cells [3]. Beside
conventional CPPs such as TAT, a new generation of synthetic CPPs such as
(RXR) 4 [4], Bpep [5] or Pip2B [6] were developed together with our co-
workers to improve the internalisation properties of the CPP-cargo conjugates.
Here, we present our new results on the anti-apoptotic effect of BH4-peptide
coupled to these CPPs and provide insights into their intracellular trafficking.
Transduction efficiency was assessed by flow cytometry and by laser scanning
confocal microscopy. Biological activity was tested in vitro as the ability to pro-
tect primary mouse cardiomyocytes from death induced by staurosporine and in
vivo using wild-type mice submitted to an ischemia/reperfusion protocol (40
minutes of left coronary artery occlusion and 60 minutes of reperfusion).
Our findings demonstrate that CPP-BH4 peptide conjugates promote an
anti-apoptotic activity both in vitro and in vivo, and imply that they may
become useful therapeutic agents for clinical application.
1. Ono, M., et al., Eur J Cardiothorac Surg, 2005. 27(1): p. 117-21.
2. Vives, E., P. Brodin, and B. Lebleu, J Biol Chem, 1997. 272(25): p. 16010-7.
3. Lebleu, B., et al., Adv Drug Deliv Rev, 2008. 60(4-5): p. 517-29.
4. Abes, S., et al., J Control Release, 2006. 116(3): p. 304-13.
5. Jearawiriyapaisarn, N., et al., Mol Ther, 2008. 16(9): p. 1624-9.
6. Ivanova, G.D., et al., Nucleic Acids Res, 2008. 36(20): p. 6418-28.
0177
Cyclosporine A cannot postcondition the ischemic rat heart due to
insufficient inhibition of mitochondrial permeability transition pore
opening at reperfusion
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Background: Cyclosporine A (CsA), that inhibits the opening of the mito-
chondrial permeability transition pore (mPTP), can reduce infarct size in in
vivo rabbits, mice, and even in humans. Unlike ex vivo, infarct size reduction
by CsA postconditioning has however been equivoqual in the in vivo rat heart.
Aim: We questioned whether this might be due to poor inhibition of mPTP
opening at the time of reperfusion.
Methods: Adult male Wistar rats underwent 30-min coronary occlusion
followed by 2 h of reperfusion (I/R). They were randomly assigned (n=7/
group) to one of 4 experimental groups. “Sham” rats received no I/R. “Con-
trol” rats received I/R with no additional intervention. “Pre-CsA” group
received an IV bolus of 10 mg/kg CsA, 10 min before Ischemia. “Post-CsA”
group received an IV bolus of 10 mg/kg CsA, 5 min before reperfusion. At the
end of reperfusion, area at risk and infarct size were quantified by blue dye
injection and TTC staining. Four additional groups of (n=7/group) rats under-
went a similar protocol. Yet at 15 min of reperfusion, myocardium from the
area at risk was harvested for isolation of mitochondria and assessment of in
vitro calcium-induced mPTP opening using the Ca2+ retention capacity (CRC)
technique (fluorimetry). 
Results: Infarct size (62±3% of risk region in control) was significantly
reduced in the Pre-CsA (24±5%) but not in Post-CsA group (52±2%). CRC
was significantly improved in Pre-CsA group (382±27) versus control group
(217±26 nmoles CaCl2/mg prot). In contrast, CRC was not increased in the
Post-CsA group (227±36). Moreover, addition of 1µM CsA in the cuvette sig-
nificantly increased CRC in Pre-CsA, but neither in control nor in Post-CsA
mitochondria.
Conclusion: In this in vivo rat model, preconditioning but not postcondi-
tioning by CsA reduced infarct size. CRC experiments suggest that failure of
Post-CsA to reduce infarct size may be related to the fact that mPTP opening
might not be prevented when CsA is administered late after the onset of
ischemia.
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Essential role of endothelial ERalpha in the coronary and myocardial
protective effects of estradiol in ischemia/reperfusion
Julie Favre (1), Jean-Paul Henry (2), Isabelle Fourquaux (3), Christian
Thuillez (2), Françoise Lenfant (1), Jean-François Arnal (1), Vincent
Richard (2)
(1) INSERM U858, I2MR – Equipe 9, Toulouse, France – (2) INSERM
U644, Rouen, France – (3) CMEAB, Toulouse, France
Rationale: Estradiol (E2) exerts protective effects in cerebral and cardiac
ischemia (I) /reperfusion ®. Cardiac I/R affects both myocardial and coronary
endothelial cells, however the implication of the endothelium in the protective
action of E2 in vivo as well as the cellular targets of the anti-ischemic effects
of E2 are unknown. 
Objectives: To assess the coronary endothelial protective effects of E2 in
I/R, and the role of estrogen receptor α (ERα) in this setting. 
Methods and results: mice were subjected to 30 min I-1 hour R in vivo,
after which acetylcholine-induced relaxation of isolated coronary segments
was assessed ex vivo. E2 did not affect endothelial function in normal mice.
I/R induced a coronary endothelial dysfunction in untreated ovariectomized
(Ovx) mice, that was prevented by chronic E2. This endothelial protective
effect of E2 was absent in ERα-/- mice. E2 also significantly limited the inf-
arct size compared to untreated Ovx mice. Post-ischemic coronary endothe-
lial function of chimeric mice inactivated for ERα in the hematopoietic
compartment remained protected by E2, as observed for infarction. Further
inactivation of endothelial ERα (using a Tie2-Cre recombinase to inactivate
ERα in both endothelium and hematopoietic cells) abolished the protective
action of E2 on both coronary endothelial function and on infarct size limi-
tation. 
Conclusion: Endothelial ERα plays a crucial role in E2-induced endothe-
lial and myocardial protection after I/R. We demonstrate for the first time
using genetically modified mice, that targeting endothelial protection per se
can confer cardiomyocyte protection in I/R. 
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Cardiac fibroblasts protect cardiomyocytes from simulated ischemia
reperfusion injury through paracrin mechanisms
Maryline Abrial, Claire Crola, Fabrice Ivanes, Souhila Benhabbouche,
Denis Angoulvant, Michel Ovize, René Ferrera
INSERM, U886, Lyon, France
Objectives: Cardiac fibroblasts (CF) are the largest cell population of the
heart. We hypothesized that CF, may be implicated in endogenous cardiopro-
tection against ischemia reperfusion injury. 
Method: Neonatal rat cardiomyocytes (NRC) and CF were isolated from 2
days old Wistar rats hearts and cultured separately. They were subsequently co
cultured either with direct cell contact in the same culture dish or indirect cell
contact using a semi-permeable cell culture insert containing CF in the NRC
culture dish. Isolated cell culture and co cultures were subjected to 3 hours of
simulated ischemia followed by 20 hours of simulated reperfusion (n=5/
group). At the end of reperfusion, MTT cell viability assay was performed as
well as LDH and troponin I measurement to quantify cell death. Data are
means ± SEM. Group comparison was performed by 1 way ANOVA. 
Results: Compared to isolated NRC alone, direct co culture groups showed
up to 60±10% reduction of cell death. Indirect co culture groups showed the
same level of protection suggesting a paracrin effect (Figure 1). Analysing dif-
ferent cell ratio of CF/NRC we observed that the highest protection was
obtained with a 1:1 co culture ratio suggesting a dose response effect. Both
cell viability and cell death assays showed concordant results. 
Conclusion: Our data suggest for the first time, that CF may participate in
endogenous cardioprotection against ischemia reperfusion injury. They sug-
gest that this protection may be mediated by paracrin mechanisms with a dose
response pattern. In our model, the highest protection was observed with a 1:1
co culture ratio of CF and NRC.
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Simulated urban carbon monoxide air pollution exacerbates rat heart
ischemia-reperfusion injury: implication of NO pathway
Grégory Meyer (1), Lucas Andre (2), Stephane Tanguy (1), Charlotte
Farah (1), Sandrine Gayrard (1), Sylvain Richard (2), François Boucher
(3), Olivier Cazorla (2), Philippe Obert (1), Cyril Reboul (1)
(1) Université d’Avignon, EA4278, Avignon, France – (2) U637, Montpel-
lier, France – (3) UMR5525, Grenoble, France
Carbon monoxide (CO) is a ubiquitous environmental pollutant, which has
been correlated with mortality and morbidity from cardiovascular diseases. In
a previous study, we highlighted that CO exposure exacerbated ischemia-rep-
erfusion (IR) injuries. The aim of this study was to investigate the potential
implication of cardiac NO pathway on the deleterious effects of prolonged CO
exposure on myocardial sensitivity to IR.
After 4 weeks of low level CO exposure, regional myocardial IR on iso-
lated, Langendorff buffer perfused, rat heart was performed. This IR protocol
was performed in presence or not of S-methyl-isothiourea (SMT, 1µM) a spe-
cific iNOS inhibitor. In addition, an isolated cardiomyocyte anoxia-reoxygen-
ation protocol was performed with or without SMT. The effects of CO
© Elsevier Masson SAS. All rights reserved.
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exposure on myocardial eNOS and iNOS expression as well as eNOS uncou-
pling and total NO production were also evaluated. 
The first result of this study is that, despite the monomerization of eNOS,
myocardial NO production was markedly increased in CO rats when compared
to Ctrl ones. In presence of SMT, this increased myocardial NO production
was blunted, suggesting therefore a major implication of iNOS. In addition,
iNOS inhibition markedly prevents the deleterious effects of CO exposure on
myocardial sensitivity to IR, which was characterized by a reduced infarct size
in CO group perfused with SMT (29% vs. 51% of risk zone). This result may
be explained by the prevention of the deleterious effects of CO on Ca2+ han-
dling observed at the cellular level in presence of SMT. This study highlights
the implication of increased iNOS expression, which leads to an excessive pro-
duction of NO and thus an increase formation of reactive nitrogen species, in
the exacerbated IR injuries observed consecutive to a simulated urban carbon
monoxide air pollution exposure. 
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Cardioprotection of cyclosporine A at reperfusion requires an active
Kallikrein Kinin System in mouse
Gina Youcef, Marie-Pascale Vincent, Georges Zadigue, Christine Richer-
Giudicelli, François Alhenc-Gelas, Anne Pizard
UMRS 872, équipe 2, Paris, France
Background: Cardioprotective strategies, called postconditionning, that
modify the conditions of reperfusion and limit lethal reperfusion injury could
have a major clinical potential in acute myocardial infarction because reperfu-
sion is far more modifiable than ischemia. The calcineurin inhibitor Cyclospo-
rine A (CsA) reportedly reduces myocardial infarct size when given
exogenously at reperfusion in mouse as well as in human. Bradykinin (BK) is
equally protective in mouse suggesting that both molecules might share the
same intracellular pathways. CsA and BK are indeed able to modulate the
opening of the mitochondrial Permeability Transition Pore (mPTP) to trigger
their cardioprotection effects during ischemia-reperfusion (IR). Our study
investigates for the first time whether in mouse the System Kallikrein Kinin
(SKK) is involved in the cardioprotection afforded against IR by CsA using
Tissue Kallikrein deficient mice (TK-/-) and their wild-type littermate (TK+/+).
Methods and Results: A branch of the left main coronary artery was
reversibly ligated in mice to produce 30-min-ischemia followed by reperfusion
(120 min), after which the degree of myocardial necrosis (infarct size (IS) as
a percent of area at risk (AAR)) was assessed by measuring the AAR and IS
using a computerized videoplanimetry after Evans Blue and triphenyltetrazo-
lium chloride staining respectively. Over one-year-old male mice of the two
genotypes, TK+/+ and TK-/- were divided in two groups receiving (5 min before
the reperfusion, i.v.) either the vehicule or 10 mg/kg of CsA. As expected,
CsA (10mg/kg) started 5 min prior to reperfusion reduced infarct size from IS/
AAR= 35.4±3.4% (n=5) of the ischemic zone in Ct-TK+/+ hearts to IS/AAR
=14.4±3.1% (n=4; P=0.01) in Csa-TK+/+ hearts. Interrestingly, preliminary
results showed that CsA is unable to reduce the infarct size in TK-/- mice (Ct-
TK-/- IS/AAR= 33.4±8.2%, n=5, vs CsA-TK-/- IS/AR= 27.3±6.5%, n=6) sug-
gesting that the protective effets of CsA are abolished in absence of the TK.
Conclusions: Although at present, the molecular mechanisms of CsA post-
conditionning are unclear, our preliminary results suggest that the presence of
the normal level of TK in mice is essential in the cardioprotective effets of
CsA at reperfusion.
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Platelet count on admission predicts. 
Severe microvascular obstruction in patients with reperfused ST-ele-
vation myocardial infarction
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Delépine (1), Fabrice Prunier (1), Alain Furber (1)
(1) UPRES 3860, Cardiologie CHU Angers, Angers, France –
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Objectives: To elucidate the clinical and biological factors related to the
development of microvascular obstruction (MVO) following successful pri-
mary transcutaneous coronary angioplasty in patients with acute ST-elevation
myocardial infarction (STEMI).
Background: Reperfusion injury is associated with poor functional and
clinical outcomes. It is still unknown if the extent of microvascular obstruc-
tion, as assessed by quantitative contrast-enhanced magnetic resonance
imaging (CE-MRI), is related to different clinical and biological factors.
Method: CE-MRI was performed on Day 5 and after a period of 3 months
in 77 patients with STEMI who underwent successful coronary reperfusion
with primary coronary angioplasty within 12 hours of the onset of symptoms.
Patients were classified into four groups based on the MVO mass quartiles, the
fourth quartile presenting a MVO>3.0850g.
Results: A total of 44 patients exhibited MVO. The fourth quartile was
associated with significantly greater infarct size, lower rate of preinfarction
angina, higher rate of clinical inflammatory response (including pericardial
effusion), and left anterior descending (LAD) artery culprit location, as well as
higher platelet counts on admission. Multivariate logistic regression analysis
revealed that platelet count on admission, absence of preinfarction angina, and
peak creatine kinase were the only independent predictors of severe microvas-
cular injury. Peak creatine kinase >4000IU/l and a platelet count >290Giga/l
were the only independent predictors of left ventricular end-systolic volume
index (LVESVI) >70ml/m2.
Conclusions: Platelet count on admission is a new predictive factor asso-
ciated with impaired microvascular reperfusion and poor functional recovery
after primary coronary angioplasty.
Quantitative assessment of MVO
0011
Silent cerebral after cardiac catheterization as detected by diffusion
weighted Magnetic Resonnance Imaging: a randomized comparaison
of radial and femoral approaches
Guillaume Coutance (1), Janusz Lipiecki (2), Didier Carrié (3), Francesco
Burzotta (4), Michèle Hamon (5), Rémy Morello (6), Sabine Fradin (7),
Martial Hamon (1)
(1) CHU Caen, Soins intensifs cardiologiques, Caen, France – (2) CHU
Clermont Ferrand, Cardiologie, Clermont Ferrand, France – (3) CHU de
Toulouse, Cardiologie, Toulouse, France – (4) Catholic University of the
Sacred Heart, Roma, France – (5) CHU de Caen, Radiologie, Caen,
France – (6) CHU de Caen, Biostatistiques, Caen, France – (7) CHU de
Caen, Biochimie, Caen, France
Background: Studies suggest that asymptomatic cerebral infarction detect-
able by DW-MRI might exist after PCI with a frequency as high as 15 to 22%
of cases. We have set up a prospective multicenter trial to assess the rate of
silent cerebral infarction after cardiac catheterization and to compare the
impact of the arterial access site (femoral versus radial access) upon it.
Study design: This prospective study has been performed in patients with
severe aortic stenosis. To assess the occurrence of cerebral infarction, all
patients underwent cerebral DW-MRI and neurological assessment within 24
hours before and 48 hours after cardiac catheterization, and retrograde cath-
eterization of the aortic valve. Randomization for the access site was per-
formed before coronary angiography. The primary end-point of the study
was a direct comparison of ischemic cerebral lesions as detected by serial
cerebral DW-MRI between patients explored either by radial or femoral
access. 
Results: One hundred and sixty five patients were randomized. Ninety five
percent of the patients had the complete protocol (157 patients, 77 femoral
access, 80 radial access). All clinical characteristics were similar in both
groups. The second MRI revealed at least one new ischemic lesion in twenty
five patients (15.9%); 9 (11.7%) with femoral access, 15 (18.8%) with radial
access (p=0.22). All these new ischemic lesions were asymptomatic. In sub-
studies analyses, no difference between radial and femoral access were found
considering the number of HITS (High intensity transient signals) as assessed
by transcranial Doppler, serum S-100B protein levels or neuropsychological
assessment (Mini Mental State Evaluation, MMSE).
Conclusion: In this prospective trial, we did not find any difference in the
rate of silent brain infarct comparing radial and femoral access in patients with
severe aortic stenosis undergoing cardiac catheterization with retrograde cath-
eterization of the aortic valve. 
Study registration: NCT 00329979
0451
Impact of diverting off-hours calls to emergency medical dispatch
centers on time delays and acute revascularization procedures for
patients with acute myocardial infarction. Data from RICO survey
Francois Dumont (1), Luc Lorgis (2), Aurélie Gudjoncik (2), Jean-Noël Beis
(1), Gilles Dentan (3), Jean-Claude Beer (2), Gilles Morel (1), Marianne
Zeller (4), Marc Freyz (4), Yves Cottin (2)
(1) Université de Bourgogne, Département de Médecine Générale, Dijon,
France – (2) CHU Dijon, Service de Cardiologie, Dijon, France – (3) Cli-
nique de Fontaine, Fontaine Les Dijon, France – (4) CHU Dijon, Dépar-
tement d’Anesthésie Réanimation, Dijon, France
Background: Since 2005, French health act raise public emergency med-
ical dispatch centers (EMDC) as the first and unique contact for patients
requesting medical help after hours. This study aimed to analyze the impact of
diverting after hours calls to an EMDC on time delays and revascularization
procedures for patients with acute myocardial infarction in the Côte d’Or
French department.
Methods: The RICO survey prospectively collects key data on all hospital-
izations for AMI in the department. It provided data from 2001 to 2008.
Demographic features, cardiovascular risk factors, personal and familial his-
tory, clinical and hemodynamic features were gathered on admission. Acces-
sibility statistics were calculated for every district in the area. The study also
addressed time delays. Two groups were analyzed: before redirecting to
EMDC (2001-2004) and after redirecting to EMDC 
(2005-2008). 
Results: Of the 6717 patients admitted 2001, 3199 (48%) were admitted
before redirecting to EMDC and 3518 (52%) after redirecting to EMDC.
Accessibility to health care structures was not significantly different. The
rates of off-hours calls remained stable while the rate of calls made to
EMDC increased significantly from 42% to 58% (p< 0,001). The median
delay from first intervention to hospital admission decreased from 104 min-
utes to 90 minutes (p<0.001) and the median interval from first call to
intensive care unit admission dropped from 76 minutes to 60 minutes
(p<0.001). 
Conclusion: In the setting of real world, improving the quality of prehos-
pital organization is effective and successful in reducing delays and access to
revascularization.
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Low pressure reperfusion is able to protect ischemic heart even after
the initiation of reperfusion
Souhila Benhabbouche, Claire Crola, Maryline Abrial, Fabrice Ivanes,
Michel Ovize, René Ferrera
INSERM, U886, Lyon, France
Objectives: The aim of this study was to evaluate whether the maneuver
of low pressure reperfusion may be protective against myocardial infarction
when applied after the initiation of reperfusion. 
Method: Isolated rat hearts (n=135) underwent 40 minutes of global
ischemia at 37°C followed by 60 minutes of reperfusion on Langendorff appa-
ratus. Hearts were randomly assigned into the 9 following groups: Control (no
intervention), postconditioning (POST, 2 episodes of 1 min ischemia and rep-
erfusion), and low pressure reperfusion (LPR, consisting in reduction of per-
fusion pressure at 70 cm H2O). In subgroups, POST and LPR were applied
after a delay of 3, 10 and 20 minutes. 
Results: As expected, infarct size (TTC staining) and LDH release were
lower in LPR and POST versus controls (P<0.01) whereas functional parame-
ters (coronary flow, rate-pressure-product) were improved (P<0.01). While the
POST delayed beyond 3 min of reperfusion lost its efficacy, LPR allowed sur-
prisingly a reduction of necrosis (less infarct size and LDH release) even after
3 and 10 minutes of reperfusion (P<0.01). This delayed cardioprotection of the
BPR was correlated with better functional recovery and mitochondrial respira-
tory index. Furthermore, calcium overload necessary to induce MPTP opening,
was similar in all cardioprotected groups, suggesting a crucial role of MPTP
in this delayed protection. 
Conclusion: In relation with MPTP opening inhibition, LPR may exert an
efficient postischemic cardioprotection, even if its application is delayed up to
10 minutes after the initiation of reperfusion.
0448
Patent foramen ovale closure limits recurrence of cryptogenic stroke:
MRI-based long-term follow-up study
Patrice Guérin (1), Thibaut Manigold (2), Benoît Guillon (3), Hubert
Desal (4), Elisabeth Auffray-Calvier (4), Jean-Marc Langlard (2), Béatrice
Delasalle (1), Renaud Fressonnet (2), Nicolas Piriou (2), Dominique Cro-
chet (1)
(1) INSERM, UMR915, l’Institut du Thorax, , Cardiologie Intervention-
nelle, 44035 Nantes Cedex 01, France – (2) CHU Nantes, l’Institut du
Thorax, Service de Cardiologie, Nantes, France – (3) CHU Nantes, Ser-
vice de Neurologie, Nantes, France – (4) CHU Nantes, Service de Neuro-
radiologie, Nantes, France
Background and purpose: Patients with cryptogenic stroke and patent
foramen ovale (PFO), especially when associated with atrial septal aneurysm
(ASA), are at risk of recurrent cerebrovascular events. This study seeks to
assess long-term outcome in cryptogenic stroke patients, based on clinical and
MRI evaluation, because transient ischemic attacks (TIA) or stroke may be
asymptomatic.
Method: 72 consecutive patients, under 55 years of age, with ischemic
stroke and PFO and associated ASA or large PFO with spontaneous right-to-
left shunts, closed percutaneously, were assessed at least one year after clo-
sure. Follow-up included cardiac and neurological assessment, contrast tran-
sthoracic echocardiography (TTE), contrast transcranial doppler (TCD) and
cerebral MRI. 
Results: Data were available in 71 patients (40.5±9.0 years; sex ratio: 1.5).
Percutaneous PFO closure was successful in all patients; ASA was observed
in 90.1%. At a mean follow-up of 17.8±8 months, no stroke recurrence was
noted, clinically or on MRI. Residual shunt was absent on contrast TTE in
83.8% of cases, and in 65.6% after Valsalva, dropping to 65.2% and 24.6%
respectively using TCD, with a majority of small shunts (Figure 1). Final clin-
ical follow-up, at 3.0±1.1 years, found no stroke recurrence. 
Conclusion: Percutaneous PFO closure associated to long-term antiplatelet
therapy seems safe, avoiding further symptomatic or asymptomatic ischemic
events, despite small residual shunts. To the best of our knowledge, this is the first
study to assess ischemic stroke recurrence from clinical signs and MRI follow-up
0384
Systematic review of drug-eluting stents effectiveness and efficiency –
recommendations for clinical use from the French national health
authority
Emmanuelle Schapiro, Fabienne Midy, Elodie Velzenberger, Hubert Gal-
miche, Catherine Denis, Catherine Rumeau-Pichon
Haute Autorité de Santé (HAS), Service de l’évaluation des dispositifs,
Saint-Denis-La-Plaine, France
Objectives: The French National Authority for Health (HAS) assessed the
efficacy, safety, and efficiency of drug-eluting stents (DES) in response to data
indicating a greater incidence of very late intra-stent thrombosis in non-
selected, DES-implanted patients compared to Bare-Metal Stents (BMS). 
Methods: Systematic literature review, clinical meta-analysis and cost-
effectiveness study were performed and discussed by a working group. Cri-
teria to assess efficacy and safety were: clinically documented target lesion
revascularisation (TLR), intra-stent thrombosis, death and myocardial infarc-
tion. Efficiency assessment was based on the cost per TLR avoided. A total of
105 studies, comparing DES to other available therapies, were analysed in dif-
ferent subpopulations.
Results and conclusions: In the non-selected patient group, no benefit
(especially economic) from DES implantation was observed. In a selected sub-
group, DES reduced the need for TLR. The number of patients needed to treat
to avoid one revascularisation was on average 7 to 14. DES was not associated
with an increased risk of safety during the follow-up (≤ 4 years). DES effi-
ciency varies according to clinical and lesion characteristics and is highly
dependent on the price difference between DES and BMS.
HAS recommends limiting DES use in subgroups of patients at high risk of
restenosis (lesion length > 15 mm, vessel diameter < 3 mm or diabetic patients).
For special situations (total coronary occlusion, first BMS intrastent rest-
enosis, some multi-vessel lesions in native coronary arteries with high risk of
restenosis when the surgical risk is high, unprotected left main stenosis), DES
may be considered after a joint medical-surgical discussion. DES requires pro-
longed dual antiplatelet therapy, increasing the risk of post-surgical bleeding.
In other indications for angioplasty, BMS should be favoured. 
© Elsevier Masson SAS. All rights reserved.
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ECG recorded at discharge in patients treated with primary PTCA
for acute myocardial infarction gives a better prediction of long-term
cardiac death than ECG recorded 1 or 24 hours after reperfusion
Frédéric Treguer (1), Idrissa Toure (2), Wissam Abi-Khalil (1), Fabrice
Prunier (1), Alain Furber (1)
(1) UPRES 3860, Laboratoire Protection et Remodelage Myocardique,
Université d’Angers et Service de Cardiologie, CHU d’Angers, Angers,
France – (2) CHU ANGERS, Service de Cardiologie, Angers, France
Background: Assessment of the sum of early resolution of ST-segment
elevation (sum STR) and maximum deviation in single lead (max STE) have
been shown to have prognostic significance 90–180 minutes after reperfusion.
However, the prognostic impact of 24 hour or discharge ECG after myocardial
infarction is unclear.
Objectives: We sought to determine whether long-term, prognostically
useful information could be obtained from a 24 hour or discharge ECG after
primary or rescue PTCA.
Methods: An electrocardiographic study of 261 consecutive patients
(between Januar and December 2005) with acute myocardial infarction treated
by PTCA was undertaken. 12-lead ECG was assessed at baseline, 1 hour and
24 hours after reperfusion, and at discharge. Max STE was identified on each
ECG. Sum STR was determined between the three later ECGs and the baseline
ECG.
Results: The mean patient follow-up was 43 ± 15 months. By univariate
analysis, max STE on the discharge ECG was associated with increased car-
diac death (OR=2.361, 95%CI 1.017–5.485, p=0.046), heart failure
(OR=2.968, 95%CI 1.095–8.050, p=0.033) and composite end-points (all-
cause death, myocardial infarction and heart failure) (OR=2.270, 95%CI
1.079–2.280, p=0.006). By multivariate analysis, max STE (≥2 mm) on the
discharge ECG remained a significant independent predictor of cardiac death
(OR=2.952, 95%CI 1.269–4.062, p=0.047), heart failure (OR=4.073, 95%CI
1.109–14.953, p=0.034), and composite end-point (OR=3.157, 95%CI 1.556–
6.407, p=0.001). 
Conclusions: Max STE predicts long-term cardiac death more accurately
than sum STR. The prognosis of an individual patient can be determined more
accurately from the max STE identified on an ECG recorded at discharge after
reperfusion.
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Hemorrhagic Risk Of Different Perioperative Anticoagulation Proto-
cols In Patients Implanted With A Cardiac Pacemaker Or Defibrillator
Walid Amara, Ikram Benyoussef, Jad Kamel, Fabien Monsel, Jacky Sergent
GHI Le Raincy-Montfermeil, Sce Cardiologie, Montfermeil, France
Background: Perioperative management of anticoagulation in patients
referred for pacemaker or cardiac defibrillator implantation isn’t consensual. Our
objective was to evaluate, in a large cohort, hemorrhagic complications in
patients having implantation or replacement of a cardiac pacemaker or defibril-
lator, and to assess perioperative anticoagulation effect on hemorrhagic risk.
Methods and Results: A cohort of 461 consecutive having implantation or
replacement of a cardiac pacemaker or defibrillator has been analyzed. Thirty
patients (6.5%) had oral anticoagulants (OAC) switched to heparin/low-molec-
ular-weight heparin, while 76 (16.5%) had their oral anticoagulation disrupted
habitually for 48 hours. A total of 6/30 (20%) and 2/76 (2.6%) patients in the
bridge and OAC, respectively experienced a pocket hematoma (bridge vs.
OAC, p<0.05), while 10/355 (2.8%) had a pocket hematoma in the control
group (bridge vs. control p=0.006). Duration of the hospital stay was longer in
the bridge group in comparison with OAC and control groups (9 vs. 7 vs. 6
days respectively; p=0.006).
Conclusions: Oral anticoagulation bridging with heparin or low-molecular-
weight heparin is associated with a higher risk of pocket hematoma and a
longer duration of hospitalization, in comparison with a strategy allowing a
temporary disruption of OAC adapted to the thrombo-embolic risk. 
0108
Risk factor for pacemaker infection: a case-control study
Benoît Herce, Raphaël Sandras, Francois Lesaffre, Pierre Nazeyrollas,
Angeline Martin, Jean-Pierre Chabert, Huu Tri Bui, Sophie Tassan,
Damien Metz
CHU Reims, Reims, France
Introduction: In the past few years, there has been a significant increase
in the number of pacemaker (PM) implantations and an even greater increase
of PM infections. Within this context, we have conducted a case-control study
in order to define the risk factors for pacemaker infection.
Methods: Our study population included all of the patients hospitalized in
our department for a first PM implantation between October 1996 and July
2007. Each patient with a PM infection during hospitalization or during
follow-up was matched with 2 control subjects in the same population,
according to sex, age and date of implantation. The patient’s medical history
and peri-operative data were used in univariate and multivariate analysis to
assess risk factors for PM infection.
Results: Primary pacemaker implantation was performed in 2496 patients
and 372 replacements during follow-up were done. We found 35 PM related
infection and matched 70 controls. The infection rate was 1.4% per implanted
patient and 1.2% per procedure during a mean follow up of 918 [6-3428] days.
The mean delay between PM implantation and infection was 322 days with a
median of 86 days. A germ was identified on culture’s device in 40% of the
cases, 50% were staphylococcus aureus. PM leads were removed percutane-
ously in 97% of the patients, one patient required surgical removal. 
Diabetes mellitus (p=0.002), heart disease (low ejection fraction, valvular
disease, previous heart surgery) (p=0.047), additional procedures related to
PM implantation (temporary pacing, electrophysiological test, high frequency
ablation) (p=0.05), dual-chamber pacing (p=0.016) and early complications
(hematoma, leads displacement), which occurred in none of the controls, were
related with PM infection in univariate analysis.
Among these, diabetes mellitus (p=0.045; OR=3.65), history of heart dis-
ease (P=0.028; OR=3.12) and dual-chamber pacing (p=0.021; OR=4.07), were
independently associated with PM infection.
Conclusion: In our study, cardiac device infection rate was relatively low,
early local complications, diabetes mellitus, history of heart disease and dual-
chamber pacing, appeared as risk factors for PM infection.
0145
RV Septal Pacing in Clinical Practice: Long-Term Results of the
NOVUS Septal Study
Jean-Pierre Cebron (1), Daniel Gras (1), Marc Burban (1), Marc Hero (2)
(1) Nouvelles Cliniques Nantaises, Nantes, France – (2) Medtronic
France, CRDM, Boulogne-Billancourt, France
Background: Numerous studies have shown right ventricular (RV) apical
pacing to have a negative effect on hemodynamics, leading to the consider-
ation of an alternative pacing site, such as septal placement. 
Objective: The aim of the Novus Septal Study, is to evaluate the long-term
performance of the Novus 5076 RV lead (Medtronic, MN, USA), when
implanted at the RV septum in routine practice.
Methods: Implantation of a RV septum lead was performed in 560 consec-
utive patients (Male 64%, average age 76 +/- 8 years), due to AV block in
69%, sinus node disease in 27% and drug refractory Heart Failure symptoms
in 4%. A single-, dual- or triple-chamber pacemaker device was used in 17%,
79%, and 4% of the cases respectively. Appropriate RV Septal lead posi-
tioning was validated by using per-operative LAO 30° projection (in 93%)
and/or negative Q wave deflection in Lead I (68%). Time duration of RV lead
placement was recorded at implant. Electrical RV lead parameters, including
Lead impedance (LI), Pacing Thresholds (PT) and R wave sensing (RWS),
were systematically monitored at 1 and 5 mn after implantation and at 3 month
follow up (FU).
Results: Long-term RV septal pacing could not be achieved in 20 patients
(4%), due to failure in positioning the RV lead at septum in 15 (finally
implanted at the apex), to lead dislodgement in 3, to increase in PT in 1 and
low sensing in 1, as recorded at 3 month FU. 
Remaining patients were divided into 4 subgroups, based on the methods
selected to validate RV septal lead placement with the results as shown here-
under: decreasing of impedance at 3 month FU for all groups (p<0.001)
 Conclusion: Long-term reliable RV septal pacing can be achieved in rou-
tine (96%) patients with standard indications for cardiac pacing or CRT. There
is no difference for RV septal duration during implant between all groups
(median Mood test). RV Septal lead pacing and sensing thresholds remain
stable over time, while lead impedance can potentially decrease. 
0149
The Automatic Atrial Capture Management:
Results of The CASA Study
Jean-Luc Rey (1), Marc Hero (2)
(1) CHU Hôpital SUD, Amiens, France – (2) Medtronic France, CRDM,
Boulogne-Billancourt, France
The CASA study has included 297 patients in France implanted with an
EnPulse® dual chamber pacemaker (Medtronic, Minneapolis, USA). Purpose
of this study is to compare manual atrial threshold (MAT) and threshold
assessed by the automatic atrial capture management function (ACM).
Methods: Patients are 76 +/- 10 years old; indications were atrio-ventricular
block (AVB) 70% and sinus dysfunction (SD) 30%; 31% had paroxystic atrial
arrhythmias before implantation. Measurement of P wave, manual atrial
threshold and atrial lead impedance have been performed at implantation, before
discharge, 6 to 12 weeks after and at 6 months follow-up. At each follow-up
automatic atrial thresholds are collected by interrogation of the device via telem-
etry and compared with the manual values by R coefficient correlation test.
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Results: P wave amplitude and atrial lead impedance are stable during
follow-up without significant difference. Concerning atrial thresholds, there is
no difference between manual and automatic thresholds at each follow-up. R
coefficients are very high showing an excellent correlation between the two
methods. 
 Conclusion: We are observed a very good correlation between atrial
threshold assessed by automatic atrial capture management function and
manual atrial threshold test. 
0186
Comparison per-operative and intra-individual ventricular pacing
parameters between apex and septo-basal positionning
Bouchaïb Deriouich (1), Marc Hero (2)
(1) Centre Hospitalier Général d’Evreux, Evreux, France – (2) Medtronic
France, CRDM, Boulogne-Billancourt, France
Apex pacing of the right ventricle (RV) disrupts the left ventricular contrac-
tility sequence. It can therefore generate an intra-ventricular and/or inter-ventric-
ular dyssynchrony. Proximal septal pacing of the RV can be considered as an
alternative to apex stimulation. The aim of this study is to compare the intra-
operative feasibility of both methods, safety and stability of septal stimulation
parameters before leaving the hospital, at one month and at 6 months follow-ups.
Methods: 128 patients were implanted with single or dual chamber pace-
maker for conduction disorders or sinus dysfunction. The bipolar active lead
was initially positioned at the apex of the RV and permanently at the proximal
septum of the RV. Septal position was confirmed by scopy (AP and LAO
45°). The positioning time and the scopy duration were notified. Electrical
lead parameters, including lead impedance (LI), pacing threshold (PT), slew-
rate and R wave sensing (RWS) were monitored at both sites during implan-
tation. During follow-ups LI, PT and RWS were monitored. 
Results: 1 – There was no difference between electrical parameters during
the implantation between the apex and the septo-basal positioning. 2 – During
follow-ups the electrical parameters were stable without significant statistic
difference.
The median lead positioning time was about 3 minutes and median fluoros-
copy time near 60 seconds. RV septal lead could be replaced in two cases due
to lead dislodgement (2%). A case of left superior vena cava had shown an
easy septal positioning.
Conclusion: Long term reliable RV septal pacing can be achieve in routine
(98%) patients with standard indications for cardiac pacing. RV septal posi-
tioning is easy and electrical parameters are stable during long term follow-up
and compared to the apex conventional positioning with short procedure dura-
tion and exposure time to X-rays. 
0117
Inter-atrial conduction delay and short left atrio-ventricular interval
may be responsible for diastolic heart failure
Anaelle Mathe, Jean-Christophe Eicher, Géraldine Bertaux, Olivier Bar-
thez, Régine Debin, Clothilde Billard, Jean-Eric Wolf, Gabriel Laurent
CHU BOCAGE, Dijon, France
Introduction: Inter atrial conduction delay (IACD) may impair left atrial
(LA) emptying function. Some patients suffering from diastolic heart
failure (DHF) present IACDs. We hypothesized that IACD associated with
short left atrio-ventricular interval (LAVI) may impair left ventricular
active filling as it reduces the LA “kick” which occurs against closing
mitral valve. 
Methods: An IACD on surface ECG was defined as a p wave prolongation
greater than 120ms. Right (RAVI) and LAVI were measured during invasive
electrophysiological testing using a 24-pole mapping catheter placed around
the tricuspid annulus with the tip inside the coronary sinus so that distal
dipoles could record the lateral wall of the left atrium and that proximal
dipoles could map the lateral wall of the right atrium. Transthoracic echocar-
diography was used to assess left ventricular systolic function (LVSF) and to
perform tissue Doppler of the atria: mitral A wave duration, mitral E/A ratio
and E/e’ index.
Ten patients presenting IACDs and normal PR intervals were included in
this study: 5 DHF patients (class III NYHA, none with more than mild mitral
regurgitation, preserved LVSF), and 5 age-matched no-DHF patients. 
Results: As expected, DHF patients exhibited higher E/A and E/e’
ratios than no-DHF patients (3.4 ± 1.3 vs 1.3 ± 0.4, p=0.01), (22.6 ± 4.6
vs 9.2 ± 2.2, p=0.004, respectively). Mean P wave duration was similar in
both groups (DHF: 135 ± 10ms vs no-DHF patients: 125 ± 15ms, p=NS).
Mean PR interval was slightly shorter in DHF patients when compared to
no-DHF patients (DHF: 168 ± 23ms vs no-DHF: 186 ± 13ms, p=0.04).
While both groups had a similar mean RAVI, LAVI was significantly
shorter in DHF as opposed to no-DHF patients (76 ± 19ms vs 145± 13ms,
p=0.03, respectively). As opposed to no-DHF, DHF patients presented a
shorter mitral A wave duration (103.8 ± 7.9ms vs 158 ± 24.9ms, p=0.0017,
respectively), 
Conclusions: Patients with IACD, normal PR interval and DHF may
present a left atrio-ventricular asynchrony (delayed and shortened left atrial
contraction due to the mitral valve closure). Although this phenomenon may
probably not be the only factor involved in DHF, its correction by an atrial
resynchronization therapy might help to restore the left ventricular active
filling.
0044
Should all patients with severe decrease in left ventricular ejection
fraction be implanted with CRT-D?
David Le Saux, Céline Morvan, Philippe Castellant, Marjaneh Fatemi,
Jacques Mansourati 
CHU Brest, Département de Cardiologie, Brest Cedex, France
Introduction: ICD has demonstrated its effectiveness in reducing sudden
death in primary and secondary prevention in ischemic and dilated heart dis-
ease. However, this device does not prevent death from heart failure in the
absence of cardiac resynchronization therapy (CRT).
Aim: The objective of this study was to assess the clinical and ECG out-
come (in particular the width of QRS) in patients with prophylactic ICDs in
case of severe left ventricular dysfunction with no indication of resynchroni-
zation.
Methods and results: This single center retrospective study included 60
patients (60 ± 10 years, 53 men and 7 women) with an ICD implanted prophy-
lactically at the University Hospital of Brest between 2002 and 2007. Left ven-
tricular ejection fraction was 25 ± 5%, QRS width was 116±27 msec and
NYHA class was 1.5 ± 0.7 at implantation. After a follow-up of 32 ± 14
months, NYHA class was stable (1.3±0.4, NS) while the width of the QRS
increased significantly to 124 ± 26 msec. Heart failure occurred in 13% of the
cases (8 patients) and was responsible for 40% of deaths (2 patients). No
patient has required the use of resynchronization in the absence of functional
criteria (NYHA III/IV) and QRS > 120 msec during this period.
Conclusion: Our study confirms data of the literature indicating that
patients with ICDs for severe left ventricular dysfunction died, mostly of heart
failure. However, during the first 3 years of follow-up, we found no evidence
to support the immediate use of CRT-D in these patients.
Follow-up 
(Nb) 
P Wave 
(mV)
Impedance(O
hm)
MAT(Volt) R coefficient ACM(Volt)
Implant 
(297)
2.8±1.6 614±225 0.8±0.5   
Post-op 
(269)
2.3±1.2 537±153 0.7±0.4 1 1 0.844 0.7±0.4 1
6-12 
Weeks
(238)
2.3±1.05 518±146 0.6±0.4 2 2 0.849 0.7±0.4 2
6 months 
(186)
2.4±1.2 498±142 0.7±0.4 3 3 0.891 0.7±0.5 3
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Predictors of failure of percutaneous pacemaker leads extractions
Benoît Herce, Raphaël Sandras, François Lesaffre, Jean-Pierre Chabert,
Angeline Martin, Pierre Nazeyrollas, Damien Metz
CHU reims, Reims, France
Introduction: The need for stimulation lead extraction is growing, mainly
because an ageing population, the steady increase of device implantation and
also because of lead failure requiring extraction.
Objective: The main objective of our study was to identify the predictors
of failure of extractions of chronic leads.
Methods: We conducted a retrospective monocentric study at the Univer-
sity Hospital of Reims including all of the patients who were submitted to a
percutaneous lead extraction procedure between 1993 and 2007. 
Results: 152 consecutive patients were included, accounting for 163 pro-
cedure and 241 leads. 66% were men, mean age of 72 + / -12 years, 20.9%
weres diabetic and 50.3% hypertensive.
The mean delay between implantation and explantation was 64.9+/- 58
months. 
Indications of explantations were 49% of infection cases (including 11% of
tricuspid endocarditis), 43% lead dysfunction and 7% other. 
Percutaneous explantationwas complete in 87,1% of cases, surgical explan-
tation was performed because of complete or partial failure in 6,1% of
patients.
Complications occurred in 6 patients (3.7%) with one death after cardiac
surgery, two pericardial effusion resolved spontaneously, one pulmonary
embolism and two scepticemia.
Two independant predictors of total success (p<0.01) were found: the delay
between implantation and explantation (success 58 + / – 55 months and failure
104 + / -55 months, p<0.001) and number of lead requiring removal (1 versus
2 or 3 lead, p=0.047). 
Conclusion: Percutaneous extraction of Pacemaker leads is effective with
a low complication rate.
The age and the number of lead to extract are independent predictors of
failure.
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Ventricular Pacing Rate And Atrial Arrhythmias According To Indi-
cation Of Pacing And Programming MVP™ Function At 9 Months
Follow-Up
Jean-Luc Rey (1), Marc Hero (2)
(1) CHU Hôpital SUD, Amiens, France – (2) Medtronic France, CRDM,
Boulogne-Billancourt, France
Methods: The multicenter observational Generation MVP™ study
included 224 patients aged 77 +/- 10 years (men: 53%) implanted for sinus
dysfunction (SD) or brady-tachy syndrome (SBT) (n=116) or atrio-ventricular
block (AVB) (n=108). Programming function MVP™ has been left to the dis-
cretion of the physician. Percentage of ventricular pacing and percentage of
patients with paroxystic or persistent atrial arrhythmias was assessed at 9
months on average according to the indication of pacing and the state of pro-
gramming function MVP™.
Results: Percentage of ventricular pacing at 9 months is significantly lower
for the 2 groups of indication for patients with MVP™ function activated [On]
compared with patients without function MVP™ [Off]. Comparisons groups
were made by the Mood’s median test.
Percentage of patients with atrial arrhythmias at 9 months was significantly
lower when the MVP™ function is programmed to [On] only in the AVB
group.
Conclusion: In this study in current practice, at 9 months follow-up pro-
gramming function MVP™ is associated with a significant decrease of ven-
tricular pacing for indications of SD-BTS and AV block. Moreover
programming function MVP™ is associated with a significant decrease of per-
centage for patients with atrial arrhythmias for AVB indications.
 0184
Evolution of the gain in sponteneous conduction between atrio-ventri-
cular delay hysteresis algorithms and a new pacing mode
Pierre Le Franc (1), Marc Hero (2)
(1) Clinique Saint Hilaire, Rouen, France – (2) Medtronic France,
CRDM, Boulogne-Billancourt, France
Most of studies show the interest to decrease ventricular pacing in patients
implanted with a dual chamber pacemaker. Algorithms developed to search
spontaneous ventricular activity consisted first in increasing AV delay (AV
delay hysteresis: AVDH). More recently, new modes of pacing were proposed:
MVP™ mode (Managed Ventricular Pacing) Medtronic-USA or Safe-R™,
(Sorin-Italia). The aim of this study was to evaluate the gain of spontaneous
conduction between different generations of AVDH and the MVP™ mode.
Methods: we studied two populations of patients implanted for conduction
disorder (CD) or sinus dysfunction (SD) distributed in three groups. Group I:
115 patients implanted with Kappa® series pacemaker (Medtronic-USA) and
first generation AVDH (AVDH, CD: 56%, SD: 44%). Group II: 168 patients
implanted with Enpulse® series pacemaker (Medtronic-USA) and second gen-
eration AVDH (AVDH+, CD: 52%, SD: 48%). Group III: 156 patients
implanted with Adapta® series pacemaker (Medtronic-USA) and the MVP™
mode (CD: 40%, SD: 60%). Populations were not different in sex, age and
pacing indications. Patients who presented less than 1% of spontaneous ven-
tricular activity were excluded from analysis. We compared first the gain in
ventricular detection induced by AVDH vs. AVDH+ and secondly the per-
centage of ventricular pacing between AVDH+ and MVP in the two popula-
tions (Mood’s median test).
Results: shown in the following table:
Conclusion: AVDH+ results in a decrease in VP in patients without con-
duction disorder but not in patients with conduction disorder. The use of
MVP™ results in a significant decrease of ventricular pacing compared to first
and second generation of AVDH algorithms in both patients with or without
conduction disorder with a high gain in spontaneous AV conduction.
0185
Comparison per-operative and intra-individual widths of ventricular
pacing complex, between apex and septo basal positioning
Bouchaïb Deriouich (1), Marc Hero (2)
(1) Centre Hospitalier Général d’Evreux, Evreux, France – (2) Medtronic
France, CRDM, Boulogne-Billancourt, France
Introduction: The recommendations in Europe and North America con-
sider the width of the QRS is the only accepted criteria of cardiac desynchro-
nization (≥ 120 ms). The echocardiographic criteria have not been previously
scientific validation. More the QRS is wide, more desynchronization is
serious. In our study, we compared the QRS pacing at conventional apex posi-
tion and at the proximal septum position. This is a comparison per-operative
and intra-individual. 
Method: 128 patients (78 +/- 9 years old) were implanted with a single or
dual chamber pacemaker for conduction disorder (75%) or sinus dysfunction
(41%). The ventricular active bipolar lead (bi-pole ≤ 10 mm) is initially tested
at the apex and secondarily at the proximal septum. The width of the QRS
pacing is averaged over 2 complex measured at the beginning of the spike to
the end of QRS for derivations D2, AVR and V1, with a scrolling speed of
50 mm/s.
Results: We observe a significant QRS width reduction in during septal
stimulation (153 + / – 23 ms) versus apex stimulation (162 +/- 22 ms). The
comparison of values was performed by Mood’s median test (p<0.01), com-
pleted by a Student test (p<0.005).
Conclusion: The septo-basal stimulation produces a wide QRS decreased
significantly compared to apex stimulation. It is therefore less harmful to
hemodynamic. It can be seen as a method of choice for patients potentially
pacemaker-dependent. Dyspnea during effort and/or at rest has not been found
during one month after implant in all patients.
0187
Positioning of proximal septum for right ventricular pacing
Bouchaïb Deriouich (1), Marc Hero (2)
(1) Centre Hospitalier Général d’Evreux, Evreux, France – (2) Medtronic
France, CRDM, Boulogne-Billancourt, France
Introduction: The target of stimulation is the septo-basal segment of the
inter-ventricular septum. The process to identify the proximal inter-ventricular
septum is anatomic by fluoroscopy and electric by ECG interpretation.
Methods: This type of stimulation was performed in 128 patients (aged
78 +/- 9 years) implanted for conduction disorders or sinus dysfunction. A
postoperative echocardiogram was performed randomly in 20 patients, with
4 systemic incidences, parasternal, long axis and short axis, apex 4 cavities
and under xiphisternal, the lead position should be located upstream of ven-
tricular pillar.
Results: In septo-basal position, during electrical stimulation, it is noted a
thickening at the base of the QRS like a real aspect of pre-excitation
(Figure 1). 
The fluoroscopic tracking is done from the front, with the systematic estab-
lishment of ventricular lead in the pulmonary artery trunk (Figure 2). The
second phase is the withdrawal in the ventricular chamber with a slight
upward movement with guide slightly withdrawn up to supraventricular crest
(Figure 3). The final shape of the lead is antero-posterior (Figure 4) and LAO
45° (Figure 5) where the thoracic spine is face up the distal extremity of the
lead. 
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Conclusion: Anatomic criteria, fluoroscopy ECG criteria contribute to a
better positioning of proximal septum for right ventricular pacing. Echocardio-
graphy confirmed in 20 patients the lead positioning.
0172
Genetic and phenotypic heterogeneity of hereditary progressive car-
diac conduction defect
Aurelie Longueville (1), Florence Kyndt (2), Jean-Jacques Schott (3),
Hervé Le Marec (1), Vincent Probst (1)
(1) L’institut du thorax, CHU de Nantes, Cardiologie, Nantes, France –
(2) L’institut du thorax, Nantes, France – (3) L’institut du thorax, unité
INSERM 533, Nantes, France
Background: Progressive cardiac conduction defect (PCCD) is a frequent
cause of pacemaker implantation. We have previously described a French
family in which SCN5A mutation leads to PCCD demonstrating that PCCD
could be a genetic disease.
The aim of this study was to identify using a genetic epidemiological
approach new families and new genes involved in PCCD.
Methods and results: Using the French social security number, we have
been able to determine birth town of the 4491 patients implanted with a pace-
maker (PM) for PCCD between 1995 and 2005 in our area.
We have then drawn up a map representing the frequency of PM implanta-
tions for PCCD. An area was considered as a high prevalence spot if the prev-
alence was at least 4 times higher than in the major cities. The map showed a
large heterogeneity of the frequency of the disease with a frequency of 0,21%
in the major city whereas it was as high as 2.28% in certain parishes.
Familial studies performed in the parishes with the highest frequency of the
disease allowed us to identify six large families. In one of these families, a
whole genome linkage analysis identified a new locus on the chromosome
16q23-24 whereas the five other families were not related to the previously
described loci.
Conclusion: The identification of a novel locus on chromosome 16q23-24
and the identification of six families affected by PCCD demonstrated the effi-
ciency of the genetic epidemiological approach to identify familial forms of
frequent diseases and proved the genetic heterogeneity of PCCD.
0456
Patients’ evaluation of internal cardioverter-defibrillator implanta-
tion under sedation
Julie Roy-Giocosa, Gilles Lande
CHU de Nantes, Cardiologie, Institut du Thorax, Nantes Cedex 1, France
Background: Internal cardioverter-defibrillators (ICD) implantation under
sedation is widely practiced. Safety and feasibility of such procedures are well
documented. However, there are few studies describing patient acceptability of
implantation under sedation.
Methods: The aim of our study was to assess patient pain during cardio-
verter-defibrillator implantation under intraveinous midazolam and nalbuphine
and to identify parameters that interact with patient feeling during theses inter-
ventions.
Patients were asked to rate the intensity of pain on a 10-point visual ana-
logue scale (VAS) the day after the implantation. Quality of information, anx-
iety, potential memories and overall satisfaction were also investigated.
Patients implanted with a pacemaker (PM) were submitted to this standardized
questionnaire too. 
Results: There were 55 patients in the “ICD” group and 61 patients in the
“PM” group who answered the questionnaire. There were no differences in the
pain level (ICD VAS= 1, 25 +/- 1.73; PM VAS= 1.83 +/- 1.74, p=0.08) or in
any investigated parameters between the 2 groups. No side effects have been
reported.
Conclusion: Internal cardioverter-defibrillator implantation under sedation
is painfulness and very well tolerated. Patient tolerance is the same as patients
who were implanted of a pacemaker. These results testify of the efficacy of
the sedation protocol used for internal cardioverter implantation and defibril-
lation testing.
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A novel familial cardiac arrhythmia associated with a dilated cardio-
myopathy is due to a mutation in SCN5A
Mohamed-Yassine Amarouch (1), Gabriel Laurent (2), Samuel Saal (3),
Laurence Faivre (3), Géraldine Bertaux (2), Sylvie Falcon-Eicher (2), Oli-
vier Barthez (2), Christel Thauvin-Robinet (3), Philippe Charron (4), Pas-
cale Richard (4), Vincent Probst (1), Estelle Baron (1), Isabelle Baró (1),
Julien Barc (1), Jean-Jacques Schott (1), Jean Merot (1), Yves
Coudiere (5), Rodolphe Turpault (5), Gildas Loussouarn (1), Florence
Kyndt (1), Jean-Eric Wolf (2)
(1) UMR915 l’institut du thorax, IRT – UN, Nantes, France – (2) CHU
Dijon , Service de Cardiologie, Hôpital le Bocage, Dijon, France – (3)
CHU Dijon, Centre de Génétique, Hôpital d’Enfants, Dijon, France – (4)
Centre de Référence Maladies Cardiaques Héréditaires, Groupe La Pitié
Salpêtrièr, Paris, France – (5) Laboratoire de Mathématiques Jean Leray
UMR 6629 du CNRS, Nantes, France
Voltage-dependent cardiac sodium channels are complexes including α and
β subunits allowing sodium influx during the depolarization phase of the ventric-
ular action potential. The main pore-forming α subunit, Nav1.5, is encoded by
SCN5A. Using a candidate-gene approach, we detected a R222Q substitution in
Nav1.5 in a family comprising 10 members affected by a new cardiac pheno-
type. Affected patients had a “chaotic” surface ECG displaying rare sinus or
junctional beats competing with numerous premature ventricular contractions
with various right bundle branch block patterns and right to left axis variations.
Arrhythmia mechanisms involved ectopic foci originating from the Purkinje
system. To evaluate the incidence of this substitution on Nav1.5 channel func-
tion, whole-cell patch-clamp experiments were performed on COS-7 cells trans-
fected with the human α and β1 subunits. The presence of the mutation did not
modify the Na+ current density. In contrast, the channel activation curve was
shifted toward more negative potentials (V1/2act, WT:–30.6±2.1 mV, n=11;
R222Q: –42.3±1 mV, n=11, p<0.001, vs WT; heterozygous: –37.2±1.6 mV,
n=9; p<0.05, vs WT). Activation kinetics were accelerated in mutant homozy-
gous condition only (p<0.001, vs WT). Inactivation voltage sensitivity was also
changed (V1/2inact, WT: –79.6±0.7 mV, n=10; R222Q: –84.6±0.7 mV, n=8,
p<0.001; heterozygous: –82.2±1 mV, n=9; p<0.05), and inactivation kinetics
accelerated. Finally, recovery from inactivation was not modified by the R222Q
mutation. We studied the impact of the current biophysical changes in virtual
models of the Purkinje and ventricular action potentials. The premature ventric-
ular contractions were explained by the appearance of electrical abnormalities in
Purkinje and not in ventricular model, consistent with the ectopic foci origi-
nating from the conducting tissue. We are currently performing computer simu-
lations in a Purkinje/ventricle multicellular model.
0483
Pro-Arrhythmic Right Ventricular Electrophysiological Remodelling
in a Rat Model of Pulmonary Hypertension
Olivier Bernus, David Benoist, Ed White
University of Leeds, Leeds, Royaume-Uni
Sudden cardiac death in heart failure (HF) is often caused by arrhythmias.
In the left ventricle, arrhythmogenesis in HF has been associated with signifi-
cant electrophysiological remodelling. However, the arrhythmic risk in right
ventricular (RV) failure remains unexplored. In this study we have utilized a
rat model of pulmonary artery hypertension (PAH) to evaluate this risk.
Wistar rats were injected with monocrotaline at 30 mg/kg or 60 mg/kg to
induce RV hypertrophy (HYP, n=6) or failure (FAIL, n=6) respectively, or
with saline (CON, n=5). Animals were sacrificed 3 weeks after injection or
upon showing clinical symptoms of HF. Isolated hearts were Langendorff-per-
fused with a bicarbonate Tyrode solution at 37°C. Action potential duration
(APD) and conduction velocity (CV) were measured optically across the RV
at pacing frequencies between 5-13Hz using the voltage-sensitive dye DI-4-
ANEPPS.
HYP and FAIL animals showed increased heart weight to body weight ratios
(HW/BW) when compared to CON (5.44±0.29 and 5.80±0.21 vs 4.02±0.13
respectively). APD measured at 80% of repolarisation showed a strong correla-
tion with HW/BW (R=0.85), with a significant prolongation in both HYP
(76.6±14.6ms, P<0.001) and FAIL (89.2±11.7ms, P<0.0001) groups when com-
pared to CON (52.3±6.1 ms). Steeper APD restitution curves were observed in
HYP and FAIL groups (e.g. maximal slope in FAIL was 1.39±0.8 vs 0.27±0.15
in CON, P<0.05), as well as steeper CV restitution curves (e.g. maximal slope
in FAIL was 0.63±0.12 vs in 0.07±0.05 CON, P<0.001). All CON hearts
showed a 1:1 response at all pacing frequencies. However, above 9Hz, 1 HYP
(17%) and 4 FAIL hearts (67%) showed alternans. 
Electrophysiological remodelling is evident in HYP and FAIL RV of
monocrotaline-injected rats. APD prolongation, steeper APD and CV restitu-
tion curves, and alternans, are typically associated with a pro-arrhythmic state.
We therefore conclude that the failing RV is more susceptible to develop
arrhythmias in this model.
0121
Basal exit site of clinical ventricular tachycardia is an independant
predictor of antitachycardia pacing failure in implantable cardiover-
ter defibrillators recipients
Stéphane Boulé (1), François Brigadeau (1), Christelle Marquié (1), Julia
Salleron (2), Claude Kouakam (1), Laurence Guédon-Moreau (1), Didier
Klug (1), Dominique Lacroix (1), Salem Kacet (1)
(1) CHRU de Lille – Hôpital cardiologique, Service de Cardiologie A,
Lille, France – (2) CERIM – Service de Biostatistiques, Université de Lille
2, Lille, France
Background: Little is known about predictors of antitachycardia pacing
(ATP) failure in implantable cardioverter defibrillators (ICDs) recipients. Distance
between the stimulation site and the ventricular tachycardia (VT) site of origin
may critically affect ATP effectiveness. We hypothesized that ATP may be less
effective in ICDs patients who had basal VT than in those who had apical VT.
Methods: We reviewed data from 52 patients with sustained monomorphic
VT and left ventricular disease referred for ICD implantation. The clinical VTs
site of origin (basal, mid-ventricular or apical) was determined in each patient,
using the 12-lead ECG. VTs episodes treated with conventional ATP during
the one-year follow-up were studied. ATP success rate (%), defined as the
ratio between the number of successful ATP sequences and the number of
delivered ATP sequences, was determined in each patient.
Results: VTs exit site was apical in 19 patients (36%), basal in 18 patients
(35%), and mid-ventricular in 15 patients (29%). In those 52 patients (67±11
years, mean LVEF 38±12, previous myocardial infarction: 41 (79%)), 1393
ATP sequences, delivered to treat 761 VTs episodes, were analyzed. ATP suc-
cess rate was found to be associated with the VTs site of origin (median [inter-
quartile range]): basal (33% [11-67]), mid-ventricular (50% [37-100]), apical
(100 [41-100]) (p=0,027). Multivariate analysis, included nine relevant vari-
ables, identified basal VTs site of origin as an independant predictor of ATP
failure (p=0,023).
Conclusion: ATP is less effective in ICDs patients who had basal VT than
in those who had apical VT.
0253
Cav1.2 mutation associated with systemic carnitine deficiency and
short QT syndrome without dilated cardiomyopathy
Mohamed Yassine Amarouch (1), Julien Barc (1), Beziau Delphine (1),
Florence Kyndt (1), Hervé Le Marec (1), Dominique Babuty (2), Vincent
Probst (1), Jean-Jacques Schott (1), Isabelle Baro (1)
(1) U915- l’institut du thorax, Nantes, France – (2) CHU Trousseau,
Tours, France
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Short QT syndrome (SQTS) emerged as a new inherited channelopathy
characterized by constantly short QT interval (QTc≤360ms). A family with
SQTS and systemic carnitine deficiency was identified. Compound heterozy-
gous variants of membrane carnitine transporter OCTN2 has been detected in
a 6 year-old male (QTc=346ms), who experienced a syncope episode. His
mother (QTc: 359 ms), who is also compound heterozygous for OCTN2 was
symptomatic, with ventricular fibrillation. It has been reported that OCTN2
mutations are associated with cardiomyopathy development, that is surpris-
ingly absent in this family. In addition, using a candidate-gene approach, we
detected a variant of CACNA1C, encoding Cav1.2, the α1c of the cardiac L-
type Ca2+ channel, in the proband and his mother, leading to the p.A223P sub-
stitution. The grandmother (QT: 405 ms), who carried one OCTN2 variant
only and the CACNA1C variant, was asymptomatic. The CACNA1C variant
seems to be uncausal for the SQTS but could contribute to the absence of
dilated cardiomyopathy.
First, the incidence of CACNA1C variant on Cav1.2 function was studied.
Whole-cell patch-clamp experiments were performed on HEK-tsA201 cells
expressing α1c, β2a, and α2δ1b rat subunits, of the cardiac Ca2+ channel com-
plex. The human A223P mutation corresponds to the rat A253P. A253P
Cav1.2 generated a reduced ICaL (-5.43±0.79pA/pF, n=70) when compared
with WT Cav1.2 (-11.28±1.43pA/pF, n=69, p<0.001). The voltage dependence
of ICaL activation (V1/2act: –11.54±1.15mV, n=9, vs –12.94±1.03mV, n=19;
slope: 6.37±0.28mV vs 6.46±0.27mV, for mutant and WT channels, respec-
tively) and inactivation (V1/2inact: -13.46±1.30mV, n=8, vs –16.70±1.23mV,
n=11; slope: -6.86±2.14mV vs –7.70±0.33mV) did not show any difference.
Western blot and biotinylation experiments showed similar global and cell sur-
face expression of WT or mutant Cav1.2. We are currently investigating the
effects of β2a and α2δ1b auxiliary subunits on the WT and mutated Cav1.2
activity. 
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The p.Arg231Cys KCNQ1 mutation causes familial Atrial Fibrillation
and Long QT Syndrome
Sabine Duchatelet (1), Daniel C. Bartos (2), Didier Klug (3), Isabelle Den-
joy (4), Rachel Peat (1), Jean-Marc Lupoglazoff (5), Véronique
Fressart (6), Myriam Berthet (1), Craig T. January (7), Brian P. Delisle
(2), Pascale Guicheney (1)
(1) INSERM U956, Paris, France – (2) University of Kentucky, Lexington,
Etats-Unis – (3) Hôpital cardiologique de Lille, Lille, France – (4) Hôpital
Lariboisière, Service de cardiologie, Paris, France – (5) Hôpital Robert
Debré, Service de cardiologie Infantile, Paris, France – (6) Hôpital Pitié-
Salpêtrière, Service de Biochimie Métabolique, Paris, France – (7) Univer-
sity of Wisconsin-Madison, Madison, Etats-Unis
Long QT syndrome (LQTS) is a rare genetic cardiac disease characterized
by a longer QT interval, risk of syncope and sudden death. Many mutations
have been identified in KCNQ1 encoding a K+ channel subunit that underlies
the K+ repolarising outward current IKS with the auxiliary K+ channel subunit
KCNE1. Most mutations cause LQTS by reducing the IKS current. Some rare
mutations associated with activation of IKS, result in short QT syndrome or
familial atrial fibrillation (AF).
We identified the heterozygous p.Arg231Cys KCNQ1 mutation in six fam-
ilies: one with AF and five others with LQTS. Further genetic testing of the
AF proband did not reveal any additional mutation in AF causing genes
(KCNQ1, KCNH2, SCN5A, KCNE2, KCNE3, KCNE5, KCNA5, KCNJ2,
NPPA, GJA5, SCN1B and SCN2B). Hypothesizing that additional genetic fac-
tors could cause AF development in this family, we genotyped all family
members for 12 different SNPs in ten genes (KCNH2, KCNE1, KCNE4,
KCNE5, SCN5A, GJA5, SLN, IL10, PITX2 and ZFHX3) reported as risk or
protective factors for AF, but did not find specific alleles which could discrim-
inate AF versus LQTS patients. Interestingly, in the AF family, only one son
harboured the p.Arg231Cys mutation without AF, and he carried the 97T pro-
tective allele in KCNE5 (rs17003955, c.97C>T, p.Pro33Ser), a gene encoding
a subunit reducing IKs, with a higher expression level in atria than ventricles.
The 97C allele was shared by most of the LQTS patients, thus this SNP cannot
contribute by itself to the various phenotypes.
Co-expression of KCNE1, WT- and p.Arg231Cys-KCNQ1 in HEK293
cells generated larger IKS at negative potentials but smaller IKS at positive
potentials. These data show that co-expression of WT- and p.Arg231Cys-
KCNQ1 results in both gain- and loss-of-function of IKS. 
To conclude, these mixed functional characteristics of p.Arg231Cys-
KCNQ1 may explain the phenotypic variability and the occurrence of LQTS
or AF in the different p.Arg231Cys-KCNQ1 carriers.
0438
Catheter ablation of monomorphic ventricular premature beats in
electrical storm
Jean-Baptiste Gourraud (1), Olivier Billon (2), Gilles Lande (1), Pierre-
Antoine Gourraud (3), Hervé Lemarec (1), Sélim Abbey (1)
(1) CHU Nantes HGRL, L’Institut du Thorax, Saint Herblain, France –
(2) CHD les oudairies, Cardiologie, La Roche Sur Yon, France –
(3) Methodomics, Mortagne Sur Sèvre, France
Purpose: In patient implantated with implantable cardiac defibrillator
(ICD), electrical storm (ES) affects both quality of life and prognosis. ES is
often triggered by monomorphic ventricular premature beats (VPB) and is thus
prevented by catheter ablation (CA). Few studies have evaluated efficacy of
CA in ES triggered by VPB. We here report the outcome of the largest mono-
centric study so far. 
Methods: Between Jan 2007 and Oct 2009, 10 patients with ES triggered
by VPB were recruited (40% women, mean age 62 yo, 37-82). Patients with
acute coronary syndrome, heart failure, changes in therapeutics and dys-
kaliemia were exclued. Mapping and CA were performed in emergency by the
Carto system. 
Results: 4 patients had coronary artery disease (40%), 3 a right ventricular
dysplasia (30%) and 3 no heart disease (30%). Mean left ventricular ejection
fraction was 47% (30-65%). Patients had antiarrhythmic drugs (AAD) before
ES, including beta blockers (70%), amiodarone (40%), class Ib (10%) and
class Ic antiarrhythmic agent (10%). 
6 patients had recurrent VT in salvoes (60%), 3 ventricular fibrillation
(30%) and 1 twinsting spikewave burst arrhythmia (10%).The ectopic beats
originated from right ventricular output (40%) and left ventricular infero-lat-
eral wall (30%), anterior wall (20%) and interventricular septum (10%).
Mean follow-up was 12 months (3-30). Estimated survival without sus-
tained ventricular arrhythmia was 78,5% at 6 months [38.1; 94.3] . 4 patients
had recurrence whose 3 with a different morphology of VPB. The fourth
patient had recurrence with similar VPB after an ECG mapping procedure. No
patient died during the follow up.
Conclusion: ES triggered by VPB can occur in different heart diseases in
spite of AAD. CA by targeting VPB, can abolish ES and reduce recurrence of
arrhythmia. It can be interesting to achieve in association with AAD and ICD. 
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MOG1, a new susceptibility gene for Brugada syndrome 
Darouna Kattygnarath (1), Svetlana Maugenre (2), Nathalie Neyroud (2),
Elise Balse (2), Isabelle Denjoy (3), Gilles Dilanian (2), Raphaël Pedro
Martins (2), Véronique Fressart (1), Myriam Berthet (2), Jean-Jacques
Schott (4), Bernard Hainque (1), Alain Coulombe (2), Stephane Nicolas
Hatem (2), Pascale Guicheney (2)
(1) AP-HP, Groupe Hospitalier La Pitié Salpétrière, Biochimie Métaboli-
que – UF Cardiogénétique et Myogénétique Moléculaire, Paris, France –
(2) Faculté de médecine La Pitié Salpétrière, INSERM UMRS 956, Paris,
France – (3) AP-HP, Hôpital Lariboisière, , Service de Cardiologie,,
Paris, France – (4) Institut du thorax – INSERM UMRS 915 , Nantes
Cedex, France
Objective: The purpose of this study was to investigate whether MOG1 is
a new susceptibility gene for Brugada syndrome (BrS).
Background: BrS is caused mainly by mutations in SCN5A gene, encoding
the α subunit of the cardiac sodium channel, Nav1.5. However, less than 20%
of probands have SCN5A mutations, suggesting other genes implication.
MOG1 has recently been identified as a new partner of Nav1.5, playing a
potential role in regulation of sodium channel expression and trafficking.
Thereby, we hypothesized that MOG1 may be related to BrS.
© Elsevier Masson SAS. All rights reserved.
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Methods: MOG1 gene was screened by direct sequencing in 205 BrS
patients negative for SCN5A. Functional analysis of MOG1 mutation was per-
formed by using patch-clamp, immunocytochemistry and microscopy. Effect
of silencing endogenous MOG1 on sodium current was studied by patch-
clamp. 
Results: Genetic screening revealed a missense mutation E83D in a symp-
tomatic female with spontaneous type-1 BrS ECG. While overexpression of
wild type MOG1 increased sodium current by 103%, mutant E83D had no
effect. Microscopy revealed that Nav1.5 channels failed to traffic properly to
membrane in presence of mutant E83D. Finally, silencing endogenous MOG1
demonstrated a decrease of sodium current density by 54%.
Conclusion: E83D mutation leads to sodium current reduction by alter-
ation of Nav1.5 channel surface expression, a major loss of function, consis-
tent with the BrS phenotype. Moreover, silencing endogenous MOG1 reduces
sodium current density, demonstrating that MOG1 is probably an important
partner for surface expression of Nav1.5 channels. Altogether, our data sup-
port MOG1 as a novel candidate gene for BrS.
0245
Influence of the autonomic nervous system in the detection of torsa-
dogenic molecules
Aude Ouillé (1), Jean-Yves Le Guennec (1), Eric Martel (2), Serge
Richard (2), Pascal Champéroux (2)
(1) INSERM, U637 physiopathologie cardiovasculaire, Montpellier,
France – (2) CERB, Baugy, France
Introduction: QT interval assessment by telemetry has become one of the
most useful model in testing strategies adopted for detection of drug induced
QT prolongation in non clinical safety pharmacology studies. This study
reports experimental data showing that the autonomic nervous system might
influence drug induced QT prolongation.
Methods: Beagle dogs and Cynomolgus monkeys were instrumented with
telemetric transmitters and epicardial ECG leads. Effects on QT interval and
heart rate of reference drugs such as sotalol, dofetilide, terfenadine, thior-
idazine and moxifloxacin were analysed with the QT shift method.
Results: Two cases of unexpected absence of QT interval prolongation are
reported in dogs with thioridazine and terfenadine in conscious Beagle dogs
under conditions of concomitant tachycardia. The QT prolongation of these
two molecules was unmasked by co-treatment with sympatholytic agents,
atenolol and clonidine respectively suggesting that sympathetic activation and/
or parasympathetic withdrawal might impair a drug induced QT prolongation.
Sotalol and dofetilide are responsible for exaggerated QT prolongation in
monkeys but not in dogs.
Conclusion: The apparent absence of changes in the QT interval due to
novel drug candidates should be interpreted cautiously under conditions of
concomitant tachycardia or elevated heart rate levels, in non-clinical safety
studies. Cynomolgus monkeys model, contrary to the dog, enable to discrimi-
nate torsadogenic molecules responsible for exaggerated APD90 prolongation
and Reverse use dependence, from others. The difference of known torsa-
dogenic drugs on QT prolongation in Beagle dogs and Cynomolgus monkeys
might be due to difference in the sympathetic/parasympathetic balance. 
0170
Early repolarization syndrome: Identification of a malignant form in
a large French family
Jean-Baptiste Gouraud (1), Vincent Probst (1), Philippe Mabo (2), Frédé-
ric Sacher (3), Hervé Le Marec (1)
(1) L’institut du thorax, CHU de Nantes, Cardiologie, Nantes, France –
(2) CHU de Rennes, Rennes, France – (3) Chu de Bordeaux, Bordeaux,
France
Introduction: Early repolarization (ERS) in the inferolateral leads has
been recently recognized as a frequent syndrome associated with idiopathic
ventricular fibrillation (VF). Missense mutation in the KCNJ8 gene has been
recently reported but to date there is no description of large family affected by
the disease and the mode of transmission of the disease remains unknown. 
Methods: Patients were considered to be affected by the ERS in the pres-
ence of a distinct J-wave defined as a positive deflection inscribed on the S
wave or in case of sudden cardiac death if no ECG was available. 
Results: We have identify a large French family in which 11 sudden deaths
occurred in young adults. Seven out of 11 sudden deaths occurred before age
35. A normal cardiac pathological findings and negative toxicological test
results were available in 3 individuals (Ind V-3, V-9, V-23). The ECG of ind
V-17 who experienced aborted SCD and finally died during an electrical storm
10 years after she was implanted with an ICD showed a typical aspect of ERS.
Familial screening identify a large family of 66 members. An ECG was avail-
able in 15 and revealed a typical aspect of ERS in 2 and a minor form of ERS
in 11. In this family, the disease was transmitted with an autosomal dominant
trait.
Conclusions: The identification of this family demonstrates for the first
time that malignant form of ERS can be transmitted with an autosomic domi-
nant mode. The identification of this family is the first step toward the identi-
fication of the genetic factors involved in ERS.
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TOPIC 18 – Electrophysiology, channels
and genetics
0206
Ubiquitylation of hERG1 potassium channel by Nedd4-2 ubiquitin
ligase
Maxime Albesa, Liliana Sintra Grilo, Hugues Abriel
University of Bern, Bern, Suisse
Background: The voltage-gated cardiac potassium channel human ether-à-
gogo-related gene 1 (hERG1) plays a key role in the repolarization phase of
the cardiac action potential (AP). Its importance in the duration of the AP is
exemplified by mutations in its gene KCNH2 found in patients with congenital
long QT syndrome (LQTS) or short QT syndrome. Several of these mutations
lead to defect in biosynthesis and maturation of the channel, underlying the
importance to study the molecular determinants of hERG1 trafficking. Ubiqui-
tylation of voltage-gated cardiac ion channels Nav1.5 and KCNQ1 by the
ubiquitin ligase Nedd4-2 has been shown to regulate the number of these
channels at the membrane. These regulations were shown to depend on a PY
motif (L/PPxY) found in Nav1.5 and KCNQ1 but also present in hERG,
allowing the interaction with WW domains of ubiquitin ligases of the Nedd4
family. The aim of this study was to investigate whether hERG could be reg-
ulated by the ubiquitin ligase Nedd4-2.
Methods: We co-expressed in HEK293 cells hERG1 with Nedd4-2, and
recorded by voltage-clamp whole-cell configuration the potassium current.
Amount of hERG channels in total HEK293 lysates, and at the cell surface
were assessed by Western blot and biotinylation assays. Co-immunoprecipita-
tion experiments were used to investigate the interaction between hERG1 and
Nedd4-2 proteins. Finally, ubiquitylation of the channel was assessed by pull-
down GST-S5A and immunoprecipitation experiments.
Results: We found that co-expression of Nedd4-2 significantly reduced
potassium currents, and concomitantly decreased hERG total protein and
hERG mature form at the plasma membrane. We then determined that the
Nedd4-2 effect on hERG1 is dependent on the interaction between Nedd4-2
and the PY motif of hERG, and that deletion of the hERG PY motif abolishes
Nedd4-2-dependent regulation. Finally, we found that down regulation of
hERG1 current and protein is done via its ubiquitylation by Nedd4-2.
Conclusion: Our data suggest that ubiquitylation by Nedd4-2 of hERG1
protein and its subsequent current down-regulation could be an important
mechanism allowing the modulation of the duration of the human cardiac
action potential.
0381
Rab11 regulates the exocytosis of potassium channels in cardiac myo-
cytes
Raphaël P Martins, Laetitia Chaussumier, Gilles Dilanian, Alain Cou-
lombe, Stéphane N Hatem , Elise Balse
INSERM UMRS956-UPMC Paris 6, Paris, France
Background: Exocytosis of channels into plasma membrane is an impor-
tant regulatory mechanism of cell excitability. A number of proteins control
exocytosis such as soluble N-ethylmaleimide (NEM)-sensitive factor attach-
ment receptors (SNARE) that mediate membrane fusion and Rab-GTPases
wich regulate sorting, tethering and docking of trafficking vesicles. However,
little is known on the role of channel exocytosis on cardiac excitability. 
Objective: We aimed at investigating conditions able to regulate cardiac
potassium Kv channels density in atrial myocytes. 
Methods: Expression of SNARE complexes and Rab-GTPases isoforms
was studied at mRNA and protein levels in both human and rat atria. Outward
potassium currents were recorded by patch-calmp in cultured adult atrial myo-
cytes after transfection of dominant negative (DN) or constitutive active (CA)
isoforms of Rab-GTPases. 
Results: Several isoforms of Rab4, Rab5 and Rab11 were detected in both
human and rat myocardia. Only Rab11 CA induced a slight but significant
decrease in IKur in comparison to Rab11 DN. Kv1.5 channels, the molecular
basis of the atrial repolarizing current IKur co-immunoprecipitated with
Rab11. Depletion of membrane cholesterol by methyl-cyclodextrin (MCD)
increased IKur by enhancing the number of functional channels in the mem-
brane, an effect suppressed upon NEM dialysis. Only Rab11 DN prevented the
MCD-induced current increase. Rab11-associated recycling endosome is also
responsible for the delivery of Kv1.5 channels following mechanical stimula-
tions. 
Conclusion: In atrial myocytes, exocytosis of Kv1.5 channels is a highly
regulated process and can be stimulated under certain circumstances, for
instance modification of the lipid environment and mechanical stress. Exocy-
tosis involves vesicle fusion and trafficking processes, particularly the Rab11-
associated slow recycling pathway. 
0240
Identification of a new Brugada syndrome mutation in SCN5A N-ter-
minal domain abolishing the sodium current INa in a heterologous
expression system
Jérôme Clatot (1), Nathalie Neyroud (1), Svetlana Maugenre (1), Isabelle
Denjoy (2), Stéphane Hatem (1), Alain Coulombe (1), Pascale Guicheney (1)
(1) INSERM UMRS 956 – UPMC Université Paris 6, Paris, France – (2)
AP-HP, Hôpital Lariboisière, Cardiologie, Paris, France
The Brugada syndrome (BrS) is an autosomal inherited cardiac arrhythmia
characterized by a ST-segment elevation in the right precordial leads (V1 to
V3) of the electrocardiogram, and a risk of syncope and sudden death. The
SCN5A gene encodes the cardiac sodium channel, Nav1.5, which is involved
in 20 to 30% of BrS cases. We have screened SCN5A in a BrS cohort and we
have found mutation R104W affecting an evolutionarily conserved residue in
the intracellular N-terminal region of the channel of which the function is still
unknown. Here, we aimed to characterize biophysical properties of the mutant
channel. The sodium current INa was recorded in HEK293 cells transiently
transfected with wild-type (WT) or mutant (R104W) channel using the whole-
cell configuration of the patch-clamp technique. In our model, the mutation
R104W abolished the INa current and co-transfection with the Beta1 subunit,
or incubation of cells at 30°C did not rescue INa current. This result suggests
that the N-terminal region of Nav1.5 plays a critical role on the cardiac sodium
channel function. Results of immunocytochemistry indicate that the mutant
R104W channel is correctly addressed to the plasma membrane in HEK cells.
Further investigations are needed to elucidate the mechanism by which the
R104W mutant impairs Nav1.5 conductance. 
0258
Beta-adrenergic stimulation increases SR Ca2+ leak in cardiomyocy-
tes independently of the cAMP/PKA signaling pathway
Jakob Ogrodnik (1), Daniel Gutierrez (2), Ernst Niggli (2)
(1) Department of Clinical Research, University of Bern, Bern, Suisse –
(2) Department of Physiology, University of Bern, Bern, Suisse
In cardiac muscle, excessive phosphorylation of Ca2+ release channels
(ryanodine receptors, RyRs) during β-adrenergic stimulation has been linked
to arrhythmogenic diastolic Ca2+ leak from intracellular Ca2+ stores (the sarco-
plasmic reticulum, SR). Using confocal Ca2+ imaging, we recently reported
that β-adrenergic stimulation (1 μM isoproterenol, Iso) increases SR Ca2+ leak
severalfold in quiescent, whole-cell voltage-clamped guinea-pig ventricular
myocytes without altering SR Ca2+ content, and in a manner that is indepen-
dent of extracellular Ca2+ (Ogrodnik & Niggli 2010, J Physiol 588:225-242).
Intriguingly, here we show that increasing cAMP production and PKA activity
by direct stimulation of adenylate cyclase with forskolin (1 μM) does not sig-
nificantly elevate SR Ca2+ leak under otherwise identical experimental condi-
tions. As successful robust downstream activation of the cAMP/PKA signaling
pathway was confirmed by comparable stimulation of L-type Ca2+ current and
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SR Ca2+-ATPase activity in both Iso and forskolin, these disparate results sug-
gest a distinct signaling pathway by which β-adrenergic stimulation increases
SR Ca2+ leak. Interestingly, we had found that the increased SR Ca2+ leak
observed in Iso was likely mediated by CaMKII, rather than PKA, as treat-
ment with the CaMKII inhibitor KN-93 (5 μM) suppressed the increase
without altering SR Ca2+ content, in contrast to inhibition of PKA with H-89
(5 μM). Taken together, we conclude that CaMKII activation during β-adren-
ergic stimulation may be rapid, may not require elevated cardiomyocyte Ca2+
cycling, and may increase SR Ca2+ leak independently of the cAMP/PKA sig-
naling pathway, possibly via increased nitric oxide production (Curran et al.
2009, Biophys J 96:120-121a).
0243
Ion channels blocking profile of different drugs taken from the TdPS-
creen® predictive database
Aude Ouillé (1), Pascal Champéroux (2), Eric Martel (2), Delphine
Bouard (2), Serge Richard (2), Jean-Yves Le Guennec (1)
(1) INSERM, U637 physiopathologie cardiovasculaire, Montpellier,
France – (2) CERB, Baugy, France
Introduction: Currently, to detect torsadogenic molecules in pre-clinical
development, screening on hERG is the first test applied (Guidelines ICH
S7B). Nevertheless, it is well known that the inhibition of IKr is not in direct
relation with the molecule torsadogenic effect. In this case, how do these mol-
ecules act? Do they inhibit others channels?
Methods: Patch-clamp experiments were performed on four other currents,
IK1, INa, ICaL, and IKs, on which we have tested known molecules taken from the
predictive data base, TdPSreen®. This algorithm is based on a model of iso-
lated canine Purkinje fibres on which 45 reference compounds were tested. It
enabled a clear separation of drugs into three groups (A) drugs with numerous
or several reports (>2 cases) of TdP, (B) drugs causing QT prolongation and/
or TdP only, the latter at a very low frequency (≤2 cases), (C) drugs without
reports of TdP or QT prolongation. The group A is divided in two subgroups,
A1 (20% of the molecules) with compounds causing an exaggerated increase
in APD90 combined with a high reverse use dependence, and A2 (80% of the
molecules) with compounds causing a triangulation of the delayed phase of
repolarisation without shortening of APD90.
Key results: Sotalol and dofetilide (A1) block only IKr, whereas A2 mole-
cules inhibit almost all the tested currents, and in particular sodium current.
Sotalol (A1) and moxifloxacin (B) inhibit hERG in the same way, but moxi-
floxacin inhibits also ICaL and INa.
Discussion: In vitro and ex vivo experiments confirm that torsadogenic
molecules have at least two profiles. It’s an important information not to forget
during pre-clinical studies, to use tests as much reliable as possible, it means
which will produce neither false negatives, neither false positives as it can be
the case if studies are restricted to hERG.
0368
Major role for accessory Cavβ subunits in calcium channel regulation
by Nedd4-1 ubiquitin ligases
Jean-Sébastien Rougier (1), Maxime Albesa (1), Hugues Abriel (1), Patri-
cia Viard (2)
(1) University of Bern, Department of Clinical Research, Bern, Suisse –
(2) University College London, Department of Neurosciences, London,
Royaume-Uni
Calcium entry into excitable cells is regulated by controlling both the activity
of voltage-dependent calcium channels (Cav) and their availability at the plasma
membrane. Voltage-dependent calcium channel subunits Cavβ and Cavα2δ-1
play a major role in these regulations. Neuronal precursor cell-expressed devel-
opmentally down-regulated 4 (Nedd4) ubiquitin ligases have previously been
shown to ubiquitylate and down-regulate cardiac KCNQ1 and Nav1.5 channels.
Here we investigated whether Nedd4 ligases may also regulate cardiac Cav1.2
channel and their accessory subunits Cavβ and Cavα2 δ -1. 
The pore subunit Cav1.2α1 was expressed together with Cavβ2 and Cavα2
δ -1 in tsA-201 cells. Whole cell barium currents were recorded using the
patch-clamp technique. Nedd4-1 decreased Cav current, whereas neither
Nedd4-2 nor WWP2 had any effect. Importantly, we show that Cavβ subunits
are essential for the Nedd4-1-induced regulation. This effect was not isoform-
specific as all four Cavβ tested (Cavβ1-4) supported the effect of Nedd4-1. By
contrast, expression -or lack of- Cavα2 δ -1 had no incidence on Nedd4-1-
induced regulation of Cav1.2 channel.
Over-expressing Nedd4-1 in HEK293 cells also reduced both the surface
expression of Cav1.2α1 and the total amount of Cav1.2α1, Cavβ2 and Cavα2
δ -1 recovered in whole cell lysates. As in the whole cell recordings, Cavβ was
required to support these effects, whilst Cavα2 δ -1 did not affect the regula-
tion. Remarkably, immuno-precipitation and pull-down of ubiquitylated pro-
teins failed to show any increase in the ubiquitylation of either Cav subunit,
suggesting that Nedd4-1 acts indirectly on the channel, via a yet to be identi-
fied mechanism. 
Our data unraveled a new role for Cavβ subunits, promoting Nedd4-1-
induced down-regulation of Cav channels, a new regulatory pathway control-
ling the availability of Cav channels at the plasma membrane.
This work was funded by the Welcome Trust (J-S.R., P.V.).
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TOPIC 19– Electrophysiology, atrial
arrhythmias
0375
Alterations of the sodium current properties in a murine model of
Myotonic Dystrophy type 1
Vincent Algalarrondo (1), Karim Wahbi (1), Alain Coulombe (2), Gene-
viève Gourdon (3), Denis Duboc (4), Stéphane Hatem (2)
(1) Institut de Myologie, Hôpital Pitié-Salpêtrière, Paris, France –
(2) INSERM UMRS 956, UPMC, Paris, France – (3) INSERM U 383-
Hôpital Necker-Enfants malades, Paris, France – (4) Service de cardiolo-
gie, Hôpital Cochin., Paris, France
Introduction: Myotonic dystrophy (DM-1) is a dominant autosomal mul-
tisystemic disorder caused by the expansion of an unstable CTG trinucleotide
repeat in the 3’ untranslated region of the DMPK gene. Cardiac abnormalities
due to DM-1 consist of conduction block and arrhythmias, notably AF. How-
ever molecular mechanisms underlying these electric disorders are mostly
unknown. 
Methods: A murine model of transgenic mice expressing human DM-1
region with more than 300 CTG repeats was generated. Action potentials (AP)
were recorded on atrial trabeculae by means of the microelectrode technique.
Sodium current (INa) recordings were performed by the patch-clamp technique
on fresh isolated atrial myocytes.
Results: Although no difference was observed on basal ECG, injection of
flecainide induced more severe bradycardias, increased prolongation of the P
wave, of the PR interval QRS duration and of the QT interval in DM-1 mice
respectively to wild mice. AP recordings showed significant decrease in [dV/
dt]max (mean ± SD: 156±49V/s vs. 172±36V/s in control; n=77; P=0.02) and
marked shortening of action potentials in DM-1 mice (APD 50%: 8.1±1.6ms
vs. 10.3±1.1ms; n=77; P<0.001). No change was observed in INa density
between WT and DM-1 mice. However the activation-voltage relationship was
shifted toward negative value (V0.5: -52.2 ± 6.0mV vs. -43.2 ± 4mV in control;
n=6; P=0.015) and the rate of INa inactivation was increased in DM-1.
Conclusions: The increase sensitivity of DM-1 mice to flecainide associ-
ated with the modifications of action potential shape and the current properties
indicate that altered INa properties exhibiting a loss of function of Na+ channels
could contribute to cardiac electrical disorders in this myopathy. However,
mechanisms causing INa alterations remain to be assessed.
0073
Changes in Connexin43 distribution pattern are associated with pos-
toperative new onset atrial fibrillation
J.-E. Wolf (1), O. Bouchot (2), D. Vandroux (3), A. Mathé (1), Pierre
Athias (4), G. Laurent (1)
(1) Cardiologie, CHU Le Bocage, Dijon, France – (2) Chirurgie Cardio-
vasculaire, CHU Le Bocage, Dijon, France – (3) NVH Medicinal, CHU
Le Bocage, Dijon, France – (4) CHU Le Bocage, Institut Recherche Car-
diovasculaire, Dijon, France
Atrial fibrillation (AF) is a complication after cardiac surgery, but the
underlying mechanisms remain unclear. We aimed to evaluate whether alter-
ation of atrial connexin43 (Cx43) distribution may be a predisposition factor
of postoperative new onset AF. This study included 79 patients undergoing
“on pump” cardiac surgery (coronary artery bypass grafts, valve replacements
or both). Right atrial appendage (RAA) tissue samples were taken at the aortic
clamping (baseline, BSL) and just before the clamp was removed (post
ischemic time, PIT). Cardiac rhythm was monitored continuously for 48 hours,
and then daily and additional ECGs were performed. In a subgroup of 25 age-
matched patients with normal left atrial size and no AF history (AF+ group,
n=11 and AF- group, n=14) immuno-histological and Western blotting anal-
yses were performed. Cx43 distribution was assessed using a four level
ranking scale (“side to side” vs “end to end” calculated ratio: score 1=0-24%,
score 2=25-49%, score 3=50-74%, score 4=75-100%). New onset AF occurred
in 35.5% of the patients. Older age (>65 years) was the only independent pre-
dictive factor for AF. In the AF+ group, 8/11 patients had a Cx43 distribution
pattern scored 1 at BSL, and changed to 3 or 4 at PIT, corresponding to a lat-
eralization phenomenon, which was not associated with a longer cross clamp
time or a valve replacement. Three patients who had a score of 3-4 at BSL
developed AF after surgery. None of the AF- patients had a score of 3 or 4 at
BSL or after PIT. AF incidence was not correlated with atrial fibrosis at BSL
and the Cx43 phosphorylation of at BSL and PIT. Postoperative AF was
linked to higher plasma TNFα. During “on pump” cardiac surgery, a lateral
Cx43 distribution pattern in RAA at BSL or a lateralization phenomenon
during the ischemic period may be associated with post operative new onset
AF. Inflammation may be involved in these changes which could alter conduc-
tion anisotropy in the atria and promote arrhythmias.
0075
Implication of PKC in catecholaminergic automatic activity induced
in the rat pulmonary vein
Pierre Bredeloux, Ian Findlay, Jean-Louis Freslon, Véronique Maupoil
EA 4433 Physiologie des Cellules Cardiaques et Vasculaires, Tours,
France
Cardiac muscle in pulmonary veins (PVs) has been implicated in the induc-
tion of paroxystic atrial fibrillation in human. In rat PVs, noradrenalin (NA)
induces automatic activity in bursts which depends on the concomittant acti-
vation of α1 and β1-adrenergic receptors (Maupoil et al., 2007). In these prep-
arations the stimulation of α1-adrenergic receptors with the selective agonist
cirazoline induces an unexpected negative inotropic effect which is prevented
by prazosin. The aim of this study was to examine the involvement of PKC in
these effects of cirazoline and NA. 
PVs rings dissected from male Wistar rats surperfused with a physiological
saline solution were electrically stimulated at a frequency of 0.1 Hz. The con-
tractile response of the cardiac muscle was recorded.
The PKC activator, PDBu, induced a slight concentration-dependant
increase in the contraction amplitude of PV cardiac muscle (+5-15% with 10-
6M
 to 10-5M) whereas cirazoline induced a concentration-dependant negative
inotropic effect (Emax:-79% at 10-6M). 
The PKC inhibitor staurosporine (10-5M) significantly decreased the ampli-
tude of PV cardiac muscle contractions (-31%) but was unable to reverse or
prevent the negative inotropic effect of cirazoline. However, staurosporine (10-
6
 to 10-5M) was able to stop and prevent the automatic activity in bursts
induced by the perfusion of NA (10-5M). In these experimental conditions,
PKA did not seem to be inhibited by staurosporine since isoprenaline (10-6M)
maintained a classical positive inotropic effect.
In conclusion, our results suggest that in rat PVs, the automatic activity in
bursts induced by the concomittant activation of α1 and β1-adrenergic recep-
tors is dependent upon PKC activation whereas the negative inotropic effect
induced by the selective stimulation of α1 adrenergic receptors is PKC-inde-
pendant.
0457
Ablation of paroxysmal atrial fibrillation using a cryoballoon cathe-
ter: efficacy, safety and predictors of arrythmia recurrence 
Aurélie Guiot, Arnaud Savoure, Bénédicte Godin, Frédéric Anselme
CHU Charles Nicolle, cardiologie, Rouen, France
Introduction: Radiofrequency catheter ablation has emerged as an effec-
tive treatment for patients with drug-refractory atrial fibrillation (AF). The
objective of this study is to evaluate the efficacy and safety of pulmonary vein
isolation (PVI) with a cryoballoon catheter. 
Methods: In 38 consecutive patients with symptomatic paroxysmal AF
(25 males, age 57+/-11 years), circumferential PVI was performed using a cry-
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oballoon catheter. Before discharge, all patients were subjected to 24-hour
Holter electrocardiograms, echocardiography, and esophageal endoscopy.
Magnetic resonance imaging was performed prior to and 3 months after abla-
tion. At a mean follow up (FU) of 4.5 +/- 1.0 months after ablation, patients
underwent clinical review and 24-hour Holter electrocardiograms. Clinical and
demographic variables were analyzed via logistic regression to assess for pre-
dictors of recurrence. Results: Twenty-eight of the 38 patients (74%) had
complete isolation of all PVs. Out of 152 treated veins, 142 were completely
isolated (93%). Residual conduction persisted in the right inferior pulmonary
vein in 8 patients. The number of balloon applications per vein was 2.2 ± 0.7.
The mean procedure and fluoroscopy times were 164.5 ± 37.9 and 32.6 ±
12.0min, respectively. Eight patients had evidence of mild pericardial effu-
sions requiring no further treatment. Four patients (10.5%) experienced
phrenic nerve palsy, 3 of which resolved immediately and one at 2 weeks. FU
at 4.5 +/- 1.0 months showed freedom from AF in 24 patients (63%) and
freedom from AF without antiarrhythmic drug therapy in 17 patients
(47%). Of all clinical variables analyzed, only early recurrence of AF within 4
days post ablation was associated with long term AF recurrence (p=0.0001;
OR=0.04; CI= [0.003-0.288]). 
Conclusion: PVI can be safely achieved with the cryoballoon catheter with
a moderate success rate at 4.5 months FU. Early recurrence of AF is a clinical
predictor for long term AF recurrence.
0028
Cryoablation of the Pulmonary Veins in Recurrent Symptomatic
Paroxysmal Atrial Fibrillation: 23 Cases
Angéline Martin (1), Jérôme Lacotte (2), François Lesaffre (1), Raphaël San-
dras (1), Benoît Herce (1), Jean-Pierre Chabert (1), Pierre Nazeyrollas (1),
Robert Frank (3), Damien Metz (1)
(1) CHU reims, cardiologie, Reims, France – (2) clinique de Massy, car-
diologie, Massy, France – (3) CHU La Pitié Salpétrière, rythmologie,
Paris, France
Background: Cryoablation for atrial fibrillation (AF) is a recent technique
that may be proposed as an alternative to radiofrequency ablation (RF) in
cases of paroxysmal AF, which are debilitating and/or uncontrolled by anti-
arrhythmics drugs. Only a few studies involving small numbers of patients
have been published to date, leaving many unanswered questions about the
long term benefits of cryoablation.
Objectives: This study was conducted to evaluate the functional benefit
obtained after cryoablation of the pulmonary veins in patients with symptom-
atic and disabling paroxysmal AF.
Methods: All patients with paroxysmal AF underwent cryoablation
between September 2007 and December 2008 at the University Hospital
Center Pitié-Salpétrière. The results were studied retrospectively.
Results: 23 patients with paroxysmal AF, but without underlying heart dis-
ease were inclued (19 men, mean age 51+/- 10 years). On average, 82.6% of
the pulmonary veins were disconnected during the operation. Complications
were documented in 10 patients (43%) with paralysis of the right phrenic
nerve being the most common, accounting for 40% of complications. Recur-
rence of AF after cryoablation was documented in 15 patients, or 62.5%, with
a mean follow-up of 11.8 months. However, 14 patients (60%) reported a
functional improvement after intervention. 
Conclusions: Isolation of pulmonary veins by cryotherapy was obtained in
82.6%. Although, the recurrence rate is high, a functional benefit was docu-
mented in most patients.
0306
Anatomical effect of gap conduction closure by radiofrequency (RF)
after pulmonary vein (PV) cryoablation
Vincent Mouquet (1), Jean-Sylvain Hermida (2), Maciej Kubala (2), Serge
Quenum (2), Georges Nadji (2), Nourredine El Hajjaji (1), Jean Ernst Pou-
lard (1)
(1) CH, cardiologie, Abbeville, France – (2) CHU, cardiologie, Amiens,
France
Aim: Evaluate the effect on PV of a hybrid strategy, associating a cryoiso-
lation of PV, supplemented of residual conduction gaps closure by
RF.Methods:49 consecutive patients underwent cryoballoon isolation of PV
with additional RF.A comparative TDM study of the PV diameters before and
6 months after ablation was done.
Results: 189 PV were disconnected.A reduction in LSPV diameter
(19.2±3.0; 17.8±4.9 mm, p=0.014) was noted.Cryotherapy isolated PV did not
note reduction,for hybrid veins,a reduction was noted in LSPV
(18.8±3.6;15.9±7.1; P=0,046). No stenosis appeared with cryotherapy against
3 in the hybrid group (4.1%; p=0,032).
Conclusion: Balloon Cryoablation of the PV with additional segmental RF
ablation may cause stenosis. Exclusive cryotherapy is safe for PV.
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0230
MiRNAs are involved in the cardiac conduction defects of Scn5a+/- mice
Anne Bourgé, Patrice Naud, Céline Marionneau, Jean Mérot, Flavien
Charpentier
Institut du Thorax, Nantes, France
Loss-of-function mutations of SCN5A, the gene encoding the cardiac Na+
channel Nav1.5, are associated with progressive cardiac conduction defects,
one of the most common cardiac conduction disturbances, and the Brugada
syndrome, which both exhibit variable phenotypic penetrance. In order to
understand Nav1.5 implication in these syndromes, a mouse model invalidated
for Scn5a at the heterozygous state (Scn5a+/-) was developed.
We observed that Scn5a+/- mice show similar phenotypic heterogeneity as
SCN5A-mutated patients. In 10-week-old Scn5a+/- mice, ECG recordings dis-
tinguished 2 subgroups: one with severe conduction defects (QRS>18 ms) asso-
ciated with extensive fibrosis development during ageing and the other with a
mild phenotype (QRS range: 13-18 ms; in wild-type littermates: 10-18 ms) and
less fibrosis. These latter mice have similar Nav1.5 mRNA expression than mice
with a severe phenotype mice but a higher Nav1.5 protein expression. We
hypothesized that these disparate alterations of Nav1.5 protein and mRNA
involve variable miRNA expression. We used TaqMan low density arrays to
study the expression of 335 miRNA in left ventricles of wild-type and Scn5a+/
- mice at the ages of 7 and 25 weeks. At both ages, the expression of the most
expressed miRNA in heart, miR-1 and miR-133, was not altered in Scn5a+/-
mice. At 7 weeks, the expression of only miR-23a was altered (down-regulated)
in Scn5a+/- mice with no difference between the phenotypes. At 25 weeks, 10
miRNA were significantly over-expressed in Scn5a+/- mice with a severe phe-
notype. Among them miR-339, miR-31 and miR-574 were up regulated by 32-
47% in mice with a severe phenotype versus WT and Scn5a+/- mice with a mild
phenotype. Interestingly, miR-31 is a putative regulator of the expression of dys-
trophin, which interferes with Nav1.5 anchoring in sarcolemma. No miRNA was
abnormally expressed in Scn5a+/- with a mild phenotype.
Our study suggests that miRNA are involved in the cardiac phenotype of
Scn5a+/- mice.
0239
Prediction of digoxin blood levels in hospitalized elderly patients by
use of pharmacokinetic modelling
Laurent Bourguignon (1), Adrien Michaud (1), Sylvain Goutelle (2)
(1) Hospices Civils de Lyon, Hôpital des Charpennes, Pharmacie, Villeur-
banne, France – (2) Hospices Civils de Lyon, hôpital Pierre Garraud,
Pharmacie, Lyon, France
Digoxin is characterized by a narrow therapeutic range, and a significant
toxic risk. However it remains useful for patient with atrial fibrillation or heart
failure. In the elderly, the increased half-life of digoxin and the large pharma-
cokinetic variability are serious issues in the clinical use of digoxin.
A pharmacokinetic population study was carried out to create a model able
to predict the concentrations achieved in elderly patients according to the
dosage regimen administered. 
A nonparametric compartmental approach was chosen, using the NPAG
algorithm and 39 data files of elderly hospitalized patients who received digoxin
therapy under therapeutic drug monitoring. Two structural models were tested
and linear relations were searched between pharmacokinetic parameters and
physiological variables of the patients. The best model was selected using the
Akaike criterion. The predictive abilities were estimated using bias and preci-
sion. Model validation in 15 other patients was also performed.
Overall, three-compartment models fit data significantly better than two-
compartment models. The best model obtained was a three-compartment, six-
parameter model with linear relation between creatinine clearance and digoxin
elimination rate constant. The predictive capabilities of this model after baye-
sian estimation of individual parameters were very good: bias was -0.06 µg/l,
precision was 0.12 µg2/l2, and correlation coefficient was 0.76. The validation
performed in 15 other patients also showed good predictive performance.
This model adequately predicted blood concentrations of digoxin in elderly
patients. Although the relation between blood levels and cardiac effects of
digoxin is uncertain, this model can be used along with a Bayesian estimator
to determine the dosage regimen to achieve a concentration target.
The prediction of digoxin concentrations may reduce the risk of overdose and
the iatrogenic effects of this drug especially in the fragile elderly population.
0069
Heterozygous deletion of the lysine 32 in Lmna gene leads to dilated
cardiomyopathy in mice
Marie-Elodie Cattin (1,2), Valérie Decostre (1,2), Maron S (5),
Schlossarek S (5), Shaida Varnous (1,2), Nathalie Mougenot (3), Yves
Fromes (1,2), Lucie Carrier (1,2,5), Gisèle Bonne (1,2,4) 
(1)INSERMU974, Paris, France – (2) UPMC Université Paris 06,
UMR_S974 ; CNRS, UMR 7215 ; Institut de Myologie, IFR14, Paris,
France – (3) INSERM, IFR14, Paris, France – (4) AP-HP, Groupe Hos-
pitalier Pitié-Salpêtrière, U.F. Cardiogénétique et Myogénétique, Service
de Biochimie Métabolique, Paris, France – (5) Institute of Experimental
and Clinical Pharmacology and Toxicology, University Medical Center
Hamburg-Eppendorf, Hamburg, Germany.
Emery-Dreifuss Muscular Dystrophy (EDMD) associates skeletal muscle
disease and dilated cardiomyopathy (DCM) with conduction and/or rhythm
defects. The autosomal form of the disease is due to mutations in the LMNA
gene, encoding lamins A/C, proteins of the nuclear envelope. The mechanisms
by which mutations in such ubiquitous proteins lead to pathology affecting only
striated muscle remain to be elucidated. In order to understand those pathophys-
iological mechanisms, we have created a mouse model reproducing a mutation
responsible for a very severe form of EDMD: the LmnadelK32 mouse.
The heterozygous LmnadelK32/+ mice present a progressive cardiac contractile
dysfunction, evolving in DCM which leads to death between the age of 250
and 500 days. There is no rhythm or conduction defect. 
Despite an equal level of Lmna mRNA in mutant mice at all stages of the
disease compared to WT, lamins A/C protein amount in myocardium of
asymptomatic LmnadelK32/+ mice is about 50% compared to WT mice. Surpris-
ingly, in symptomatic mice this protein amount is similar to age-matched WT.
Thus, it appears that part of mutant lamin is degraded in asymptomatic but not
in symptomatic mice. We are now investigating the ratio of WT vs mutant
lamins (mass spectrometry approach) and the proteasome activity at different
stages of the DCM.
In addition, the ERK1/2 MAP kinase signalling pathway has been shown
to be activated in asymptomatic mice and this activation is positively corre-
lated with cardiac function. A transcriptomic study of the heart of asymptom-
atic LmnadelK32/+ mice is also ongoing to determine all pathways activated by
the mutant lamins.
In conclusion, the LmnadelK32/+ mice constitute the first murin model har-
bouring a heterozygous Lmna gene mutation which develops a phenotype
affecting specifically the heart. The pathophysiological mechanisms are still
unknown but proteasome system as well as MAP Kinase pathway appear to be
implicated in the development of the DCM.
0388
Plakophilin 2a is the unique isoform expressed in the heart: conse-
quences on genetic screening in arrhythmogenic right ventricular car-
diomyopathy
Estelle Gandjbakhch (1), Philippe Charron (1), Véronique Fressard (2),
Geoffroy Lorin De La Grandmaison (3), Francoise Simon (2), Françoise
Gary (4), Alexia Vite (4), Bernard Hainque (2), Françoise Hidden-
Lucet (1), Michel Komajda (1), Eric Villard (4)
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(1) CHU Pitié-Salpêtrière, Département de Cardiologie, Paris, France – (2)
CHU Pitié-Salpêtrière, Service de Biochimie (Unité de Cardiogénétique et
Myogénétique), Paris, France – (3) AP-HP, Hôpital Raymond Poincaré,
92380, Garches, Département d’anatomie pathologique et de médecine
légale, Garches, France – (4) INSERM UMRS 956, Paris, France
Introduction: Arrythmogenic right ventricular cardiomyopathy (ARVC) is
an inherited heart muscle disease caused by dominant desmosomal gene muta-
tions, mostly Plakophilin 2 (PKP2). PKP2 was previously described as two
different isoforms (short PKP2a and long PKP2b), differing by the alternative
splicing of the exon 6. Several mutations located in PKP2 exon 6 (exclusively
present in PKP2b) were already reported as causal mutations in ARVC. In this
study, we focused on a heterozygous missense pArg490Trp variant located in
PKP2 exon 6. In order to ascertain its pathogeneicity.
Methods and results: pArg490Trp variant was identified by direct
sequencing in 2 independent ARVC probands out of 400 (one of Turkish and
one of French origin) and was not found in 470 controls. In silico analysis
strongly suggests that PKP2 exon 6 is an Alu-derived sequence included in the
primate genomes. This finding, associated with a unique report of the PKP2b
transcript on several molecular databases, suggests that exon 6 is only rarely
spliced. This was confirmed by molecular analysis, performed on several heart
tissue samples from controls and pArg490Trp carrier, showing that PKP2a
was the very major isoform at the transcript level and the only detectable iso-
form at the protein level in all individuals. The pArg490Trp variant was not
associated with aberrant exon 6 splicing nor allele specific mRNA down reg-
ulation. No additional putative causative variant in linkage disequilibrium with
pArg490Trp was identified in the gene. Finally, an heterozygous missense
variant pGlu2343Lys in desmoplakin (DSP) gene was identified in one
proband. Although both PKP2 and DSP variants cosegretated in the family,
the DSP variant was likely to be the disease causing mutation. 
Conclusion: As PKP2b is a very rare transcript, these results strongly sug-
gest that pArg490Trp and other variants located in PKP2 exon 6 are rather rare
polymorphisms and should not be considered as true disease-causing muta-
tions. This also suggests that the systematic molecular screening of PKP2 exon
6 is useless in ARVC and should be abandoned. 
0446
Inhibitory effect on sympathetic overactivity of single bout of Func-
tionnal Electromyostimulation in chronic heart failure
Marc Labrunée (1), Fabien Despas (1), Nicolas Franchitto (1), Julia
Satge (1), Marine Lebrin (1), Michel Galiner (2), Jean-Michel Senard (1),
Atul Pathak (1)
(1) INSERM U858, équipe 8, Toulouse, France – (2) CHU Toulouse, Car-
diologie, Toulouse, France
Background: Chronic Heart Failure (CHF) is characterised by sympathetic
overactivity (SO). Beneficial effects of Functional ElectroStimulation (FES) of
lower limb are known in CHF and we hypothesize that these effects are medi-
ated by reduce of SO.
Objectives: This study evaluated the immediate effects of single bout FES
treatment. 
Methods: 11 subjects with CHF were recruited (62,7 +/- 11,7 yo, 82%
NYHA=3). A cross-over protocol was used with comparison of FES versus
placebo stimulation witch correspond to an electrical stimulation on the same
place without muscle contraction. Sympathetic activity was evaluated by
Muscle Sympathetic Nerve Activity (MSNA). Respiratory and Hemodynamic
parameters were obtained by Finometer.
Results: In comparison with data obtained post placebo stimulation, after
5 minutes of FES of single lower limb, MSNA decrease significantly during
the first minute(- 9,5%, p=0,0039) without alteration of hemodynamic and res-
piratory parameters. At the second minute post FES, MSNA was similar with
post Placebo. This study shows an unexpected inhibitory effect of FES on
sympathetic overactivity. We sought thinking that inhibitory effect could be
related to stimulation of cutaneous afferents witch could be predominant over
the sympathoactivation normally produced by musculo-articular afferents. At
the opposite, placebo stimulation isn’t suffisant to activate cutaneous afferents.
Conclusion: This mechanism hasn’t been yet evoqued and could be ben-
efic in CHF. Complementary study should be further realized to confirm these
hypotheses.
0045
Tako-Tsubo syndrome: Acute evolution and long-term prognosis.
About 13 cases
Anne-Sophie Leborgne-Meyer, Pierre-Yves Pennec, Philippe Castellant,
Jean-Christophe Cornily, Martine Gilard, Jacques Mansourati 
CHU Brest, Département de Cardiologie, Brest Cedex, France
The Tako-tsubo syndrome was described for the first time in 1991. If the
clinical presentation is well known, its pathophysiology and long-term evolu-
tion are less clear.
Objective: The aim of our study was to report the clinical characteristics
of patients, and short and long term outcome from a single center experience.
Methods: This retrospective study included 13 patients hospitalized at the
University Hospital of Brest with a diagnosis of Tako-Tsubo Syndrome. Clin-
ical data were collected from patients charts and outcome was assessed after
calling cardiologists and/or physicians.
Results: The study population was composed exclusively of women in a
peri and post menopausal status, presenting at the hospital as acute coronary
syndrome. A precipitating factor was found in 84% and was in 90% of these
cases psychological. The in-hospital evolution was favorable without major
complications or death. Short and long term follow-up showed a total recovery
of left ventricular function and segmental kinetics in all cases. Symptoms were
still present in 38.4% of patients. Recurrence rate was 7.7%. No death
occurred during follow-up.
Conclusion: Clinical presentation and left ventricular function outcome are
comparable to published data. Recurrence rate is probably underestimated and
the persistence of functional symptoms is not uncommon.
0435
Cardiovascular manifestations associated with severe H1N1 influenza
virus infection. A 17-cases prospective study
Philippe Paule, Nicolas-Charles Roche, Sébastien Kerebel, Jean-Marie
Gil, Laurent Fourcade
Hôpital d’Instruction des Armées LAVERAN, Service de Cardiologie,
Marseille Cedex 13, France
During the spring of 2009, a pandemic influenza H1N1 virus emerged and
spread globally. Influenza is a recognized cause of acute myocarditis. Diag-
nosis of acute myocarditis may be difficult, particularly because clinical pre-
sentation of myocarditis is variable. Even many patients are asymptomatic
with only electrocardiographic abnormalities.
Method and results: we report a prospective series of 17 consecutive
patients hospitalized for severe biologically proven H1N1 influenza infection
between October 2009 and January 2010: 7 men and 10 women, 43 years old
on average. 15 were admitted in a medical intensive care unit and 2 in a rean-
imation yard. Two patients had chronic obstructive pulmonary disease, 2 were
asthmatic and one was diabetic. Clinical presentation was always pneumonia
but no patient presented with chest pain. Physical examination found no sign
of heart failure. All patients presented with biological inflammatory syndrome
(C reactive protein: 134 mg/L on average), but none had troponine I elevation.
ECG was performed in all cases. It was strictly normal in 16 cases. Only
one young black woman had T wave negativity in leads V1 to V3. Echocar-
diography revealed neither left ventricular dysfunction nor segmental motion
abnormality or pericardial effusion. Cardiac MRI was performed with cine-
MRI and T2-weighted sequences, first-pass perfusion of gadolinium and late
enhancement sequences. It showed no abnormality. Holter monitoring
remained normal. Two months after the acute episode, stress ECG showed
normalisation of the repolarisation during exercise, compatible with a partic-
ular pattern in a black person. 
Conclusions: at the time of admission in our series of 17 patients with
severe influenza H1N1 virus infection, we found no clinical or paraclinical
(ECG or troponine I) disorder suggestive of acute myocarditis.
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Cardiac muscarinic receptor overexpression as a possible cause of
vagal hyperreactivity
Angelo Livolsi (1), Nathalie Niederhoffer (2), Nassim Dali-Youcef (2),
Walid Mokni (2), Catherine Olexa (1), Dang Anh Duong (2), Pascal Bous-
quet (2)
(1) CHU de Strasbourg, Pédiatrie 1, Strasbourg, France – (2) Laboratoire
de Neurobiologie et Pharmacologie Cardio-vasculaire, Strasbourg, France
Background: Vagal hyperreactivity associated with baroreflex dysfunction
could account for vasovagal syncopes. However, no underlying cardiac abnor-
mality for vagal hyperreactivity has been described so far.
Objective: The aim of our study was to identify vago-cardiac abnormali-
ties possibly underlying vagal hyperreactivity. To this purpose, we explored
cardiac muscarinic receptor and acetylcholinesterase (AchE) levels in a rabbit
model of vagal hyperreactivity. We also sought blood markers of the observed
abnormalities.
Methods: The severity of vagal hyperreactivity was evaluated in conscious
animals by measuring the duration of the R-R interval on ECG recording after
intravenous injection of phenylephrine. Total, M2 and M3 muscarinic receptor
densities were assessed in cardiac tissue using radioligand binding experi-
ments; M2 receptor expression was also determined in peripheral mononuclear
white blood cells using quantitative real time PCR (Q-RT-PCR). Cardiac
AchE expression was evaluated by Q-RT-PCR and AchE enzyme activity in
erythrocytes was assayed colorimetrically. 
Results: The R-R interval duration was largely enhanced in hyperreactive
rabbits as compared to control animals (10644±878 versus 1867±251 ms). In
the heart of these rabbits, 2.3- to 3-fold increases in total, M2 and M3 musca-
rinic receptors densities were observed; moreover, muscarinic receptors densi-
ties were significantly correlated to the severity of cardiac pauses. The M2
receptor expression was increased similarly in peripheral mononuclear white
blood cells. Vagal hyperreactive rabbits displayed an AchE mRNA amplifica-
tion ratio of 3.6 versus normal rabbits; this was associated with twice the
enzyme activity in erythrocytes.
Conclusion: Our results suggest that cardiac muscarinic receptor overex-
pression plays a critical role in the development of vagal hyperreactivity;
increased AchE levels might represent a compensatory consequence of vagal
hyperreactivity. They also show that cardiac abnormalities can be inferred
with high confidence from muscarinic receptor and AchE levels in blood cells,
which may be of great practical interest. Finally, these data support the
hypothesis that muscarinic receptor overexpression could become a marker of
risk among subjects exhibiting vagal or vasovagal syncopes.
0111
A role for cardiotrophin-1 in myocardial fibrosis and left ventricular
dysfunction
Natalia Lopez-Andres (1), Carmen Inigo (2), Idoia Gallego (2), Patrick
Lacolley (1), Faiez Zannad (1), Patrick Rossignol (1), M Antonia
Fortuno (2), Javier Diez (2)
(1) INSERM U961, Vandoeuvre-Les-Nancy, France – (2) CIMA. Univer-
sité de Navarre, Pampelune, Espagne
Background and aims: Cardiotrophin-1 is a cytokine belonging to the
interleukin-6 superfamilly that promotes cardiac hypertrophy in vitro and in
vivo. However, the involvement of CT-1 in myocardial fibrosis and left ven-
tricular (LV) dysfunction remains unknown. 
Methods: CT-1 (20 μg/Kg/day) or vehicle were administrated to Wistar
rats for 21 days. Blood pressure (BP) and heart rate were recorded by telem-
etry. LV dimensions and cardiac function were analysed using M-mode
echocardiography and Doppler assessment. Myocardial expression of extracel-
lular matrix (ECM) proteins was quantified by RT-PCR and Western Blot in
CT-1-treated rats and CT-1 null mice. Cardiomyocyte morphology and myo-
cardial fibrosis were evaluated by histological analysis in the two animal
models. The effect of CT-1 on proliferation of Rat-2 fibroblasts was assessed
by MTT assay and ki67 immunodetection, and their effects on ECM proteins
by RT-PCR, Western Blot and zymography. 
Results: Compared with vehicle-treated rats, CT-1-treated rats presented
increased plasma levels and myocardial expression of CT-1. Whereas CT-1
treatment did not modify BP, it was associated with increased E/A ratio and
reduced LV fractional shortening and LV ejection fraction. CT-1-treated rats
also presented LV dilatation and cardiomyocyte elongation. Collagen volume
fraction (CVF), as well as the expression of α-1-procollagen, collagen type I,
collagen type III and MMP-13/TIMP-1 ratio were increased in the myocar-
dium of CT-1-treated rats. Compared with wild type mice CT-1-null mice
exhibited decreased myocardial expression of α-1-procollagen, collagen type I
and CVF. Incubation of Rat-2 fibroblasts with CT-1 increased cell prolifera-
tion, α-1 procollagen, collagen type I and type III expression and MMP-13
activity in a concentration-dependent manner, being these effects abolished by
CT-1-receptor antibodies.
Conclusion: CT-1 induces profibrotic effects both in vivo and in vitro.
These effects may be involved in the ability of this cytokine to produce LV
dysfunction.
0032
Zucker fa/fa rats, a rat model of metabolic syndrome, shown cardiac
diastolic impairment
Nassiba Merabet, Paul Mulder, Lionel Nicol, Christian Thuillez
Unité inserm 644, Rouen, France
Background: In humans, metabolic syndrome (MS) is associated with
structural and functional changes of the myocardium. However, it is unk-
nown whether Zucker fa/fa rats, a rat model of MS which is often used to
determine the metabolic effects of drugs in MS, have altered cardiac func-
tion similar to those observed in humans. 
Objectives: The objective of the study is to evaluate cardiac systolic and
diastolic function in an experimental model of metabolic syndrome. 
Methods: We assessed cardiac performance in 24 week-old Zucker fa/fa
rats and their lean littermats (n=12 per group) by determination of systemic
hemodynamics and LV cardiac hemodynamics (pressure-volume (P-V) con-
ductance catheter system), as well as LV tissue perfusion (MRI) and LV tis-
sue hypoxia (Hypoxia Induced Factor-α (HIF-α) by western blot). 
Results: Compared to lean rats, heart rate and systemic blood pressure were
increased in Zucker fa/fa (+9% and +9% respectively), and diastolic function
was impaired, as illustrated by the increases in LV end-diastolic pressure
(+14%), Tau (+42%) and LV end-diastolic P-V relation (+86%), while LV
end-systolic P-V relation was not modified. Moreover, in Zucker fa/fa rats,
LV tissue perfusion was significantly reduced (-28%) and HIF-α protein
levels were increased (-42%), but this does not reach statistical significance. 
Conclusion: Our data show that Zucker fa/fa rat have preserved LV sys-
tolic function but reduced relaxation, increased diastolic stiffness and
decreased myocardial perfusion. Thus, this experimental approach in this rat
model allows the evaluation of the effect of emerging therapies both in meta-
bolic syndrome and diastolic dysfunction. 
0127
Differential proteomic analysis of failing left ventricles in female mice
overexpressing FKBP12.6 using 2D-DIGE analysis
Patricia Rouet-Benzineb (1), Miresta Previlon (1), Philippe Chafey (2),
Guilhem Clary (2), Morgane Le Gall (2), Cédric Broussard (2), François
Guillonneau (2), Jean-Jacques Mercadier (1)
(1) INSERM, U698, Paris, France – (2) INSERM , Plate forme protéomi-
que de Cochin, Paris, France
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In cardiac myocytes, FKBP12.6 (FK506 binding protein or calstabin 2)
binds to and modulates the activity of the ryanodine receptor type 2
(RyR2), the Ca2+-channel of the sarcoplasmic reticulum (SR). FKBP12.6
is thought to favour synchronous RyR2 opening during systole and to pre-
vent SR calcium leak during diastole. Increased Ca2+ leak through RyR2
during diastole has been implicated in the pathophysiology of heart failure
(HF). We made the hypothesis that, by altering SR Ca2+ homeostasis,
FKBP12.6 overexpression would influence Ca2+-dependant signalling
pathways during pressure overload-induced HF. In addition, RyR2 may not
be the only cellular target for FKBP12.6 in cardiomyocytes. We used our
mouse model of cardiac specific conditional overexpression of FKBP12.6.
Wild type (WT) mice and mice overexpressing FKBP12.6 (DT) were sub-
mitted to transverse aortic constriction (TAC) and compared at 30 days to
sham-operated mice of the same genotype. We analyzed total proteins
extracted from the LV of 12 female mice (3 WT sham-operated (WT
sham), 3 WT TAC, 3 FKBP12.6 sham-operated (DT sham), and 3
FKBP12.6 TAC (DT TAC)). TAC mice were selected for the presence of
congestive heart failure according to the presence of pulmonary oedema
(defined as the ratio of lung weight to tibia length > lung weight to tibia
length in sham-operated mice + 3 SD). Quantitative differential proteomic
analysis was performed using 2D-DIGE (2 Dimensional- Differential In-
Gel Electrophoresis), a powerful tool to overcome the high inter-experi-
ment variations observed with classical 2D gels. Data processing and spot
quantification were performed using DeCyder software (GE Healthcare
Bio-Sciences). The average protein abundance changes and Student’s t-test
p-values were calculated across four-way pairwise comparisons (WT Sham
vs WT TAC, DT Sham vs DT TAC, WT Sham vs DT Sham, WT TAC vs
DT TAC) and were considered significant for any spot for p-values < 0.05
and for a differential threshold set at a 1.5-fold change in protein spot
intensity either positively or negatively. Our results show that there are a
large number of differentially expressed proteins between WT and DT
failing left ventricles. Whatever the alteration (up or down regulation) the
effect appeared less pronounced in DT TAC than in WT TAC vs the
respective sham group.
0129
Temporal changes in activation of calcineurin-NFAT signalling in
female mice overexpressing FKBP12.6 during pressure overload-
induced cardiac hypertrophy and failure
Miresta Previlon, Fannie Semprez, Jean-Jacques Mercadier, Patricia
Rouet-Benzineb
INSERM, U698, Paris, France
The ryanodine receptor (RyR2) forms a complex with a small accessory
protein FKBP12.6 (FK506 binding protein or calstabin 2) that stabilizes
the Ca2+-channel, controlling its opening probability and favouring its
closed state. Importantly, RyR2 is not the only target of FKBP12.6.
FKBP12.6, an immunophilin cytosolic receptor, also binds to and inhibits
the Ca2+-calmodulin-dependent phosphatase, calcineurin. Strong, sus-
tained activation of the calcineurin/NFAT pathway has been incriminated
in the physiopathology of heart failure. Accordingly, the aim of our study
was to examine whether FKBP12.6 overexpression would influence cal-
cineurin/NFAT signalling. We used our mouse model of cardiac specific
overexpression of FKBP12.6 submitted to transverse aortic constriction
(TAC). Since calcineurin activates the expression of the modulatory cal-
cineurin-interacting protein 1 (MCIP1 or calcipressin) via NFAT, we mea-
sured the expression of MCIP1 as an estimation of the degree of
calcineurin/NFAT pathway activation in left ventricles of wild type female
mice (WT) and female mice overexpressing FKBP12.6 (DT) killed at var-
ious time points after TAC (3, 7, 15 and 30 days). Mice were compared to
sham-operated animals of the same genotype. In response to TAC, WT and
DT mice developed left ventricular hypertrophy from 8% at day 3 to 60%
at day 30 in WT mice and from 15% at day 3 to 74% at day 30 in DT
mice. LVH tended to be greater in DT mice compared to WT. The transi-
tion to heart failure was observed in both genotypes 7 days post-TAC. The
number of mice with failing left ventricles increased with time and was
greater in DT than in WT groups. Increases in MCIP1 mRNA levels
occurred as early as day 3 in the LVs of both genotypes after TAC. MCIP1
mRNA levels further increased 30 days post-TAC, more in failing than in
non-failing ventricles. At day 7, MCIP1 mRNA levels appeared higher in
DT than in WT LVs. Taken together, our data indicate that FKBP12.6
overexpression does not mitigate the development of LVH or the transition
to HF after TAC, at least in female mice.
0120
Interest of a multimodal approach during a CRT opitmization
Christophe Thebault (1), Erwan Donal (1), Alfredo Hernandez (2), Kevin
Tse Ve Koon (2)
(1) CHU Rennes, cardiologie, Rennes, France – (2) LTSI INSERM U 642,
Rennes, France
Optimization of CRT device (BiV) is needed. Whinnet et al. has shown a
parabolic response to varying atrio ventricular (DAV) an interventricular (VV)
delays. Our study aimed to assess the interest of a multiparametric approach
using echocardiography and noninvasive haemodynamic measures.
Taking into account results from the «strain delay index» (which depicted
the conctractile reserve using the strain peaks of each LV segments after aortic
valve closure -AVC-. In our study strain peaks were named Pspt for septal and
Plat for longitudinal peaks, numbered for 1 for the basal to 3 for the apical
segment) suggested by Lim et al. we developped a new indice called the
«strain integral index» by calculating the area under the curve of each LV lon-
gitudinal segment’s strain curve from the onset to the maximum, to the AVC
and their difference (named Dspt for the septal and Dlat for the lateral seg-
ments) in the apical four chambers view.
During a BiV optimization, we recorded echographic and non invasive hae-
modynamic datas using a fixed protocol (DAV set at 160ms, 20ms decreased
to the first intrinsec capture and then VV scan).
We present our results using a PCA (Principal Components Analysis)
method which describe in a factorial and structural way all the numerous vari-
ables according to their strenght relationship. The significance level of each
variable is represented by the distance to the origin, the most contributive are
closed to the abscissa and the independantly related variables are localised on
the orthogonal axis.
The figure 1 shows our PCA: all the configurations are represented with a
colour point, the circle stands for the optimal echographic and the triangle is
the optimal haemodynamic setting. The rDFMRR stands for the ratio mitral
inflow duration/ cardiac cycle, the TRIVG for the isovolumic LV relaxation
duration and the DIV for the intraventricular delay.
This figure shows that the most important variable is the strain integral
index (Dspt 1-2) when optimizing a BiV.
PCA
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Myocardial function by Longitudinal Global Strain correlates to exer-
cise capacity in patients with Hypertrophic Cardiomyopathy
Alexandre Bensaid, Julien Nahum, Laurent Macron, Dussault Caroline,
Jean-Luc Dubois-Randé, Pascal Guéret, Pascal Lim
Hôpital Henri-Mondor, Département de cardiologie, Créteil, France
In patients with hypertrophic cardiomyopathy (HCM), left ventricular ejec-
tion fraction by Simpson biplane (LVEF2D) has limited value in assessing
myocardial contractility. To overcome this limitation, longitudinal global
strain (global-ε) by speckle tracking could be an alternative. 
Methods: Global-ε was assessed in 25 HCM patients (58±13 years,
18 men) with preserved LVEF2D (67±8%, range 50-79), referred for exercise
echocardiography. Global-ε was compared to exercise capacity and 3D LVEF
(LVEF3D). 
Results: On the whole, global-ε averaged -16±5% (range -25 to -9) and
better correlated to LVEF3D (r=-0.69, p=0.001) than to LVEF2D (r=-0.52,
p=0.01). Importantly, despite preserved LVEF2D, impaired contractility was
observed in 7/25 (28%) patients by 3D echocardiography (LVEF3D <50%) and
in 10/25 (40%) by global strain (>-15%). However, only impaired contractility
by global-ε (>-15%) was associated to a lower exercise duration (5.6±1.8 min.
with global strain >-15% vs. 7.5±2.2 min with global strain ≤-15%, p=0.03)
and a lower expected work load (58±20% vs. 77±12%, p=0.03). 
Conclusion: In patients with HCM and preserved LVEF2D, longitudinal
global strain impairment is associated with lower exercise capacity, suggesting
that alterations of contractile apparatus could be recognised by speckle
tracking derived strain analysis. 
0367
Early transient cardiac insulin resistance after myocardial infarction
in rats: study by nuclear imaging with 125I-6-deoxy-6-iodo-D-glucose
(6DIG)
Stéphane Grauzam (1), Cécile Moro (1), Marie-Claire Toufektsian (1),
Marie-Gabrielle Jouan (1), Julien Vollaire (2), Joël De Leiris (1), Cathe-
rine Ghezzi (2), François Boucher (1)
(1) Laboratoire PRETA-TIMC, La Tronche Cedex, France – (2) Labora-
toire d’étude des Radio-pharmaceutiques LER, INSERM U877, La Tron-
che, France
Background: Recent experimental data have reported that several cellular
phenomena involving TNF-α, IL-6 and leptin are initiated one week after rep-
erfused myocardial infarction in rats. Leptin can shift energy metabolism from
glucose utilization to fatty acid consumption, driving unfavorable conditions
and promoting hypertrophy. Hyperleptinemia may contribute to cardiac
remodeling through the induction of a temporary myocardial insulin resisant
state. We have therefore evaluated global and cardiac insulin sensitivity in rats
7 and 14 days after reperfused myocardial infarction (MI). 
Methods & Results: Male Wistar rats (325 g) were subjected to in vivo
temporary (60 min) left coronary artery ligation (MI, n=15). In a 2nd group,
rats were subjected to the same surgical procedure but the ligation remained
untied (Sham, n=15). Finally, a 3rd group was constituted with non operated
animals (NOP, n=15). Fasting glycaemia was measured three days before (d-
3) and seven days (d7) after surgery. Cardiac insulin sensitivity was evaluated
by nuclear imaging (γ-Imager, Biospace, France) at d7 and d14, using 6DIG,
an iodinated glucose tracer. Global insulin sensitivity was estimated by the
euglycaemic-hyperinsulinemic clamp technique. Fasting glycaemia did not
significantly change between NOP, Sham and MI at d-3 and d7 (respectively
81 mg/dL±3.6, 79.5±3.9, 81±3.8,NS). Moreover, the glucose infusion rate
(GIR) assessed by the clamp technique was not significantly altered at d7 in
MI rats compared with NOP (GIR = 11.6±0.79 vs. 17.2±0.91, NS). In contrast,
myocardial insulin sensitivity (6DIG) was lower in MId7 vs. NOP (1.09±0.03
vs. 2.46±0.25, P<0.001). This phenomenon was almost reversed 14 days after
surgery (1.88±0.22 vs. 2.46±0.25, NS). 
In conclusion: our data show that the myocardium becomes temporary
resistant to insulin 7 days after reperfused MI, concomitantly with leptin over-
expression. Meanwhile, global insulin sensitivity remains not significantly
modified. 
0382
Determinants and Prognosis Influence of Exercise Obstruction in
Hypertrophic Cardiomyopathy. An Exercise Echocardiography Study
Guillaume Deswarte (1), Anne-Sophie Polge (1), Alain Millaire (1), Mar-
jorie Richardson (1), Nicolas Lamblin (1), Christophe Bauters (1), Ghis-
laine Deklunder (1), Thierry Le Tourneau (1,2)
(1) Hôpital Cardiologique, Lille, France – (2) Hotel Dieu-Institut du Tho-
rax, Nantes, France
Background: Determinants and prognosis value of exercise peak gradient
in HCM are unknown. We sought to assess the determinants of exercise peak
gradient and the prognosis value of rest and exercise echocardiography in
patients with HCM.
Methods: A comprehensive echocardiography was performed at rest and
during exercise in 139 (45±17 years, 95 males) patients referred to our insti-
tution for the evaluation of HCM. Medications were left unchanged for exer-
cise. Follow up averaged 2.3±1.5 years after exercise echocardiography. The
main endpoint was a composite endpoint of cardiac death, appropriate dis-
charge of defibrillator and unplanned hospitalization for cardiac cause.
Results: Forty-nine patients (35%) exhibited a baseline obstruction, 22
(16%) had latent obstruction (baseline peak gradient < 30 mmHg and exercise
peak gradient ≥30 mmHg), and 68 (49%) had not significant obstruction. In
multivariate analysis peak gradient at rest (P<0.0001) and septal mitral
annulus S velocity (p<0.0001) were the predictors of exercise peak gradient.
By excluding peak gradient at rest, the main predictors were sinus rhythm
(P=0.023), septum thickness (P=0.02), septal mitral annulus S velocity
(P=0.01) and posterior mitral valve length (P=0.009) but the prediction value
of this model was low. Independent predictive factors of outcome were sinus
rhythm (HR 0.16, P=0.003), NYHA class (HR 2.04, P=0.037), peak gradient
at rest (HR 1.03, P<0.0001), LV EF (HR 0.95, P=0.036), and peak systolic
blood pressure during exercise (HR 0.98, P=0.021). Peak gradient during exer-
cise was not a predictive factor of outcome. 
Conclusion: Baseline or latent obstruction is found in more than 50% of
patients with HCM despite medical treatment. Baseline peak gradient is not
only the main determinant of maximal peak gradient during exercise, but also
the main predictor of outcome in this series of patients. The only predictor of
outcome during exercise is the maximal systolic blood pressure value.
0079
Only few prognostic factors are correlated with daily-life symptoms in
ischemic cardiac heart failure patients
Maxime Guenoun (1), Philippe Meurin (2), Dominique Guedj (3), Patrick
Jourdain (4), Marie-Christine Malergue (5), Jean-Yves Tabet (2), Franck
Paganelli (1)
(1) Hôpital Nord, Cardiologie, Marseille, France – (2) les grands prés,
cardiologie, Villeneuve Saint Denis, France – (3) Cabinet de Cardiologie
et Collège National des Cardiologues Français, Paris, France – (4) Cen-
tre Hospitalier, Pontoise, France – (5) Institut Jacques Cartier, Massy,
France
Background: prognostic factors are well known in ischemic chronic heart
failure (ischemic CHF), however it is unclear whether these factors are corre-
lated with the intensity of the symptoms.
Methods and results: We studied 465 consecutive patients (among the
3119 of the prospective multicenter INDYCE registry in which stable CAD
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outpatients were included) who had been hospitalized for acute heart failure in
the previous year. These patients (72.2 ± 10.5 years old, male 77%) had a
mean left ventricular ejection fraction (LVEF) of 44.1 ± 12.7% (LVEF<40%:
39% of the patients ; 40-50%: 28% ; >50%: 33%): 80% of them were
receiving a beta blocker agent, 34.2% had diabetes and 61% had suffered from
a previous myocardial infarction.
Patients assessed the intensity of their symptoms (dyspnea and/or chest
pain) by rating a 100 mm analogic visual rating scale (VRS). Each individual
score was afterwards measured by a blinded independent observer. Mean VRS
was of 47.3±24.6 mm with a median value of 49.4 mm.
They were then divided in two groups: « symptomatic patients » in whom
VRS was superior to the median VRS (n=232, VRS = 68.3±11.8 mm) and
pauci or asymptomatic patients in whom VRS was inferior to the median
(n=233, VRS = 26.9±14.2 mm)
Only 5 parameters were significantly different between the 2 groups: rest
heart rate (HR ; 64.2 ± 11.0 in the paucisymptomatic group vs 68.7 ± 13.4 in
the symptomatic one, p<0.0001, i.e patients with HR ≥70bpm: 31.9% vs
44.4% p<0.0001), regular physical exertion (52.9% vs 30.4% p< 0.0001),
LVEF (46.2 ±12.2% vs 42.5±7.2%, p=0.002), renal failure (30.3% vs 41.3%,
p=0.02) and existence of a left bundle branch block (19.5% vs 32.1% p=0.02)).
By contrast ,many clinical (age, sex,BMI,Diabetes,hypertension, current
smoking, dyslipidemia,chronic obstructive pulmonary disease,beta blocker
administration and doses), EKG (atrial fibrillation, left ventricular hyper-
trophy) and echographic (telediastolic left ventricular diameter, E/A ratio, tele
diastolic inter ventricular septal thickness, left atrium area) classical prognostic
parameters were not correlated with symptoms intensity .
Conclusion: In this large survey, only two potentially modifiable parame-
ters ( rest HR ≥ 70 bpm and absence of regular physical exertion) seem to be
correlated with the intensity of symptoms in ischemic CHF patients.
0366
Left ventricular global and regional systolic function in primary res-
trictive cardiomyopathy vs cardiac amyloidosis: a speckle-tracking
echocardiographic strain analysis study
Rim Saad, Adrien Salem, Yvan Le Dolley, Sebastien Ansaldi, Franck
Thuny, Jean-François Avierinos, Sebastien Renard, Gilbert Habib
Hôpital de la Timone, cardiologie, Marseille, France
Both cardiac amyloidosis (CA) and primary restrictive cardiomyopathy
(RCM) are characterized by early impairment of diastolic left ventricular func-
tion. Early LV systolic function abnormalities can be detected by deformation
analysis using speckle-tracking echocardiographic strain analysis (2D strain).
However, comparison between CA and RCM using 2D strain has never been
performed.
Purpose: Our goal was to compare global and regional systolic function in
patients with RCM vs. patients with CA using 2D strain (2DS). 
Materials and methods: 16 patients with RCM and 16 patients with CA
were prospectively included. All patients underwent both clinical evaluation as
well as a comprehensive echocardiographic, Doppler, and 2D strain study.
Left ventricular ejection fraction (LVEF), global longitudinal strain (GLS) and
regional longitudinal peak systolic strains (PSS) were measured by 2DS in
apical 4, 2 and 3 chambers views. Radial and circumferential PSS were mea-
sured in the parasternal short axis view.
Results: As compared to RCM, patients with CA presented with higher
LVEF (52% vs. 40%, p=0.01) despite similar GLS (-9.9% vs. -11.7%, p=ns).
However, longitudinal basal PSS (-5.2% vs -8.5%, p=0.02) and middle PSS (-
7.7% vs. -9.8%, p=0.04) were significantly lower in CA than in RCM. Longi-
tudinal apical, radial and circumferential PSS were similar in patients with
RCM and CA.
Conclusion: Cardiac amyloidosis is characterized by more severe left
ventricular longitudinal dysfunction than primary restrictive cardiomyop-
athy, as assessed by 2D strain analysis. Despite apparently better LV sys-
tolic function, patients with cardiac amyloidosis present with more
depressed peak systolic deformation than patients with RCM, particularly
in the basal and middle LV segments. 2D strain is potentially helpful to
differentiate patients with cardiac amyloidosis from those with primary
RCM. 
0415
High sensitivity cardiac troponin T is a sensitive marker of both myo-
cardial infarction and unstable angina, but 2 dosages should be
encouraged for unstable angina
Stéphane Zuily (1), Camille Chenevier-Gobeau (2), Yann-Eric
Claessens (3), Karim Wahbi (1), Luc Cynober (2), Simon Weber (1),
Christophe Meune (1)
(1) Cochin Hospital, Cardiology Department, Paris, France – (2) Cochin
Hospital, Département de Biochimie A, Paris, France – (3) Cochin Hos-
pital, Emergency department, Paris, France
Background: high sensitive troponin (hs-cTn) assays are accurate markers
of acute myocardial infraction (AMI). Their ability to detect unstable angina
(UA) is unknown.
Methods: we compared the performance of hs-cTnT versus conventional
cTnI in consecutive patients admitted to the intensive care unit for suspected
acute coronary syndrome, on admission and 3 hours and 6 hours after admis-
sion. Patients with ST-elevation myocardial infarction (STEMI) were not
included.
Results: 87 patients were included. After comprehensive assessment,
the final adjudicated diagnosis was AMI in 17 patients, UA in 26, cardiac
but non-coronary cause in 6, and non cardiac cause in 38 patients. cTnI
measured at admission was above the recommended cut-off value (0.14ng/
ml) in 10 patients with AMI. The application of a lower cut-off value of
0.07 ng/ml (15-23% imprecision) allows the identification of 16 patients
with AMI and 5 with UA; repetition of the cTnI at 3 or 6 hours after
admission detected 10 patients with UA. Hs-cTnT measured on admission
identified 16 patients with AMI and 17 with UA. The accuracy of hs-cTnT
(area under the receiver-operating-characteristics curve (AUC), 0,84 on
admission and 0,88 at 3 hours), was better than cTnI (AUC 0,77) for the
detection of UA. Sensitivity and specificity of hs-cTnT for the diagnosis
of UA were 65 and 86% on admission, 77% and 88% when measured at 3
hours.
Conclusion: hs-cTnT is a sensitive marker of both non ST-segment eleva-
tion AMI and UA. In contrast to AMI, hs-cTnT measurement should be
repeated 3 hours after admission to detect UA. Both the identification of
patients with elevated hs-cTnT concentrations (at admission or 3 hours later),
and patients with increased hs-cTnT between the two measurements are rele-
vant.
Accuracy of Tn in the diagnosis of unstable angina
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0369
Lipoprotein-associated phospholipase A2 (LpPLA2): development of
a turbidimetric immunoassay and evaluation in patients with acute
heart failure
Jean-Christophe Charniot (1), R Khani-Bittar (2), Jean-Paul Albertini (1),
A Jansen (3), C Cherfils (2), V Fesel-Fouqier (2), P Giral (4),
C Cosson (5), M Daubord (2), D Bonnefont-Rousselot (2)
(1) Hôpital Avicenne, Cardiologie, Bobigny, France – (2) Pitie Salpetriere
Hospital, Paris, France – (3) diaDexus Inc, San Francisco, Etats-Unis –
(4) UMPC University Paris 06 UMR S 939 F, Paris, France – (5) Bioche-
mestry Laboratory, Kremlin-Bicêtre Hospital (AP-HP), Paris, France
Background: Lipoprotein-associated phospholipase A2 (Lp-PLA2), that
hydrolyze phospholipids, is a marker of inflammation that plays a critical role
in atherogenesis and endothelial dysfunction.
Aims: (1) compare Lp-PLA2 values obtained with a Plac? turbidimetric
immunoassay with those obtained with a Plac? ELISA test; (2) evaluate pre-
dictive value of Lp-PLA2 in patients with de novo cardiogenic shock (CS) due
to ischemic (ICM) or dilated cardiomyopathy (DCM) without acute coronary
syndrome (ACS) and (3) studied evolution of this biomarker when cardiac
function was improved with treatment especially ACEi and statins, during a
15-month follow-up. 
Methods: Inclusion criteria: CS defined by systolic BP<90 mmHg or
hemodynamic aid with peripheral hypoperfusion. All patients had cardiac and
biological evaluations with a regular follow-up.
Results: In the 28 samples with known values, Lp-PLA2 concentrations
assayed by TIA ranged from 94 to 462μg/L. Comparison between the Plac?
TIA and ELISA revealed a good correlation in these samples (r=0.95).
20 consecutive patients with ICM (n=7) or DCM (n=13) (90% men,
57.5±10.7y, LVEF 25.3±8.5%, NT proBNP level=8540 ng/mL) were
included. At the end of the follow-up, HF symptoms decreased in 6 patients
and 3 normalized their LVEF. Mortality was 13.5% and morbidity 31.2%.
Conclusion: 1) Lp-PLA2 concentrations were elevated in CS, when
referred to the defined normal threshold value of 200μg/L and more increased
in ICM group than DCM group; 2) Lp-PLA2 concentrations remained stable
during the first month after acute HF syndrome in DCM; 3) In patients
received higher doses of statins, Lp-PLA2 levels early decreased, 4) Lp-PLA2
might be a predictive factor of major cardiac events. 
0150
Heart rate variability predicts short term mortality in acute heart
failure patient
Fabien Despas (1), Marion Castel (1), Dorothée Fruit (1), Michel
Galinier (2), Jean-Michel Senard (1), Atul Pathak (1)
(1) INSERM U858, Toulouse, France – (2) CHU Toulouse, Cardiologie,
Toulouse, France
Introduction: Analysis of Heart rate variability is a noninvasive tool to
study autonomic control of the heart. Several studies have shown disturbed
heart rate variability in patients with chronic heart failure (CHF) but nether in
decompensate status. The aim of this study was to determine whether impaired
adaptation of the heart rate variability predicts death at one month in patients
with acute heart failure.
Methods: In this study, we prospectively included 142 patients (mean
age 70,3+/-1,2 years) with acute heart failure (EF=35,0±1,2%,
BNP=1258±119 pg/ml). Heart rate variability was evaluated by analyzing
24-h Holter recordings. Heart rate variability parameters were calculated
using dedicated Holter algorithm. Clinical, biological and morphological
data were collected. Follow-up was performed by direct examination or by
contact with general practitioner, cardiologist, or family, one month after
inclusion.
Results: After a follow up of one month 26 patients died. Non survivors
had significantly decreased diastolic pression (60,6±3,8 vs. 72,0±1,6 mmHg,
p<0,05), higher BNP (1838±477 vs. 1137±101), lower hemoglobin levels
(10,6±0,4 vs. 12,2±0,2 g/dl, p<0,05) and red blood cells (3530±133 vs.
4217±71 1000/µl, p<0,05). Among parameters issued from 24-h Holter-EKG
analysis only Very Low Frequency 24 hours was significantly decreased in
non survivors (5,11±0,38 vs. 5,91±0,12, p<0,05).
Conclusion: These results suggest that clinical, biological and electrical
parameters issued from 24 hours Holter-ECG recording are able to predict
short term mortality in patients with acute heart failure. These predictive
parameters are simple to use and their clinical or pharmacological interest
need to be confirmed.
0198
Prognostic value of cardiopulmonary exercise test in patients with
heart failure treated with beta blockers
Clémentine Dufay, Annette Belin, Rémi Sabatier, Arnaud Pellissier, Laure
Champ-Rigot, Patrice Scanu, Paul Milliez, Gilles Grollier
Centre hospitalier universitaire de Caen, cardiologie, Caen, France
Purpose: The prevalence of Chronic Heart Failure (CHF) with reduced
Left Ventricular Ejection Fraction (LVEF) has risen over the last decade.
Accurately estimating prognosis for these patients is an important challenge
facing clinicians who treat CHF. The Cardiopulmonary Exercise Test (CPX)
has become an established tool in management of these patients, however, the
predictive value of CPX in those treated with beta blockers has been debated.
Methods: Three hundred ninety patients with CHF being treated with beta
blockers underwent CPX after cardiac rehabilitation and were followed for all
cause mortality, cardiac-related mortality and major cardiac events (hospital-
ization for HF, transplantation, acute coronary syndrome and arrhythmias).
Results: The study population had mean age of 57.1 years and consisted of
85.5% males. CHF was the result of an ischemic etiology in 49%. The 2-year
mortality rate was 13%. Mean resting LVEF was 35.8% and mean maximal
oxygen uptake (peak VO2) 19.5 ml/kg/min. Peak VO2, VE/VCO2 slope and
peak circulatory power were significant predictors of risk. A predictive cut off
for peak VO2 could not be established. Patients with an initial VE/VCO2
slope < 30 (calculated using the points before the non-linear part of the curve)
and overall VE/VCO2 slope < 32 (calculated using all exercise data points)
had better prognoses. Oxygen Uptake Efficiency Slope (OUES), oxygen
uptake, heart rate recovery, VE/VCO2/VO2 index and ventilatory threshold
had no predictive value.
Conclusions: Peak VO2, peak circulatory power and VE/VCO2 slope may
be used to predict risk and facilitate clinical decision making in patients
referred for eveluation of CHF who are already being treated with beta
blockers. Follow-up investigation examining the efficacy of a multivariate
score based on these parameters to predict outcomes in this patient population
warranted.
0061
The Attenuated Vasorelaxation Effect of BNP in ischemic Chronic
Heart Failure Rats
Wang Jian (1), Hu Liuhua (1), Chen Hong (2), He Ben (1)
(1) Medical College of Shanghai Jiaotong Uni, Department of Cardiology,
Renji Hospital, Shanghai, Chine – (2) Medical College of Shanghai Jiao-
tong University, Department of Pharmacology, Shanghai, Chine
Objective: Activation of natriuretic peptide system had been considered as
an important compensative mechanism in the deterioration of left ventricular
function. Recombinant human B-type natriuretic peptide (rhBNP) was admin-
istrated in the acute decompensative chronic heart failure patients as a vasodi-
lator which also had natriuretic, antihypertrophic and antifibrosis effects. The
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hyporesponsiveness to rhBNP in the chronic heart failure (CHF) patients may
contribute to the neutral results in the clinic trials.The purpose of this study
was to investigate the mechanism of attenuated vasorelaxation response to
BNP in the myocardial infactus induced CHF rats. 
Methods and Results: Chronic heart failure was induced by left anterior
descending coronary artery ligation of eight weeks duration in male Sprague
Dawley rats. Compared with Sham-Operated (SO) rats, the CHF rats were
characterised by increased LV/BW, impared cardiac systolic/diastolic function
and elevated plasm BNP concentration. Both endothelial dependent( Acetyl-
choline 10-9-10-6mmol/L) and endothelium- independent( BNP 10-10-10-7
mmol/L) vasodilative effect were significantly attenuated in rats with
CHF(p<0.01). The stimulated cGMP/BNP was significantly lower in the CHF
rat aorta(p<0.05), but this phenomena conversed with sildenafil (the cGMP-
specific PDE5 inhibitor) (p<0.01). Determination of transcriptional levels of
natriuretic peptide system components revealed a marked upregulation of
NPR-A and PDE5 in CHF aorta, but no change in NPR-C or neutral endopep-
tidase.
Conclusion: These results demonstrate that the vasodilatation effect of
BNP in CHF was attenuated despite an an enhanced vascular NPR-A expres-
sion. This phenomena may contribute to the induction of cGMP-specific
PDE5, but not local internalization or degradation of BNP. This suggests the
potential of PDE5 specific inhibitor in the treatment of chronic heart failure.
Keywords: Chronic Heart Failure; Myocardial Infarct; B-type Natriuretic
Peptide; cGMP; PDE5.
0445
Evidence for a new biomarker to measure sympathetic activity in ani-
mals and humans
Walid Mokni (1), Safir Habib (2), Alban Simon (2), Mathieu Rodic (1),
Pascal Bousquet (1,2)
(1) INSERM U715 Laboratoire de Neurobiologie et Pharmacologie Car-
diovasculaire, Centre d’Investigations Cliniques, Strasbourg, France – (2)
Hôpitaux Universitaires de Strasbourg, Centre d’Investigations Cliniques,
Strasbourg, France 
The sympathetic nervous system is involved in the regulation of several
physiological processes, such as cardiovascular function or lipid and carbohy-
drate metabolisms. Dysregulations of these processes lead to cardiovascular
and metabolic risks and pathologies. Several studies showed an association
between increased sympathetic nervous activity (SNA) and hypertension, obe-
sity, dyslipidemia and diabetes. Three or more of these pathologies can com-
bine to form metabolic syndromes (MS). To study the implication of the
sympathetic nervous system in MS, a reliable and easy method for assessing
SNA is needed. The microneurography technique (reference method) is quite
invasive and complex, whereas heart rate and blood pressure variabilities and
catecholamine measurements are not reliable enough. We aimed to identify an
easily measurable biomarker of the SNA. For this purpose, we looked at the
beta2-adrenergic receptor (β2AR) mRNA expression level in lymphocytes by
quantitative RT-PCR. Spontaneously Hypertensive Rats (SHR) were chosen,
due to their well-documented sympathetic hyperactivity. Compared to control
normotensive Wistar-Kyoto rats, an important increase in the β2AR mRNA
expression was observed in lymphocytes of 12-14 weeks SHR (x7.7 [6.6; 8.9],
P<0.005, n=7). We also assessed this biomarker candidate in patients with MS
(n=14) compared to healthy volunteers (n=15). All patients with MS exhibited
dyslipidemia and obesity; half of them were hypertensives whereas the other
50% had hypertriglyceridemia. In these patients, SNA measured by micron-
eurography was increased by 24% compared to controls (36.2+/-0.9 bursts/min
vs 29.1+/-0.8, P<0.0001). In lymphocytes from patients with MS, β2AR
mRNA expression had a tendency to increase (x1.5) but, due to important
inter-individual variations, this augmentation remained non significant. Addi-
tional measurements are needed to confirm this result in humans. 
In conclusion, lymphocyte β2AR mRNA expression may become a reliable
biomarker of the SNA. Further, investigations are in process, aiming to defi-
nitely confirm this hypothesis.
0364
Cardiac Genome-Wide Transcriptional Profiling in Arrhythmogenic
Right Ventricular Dysplasia caused by a DSC2 mutation
Elodie Morel (1), Nicolas Nazaret (2), Lara Chalabreysse (3), Fiorella
Salerno (1), Gilles Millat (4), Véronique Fressart (5), Joel Lachuer (2),
Philippe Chevalier (1)
(1) Hospices Civils de Lyon – Hôpital cardiologique Louis Pradel, Service
de rythmologie, Bron, France – (2) ProfileXpert, Bron, France – (3) Cen-
tre de Biologie et de Pathologie Est, Service Anatomopathologie, Bron,
France – (4) Hospices Civils de Lyon – Centre de Biologie et Pathologie
Est, Laboratoire Cardiogénétique, Bron, France – (5) Groupement hospi-
talier Pitié-Salpetrière, Unité fonctionnelle de cardiogénétique, Paris,
France
Introduction: Mutations in DSC2 gene cause Arrhythmogenic Right Ven-
tricular Dysplasia (ARVD). However, mechanisms by which these mutations
confer histologic substrate of ARVD remain unknown. 
Methods: A 63 year-old patient with ARVD caused by a DSC2 mutation
(p.Arg132Cys) underwent heart transplantation. The diseased heart genome-
wide expression profiling was compared to that of a non-diseased donor heart.
Total RNA were extracted with Qiagen kit (DNase I action). The retained
genes of interest were listed and classified according to their biological func-
tions using Ingenuity Pathways Analysis (Ingenuity Systems Inc, Mountain
View, CA). Results: Ultrastructural analysis of the heart of the ARVD patient
revealed myocytes necrosis, fatty infiltration and inflammation (figure1). Inge-
nuity network analysis of ARVD gene expression profiles showed a strong up-
regulation of some adherens junction proteins in the right ventricular (DSC3
(x3.3), CTNNB1 (x4.0), CSTA (x19.3), PTPRF (x22.8), PECAM1 (x3.3))
associated with over-expression of genes that regulate inflammatory responses
(LEF1 (x5.2), PTPRC (x14.4), MAP3K8 (x5.2)). An increased up-regulation
of the genes involved in apoptosis (FOS (x19.8), TP53 (x2.07), MYC (x5.7),
SMAD7 (x3.6)) was also found to be the link between inflammation and
abnormal expression of junction proteins. 
Conclusions: Theses results suggest that an abnormal DSC2 protein may
trigger compensatory over-expression of some adherens junction proteins
which may in turn activate apoptosis and inflammation. 
Histology of right ventricular
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Alteration of myofilament sensitivity to calcium in the heart of pulmo-
nary hypertensive rats
David Benoist (1), Cécile Cassan (2), Ed White (1), Olivier Cazorla (2)
(1) University of Leeds, Institute of Membrane & Systems Biology, Leeds,
Royaume-Uni – (2) INSERM U-637, Physiopathologie Cardiovasculaire,
Montpellier, France
Heart failure is characterized by a myocardial contractile dysfunction
which may involve a reduced myofilament Ca2+ sensitivity. In this study we
investigated potential changes in myofilament Ca2+ sensitivity in pulmonary
artery hypertensive (PAH) rat hearts at both compensated hypertrophic (HYP)
and failing (FAIL) stages.
Wistar rats were injected with monocrotaline at 30 mg/kg or 60 mg/kg to
induce right ventricular (RV) compensated hypertrophy or failure respectively,
or with saline (CON). Animals were humanely killed 3-4 weeks after injection
or upon showing clinical symptoms of heart failure, as confirmed by echocar-
diography. The RV wall, left ventricular epicardial (LVepi) and endocardial
(LVendo) surfaces were dissected and snap-frozen. Force-calcium (pCa) rela-
tionships were established in mechanically-isolated permeabilized myocytes at
2 and 2.3 µm sarcomere lengths (SL).
At the HYP stage, myofilament Ca2+ sensitivity, indexed by the pCa50, was
significantly increased at 2 µm SL in RV (5.85 ± 0.02 vs 5.76 ± 0.03 in CON),
LVepi (5.89 ± 0.03 vs 5.76 ± 0.02 in CON) and LVendo myocytes (5.88 ±
0.03 vs 5.78 ± 0.02 in CON). Maximal active tension was also significantly
increased in RV (41 ± 4 vs 30 ± 2 mN.mm-2 in CON) and LVendo myocytes
(48 ± 5 vs 34 ± 2 mN.mm-2 in CON). At the FAIL stage, pCa50 and maximal
active tension went back to control level in RV and LVendo cells. Stretching
the myocytes to 2.3 µm SL revealed a trend towards a loss of myofilament
length-dependant activation (LDA) in RV and LVendo cells at the FAIL stage.
Myofilament Ca2+ sensitivity is altered in the RV and LV of PAH rats. We
hypothesize that the increased myofilament sensitivity observed at the HYP
stage is a compensatory mechanism allowing the heart to cope with the pres-
sure overload. The subsequent decrease in myofilament Ca2+ sensitivity and
reduced myofilament LDA could be responsible, at least in part, for the heart’s
transition to the failing stage in this model.
0425
Percutaneous blade and balloon atrioseptostomy for left heart off loa-
ding for patients with persistent pulmonary edema in the context of
extracorporeal life support
Mathieu Bignon (1), Massimo Massetti (2), Vincent Roule (1), Rémi
Sabatier (1), Thérèse Lognone (1), Calin Ivascau (2), Gilles Grollier (1)
(1) Centre Hospitalier Universitaire, Cardiologie, Caen, France –
(2) Centre Hospitalier Universitaire, Chirurgie cardiovasculaire et thora-
cique, Caen, France
Aims: In severe myocardial dysfunction, Extracorporeal Life Support
(ECLS) can preserve organ perfusion. Occasionally the after load it produces
can further increase left ventricular end-diastolic pressure, left atrial pressure,
left ventricular wall stress and myocardial oxygen demand causing refractory
pulmonary edema. An effective strategy to prevent worsening pulmonary con-
gestion in such situations is left heart decompression by percutaneous blade
and balloon atrioseptostomy. We report our experience with this technique.
Methods: Between October 2002 and December 2009, ten patients
receiving peripheral ECLS (mean age: 51 years) underwent fluoroscopic
guided blade and balloon atrioseptostomy for refractory cardiogenic shock and
worsening pulmonary edema as determined by clinical, radiological and
echocardiographic criteria.
Results: Atrioseptostomy improved pulmonary edema and echocardio-
graphic left ventricular function indices in all cases, despite variability in the
timing of its performance after ECLS initiation, and complicated by peripro-
cedural cardiac tamponade requiring emergency pericardiocentesis only once.
Three patients were eventually discharged home: two having presented with
drug intoxication and the other with dilated cardiomyopathy who successful
underwent cardiac transplantation. One patient with H1N1 influenza myo-
carditis remains currently hospitalized. The remaining six patients died in hos-
pital due to multiorgan failure, hemorrhagic shock or septic shock.
Conclusions: ECLS can be a bridge to cardiac transplantation, the implan-
tation of ventricular assist devices, or to myocardial recovery. Occasionally it
leads to worsening cardiogenic shock. Percutaneous blade and balloon atri-
oseptostomy can be a rapid, effective, minimally invasive and well tolerated
technique for off loading the left heart, particularly in those with drug induced
myocardial dysfunction.
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Predictors in Heart Failure with Normal Ejection Fraction
Thibaud Damy (1), Anna Bennet (2), Jufen Zhang (2), Kevin Goode (2),
Khristian Lewinter (2), James Hobkirk (2), Jean-Luc Dubois-Rande (1),
Luc Hittinger (1), John Gf Cleland (2), Andrew Clark (2)
(1) CHU Henri Mondor, Fédération de Cardiologie, Créteil, France –
(2) NHS trust East Yorkshire, Academic Cardiology, Cottingham,
Royaume-Uni
Objective: To define the clinical, biological and echocardiographic vari-
ables and threshold predictors of outcome in patients with heart failure and a
normal ejection fraction (HeFNEF).
Background: There is lack of predictors of outcome in HeFNEF.
Methods: Analysis of referrals with suspected heart failure to a specialist
community clinic of suspected chronic heart failure (CHF). HeFNEF was
defined as LVEF ≥40% and receiving a loop diuretic for breathlessness. 
Results: Of 2085 patients referred, 549 had HeFNEF, 784 had LVEF<40%
and 752 had neither. Their median (IQR) age was 74 (67-80), LVEF was 52%
(45-62) and 48% were women. During a median (IQR) follow up of 63 (37-
76) months, mortality was 40%. Amongst patients with a minimum follow-up
of 5 years, those who died by 5 years were older, had a higher resting heart
rate, left atrial volume and systolic pulmonary artery pressure (sPAP). There
were more likely to be men and to have diabetes. They had lower body mass
index, diastolic blood pressure, 6 min walk-test distance, and LVEF. Receiver
operator curves for 5 year survival followed by Youden test identified only
NT-proBNP (88pmol.l-1) and LVEF (47.8%) as having prognostic thresh-
olds.Moving average graphs identified two thresholds for the deceleration time
of the early peak (E) of the transmitral flow (230 and 330ms) and for E/A
(0.92 and 1.38m.sec-1; A=atrial peaks of the transmitral flow). In multivariable
analysis, increasing age, NT-proBNP, NYHA class, and echo-derived sPAP
were predictors of an adverse prognosis; increasing Hb, beta-blocker treatment
and female sex were predictors of a better outcome.
Conclusion: Clinical and biological variables were more powerful predic-
tors of prognosis in HeFNEF than echocardiographic variables which are rec-
ommended to identify diastolic function. About a third of the patients defined
as HeFNEF have an LVEF between 40 to 50%.
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Dobutamine induced changes in right ventricle contractility and pul-
monary artery pressure as pre-operative predictors of right ventricle
failure following vontinuous flow LVAD implantation
Guillaume Deswarte (1), Pierre-François Lesault (1), Matthias Kirsch (2),
Jean-Christian Roussel (3), Emmanuelle Vermes (2), Jean-Luc Dubois-
Rande (1), Daniel Loisance (2), Daniel Duveau (3), Luc Hittinger (1),
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Background: Continuous flow left ventricular assist devices (LVADs) are
now used as alternatives to orthotopic heart transplantation (OHT) for end-
stage heart failure. However, right ventricle (RV) dysfunction is common in
these patients and post-operative right ventricle failure (RVF) is frequent and
has a bad prognosis. Our aim was to identify clinical or echocardiographic
and/or hemodynamic variables as predictors of early RVF after LVAD implan-
tation.
Methods: Patients with biventricular dysfunction were assessed for LVAD
implantation with echocardiography and right heart catheterisation without or
with dobutamine progressively increased to the maximal dose of 15µg/Kg/min.
Primary endpoint (RVF+) was defined by death caused by RVF or the need
for RV inotropic support within 14 days or an RV assist implant within
30 days after LVAD implantation. 
Results: Twenty patients were assessed for an LVAD implant of whom 12
had had a dobutamine assessment. Fourteen of the 20 were given implants. Of
these, the mean age was 58±7 years and 50% had ischaemic cardiopathy. Five
patients reached RVF+. The study showed that pre-operative clinical, echocar-
diographic and hemodynamic variables at baseline were not predictors of
RVF+. However, in the 6 patients with dobutamine assessment and LVAD
implants, increase in TAPSE and systolic pulmonary artery pressure (sPAP)
(p=0.032, for both) during the dobutamine test predicted the absence of RVF+. 
Conclusion: Dobutamine-induced changes in TAPSE and sPAP predict
RVF after LVAD implantation in patients with biventricular dysfunction, sug-
gesting that this test could be useful to determine patients suitable for LVAD.
0171
Tricuspid plane systolic excursion in patients with suspected chronic
heart failure and its value as a predictor of outcome
Thibaud Damy (1), Anna Bennet (2), Kevin Goode (2), Khristian
Lewinter (2), James Hobkirk (2), Jean-Luc Dubois-Randé (1), Luc Hittin-
ger (1), John Gf Cleland (2), Andrew Clark (2)
(1) CHU Henri Mondor, Fédération de Cardiologie, Créteil, France –
(2) NHS trust East Yorkshire, Academic Cardiology, Cottingham,
Royaume-Uni
Background: Patients whose breathlessness is thought to be due to chronic
heart failure are usually classified depending on their left ventriclar (LV) func-
tion but right ventriclar function may also have strong pronostic value.
Objective: To assess tricuspid plane systolic excursion (TAPSE) in CHF
out-patient clinic and its potential value as a predictor of outcome 
Method: Analysis of referrals for diagnosis and management of heart
failure (HF) to a community clinic. 
Results: 1547 patients were included their median (IQR) TAPSE was
18.5mm (14-22.7). Their mean (SD) age was 71±11years, 48% were women
and LVEF was 47±16%. 47% had LVEF<45% (S-HF). Of patients with
LVEF>45%, 33% were considered not to have HF (No-HF) and 20% were
considered to have HF with a normal LVEF (HeFNEF). Of the patients with
TAPSE<14mm, 72% had S-HF, 15% HeFNEF and 13% had No-HF. During
a median (IQR) follow-up of 63 (41-75) months, mortality was 34%. In mul-
tivariable analysis, increasing age, NT-proBNP, NYHA class, systolic pulmo-
nary artery pressure, COPD and digoxin treatment predicted of an adverse
prognosis; increasing TAPSE, diastolic blood pressure, haemoglobin predicted
of a better outcome. Receiver operator curves followed by a Youden test iden-
tified a threshold of 15.9mm for TAPSE. 32% of the patients with
TAPSE<15.9mm had LVEF>45%. When all patients were considered,
increasing heart rate, diastolic BP, NTproBNP, decreasing LV volume
(LVEDVI), ischaemic heart disease (IHD), absence of COPD, atrial fibrilla-
tion (AF), mitral regurgitation (MR) and S-HF were predictors
of TASPE<15.9mm. 
Conclusion: RV dysfunction as assessed by TAPSE is common in patients
presenting with symptoms suggestive of chronic heart failure regardless of left
ventricular function. TAPSE was an independent predictor of mortality and
was most strongly associated with AF, S-HF, MR and NT-proBNP.
0351
Prognosis of Heart Failure using Strain, Strain Rate and Longitudinal
Myocardial velocity
Julien Nahum, Alexandre Bensaid, Caroline Dussault, Laurent Macron,
Pascal Gueret, Pascal Lim
Hôpital Mondor, Cardiologie, Creteil, France
Objective: Longitudinal myocardial deformation indexes appear superior
to left ventricular ejection fraction (LVEF) in assessing myocardial contrac-
tility. However, few studies have addressed the prognostic value of longitu-
dinal motion markers (velocity, strain and strain rate) in predicting outcome in
heart failure (HF) patients. 
Methods: The study included 125 consecutive symptomatic HF patients
(63±16 years, 77% male, LVEF=31±10%). All patients underwent a com-
plete echocardiographic and clinical examination and brain natriuretic pep-
tide level (BNP) was assessed in 93 patients. Longitudinal myocardial
velocity by TDI, global- and SR by speckle tracking were computed from
apical views (4-, 3-, and 2-chambers views) and compared to the occurrence
of major adverse cardiac events (MACE). 
Results: On the whole, peak longitudinal velocity, global- and SR aver-
aged 5±2 cm/sec [range, 1-9], -8±3% [range -3 to -18] and -0.33±0.16s-1
[range -0.83 to -0.05], respectively. During the follow-up period (266±177
days), major adverse cardiac events occurred in 47 (38%) patients (15 death,
29 recurrent HF and 4 heart transplantations). By univariable analysis using
Cox model global- , SR and LVEF were associated with the occurrence
of MACE, while only global- remained independently predictive of outcome
by multivariate analysis. 
Conclusion: In HF population, longitudinal global strain by speckle
tracking is superior to LVEF and other longitudinal markers in identifying
patients with poor outcome. 
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Evaluation of nitric oxyde inhalation as a single pharmacological test
for the assessment of secondary pulmonary hypertension reversibility
in advanced heart failure patients 
Julie Roy-Giocosa, Jean-Pierre Gueffet, Nicolas Piriou, François Floch,
Fanny Valleix, Jean-Noêl Trochu
CHU de Nantes, Cardiologie, Institut du Thorax, Nantes Cedex 1, France
Background: Secondary pulmonary hypertension (PHT) is an indepen-
dent predictive factor of post heart transplantation mortality. The severity
and reversibility of PHT in heart failure (HF) patients is usually studied
during a pre transplant evaluation with the infusion of several pharmaco-
logical drugs. The place of inhaled nitric oxide is not yet well defined des-
pite its wide utilization as a single pharmacological test for this evaluation. 
Methods and results: The aim of our study was to compare the response
of pulmonary pressure and resistance after a 15 minutes inhalation of 120
ppm nitric oxide alone (iNO), to the response after an administration of an
association of intra-venous (IV) diuretics, nitrates, enoximone and/or
dobutamine infused 30 minutes after the end of administration of iNO.
Twenty-two patients (pts), 52.8 ± 8.1 years old, left ventricular ejection
fraction 23.8 ± 14.3%, were included between October 2008 and July
2009. At baseline systolic pulmonary pressure (SPP) were 53.7±14.2 mm
Hg, pulmonary vascular resistance (PVR) 4.4±2.4 WU and pulmonary
gradient (PG) 14.5±6.2 mm Hg. During iNO, SPP reached 53.9±9.2 mm
Hg (p=ns), PVR 3.4±1.7 WU (p=0.01), and PG 12.4±4.6 mm Hg
(p=0.002). Because of its short half life, the effect of iNO was cleared and
SPP, PVR and PG went back to baseline values in a delay of 30 min after
the end of iNO. After infusion of the IV drugs, SPP decreased to 39.1
±11.4 mm Hg (p<0.0001), PVR of 2.4 ±1.6 UW (p< 0.0001) and PG of
9.5±5.9 mm Hg (p=0.0002). A 25% decrease of PVR was reached only in
9/25 pts with iNO, in comparison to 17/25 with the association of IV phar-
macological drugs. Furthermore the combined criteria of SPP< 60 mmHg
+ PVR <4WU +PG < 15 mm Hg was obtained in 12/25 pts with iNO and
18/25 with the association of IV pharmacological drugs, i.e. 29% additio-
nal pts would have been considered for heart transplantation. 
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Conclusion: The evaluation of reversibility of PHT during pre heart-trans-
plant evaluation should not be limited to a single pharmacological test
with iNO, which can rule out HF patient for heart transplant despite a
reversible PHT. 
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The failure of HCM ventricle to increase LV torsion with exercise
Camille Soullier (1), Iris Schuster-Beck (2), Stéphane Cade (1), Stéphane
Nottin (3), Grégory Doucende (3), Michel Dauzat (2), Patrick
Messner (1), Philippe Obert (3)
(1) CHU CAREMEAU, Cardiologie, Nimes, France – (2) CHU Caremeau,
Explorations vasculaires, Nimes, France – (3) Faculté des Sciences,
Laboratoire de Physiopathologie des adaptations cardiovasculaires à
l’exercice, Avignon, France
This study sought to assess myocardial strains and especially LV twist in a
group of non obstructive HCM patients during bicycle exercise. 
The study population consisted of 15 patients with non-obstructive HCM
(mean age 50 years) and 16 age-matched control subjects. We excluded apical
forms of HCM. 
All these subjects underwent echocardiographic examination with speckle
tracking imaging at rest and during submaximal supine bicycle exercise.
At rest, despite normal LV ejection fraction, average longitudinal strain
was significantly lower in HCM patients (p<0.01). Their circumferential strain
and LV rotations were higher than in controls (p<0.05 and p<0.01). LV twist
was significantly higher in HCM patients (16±4° vs 10.4±2°, p<0.01).
With exercise, the increase of longitudinal strain was significantly less
important in HCM patients than in controls (p<0.05). Moreover, basal rotation
and LV twist did not increase with exercise in HCM patients, contrary to
healthy subjects (16±4° to 16.7±5° vs 10.4±2° to 16.5±5°, p<0.05 for LV
twist)
Inter- and intra-observer variabilities were 8.4 and 7.6%.
The HCM ventricle failure to increase LV torsion with exercise might
explain part of their reduced exercise tolerance.
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TOPIC 25 – Hypertension, remodeling,
arterial stiffness
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Does routine measurement of ankle brachial index ameliorates the
assessment of coronary risk level in patients with known or suspected
coronary artery disease. The ABICARD study
Thomas Bochaton (1), Theodora Bejan-Angoulvant (2), Enrique
Quijano (1), Elisabeth Hugon (1), Fabrice Ivanes (3), Arnaud Dulac (1),
Xavier André-Fouët (4), Denis Angoulvant (1)
(1) Groupement Hospitalier Est – Hôpital Cardiologique, Cardiologie D,
Lyon Cedex 03, France – (2) INSERM, CIC 201 Hospices Civils de Lyon,
Lyon, France – (3) INSERM U886, Physiologie Lyon Nord, Lyon, France –
(4) Hôpital Cardiologique Louis Pradel, Cardiologie D, Lyon, France
Background: Ankle-brachial pressure index (ABI) is an independent pre-
dictor of the extent of coronary atherosclerosis and cardiovascular events. To
date ABI measurement is not part of the routine examination in patient
admitted for coronary angiography. Our objective was to establish ABI mea-
surement as a routine procedure in our interventional cardiology unit to ame-
liorate the assessment of coronary risk level for patients admitted for
scheduled coronary angiography. 
Method: ABI measurement was performed on admission using a doppler
ultrasonic instrument. Patients with past medical history of peripheral arteriop-
athy were excluded. Cardiovascular risk factors and clinical findings were col-
lected. Correlations and multivariate analysis were performed on R software. 
Results: In the pilot study, 61 consecutive patients were included between
February and October 2009. 74% were males and the mean age was 64+/-12
years. ABI < 0.9 was found in 10 patients. Significant (coronary
stenosis>70%) multivessel disease was found in 7 (70%) patients with
ABI<0.9 and 10 (20%) patients with ABI≥0.9. Although not statistically sig-
nificant, patients with ABI<0.9 were older 69+/-13 vs 63+/-12 (p=0.12) and
had lower glomerular filtration rate MDRD=67+/-23 vs 77+/-19 mL/min/
1.73m2 (p=0.16). Multivariate analysis showed that ABI remains a significant
predictor of multivessel disease after adjustment on age, sex, systolic blood
pressure and diabetes. 
Conclusion: ABI was an independent predictor of coronary multivessel
disease. Routine ABI measurement in patients with known or suspected coro-
nary artery disease provides additional information regarding patient’s risk and
may be taken into account to establish optimal care strategy.
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Microalbuminuria versus Brain Natriuretic Peptide in Cardiac
Hypertrophy of Hypertensive Rats 
Youakim Saliba (1), Eliane Chouery (2), Hisham Jabbour (3), André
Megharbané (2), Majed Moubarak (3), Nassim Fares (3)
(1) Université St joseph – FM, Laboratoire de Physiologie, Beyrouth,
Liban – (2) Université St Joseph – FM, Unité de Génétique Médicale,
Beyrouth, Liban – (3) Université St Joseph – FM, Laboratoire de Physio-
logie, Beyrouth, Liban
The objective of this study is to assess a possible link between microalbu-
minuria (MA), a major risk factor of the cardiorenal syndrome (CRS) and the
brain natriuretic peptide (BNP), a marker of cardiac hypertrophy. Two kidney-
one clip (2K-1C) renovascular hypertension was induced in 24 male Wistar
rats weighing (220-250g). Rats were then randomized into 4 groups for 8
weeks: Sham, not treated; Bos, treated with bosentan; Cap, treated with capto-
pril; Bos/Cap, treated with both drugs. Blood pressure, plasma BNP and trans-
forming growth factor β1 (TGF-β1) concentrations, MA and creatininaemia
were ascertained, as well as cardiac mass, BNP, α- and β- myosin heavy chain
(MHC) gene expression. Following stenosis, Sham rats developed hyperten-
sion (p<0.001), an increase in BNP (p<0.05) and TGF-β1 (p<0.005) concen-
trations, creatininaemia (p<0.001), and urinary albumin (p<0.001). Decreases
under treatment, in blood pressure (p<0.001), creatininaemia (p<0.05), plasma
TGF-β1 (p<0.005) and BNP (p<0.05) concentrations, were concomitant with
the absence of MA which was significantly correlated with reductions in car-
diac mass (p<0.05) and hypertrophy markers (BNP and β-MHC gene expres-
sion) (p<0.005). These findings, suggest a potential link between MA
evolution and BNP, as well as a possible effect of MA-lowering therapy on
halting the progression, or even inducing the regression of cardiac hyper-
trophy.
Keywords: MA; BNP; Hypertension; Cardiac hypertrophy. 
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Soluble epoxide hydrolase inhibition prevents coronary endothelial
dysfunction in renovascular hypertension
Ji Gao (1), Jeremy Bellien (2), Jean-Paul Henry (1), Elodie Gomez (1),
Brigitte Dautreaux (1), Frédéric Bounoure (3), Mohamed Skiba (3), Chris-
tian Thuillez (1), Vincent Richard (1)
(1) INSERM U644, Rouen, France – (2) Departement de Pharmacologie,
CHU de Rouen, Rouen, France – (3) Galenic Laboratory, ADEN EA
3234, Rouen, France
Objectives: Whether or not endothelial dysfunction in arterial hypertension
is related to an alteration in epoxyeicosatrienoic acids (EETs) pathway and can
be prevented by the inhibition of EETs degradation by soluble epoxide hydro-
lase (sEH) remains to be investigated.
Methods and Results: Arterial hypertension was induced in FVB mice
using the two kidney-one clip (2K1C) model. Seven weeks after surgery,
increased carotid artery pressure (Millar tonometer) and cardiac hypertrophy
(echocardiography) were present in 2K1C mice as compared with control
mice. Left coronary artery endothelium-dependent relaxations to acetylcholine
was decreased in 2K1C mice without significant modification in the relaxing
responses to NS309 and NS1619, the openers of calcium-activated potassium
channels which are involved in the hyperpolarizing effect of EETs. Moreover,
sEH expression was increased in 2K1C mice and the cytochrome epoxygen-
ases inhibitors fluconazole and MSPPOH impaired the coronary relaxations to
acetylcholine in control mice but not in 2K1C mice. The sEH inhibitor AUDA
administered five weeks after surgery in 2K1C mice for two weeks (25 mg/L
in drinking water) prevented the increase in carotid artery pressure and cardiac
hypertrophy, improved the coronary relaxations to acetylcholine and restored
the inhibitory effect of fluconazole and MSPPOH on acetylcholine-induced
relaxations without modifying the relaxations to NS309 and NS1619.
Conclusions: These results demonstrate that an increased degradation of
EETs by sEH contributes to coronary endothelial dysfunction in 2K1C hyper-
tensive mice. The inhibition of sEH prevent this endothelial dysfunction by
restoring EETs availability appearing thus as a promising pharmacological
intervention to limit cardiovascular morbidity and mortality in arterial hyper-
tension.
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P2Y6 receptor contribution in vascular contraction – lessons from
P2Y6-/- mice
Gilles Kauffenstein (1), Laurent Loufrani (1), Bernard Robaye (2), Daniel
Henrion (1)
(1) UMR CNRS6214 INSERM771, Angers, France – (2) IRIBHM Univer-
sité Libre de Bruxelles, Bruxelles, Belgique
Background: Extracellular nucleotides are signalling molecules that exert
their effect trough cell membrane bound P2 receptors. Seven ligand-gated P2X
(P2X1–7) and eight G protein-coupled P2Y receptors (P2Y1,2,4,6,11-14) have been
cloned. P2X receptors are activated by ATP while P2Y receptors are differen-
tially activated by ATP, ADP, UTP, UDP or UDP-glucose. Activation of vas-
cular smooth muscle cells (VSMC) P2 receptors promotes vasoconstriction via
either P2X1, or pyrimidine-sensitive P2Y receptors. These processes take part
to the neurogenic response of resistance arteries. The nature of the receptor(s)
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mediating the effect of uracyl nucleotides remains uncertain. Based on both
expression pattern and functional data, P2Y2 (UTP, ATP), P2Y4 (ATP, UTP)
and P2Y6 (UDP) receptors where proposed to be involved. However, the lack
of specific antagonist makes it difficult to point their respective contribution. 
Purpose: In the present work we took advantage of the recently generated
P2Y6-/- mice to assess the role of P2Y6 receptor in resistance arteries and its
contribution in the regulation of vascular tone by nucleotides. 
Results: We found that P2Y6 receptor is responsible for UDP, UDPbS and
UTP mediated contraction of mouse mesenteric arteries, but not caudal
arteries. On the other hand the contraction to non-nucleotides vasoactive
agents was not modified. P2Y6 is not the receptor for the EDCF Up4A from
which the receptor remains unknown. In future work, we will investigate the
potential role of P2Y6 receptor in myogenic tone. 
Conclusion: We report here that P2Y6 is the exclusive receptor involved in
vascular contraction to uracyl nucleotides. These results make of this receptor
a potential target for new anti-hypertensive molecules an raise the question
about the contribution of P2Y6 receptor in other VSMC phenotype (prolifera-
tion, migration) vs other uracyl nucleotides responding receptors especially
P2Y2.
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NT-proBNP as a predictor of mortality in hypertension
Vinciane Paget (1), Nathalie Gaudebout (1), Liliana Legedz (1), Marie-
Odile Rial (1), Hugues Milon (1), Giampiero Bricca (1), Pierre
Lantelme (2)
(1) Hospices Civils de Lyon, Hôpital de la Croix-Rousse, Cardiologie,
Lyon, France – (2) Hôpital de la Croix Rousse, Service de Cardiologie,
Lyon, France
N-terminal pro brain natriuretic peptide (NT-proBNP) is a validated marker
of risk in heart failure and in acute coronary syndrome. In hypertension, NT-
proBNP is related to left ventricular hypertrophy (LVH) and has even been
proposed as a diagnostic test for this condition. On the contrary, very few data
are available concerning its prognostic value beyond traditional risk factors.
Thus, the present study aimed at examining the relation of NT-proBNP
with total mortality. In 691 consecutive hypertensive patients free of heart
failure, referred to our department for hypertension work-up (47% women,
mean age ± SD, 52 ± 14 yrs, 24-hour systolic BP, 152 ± 21 mmHg, 15% with
LVH by EKG), NT-proBNP was measured (232 ± 804 pg/ml) and analysed
after dividing by tertiles of NT-proBNP: Tertile 1 (<50.8 pg/ml); Tertile 2
(50.8 – 132 pg/ml); Tertile 3 (>132 pg/ml) or according to a threshold used for
LVH diagnosis (111pg/mL for men and 144pg/mL for women). Mortality was
assessed through a questionnaire and through the office of Civil registration
after a mean duration of 5.6 years till death or censoring date. During that
period, 40 deaths occurred. The figure shows the Kaplan-Meier survival
curves for the 3 tertiles. Of note is the significantly poorer prognosis attached
to Tertile 2 relative to Tertile 1 (log-rank test, p=0.037), Tertile 3 relative to
Tertile 2 (log-rank test, p=0.013) and Tertile 3 relative to Tertile 1 (log-rank
test, p<0.001). The result is similar for the division into two groups (log rank
test, p<0.001). In a Cox analysis including age, 24-hour systolic BP, diabetes,
smoking, hypercholesterolemia as potential confounders, the NT-proBNP
retained a significant independent prognostic value (p<0.01). Adding pro-
teinuria and Sokolov index to the model did not change the results.
Based on these results, NT-proBNP appears as a valuable prognostic
marker in hypertension and should be used as a simple tool for risk stratifica-
tion. 
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Vasorelaxant and antioxidant effects of carteolol in the spontaneously
hypertensive rat aorta
Frédérique Sauvaget, Jean-Claude Desfontis, Marc Gogny, Jacques Noi-
reaud, Yassine Mallem
ONIRIS, UPSP 5304, Nantes Cedex 3, France
Objectives: Carteolol, a β1/β2-blocking antihypertensive agent, has been
shown to be endowed with antioxidant effect in nonvascular tissue and vasore-
laxant effect involving α1-adrenoceptor antagonistic activity in non hyperten-
sive rat. However, those properties have not been studied yet in spontaneously
hypertensive rat (SHR) blood vessels. The aim of this study was designed to
search for the ability of carteolol to vasodilate SHR aorta and to protect it from
reactive oxygen species (ROS)-induced endothelial dysfunction (ED). 
Method: Twelve-week-old SHR aortic rings were mounted in organ baths
and pre-constricted with phenylephrine (PE). Cumulative concentration-
response curves (CCRC) to carteolol (0.1 to 300 μM), PE (0.1 nM to 30 μM)
and acetylcholine (Ach, 0.001 to 30 μM) were established in different experi-
mental conditions. ROS-induced ED was induced with 250 μM lucigenin, a
superoxide-synthesis activator.
Results: Carteolol produced concentration (up to 10 μM)-dependent relax-
ation of SHR aorta. The carteolol effect was unaffected by endothelium denu-
dation or the presence of LName (a non specific nitric oxide (NO) synthases
inhibitor, 100 μM). Preincubation of SHR aortic rings with carteolol (30, 100
and 300 μM) caused a rightward shift of the PE CCRC without modifying the
maximum responses. In SHR aorta, Ach induced concentration-dependent
relaxation which was not modified by carteolol (10 μM) or tempol, (a super-
oxide scavenger, 100 μM). However, both compounds markedly attenuated the
lucigenin-induced impairment of Ach-induced relaxation. 
Conclusions: This study shows that carteolol was able to vasodilate SHR
aorta by endothelium/NO-independent and α1-adrenergic-antagonism-depen-
dent mechanisms. Our results, also suggest, for the first time, that carteolol, at
sub-effective vasodilating concentration may exert protective effects in SHR
aorta by scavenging superoxide anions and improving NO relaxation.
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Influence of β-adrenergic receptor subtypes on Epac signaling
Magali Berthouze, Frank Lezoualc’h
INSERM U769, Chatenay-Malabry, France
Epac (Exchange Protein directly Activated by cAMP) is a new sensor for
cAMP and functions as a guanine nucleotide exchange factor for the small
GTPases of the Ras family. We have previously shown that Epac is involved
in cardiac myocyte hypertrophy induced by β-adrenergic receptors (βARs).
To date, the neurohormonal regulation of Epac as well as the molecular
mechanisms underlying this regulation has not been determined. 
In this study, we showed by co-immunoprecipitation that Epac interacts
with two subtypes of the βARs, β1AR and β2AR in basal conditions (no adr-
energic stimulation) in HEK293 cells. The interaction between β1AR and
Epac is increased under acute stimulation with isoprenaline (Iso; 10 µM,
10min) whereas no difference is observed in the interaction between β2AR
and Epac. In addition, we reported that Iso (10 µM, 10min) induces Epac
translocation to the plasma membrane and increases the activation of the small
G protein H-Ras as detected by pulldown assay in HEK cells overexpressing
β1AR. This effect of Iso is not observed in HEK293 cells transfected with
β2AR. Interestingly, deletion of the N-terminal part of Epac affects its cAMP-
induced translocation suggesting that its DEP domain is critical for Epac mem-
brane translocation. Finally, we analysed the involvement of the well known
adaptor protein β-arrestin in Epac signaling. We found by immunocytochem-
istry that overexpression of β-arrestin in HEK293 cells transfected with the
β2AR favours the recruitment of Epac at the plasma membrane compared to
cells expressing endogenous level of β-arrestin.
In conclusion, our data show that Epac differentially interacts with the
βARs and participates to the specificity of βAR subtype signaling. In addition,
our results suggest that β-arrestin could play a key role in Epac signaling
pathway and cardiac functional effects.
0134
New insights in the contribution of the voltage-gated Nav channels to
arterial contraction
Aurélie Fort (1), Magali Cordaillat (1), Catherine Thollon (2), Guillermo
Salazar (1), Ilana Mechali (3), Nicole Villeneuve (2), Jean-Paul
Vilaine (2), Sylvain Richard (1), Anne Virsolvy (1)
(1) INSERM U637, Montpellier Cedex 5, France – (2) Institut de recher-
che Servier, Cardiovascular division, Suresnes, France – (3) INSERM
U583, Montpellier, France
Background: Despite increasing evidence for the presence of voltage-
gated sodium channels (Nav) isoforms and measurement of Nav channel cur-
rents in arterial myocytes, no information is available to date as to whether or
not Nav channels play a functional role in arteries. The aim of the present work
was to look for a physiological role of Nav channels in the control of rat aortic
contraction.
Methods: Study was performed on rat aorta. Identification of Nav tran-
scripts and protein localization were performed by use of real-time RT-PCR
and immunohistochemistry. Vascular reactivity was investigated on isometric
tension of endothelium denuded aortic rings.
Results: Three Nav transcripts were detected in the whole aorta: Nav1.2,
Nav1.3 and Nav1.5. However, Nav1.2 was found both in the intact media or in
cells freshly isolated from that layer. Using veratridine and tetrodotoxin
(TTX), we unraveled a functional role of Nav channels in rat aorta. Two dif-
ferent mechanisms were discriminated. The first one, triggered by veratridine
(Ec50=34.2±4.8 µM) at resting tension, accounted for the effect on Nav chan-
nels localized at perivascular sympathetic nerve terminals. The other compo-
nent was unmasked with low concentrations of KCl (2-10mM) and under
conditions excluding sympathetic regulation. Addition of low KCl induced
moderate membrane depolarization (from -55.9±1.4 to -45.9±1.2 mV at 10
mM as measured with microelectrodes) and triggered a contraction potentiated
by veratridine (100µM) and blocked by TTX (1µM). KB-R7943, an inhibitor
of the reverse mode of the Na+/Ca2+ exchanger, mimicked the effect of TTX
on KCl-induced contraction and had no additive effect in presence of TTX.
Conclusion: We define a novel paradigm for a role of Nav channels in vas-
cular physiology and suggest that the TTX-sensitive Nav1.2 isoform together
with the Na+/Ca2+ exchanger, contributes to the contractile response of aortic
myocytes at physiological range of membrane depolarization.
0217
Role of the small G protein Ras and Rap in Epac hypertrophic signal-
ling in cardiac myocytes
Anne-Coline Laurent, Mélanie Métrich, Alexandre Lucas, Bertrand Croza-
tier, Frank Lezoualc’h, Eric Morel
INSERM U769, Châtenay-Malabry, France
Cyclic AMP (cAMP) is a well-known signalling molecule which is pro-
duced in response to Gs protein-coupled receptor activation. The discovery of
a cAMP sensor, named Epac (Exchange Protein directly Activated by cAMP),
that functions independently of protein kinase A, raises the question of the role
of this protein in cardiac cells. Epac is an exchange factor for Ras-like small
GTPases, Rap1 and Rap2. We previously showed that Epac activation induces
cardiomyocyte hypertrophy upon beta-adrenergic receptor stimulation. The
aim of this study was to further characterize Epac signalling cascade leading
to cardiac myocyte hypertrophy in primary cardiomyocytes. 
In a first part of our study, we showed by immunofluorescence that the
GTPases Rap1, Rap2 and Ras were expressed in cardiomyocytes at different
cellular localization. Surprisingly, we found that Rap proteins, known as Epac
direct effectors, were not involved in Epac-induced cardiac myocyte hyper-
trophy. Transient transfection of the Rap isoforms failed to increase ANF tran-
scriptional activation. Interestingly, we found that Epac- induced H-Ras
activation involved its GEF domain although Epac had no direct exchange
activity on this small GTPase protein. The effect of Epac on H-Ras activation
was dependent on a signalling cascade involving phospholipase C (PLC)/ inos-
itol 1,3,5 triphosphate receptor (IP3R) and an increase in intracellular calcium.
In a second part, we found that Epac hypertrophic effects were dependent
on H-Ras. Specifically, Epac induced via H-Ras the activation of the prohy-
pertrophic signalling pathways involving CaMKII and calcineurin/NFAT.
Consistent with this finding, Epac induced histone deacetylase 4 (HDAC4)
nuclear export with the consequent activation of the prohypertrophic transcrip-
tion factor MEF2 in a CaMKII dependent manner.
Altogether, these data show that Epac activates a prohypertrophic signal-
ling pathway which involves PLC, H-Ras, CaMKII and HDAC4 nuclear
export. 
0008
Autoantibody against cardiac β1-adrenoceptor do not alter the low-
affinity state β1-adrenoceptor-mediated inotropy in rats
Mohamed Amine Abdelkrim (1), Yassine Mohamed Mallem (1), Gérard
Chatagnon (2), Marc Gogny (1), Jean-Claude Desfontis (1), Jacques Noi-
reaud (1)
(1) Ecole Nationale Vétérinaire, UPSP 5304, Nantes, France – (2) Ecole
Nationale Vétérinaire, UE-BPR, Nantes, France
The myocardial ß1-adrenergic receptor (ß-AR) possesses 2 sites with high-
and low-affinity state for agonists. Stimulation of both states induces positive
inotropic effects. Autoantibodies against cardiac ß1-ARs (ß1-AAB) are found in
patients suffering from or animal models developing various cardiovascular
pathologies. The aim of this study was to analyse whether ß1-AAB affected dif-
ferently or not the inotropic responses due to stimulation of the two affinity
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states of the ß1-AR. Male Wistar rats were immunized with peptides corre-
sponding to the 2nd extracellular loop of the ß1-AR. At 3 months, specific IgG
concentration was measured using the bicinchoninic acid assay. Cell shortening
was measured by video-imaging in superfused (37°C ± 0.2) isolated rat cardi-
omyocytes plated on poly-L-lysine (100 µg/ml) and field-stimulated (1Hz), after
3h in the presence or not of IgG (25 µg/ml). Results were expressed as mean
values ± SEM and compared using unpaired Student t- test (Prism®V.4 soft-
ware). Cell shortening was not modified by the incubation in the presence of IgG
(control: 5.97% ± 0.35, n=36; IgG: 6.01 ± 0.58, n=14; NS). Conversely, isopro-
terenol-induced inotropy was significantly reduced in IgG pre-incubated cardi-
omyocytes (10-8 M, control vs IgG pre-incubated: +56% ± 4.1, n=18 vs +3.1%
± 3.9, n=7; P < 0.0001). CGP12177A (CGP, 3. 10-6 M) and pindolol (6. 10-6 M),
two partial agonists of the low-affinity state ß1-AR, were tested in the presence
of propranolol (10-6 M), antagonist of the high affinity state ß1-AR and IBMX
(10-4 M), a nonselective phosphodiesterase inhibitor. Both CGP (about +30%)-
and pindolol (about +22%)-induced inotropies were not affected by IgG pre-
incubation. Thus, AAB against the 2nd extracellular loop of the ß1-AR induced
a significant alteration of the high affinity state ß1-AR-induced inotropy without
detectable effects upon responses to low-affinity state ß1-AR stimulation sug-
gesting that both sites are differently affected by ß1-AAB.
0210
Crosstalk between JAK2/STAT3 and RISK pathways in the anoxic-
reoxygenated embryonic heart model
Sarah Pedretti, Anne-Catherine Thomas, Eric Raddatz
Département de Physiologie, Lausanne, Suisse
Janus Kinase 2/Signal Transducer and Activator of Transcription 3 (JAK2/
STAT3) pathway is involved in protection of adult heart against ischemia-rep-
erfusion. We previously showed that in the ventricle of anoxic-reoxygenated
embryonic heart STAT3 activation is ROS-dependent and requires specific
tyrosine phosphorylation. However, the effect of STAT3 activation on DNA-
binding and/or crosstalk with Reperfusion Injury Salvage Kinase (RISK)
pathway (notably Akt and Glycogen Synthase Kinase 3β (GSK3β)) remains
unknown.
Hearts isolated from 4-day-old chick embryos were submitted to anoxia
(30min) and reoxygenation (80min) with or without the JAK2/STAT3 inhib-
itor AG490. STAT3 DNA-binding was determined in ventricle by electro-
phoretic mobility shift assay. Time course of STAT3, Akt and GSK3β
phosphorylation (P) was determined in ventricle by immunoblotting. 
STAT3 DNA-binding ability was not altered throughout anoxia-reoxygen-
ation. At 10 and 60min of reoxygenation AG490 reduced P-STAT3 to its base-
line level. P-Akt and P-GSK3β were decreased by anoxia but increased upon
reoxygenation. At 10 and 60min AG490 abolished the reoxygenation-induced
increase of P-Akt and P-GSK3β.
Thus, in the embryonic ventricle, reoxygenation does not lead to the
expected STAT3 DNA-binding but rather to crosstalk with two key kinases of
RISK pathway. The role played by STAT3 activation in the functional
response to anoxia-reoxygenation remains to be investigated. 
0213
Activation of the adenosine A1 receptor is transiently arrhythmogenic
and stimulates ERK and Akt/GSK3beta pathways in the embryonic
heart model
Elodie Robin, Anne Catherine Thomas, Sarah Pedretti, Rachel Benoit,
Eric Raddatz
Université de Lausanne, Département de Physiologie, Lausanne, Suisse
Adenosine is a pivotal regulator of the developing cardiovascular system
but its action on activity of the embryonic heart remains controversial. Ade-
nosine is also known to modulate ERK and Akt/GSK3β (Glycogen Synthase
Kinase-3β) pathways. We investigated the effects of adenosine and specific
agonists of adenosine receptors (AR) on beating rate, conduction, arrhythmias
and phosphorylation of ERK, Akt and GSK3β.
Hearts or dissected atria, ventricle and outflow-tract obtained from 4-day-
old chick embryos were exposed to adenosine (100µM) or specific agonists of
A1AR, A2aAR and A3AR. Intrinsic beating rate and phosphorylation (P) of
the kinases in the whole heart and in atria, ventricle and outflow-tract were
determined.
Adenosine triggered arrhythmias within 5 minutes, mainly through A1AR
and A2aAR activation provoking atrio-ventricular blocks lasting for 60 min-
utes. Adenosine induced ectopy in atria but not in ventricle. After 5-10 min-
utes, adenosine and A1AR agonist increased P-ERK, P-Akt and P-GSK3β in
atria and ventricle but not in outflow-tract. By contrast, A2aAR and A3AR
agonists had no effect.
Thus, in the embryonic heart, an increase of extracellular adenosine (e.g.
under hypoxia) can induce atrial ectopy via A1AR which might contribute to
conduction disturbances associated with a spatial gradient of activation of
ERK and Akt/GSK3β pathways.
0025
MTOR and Wnt pathway crosstalk involved in preconditioning
through GSK-3β
François Vigneron (1), Béatrice Jaspard-Vinassa (2), Maryline Bonnet (1),
Liliane Tariosse (1), Simone Bonoron-Adèle (1), Thierry Couffinhal (1),
Cécile Duplaà (1), Pierre Dos Santos (1)
(1) INSERM u828, Pessac, France – (2) Université Bordeaux 2, Bor-
deaux, France
Ischemic preconditioning (IPC) protects the heart against prolonged lethal
ischemia by activating a cardioprotective signaling cascade involving Akt,
GSK-3β, and mitochondrial ATP sensitive potassium channel (mitoKATP).
However, the molecular pathways involved have not been completely charac-
terized. 
The objectives were to evaluate the role of GSK-3β and the mTOR
pathway in preconditioning, to obtain insight into the role of mitoKATP as an
end-effector in cardioprotection, to determine of the effect of sFRP1, a Wnt/
Frz antagonist, on cardioprotection and its signaling.
Two models of preconditioning were used on isolated Langendorff-per-
fused mice hearts: IPC via four cycles of 5 min ischemia/5 min reperfusion
and pharmacological preconditioning (PPC) by perfusion with diazoxide, a
mitoKATP activator. IPC, like PPC, induced an inhibition/phosphorylation
of GSK-3β through Akt activation. This was correlated with a significant
reduction of infarct size after 40 min ischemia followed by 120 min reper-
fusion as compared to control; preconditioning was impaired in GSK3
knock-in mice. Preconditioning induced the mTOR survival pathway by
increasing phosphorylation of mTOR and its targets p70S6K and 4E-BP1
by Akt activation. Perfusion of rapamycine, an inhibitor of mTOR,
impaired preconditioning. In transgenic mice hearts overexpressing sFRP1,
a Wnt/Frz antagonist, both preconditioning were abrogated: overexpression
of sFRP1 impaired GSK-3β inhibition and the subsequent mTOR activa-
tion.
In mice, the mTOR survival pathway is implicated in cardioprotection,
through a feedback regulation of mitoKATP with a central role of GSK-3β.
FrzA/sFRP1 appears to modulate these pathways during preconditioning. We
evidenced for the first time that cardioprotection involves a crosstalk between
an embryonic developmental Wnt pathway and a survival mTOR pathway,
which seems to converge on GSK-3β.
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Role of the gap junctions in the pulmonary arterial vasoreactivity in
two rat models of pulmonary hypertension
Marie Billaud, Diana Dahan, Roger Marthan, Jean-Pierre Savineau, Chris-
telle Guibert 
INSERM U885, Laboratoire de Physiologie Cellulaire Re, Bordeaux
Cedex, France
Since gap junctions regulate vasoreactivity, they could be involved in the
modifications of the pulmonary arterial vasoreactivity observed in response to
various agonists in different forms of pulmonary hypertension (PH). Monocro-
taline-treated rats (MCT) and rats exposed to chronic hypoxia (3 weeks) were
used to respectively mimic human idiopathic and hypoxemic secondary PH. 
The present study focused on (1) the expression of connexins (Cx) proteins
that form gap junctions, and (2) their role in the reactivity to agonists in intra-
pulmonary arteries (IPA) from normoxic (N), MCT and chronic hypoxic (CH)
rats. 
RT-PCR and Western blot analyses showed (1) the expression of Cx 37,
40 and 43 in N, CH and MCT rats and (2) an increase in Cx 43 expression in
CH rats. By using an organ bath system, we showed that the contraction to
endothelin-1 (ET-1) was unchanged after incubation with 300 µM 40Gap27 or
37-43Gap27, specific peptide blockers of Cx 40 and 37-43 respectively, in IPA
from N, CH and MCT rats. However, the contraction to serotonin (5-HT) was
decreased after 37-43Gap27 treatment in N rats, 40Gap27 treatment in CH rats
and incubation in either of these peptides in MCT rats. The contraction to phe-
nylephrine was decreased by 40Gap27 or 37-43Gap27 in CH and MCT rats but
not in N rats. Moreover, the contractile sensitivity to high potassium solutions
(4.7 – 100 mM) was increased in CH rats and this hypersensitivity was
reversed following 40Gap27 or 37-43Gap27 incubation. In N and MCT rats, the
contraction to high potassium was not modified by either of the Gap27 pep-
tides.
Altogether, in IPA from N, CH and MCT rats, Cx 37, 40 and 43 are differ-
ently expressed and involved in the vasoreactivity to ET-1, 5-HT, phenyleph-
rine and potassium. These data may help to better understand alterations of
pulmonary arterial reactivity observed in PH. 
This work was funded by the Fondation de France (2008002719) and
Agence Nationale de la Recherche (ANR06-Physio-015-01). 
0344
Signaling pathways involved in postconditioning-induced cardiopro-
tection of human myocardium, in vitro 
Sandrine Lemoine (1), Paolo Emilio Puddu (2), Jean-Louis Gérard (3),
Pierre Dos Santos (1), Jean-Luc Hanouz (3)
(1) INSERM U.828, Pessac, France – (2) University of Rome “La
Sapienza”, Department of the Heart and Great Vessels, Roma, Italie –
(3) CHU de Caen, Pole Anesthesie Réanimation chirurgicale, Caen,
France
Background: This study examined the respective role and relationship
between protein kinase C (PKC), mitochondrial adenosine triphosphate-sensi-
tive potassium channel (mitoKATP), and p38 mitogen activated kinase (MAPK)
in myocardial postconditioning, using human atrial muscle taken from patients
undergoing coronary artery bypass surgery and aortic valve replacement. 
Methods: After the approval of local medical ethics committee, human
right atrial appendages were obtained during cannulation for cardiopulmonary
bypass. The force of contraction (34°C, stimulation frequency 1 Hz) of right
atrial trabeculae was recorded during 30-min hypoxia followed by 60-min
reoxygenation (control group, n=10). Phorbol 12-myristate 13-acetate (PMA,
a PKC activator), diazoxide (a mitoKATP opener) and anisomycin (a p38
MAPK activator) were superfused in early reoxygenation alone and with
calphostin C (a PKC inhibitor), 5-hydroxy-decanoate (5-HD, a mito KATP
channel inhibitor), and SB 202190 (a p38 MAPK inhibitor). Developed force
at the end of the 60-min reoxygenation (FoC60) period was compared between
groups (mean ± SD).
Results: PMA (91±4% of baseline), diazoxide (85±5% of baseline), and
anisomycin (90±4%) enhanced the FoC60 as compared with Control (53±7%,
P<0.0001). The enhanced FoC60 induced by PMA was abolished by calphostin
C (52 ± 5%), and 5-HD (56±3%), but not by SB 202190 (90±8%). The diaz-
oxide induced recovery of FoC60 was attenuated by 5-HD (55±6%), but neither
by calphostin C (87±5%) nor SB 202190 (90±8%). The anisomycin induced
recovery of FoC60 was abolished by calphostin C (61±9%), and SB 202190
(52±8% of baseline), but not by 5-HD (88±6%).
Conclusions: PKC activation, opening of mitoKATP and p38 MAPK activa-
tion in early reoxygenation induced the postconditioning of human myocar-
dium, in vitro. Furthermore, PKC activation was upstream of the opening of
mitoKATP, p38 MAPK acted on PKC. Therefore, mitoKATP and p38 MAPK
seemed to be involved in two independent pathways. 
0136
Sphingosine kinase-2 mediated production of sphingosine-1-phos-
phate: a new function in mitochondrial respiration
Mélanie Paillard (1), Jie Liang (2), Graham M. Strub (2), Ludovic
Gomez (1), Nitai C. Hait (2), Jeremy C. Allegood (2), Edward J.
Lesnefsky (3), Sheldon Milstien (2), Sarah Spiegel (2)
(1) INSERM U886 Cardioprotection-UCBL1, Department of Internal
Medicine, Virginia Commonwealth University, Lyon Cedex 08, France –
(2) Virginia Commonwealth University, Department of Biochemistry and
Molecular Biology, Richmond, Etats-Unis – (3) McGuire Research Cen-
ter, Veterans Affairs Medical Center, Department of Internal Medicine,
Virginia Commonwealth University, Richmond, Etats-Unis
Sphingosine-1-phosphate (S1P) is a potent lipid mediator that regulates
diverse physiological and pathological processes acting through five specific
cell surface receptors. The majority of research to date has focused on the acti-
vation of these receptors, but there is now evidence to suggest that S1P also
exerts intracellular functions independent of its cell surface receptors. We
sought to determine if knock-out of sphingosine kinase 2 (SphK2-KO), one of
the isoenzymes that forms S1P, will impact mitochondrial function.
Mouse heart mitochondria were isolated by differential centrifugation from
both SphK2-KO and WT mice. Oxidative phosphorylation (states 3 and 4, nAO/
min/mg) was assessed using a Clark-type electrode (RCR: state 3/state 4).
We found by Western Blot that SphK2 was present in WT mitochondria
(but not KO) and that SphK2-KO mitochondria displayed a lower content of
S1P. SphK2-KO mitochondria displayed a significant decrease in oxidative
phosphorylation with complex I (23%), II (23%) and cytochrome oxidase
complex IV (21%) substrates with preserved coupling of respiration (RCR,
p=ns). A new, aberrant band of complex IV was detected by Blue-Native
PAGE in SphK2 KO mitochondria, suggesting a disorganization of complex
IV. Thus, the absence of SphK2 leads to a dysfunction in mitochondrial oxi-
dative phosphorylation with the primary defect at complex IV. This finding
supports novel actions of S1P in mitochondria.
Values are mean ± SEM, n=5-6 per group; RCR= respiratory control ratio. *p<0.05 vs. WT
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Oxidative Phosphorylation
 
Glutamate/Malate Succinate TMPD
ascorbate
 
state 3 state 4 RCR state 3 state 4 RCR 2 mM ADP
WT 251±6 29±3 9±1 355±18 100±7 3.6±0.1 897±32
Sphk2-
KO
195±18
*
19±5 13±3 274±18
*
84±9 3.3±0.2 710±54*
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Implication of TRPV channels in pulmonary arterial hypertension
Diana Dahan, Thomas Ducret, Guillaume Simon, Roger Marthan, Jean-
Pierre Savineau
Université Bordeaux2; INSERM U 885, Bordeaux, France
Pulmonary arterial hypertension (PAH) is often defined as a disease of
small pulmonary arteries characterized by the hyperreactivity to contractile
agonists and structural remodelling two phenomena which are calcium-depen-
dent. Transient receptor potential (TRP) channels constitute a large family of
non selective calcium permeable channels which are involved in several fun-
damental cell functions such as contraction and proliferation. Whether expres-
sion and/or function of TRP channels are altered during PAH are not yet fully
known and could be relevant for a better understand of the pathogenicity of
PAH.
In the present study, we focused on (1) the expression of TRPV2 and
TRPV4 proteins, because they are the most expressed TRP isoform proteins
in the pulmonary arteries, and (2) the in vivo effect of streptomycin, an
inhibitor of TRPV on PAH development. We used two animal models of
PAH: the monocrotaline (MCT)-treated rat and the chronically-hypoxic (CH,
3 weeks) rat. RT-PCR analysis reported an increase of TRPV2 expression in
both CH and MCT rats; and an increase of TRPV4 expression in CH rats.
Western blot analysis showed an increased of TRPV2 expression in MCT
rats. Streptomycin-treatment ((4 g/L i.e. 3 mM in the drinking water) of CH
rats (S+CH) prevented the development of PAH as revealed by the decrease
in both the mean pulmonary artery pressure value (40 mmHg±1.62 to
26mmHg±1.24, N=6/5, P< 0.05, in CH and S+CH rats, respectively) and the
fulton index (0.51±0.02 to 0.45±0.007, N=6, P< 0.05, in CH and S+CH rats,
respectively).
Altogether these findings indicate that TRPV2 and TRPV4 are present in
IPA wall of N, CH and MCT rats. These channels appear to be implicated in
the development of PAH and, could thus be new molecular targets for innova-
tive therapies for this disease.
This work was funded by the Agence Nationale de la Recherche (ANR06-
Physio-015-01).
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Estrogen Receptor alpha activation function-1 is required for normal
coronary endothelial function in ovariectomized mice 
Julie Favre (1), Coralie Fontaine (1), Andrée Krust (2), Henrik Laurell (1),
Gilles Flouriot (3), Vincent Richard (4), Pierre Gourdy (1), Pierre Cham-
bon (2), Françoise Lenfant (1), Jean-François Arnal (1)
(1) INSERM U858, I2MR – Equipe 9, Toulouse, France – (2) IGBMC,
Departement de génomique fonctionnelle, Ilkirch, France – (3) CNRS,
UMR 6026, Rennes, France – (4) INSERM U644, Rouen, France
Objective: The aim of the present study was to evaluate the role of
estrogen receptor (ER) α in the coronary endothelial function, a crucial cardio-
vascular surrogate endpoint. 
Methods and Results: A comparison of the acetylcholine-induced relax-
ation of coronary arteries isolated from both ERα+/+ and ERα-/- female mice
with chronic physiological levels of 17β estradiol (E2) revealed normal coro-
nary endothelial function. Unexpectedly, ovariectomy induced an alteration of
the coronary relaxation of ERα-/- but not in ERα+/+ mice, revealing that inacti-
vation of ERα, in the absence of endogenous E2, altered the coronary relax-
ation response. In the mouse model bearing the Tie2-Cre recombinase crossed
with ERα floxed ovariectomized mice, we demonstrated that deficiency
of ERα in the endothelium also elicited a marked endothelial dysfunction, that
again was partially prevented by E2. ERα contains 2 independent transactiva-
tion functions (AF-1 and AF-2) of which AF-1 appears dispensable in several
vasculoprotective actions of E2. Ovariectomized mice deficient in N-ter-
minal ERα A/B domain, and thus in ERα AF-1, also showed a marked endot-
helial dysfunction that once again was completely normalized in the presence
of E2. Finally, we generated a novel mouse model expressing an ERα defi-
cient in AF-2. In these mice, the coronary endothelial function was normal,
irrespective the presence or absence of E2. 
Conclusion: The present work demonstrates for the first time that, in
estrogen-deprived mice, endothelial ERα deficiency elicits a coronary endot-
helial dysfunction. This effect involves the N-terminal A/B domain harbouring
AF-1, which is known to be activable through ligand-independent mecha-
nisms. The endothelial expression of full-length (66 kD) and AF1-deficient
(46 kD) isoforms could thereby be of crucial importance in a context of
estrogen deprivation such as encountered after menopause. 
0232
Role of the nerve growth factor NGF in pulmonary hypertension
Véronique Freund-Michel, Marcelina Salagierska, Mathilde Dubois,
Christelle Guibert, Arnaud Courtois, Jean-Pierre Savineau, Roger Mar-
than, Bernard Muller
Université Victor Segalen – Bordeaux 2, INSERM U885, Bordeaux Cedex,
France
Introduction: Since growth factors appear as new potential targets in pul-
monary hypertension (PH), we have here studied NGF expression and poten-
tial roles in this pathology.
Methods: NGF secretion from control pulmonary arteries (PA, rat and
human) was assessed by ELISA in absence or presence of interleukin-1β (IL-
1β, 10ng/ml, 24h pretreatment), as well as from diseased PA (rat PH models
induced by chronic hypoxia, 0.5atm-21 days, or by a single monocrotaline
injection, 60mg/kg-28 days). Expression of NGF receptors (TrkA and p75NTR)
was assessed by Western blotting. Contractions of rat PA were induced in
vitro by prostaglandin F2α (PGF2α) or phenylephrine (PHE) in absence or
presence of NGF (100ng/ml, 1h pretreatment). NGF-induced proliferation and
migration of human pulmonary arterial smooth muscle (PASMC) and endot-
helial cells (PAEC) were assessed by the BrdU or the Transwell techniques.
Results: NGF secretion from control PA was increased after IL-1β in vitro
exposure (rat: +35±7%, p<0.05; human: +42±6%, p<0.01). NGF secretion was
also increased from rat PA after in vivo hypoxia (+63±7%, p<0.05) or mono-
crotaline exposure (+120±9%, p<0.01). TrkA and p75NTR receptors were
detected in control rat and human PA, as well as in PASMC and PAEC. NGF
potentiated contractions of control rat PA to PGF2α (EC50 from 32±4 to 20±4
μM, p<0.01) or PHE (EC50 from 0.15±0.03 to 0.059±0.001 μM, p<0.05). NGF
induced proliferation and migration of PASMC (maximal proliferation at
0.1ng/ml: +16±2%, p<0.01; maximal migration at 10ng/ml: +65±7%, p<0.01)
and PAEC (maximal proliferation at 100ng/ml: +39±4%, p<0.001; maximal
migration at 100ng/ml: +83±9%, p<0.001).
Conclusion: Our results show an increased NGF secretion in two rat PH
models, and suggest a role for inflammation in this increase. Moreover, NGF-
induced pulmonary artery hyperreactivity as well as NGF-induced smooth
muscle and endothelial cell proliferation and migration evidenced here support
a role for NGF in pulmonary hypertension.
0200
17beta- estradiol prevents skin flap necrosis by increasing reperfusion
of a protected vascular network, but what happens in males?
Caroline Chenu (1), Céline Toutain (1), Isabelle Raymond-Letron (2),
Laurent Brouchet (1), Pierre Gourdy (1), Jean-Francois Arnal (1), Fran-
çoise Lenfant (1)
(1) INSERM U858, Toulouse, France – (2) ENVT, Département d’Anato-
mie-Pathologie, Toulouse, France
17beta-estradiol (E2) was found to be protective in many experimental
models of myocardial and brain ischemia. More recently, we demonstrated the
protective effect of E2 in a mouse model of skin ischemia, mimicking the sur-
gery of skin flaps [1]. Whereas necrosis appeared in the half portion of the
skin flap within one week after surgery in ovariectomized mice, it was reduced
up to 10-fold when mice were pre-treated with E2 (treated at least 3 days
before the surgery). The beneficial effect of E2 appeared to involve: 1) an
increase in skin survival, revealed by measuring viability of ex vivo explants
and enhancement of the anti-apoptotic Bcl-2 protein expression in vivo. 2) a
protection of the vascular network, facilitating reperfusion which was found to
be accelerated in ovariectomized E2-treated mice, while diffuse hemorrhages
characterized untreated mice skin flaps. This protective effect of E2 was mim-
icked by a treatment with tamoxifen, a selective estrogen receptor modulator
(SERM). 
Male mice were also found to be protected by E2. However, testosterone,
as well as dihydrotestoterone, a non aromatizable androgen, reduced skin flap
necrosis, strongly suggesting a direct activation of the androgen receptor.
Thus, redundancy of action of estrogens and androgens could concur to a pre-
vention of cutaneous ischemia, and the precise mechanisms of this protection
in males are currently under investigation. 
[1] Toutain, C.E., et al., Prevention of skin flap necrosis by estradiol involves
reperfusion of a protected vascular network. Circ Res, 2009. 104(2): p. 245-54,
12p following 254.
0216
Estradiol accelerates reendothelialization through a cooperative effect
between bone marrow and endothelial cells expressing Estrogen
Receptor alpha
Céline Toutain, Cédric Filipe, Laurent Brouchet, Françoise Lenfant, Jean-
Francois Arnal
INSERM U858, Toulouse, France
Objectives: Drug-eluting stents releasing antimitotic drugs are frequently
used in patients undergoing percutaneous coronary interventions. Although
these stents inhibit proliferation of vascular smooth muscle cells and thus
reduce rates of early stenosis, they also impair proliferation of endothelial
cells. The resulting delayed arterial healing increases the risk of thrombosis
and leads to higher late stent restenosis. Optimization of endothelium repair is
then necessary to prevent intimal thickening and in-stent restenosis. 
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Methods: Using a mouse model of carotid injury, we previously demon-
strated that 17ß-estradiol (E2) accelerates endothelium regeneration through
estrogen receptor ERα but not ERβ [1] and involvement of FGF-2 [2]. How-
ever, the molecular and cellular mechanisms underlying this beneficial effect
still remain poorly understood, mainly due to the lack of appropriate models
and tools to visualize endothelium. Here, we employed « en face » confocal
microscopy to follow endothelium repair in longitudinally opened and flat-
tened mouse carotid arteries.
Results: We showed that E2 accelerates both migration and proliferation
of endothelial cells and increased the recruitment of cells in an uninjured adja-
cent retrograde zone, leading to enlarged reendothelialized area [3].
Many studies suggest that circulating bone marrow (BM) derived cells are
involved in arterial healing. Thus, we generated chimeric mice by grafting
wild type mice with ERα -/- or ERα+/+ BM and vice versa. The beneficial
effect of E2 was abolished when the ERα was absent either in donor or in
receiver mice, demonstrating that both BM and non-BM ERα-expressing cells
cooperate to mediate E2 regenerative effects. Using a cell-specific inactivation
mouse model of ERα, by the loxP/Cre recombination system, we showed that
endothelial ERα is absolutely required in the accelerative effect of E2 on reen-
dothelialization. To precise which BM derived cells are involved in the E2
effect, the implication of ERα-expressing macrophages is now under investi-
gation.
Conclusion: These results might help us to propose new strategy to opti-
mize post-angioplasty and in-stent reendothelialization.
[1] Brouchet L., Circulation, 2001.
[2] Fontaine V. Am J Pathol, 2006.
[3] Filipe C. Am J Physiol Heart Circ Physiol, 2008.
0450
Predictors of right ventricular systolic dysfunction in patients with
systemic sclerosis without resting pulmonary hypertension
Frédéric Schnell (1), Cyrille Bergerot (1), Martine Barthelet (1), Sophie
Thivolet (1), Claire Grange (2), Michel Ovize (1), Jean-François
Cordier (3), Jacques Ninet (4), Geneviève Derumeaux (1)
(1) Hôpital Louis Pradel, Laboratoire d’échocardiographie, Bron,
France – (2) Centre hospitalier Lyon Sud, Département de Médecine
Interne, Pierre Benite, France – (3) Hôpital Louis Pradel, Centre de réfé-
rence des maladies orphelines pulmonaires, Bron, France – (4) Hôpital
Edouard Herriot, Département de médecine interne, Lyon, France
Objectives: The aim of this study was to prospectively evaluate the inci-
dence and the determinants of right ventricular systolic dysfunction (RVD) in
patients with systemic sclerosis (SSc) without resting pulmonary hypertension
(PHT). 
Background: Recent studies using tissue Doppler imaging, suggest that a
subtle alteration of RV function may occur in SSc patients without PHT. 
Methods: SSc patients without PHT (n=100) underwent conventional
echocardiography combined with speckle tracking echocardiography and exer-
cise echocardiography. They were compared to controls (n=39).
Results: SSc patients had a lower RV lateral wall systolic strain (εRVLat) as
compared with controls. RVD was defined by absolute εRVLat value ≤25%, and
occured in 25% of patients. Disease characteristics were similar in patients
with or without RVD, except a more important cutaneous involvement in case
of RVD. RVD was associated with a poorer functional state (6 minute walk
distance and peak VO2) and a lower left ventricular systolic strain (εLV),
despite similar LVEF. There was no difference in rest tricuspid regurgitation
(TR) gradient, whereas exercise TR gradient was significantly higher in
patients with RVD. Indeed, exercise PHT was more frequent in SSc with RVD
than without RVD (60% vs 19%, p<0.0001). By multivariate analysis, diffuse
cutaneous involvement, exercise TR gradient >44 mmHg and absolute εLV
value <20.6% were identified as independent predictors of RVD. 
Conclusion: Frequent alteration of RV function is detected by speckle
tracking echocardiography despite normal echocardiography in SSc patients
without PHT. This alteration can be explained by stress induced PHT in addi-
tion with potential primary myocardial involvement. 
0286
Age-related changes in flow-mediated remodeling of resistance arte-
ries in male and female rats: protective effect of estradiol
Kahena Tarhouni 
INSERM U771; CNRS UMR 6214, Angers, France
In most countries the percentage of old people is increasing every year as
birth rate decreases and longevity increases. As a consequence the probability
to face cardiovascular and metabolic diseases increases. Resistance arteries
control blood flow to tissues and they have a key role in the vascular disorders
occurring in aging. In response to a chronic increase in blood flow, resistance
arteries undergo outward hypertrophic remodeling depending on oxidative
stress, the renin-angiotensin system and the NO-cGMP pathway. This capacity
of resistance arteries to adapt, functionally and structurally is a key issue in
tissue submitted to ischemia or when the metabolic need increases. Thus we
investigated flow-mediated remodeling of resistance arteries in male and
female rats aged 3 to 18 months. 
Rats were submitted to surgery in order to modify blood flow: 3 consecu-
tive first order mesenteric arteries were used. Two were ligated so that flow
increased in the third one (high flow, HF artery). Other arteries located at dis-
tance were used as control (normal flow, NF). After 2 weeks, arterial diameter
was measured in vitro in arteries. Arterial diameter in HF arteries was higher
than in NF arteries in 3-month-old male (450 vs 350, 30% increase) and
female rats (475 vs 380, +25%). In female rats, diameter increased by 23% (6
months), 15% (12 months), and 10% in 18-month-old female rats
Thus remodeling, already absent in 12-month-old rats was preserved until
the age of 18 months in female rats. In young female rats HF-remodeling was
suppressed after ovariectomy and restored by 17-beta-estradiol and in young
male rats HF-remodeling was suppressed by aromatase inhibition with letro-
zole. 
Thus, estradiol has a major role in flow-mediated remodeling of resistance
arteries and it might prevent the loss of remodeling occurring in aging. 
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Regional Myocardial Deformation is Influenced both by Myocardial
Infarction Size and by Microvascular Obstruction
Cyrille Bergerot, Nathan Mewton, Cécile Lacote-Roiron, Laura Ernande,
Julie Perrin, Michel Ovize, Pierre Croisille, Geneviève Derumeaux
Hôpital Louis Pradel, Bron Cedex, France
Background: At the acute phase of myocardial infarction (MI), infarct size
and microvascular obstruction (MVO) determined by contrast enhanced car-
diac magnetic resonance (ce-CMR) are important prognotic factors for cardio-
vascular outcome. Recently, regional myocardial strain (ε) determined by early
two dimensional speckle tracking echocardiography (STE) has been shown to
accurately assess the transmural extent (TME) of MI in comparison of ce-
CMR performed few month after MI. The correlation between STE and ce-
CMR at the acute phase and the influence of MVO on ε are unknown.
Objectives: (1) To investigate the performance of regional peak systolic
longitudinal (εL), radial (εR) and circumferential (εC) strains at the acute phase
of MI for the prediction of TME by LGE-CMR, and (2) to evaluate the impact
of MVO on these ε.
Methods: Echocardiography and CMR studies were performed 72 hours
after a first reperfused acute myocardial infarction (STEMI). Using a 16 seg-
ments model, segmental and global εL, εR and εC were measured by STE. On
the same segment model, the myocardial infarct transmural extent and the
presence (MVO+) or absence (MVO-) of MVO were quantified by ce-CMR.
Results: In 69 patients, mean infarct size was 23±13% of LV mass and
MVO occured in 63% (n=44) of patients.
(1) Prediction of TME>50% was: εL>-13% (Se=81% and Sp=83%;
AUC=0.86; CI=0.80-0.91); εR<23% (Se=84% and Sp=81% AUC=0.86;
CI=0.80-0.91); and εC>-10% (Se=69% and Sp=62%; AUC=0.71; CI=0.64-
0.79).
(2) Prevalence of MVO was 10% (118/1114 segments). In MVO+ seg-
ments, εL, εR and εC were respectively -7.8±4.9%, 14.3±11.5% and -5.9±8.7%,
significantly lower when compared to -16.3%±6.4, 34.8±17.7% and -
12.6±9.4% in MVO- segments (p<0.0001). According to TME, MVO had sig-
nificant impact on ε only for TME>50% segments (figure).
Conclusion: At the acute phase of MI, both εL and εR differentiate trans-
mural from non transmural MI, and the presence of MVO is associated with a
decreased regional function in TME>50% segments.
0246
Myocardial Parameters related to systolic anterior motion of the
mitral valve in Hypertrophic cardiomyopathy studied by MRI
Georges Fau, Alina Lintia-Gaultier, Jean-Michel N’Guyen, Karine Warin-
Fresse, Pierre-Dominique Crochet
Institut du Thorax, Centre Hémodynamique et vasculaire inter, Nantes
Cedex 1, France
Purpose: Left ventricular (LV) outflow tract obstruction in hypertrophic
cardiomyopathy (HCM) is a important prognosis factor and results from a
complex interaction between many variables including systolic anterior motion
(SAM) of the mitral valve. However, SAM is inconstant and our aim was to
analyse LV parameters related to its presence.
Methods: 50 patients with HCM defined on MRI criteria (end diastolic
thickness >15mm) were included. The clinical status and following LV param-
eters were collected: end diastolic volume (EDV), end systolic volume (ESV),
mass, ejection fraction (EF), ratio mass/EDV, segmental thickness and thick-
ening, delayed enhancement. Patients were divided in two groups according to
the presence of SAM and the collected parameters were compared.
Results: SAM was present in 21 patients (SAM group) and absent in 29
patients (control group). No differences were observed between the two
groups for EDV, ESV, mass, ratio mass/EDV, segmental thickness, delayed
enhancement and clinical status. The only related parameters to SAM were EF
(0.70±0.12 vs 0.65±0.12; p=0.032) and postero lateral segmental thickening
(0.38±0.08 vs 0.33±0.10; p=0.021).
Conclusion: SAM in HCM is more frequently observed in patients with
the highest values of LV systolic function (EF) and regional thickening of pos-
tero lateral segments. This suggests that an increased LV contractility could be
one of the mechanisms involved in the occurrence of SAM in HCM. 
0261
Left ventricular (LV) non compaction in adults: relationship between
clinical features and MRI characteristics of compacted and non com-
pacted myocardium
Karine Warin-Fresse (1), Claire Defrance (1), Patrice Guerin (2), Georges
Fau (1), Pierre-Dominique Crochet (1)
(1) Institut du Thorax, Centre Hémodynamique et vasculaire inter, Nantes
Cedex 1, France – (2) Hôpital Guillaume et René Laennec – CHU Nord,
Centre Hémodynamique, Nantes, France
Purpose: The left ventricular non compaction (LVNC) is a rare aetiology
of heart failure that occurs as a result of the interruption of the normal com-
paction of the myocardium during embryonic life. The aim of the study was
to assess the relationship between clinical features and MRI parameters of
compacted and non-compacted myocardium.
Methods and Materials: 39 patients presenting a LVNC defined on MRI
criteria (end diastolic ratio of non-compacted to compacted myocardial thic-
kness > 2.3) were included. The following data were collected: clinical fea-
tures (absence of symptom, heart failure, dysrrythmias and thromboembolic
events), and MRI parameters including number of non compacted segments,
non-compaction score (NCS), left ventricular (LV) volumes, LV ejection frac-
tion (EF) and compacted myocardial mass (CMM).
Results: Thromboembolic events were significantly more frequent
(p=0.02) in patients with the highest CMM (114±31 versus 80±25 g,). A
higher incidence of dysrrythmias (p=0.03) was present in patients with the
most severe NC score (28.4±9 versus 22.1±9). CMM was closely related to
LV dysfunction measured by EF (r=-0.365, p=0.02) and Telediastolic Index
(r=0.754, p< 0.001). No relationship was demonstrated between non-compac-
tion parameters and LV dysfunction.
Conclusion: In LVNC, clinical features are related to both compacted and
non-compacted myocardium. LV dysfunction is related to compacted myocar-
dium. This suggests that LVNC is a disease involving the whole LV myocar-
dium.
0140
Manganese-Enhanced MRI (MEMRI) quantification of myocardial
infarction in mice using a 3T clinical scanner
Bénédicte M. A. Delattre (1), Vincent Braunersreuther (2), Jean-Noël Hya-
cinthe (1), Lindsey A. Crowe (1), François Mach (2), Jean-Paul Vallée (1)
(1) University of Geneva, Faculty of medicine, Geneva, Suisse – (2) Uni-
versity Hospital, Foundation for medical researchers, Division of cardio-
logy, Department of medicine, Geneva, Suisse
Magnetic Resonance Imaging (MRI), and moreover contrast-enhanced
MRI is a powerful tool for characterization of heart function and viability.
Manganese (Mn2+) was recognized early as an efficient intracellular MR con-
trast agent to assess cardiomyocyte viability. As it is a Calcium analog, it
accumulates into viable cells and also induces a strong T1 shortening effect.
In this study Manganese-Enhanced MRI (MEMRI) is used to assess infarction
in the acute phase of a coronary occlusion reperfusion model in mice. This
model is of particular interest as it is closer to the situation encountered in the
clinical setting in which the occluded artery is ultimately reperfused. Infarction
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volume was measured, as well as global and regional function using a clinical
3T scanner. The first step of this study was to perform a dose-response curve
in order to optimize the injection protocol. Infarction volume measured with
MEMRI was strongly correlated to TTC staining (taken as a gold standard).
Figure 1 shows a typical example of MEMRI images (upper row) and TTC
staining (bottom row) for a mouse with a coronary occlusion reperfusion (A)
and a sham operated mouse (B). White colour present in TTC slices for (A)
indicating tissue necrosis correlates with hypointense signal in MEMRI
images whereas neither white TTC staining nor hypointense MR signal is
present in (B). Ejection fraction (EF) and percent wall thickening measure-
ments depicted accurately infarct related contraction deficit. This study is the
first step for further longitudinal studies of cardiac disease in mice on a clin-
ical 3T scanner, a widely available platform.
0307
Post-systolic shortening in a Rat model of stunned myocardium: a
tagged MRI study
Stéphany Gardier, Jean-Noël Hyacynthe, Manuel Jorge-Costa, Denis
Morel, Jean-Paul Vallée
Université de Genève, Genève 14, Suisse
Aim: The aim of the study was to evaluate the reliability and sensitivity of
tagged cardiac magnetic resonance imaging (MRI) in assessment of conse-
quences of short ischemia on myocardial contraction.
Methods: A model of closed-chest coronary artery occlusion was used on
20 Sprague-Dawley rats. In a 1.5 Tesla clinical MRI scanner 10 rats under-
went a 3 minutes coronary occlusion followed by 30 minutes of reperfusion.
Tagged images were acquired every 2.5 minutes. Myocardial sectors were
classified in 3 groups: antero-lateral (stunned group), anterior and infero-lat-
eral (adjacent group) and antero-septal, infero-septal and inferior (remote
group). Contraction (maximum strain) and contractility (strain rate) derived
from the myocardial strain curves were compared with a linear model using
the 3 groups of sectors and the time frames as factors. Ten other rats under-
went hemodynamic measurements with an intraventricular catheter to evaluate
cardiac function parameters along the same protocol.
Results: During the occlusion, contraction was reduced and delayed in the
stunned and adjacent groups compared to the remote group (p<0.001). The
contraction remained delayed during the first minutes of reperfusion (p<0.005)
in the stunned group (post-systolic shortening) whereas it recovered in the
adjacent group. Contractility was decreased both during the occlusion and the
first minutes of reperfusion. Hemodynamic parameters did not show any
abnormality of function after the reperfusion. 
Conclusion: We showed for the first time on a rat model that tagged MRI
of a short coronary occlusion was feasible on a 1.5 Tesla clinical scanner. We
demonstrated in the stunned sectors a transient post-systolic shortening which
was not demonstrated by hemodynamic parameters. Besides the interest of
such a model for non-invasive study of rat cardiac function, our data also sug-
gest that tagged MRI could bring an important improvement in evaluation of
the human cardiac function during stress imaging. 
0051
Cardiac Magnetic Resonance-confirmed etiologic diagnosis of tropo-
nin elevated acute chest pain syndrome and unobstructed coronary
arteries: a 3 years experience in a French University Hospital.
Guillaume Leurent (1), Bernard Langella (2), Claire Fougerou (3), Marc
Bedossa (1), Dominique Boulmier (1), Hervé Le Breton (1)
(1) CHU Rennes, Département de Cardiologie, Rennes, France –
(2) Département d’imagerie médicale, Rennes, France – (3) Centre
d’Investigation Clinique, INSERM 0203, Rennes, France
Aims: Myocardial infarctions with unobstructed coronary arteries represent
a significant problem. The place of Cardiovascular Magnetic Resonance
(CMR) is increasing in management of cardiomyopathies. We evaluated the
usefulness of 3 teslas CMR for etiological diagnosis in patients admitted for
elevated troponin acute chest pain syndrome with unobstructed coronary
arteries.
Methods: 107 consecutive patients (mean age: 43.5 years, male: 62%)
admitted during a 3-years period in our institution for an acute chest pain with
troponin elevation and unobstructed coronary arteries were assessed by a 3
teslas CMR (mean delay between occurrence of symptom and CMR was 6.9
days). Etiologic diagnosis was established according to wall motion anomalies
and pericardial effusion on cine, myocardial oedema on T2-weighted and late
gadolinium enhancement on T1-weighted imaging by 2 independent operators
(one cardiologist and one radiologist). Main characteristics were compared
between “contributive” vs “normal” CMR groups.
Results: CMR was normal in 10.3% and allowed an etiologic diagnosis in
89.7% of patients: myocarditis: 59.9%; stress cardiomyopathy (takotsubo syn-
drome): 14%; myocardial infarction: 15.8%. Patients with a normal CMR had
a significantly lower troponin elevation than patients with a contributive CMR
(peak: 2.6 vs 9.7 ng/ml, p=0.01).
Conclusion: 3 teslas CMR have now a fundamental place in the etiological
diagnosis of patient with a raised troponin acute chest pain syndrome and
unobstructed coronary arteries.
Comparision of MEMRI and TTC
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0048
Screening and management of coronary artery disease before liver
transplantation: Improved performance of cardiovascular imaging
after assessment of cardiovascular risk
Gilles Barone-Rochette (1), Benoît Maruejols (2), Marie-Noëlle
Hilleret (3), Jean-Pierre Zarski (3), Vincent Leroy (3), Jean-Philippe
Baguet (2)
(1) CHU Grenoble, USIC, Grenoble , France – (2) CHU de Grenoble,
service HTA, Grenoble, France – (3) CHU de Grenoble, Département
d’hépato-gastroentérologie, Grenoble , France
Background: The screening and management of coronary artery disease
(CAD) before liver transplantation (LT) is currently difficult but crucial. We
aimed to assess short-term prognosis of a screening method and therapeutic
management of CAD in a population with severe liver disease before LT. 
Methods: Over a 7-years period, 88 patients have received a clinical car-
diovascular evaluation, including ambulatory blood pressure monitoring and
echocardiography, for determination of cardiovascular risk (CVR). SPECT
thallium (persantine) was performed in patients at highest CVR. Coronary
angiography was done in symptomatic patients or when SPECT was abnormal. 
Results: The study population consisted in 67 men and 21 women with a
mean age of 54±4 years. The most common cause of liver disease was alco-
holic cirrhosis (62%), with 50% of patients in class B of Child-Pugh, 30%
with class C and 20% in class A. The average number of cardiovascular risk
factors (CRF) was 1.84±1.06. The most common CRF were age and dyslipi-
demia. The average EuroSCORE was 1.77±1.80. Thirty two patients (36%)
had a high total CVR and 11 (12%) had a very high total CVR. After cardio-
vascular investigations, the prevalence of CAD was 9%. Among the 8 CAD
patients, 6 (75%) received medical treatment; two revascularizations were per-
formed (1 Primary Coronary Intervention (PCI) and 1 Coronary Artery Bypass
Graft (CABG)). The LT was successful only in patients who received medical
treatment. After LT, only 3 patients presented an acute coronary syndrome, all
of them had high total CVR identified during the pre-transplant assessment.
All of these patients had a medical treatment with a favourable outcome. 
Conclusion: The assessment of CVR is essential for selecting patients at
high risk to benefit from using non-invasive imaging to detect CAD. In our
series, when CAD was detected, medical management gave better results than
revascularization by PCI or CABG, for a successful LT. 
0280
Prognostic value of multislice computed tomography compared to
invasive coronary angiography
Laure Champ-Rigot (1), Michèle Hamon (2), Jean-Jacques Parienti (3),
Sylvie Gibert (1), Martial Hamon (1,3)
(1) CHU Caen, Cardiologie, Caen, France – (2) CHU Caen, Radiologie,
Caen, France – (3) CHU Caen, Unité de recherche clinique, Caen,
France
Background: Invasive coronary angiography (ICA) represents the “gold-
standard” diagnostic test for coronary artery disease (CAD) detection. Never-
theless, multislice computed tomography (MCST) has been recently developed
and now allows non invasive coronary artery imaging.
Goal: The purpose of this study is to estimate the prognostic value of a
normal coronary MCST compared to a normal ICA.
Methods: It consists in a single center retrospective observational study,
including 293 patients who underwent either ICA (n=162) or coronary MCST
(n=131) between September 2005 and October 2007. The follow-up was orga-
nised between March and June 2009. We use a statistical method called pro-
pensity score to match patients of both groups in order to make them
homogeneous.
Results: The primary end-point is the occurrence of major adverse cardiac
events (MACE): cardiac death, non fatal myocardial infarction or coronary
revascularisation. The mean follow-up is 29.5 (±8.7) months. Using the pro-
pensity score there is 164 patients in the matched population, 82 patients in
each one. MACE rate reach 1.22% and 2.44% in coronary MCST and ICA
groups respectively (p=NS). Kaplan-Meier curves show no difference in
MACE-free survival in both groups (log rank=NS). Probability of MACE is
similar within these two groups (hazard ratio=0.75, 95% CI=0.106-5.325,
p=NS). Finally there is no difference neither for the occurrence of cardiac
death, nor hospitalisations for acute coronary syndrom between coronary
MCST and ICA groups.
Conclusion: Patients with a normal coronary MCST have an excellent
prognosis, like those with a normal ICA. Therefore coronary MCST can be
considered as a valuable tool to exclude CAD.
0053
Coronary Computed Tomography as Initial Test for Angina Pectoris:
Impact on Subsequent Invasive Procedures
Edouard Cheneau, Bruno Vahdat, Dimitri Panagides
Clinique Bouchard, Marseille, France
Background: Coronary Computed Tomography (CCT) detects coronary
obstruction with high sensibility. CCT might be useful as initial test for angina
pectoris diagnosis. However, this strategy might involve unnecessary invasive
procedures. The interest of such strategy and its impact on subsequent unnec-
essary procedures might be dependent on pre-test likelihood for having Coro-
nary artery disease (CAD).
Methods: One hundred and eighty patients with chest discomfort and sus-
pected angina were prospectively referred to CCT with a 64-slice CT scan.
Invasive angiogram was performed on the basis of CCT findings. Patients
were classified into terciles according to estimated pretest probability for
obstructive CAD using the Duke Clinical Score (low, medium and high).
Strategy failure was defined as performing invasive coronary angiogram (ICA)
without subsequent revascularization. 
Results: Pre test probability for CAD was 53% +/- 29%. Significant stenosis
was detected by CCT in 10%, 23% and 52% in low, medium and high risk
patients respectively (p<0.01). Eighteen patients (10%) were referred to ICA but
did not require revascularization. Strategy failure was 5/6 (83%) in low risk, 1/
11 (9%) in medium risk and 12/30 (40%) in high risk patients (p<0.01). 
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Conclusions: Strategy with CCT as initial step for angina diagnosis is the
most effective in patients with intermediate probability of CAD. In patients with
low or high probability, it is associated with a high rate of unnecessary ICA.
0467
Description of a new algorithm improving echo contrast detection for
EchoPiv method
Damien Coisne (1), Mathieu Lugiez (2), Michel Menard (2), Carine Gui-
vier (3), Valérie Deplano (3), Luc Christiaens (1)
(1) CHU La Miletrie, Poitiers, France – (2) L3I Université de La Rochelle,
La Rochelle, France – (3) Irphe CNRS UMR 6594, Marseille, France
Objective: Echo Particular velocity imaging (ECHOPIV) is a promising
tool detecting flow patterns in cardiovascular structures. Optical flow method
implemented for contrast movement detection usually gave semi-quantitative
information. We thought to improve pre treatment and image processing in
order to obtain more reliably results. We compare our results to the autocorre-
lation method usually used.
Methods: Our image processing algorithm is composed of different steps.
(1) Removing noise through soft wavelet thresholding method. (2) Decompo-
sition of echo-piv sequence into: (a) geometrical component, (b) textural com-
ponent (b) and © noise. (3) Based on textural component, the optical flow was
estimated through partial derivative equation method.
Comparing to autocorrelation method, our algorithm shows great robust-
ness against noise, better spatial resolution and good adaptation to local and
global flow detection as shown by the polar histogram comparison (Figure 1)
Conclusion: Cross Correlation method seems to be less adapted to detect
small or local movements probably due to larger interrogation windows and its
resolution.
Our new algorithm grants a coherent ECHOPIV movement estimation with
good local and global property, high density flow estimation and robustness
against noise.
0317
The impact of multislice CT in the diagnosis of acute chest pain
Iman Hosny 
Facullté de Médecine Université du Caire, Caire, Egypte
Objective: The purpose of this article is to address the clinical value of
recent advances of MultiSlice Computed Tomography in the diagnosis of the
major life –threatening causes of acute chest pain 
Materials and methods: Forty five patients with atypical acute chest pain
and low to intermediate cardiovascular risk were referred from the emergency
department for dedicated coronary CT angiography (CCTA) .Other 15 patients
with high clinical suspicion of pulmonary embolism or aortic dissection were
also referred for conventional CT angiography. The CT examination was car-
ried on using GE light speed VCT 64.
Table 1: CCTA Protocol 
0427
Reduction of coronary artery multi-slice computed tomographic
(MSCT) radiation and maintained diagnostic accuracy by parameters
optimization: The RAMBO study
David Pesenti-Rossi (1), Géraldine Gibault-Genty (1), Christophe Chave-
las (2), Jean-Louis Georges (1), Samer Chayeb (2), Nicolas Baron (1),
François Mignon (3), Giannina Galuscan (1), Jacques Schwob (1), Clé-
ment Charbonnel (1), Irina De Sauniere (2), Laure Nay (2), Ugo Balderac-
chi (4), Christian Hubert (3), Bernard Livarek (1), Thierry Fourme (2)
(1) Centre Hospitalier de Versailles, Cardiologie, Le Chesnay, France –
(2) Centre Hospitalier de Rambouillet, Cardiologie, Rambouillet, France –
(3) Centre Hospitalier de Versailles, Radiologie, Le Chesnay, France –
(4) Centre Hospitalier de Rambouillet, Radiologie, Rambouillet, France
Background: Multi-slice computed tomographic (MSCT) has proven in
several studies to have a high diagnostic accuracy for the detection or exclu-
sion of coronary artery disease (CAD). Recent studies suggest that use of 64-
slice scanner is associated with a non negligible lifetime attributable risk of
cancer. Therefore, the purpose of this multicenter study was to investigate a
reduction dose protocol on image quality parameters and radiation dose. 
Effect of pre-treatment on contrast detection
Scan
Range
Tracheal carina to dome of diaphragm
 Time
10-14 s
Tube settings
Voltage
120 kVp
Current
400 -700 mAs
Acquisition
Slice collimation
0.6 mm
Rotation time
0.35 s
Pitch
0.2-0.3
Bolus timing
Volume
80 mL
Flow rate
5 mL/s
Saline
30 mL 
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Methods and results: Between January 2008 and May 2009, 64-slice
scanner with retrospective ECG gating was performed in 315 consecutive
patients (overall mean age, 58.7 years ± 12.5 [standard deviation]; age range,
29–81 years): 217 men; 98 women, with a mean BMI of 24.9 kg/m2 ± 3.4
(range, 17.2–34.7 kg/m2). 
Reasons for referral were atypical chest pain in patients with low to inter-
mediate CAD combined with inconclusive ECG or stress test results (163
patients), dilated cardiomyopathy (19 patients), left bundle branch block (6
patients), coronary stent evaluation (12 patients), coronary artery bypass graft
assessment (13 patients), syncope (30) or others (72 patients).
165 were examined with a standard protocol, 150 were examined with a
reduction dose protocol by tube current and voltage optimization (mA and
Kv). Two blinded observers independently assessed image quality parameters.
The effective radiation dose was calculated using MSCT dose-length product
(DLP). 
Diagnostic image quality was obtained respectively in 89.1% and 88% of
all coronary segments without significant differences among the protocols. 
Estimated effective radiation dose of the standard protocol
(1427±226mGrays*cm / 19.9±3.1 mSv) was significantly higher than the
reduction dose protocol (911±289mGrays*cm / 12.7±4 mSv, P<0.001).
Conclusions: This study multicenter demonstrates that radiation dose can
be significantly reduced by parameters optimization with maintained diag-
nostic accuracy. 
0289
Radiolabeled Fucoidan as a tool for P-selectin detection in platelet-
rich thrombus
Francois Rouzet (1), Laure Bachelet (2), Jean-Marc Alsac (3), Alain Meu-
lemans (1), Liliane Louedec (2), Frédéric Chaubet (2), Jean-Baptiste
Michel (2), Didier Letourneur (2), Dominique Le Guludec (1)
(1) Hôpital Bichat, Médecine Nucléaire, Paris, France – (2) INSERM
U698, Paris, France – (3) Hôpital Européen Georges Pompidou, Paris,
France
Platelet-rich arterial thrombi play a major role in various human cardiovas-
cular diseases. Its procoagulant activity at the interface with the circulating
blood, promoted by activated platelets, is also the hallmark of its renewal. P-
selectin is constitutively expressed by activated platelets and endothelial cells.
Its main ligand is P-selectin glycoprotein ligand-1 which recognition and
binding involves the tetrasaccharide Sialyl Lewis X (SLex). Fucoidans refer to
a type of sulfated polysaccharide which mimics SLex and exhibits a high
affinity for P-selectin with a KD of 1.2 nM. The aim of the study was to assess
the ability of 99mTc-labeled fucoidan (99mTc-Fuco) to detect platelet activa-
tion associated with intraluminal arterial thrombi in two rat models: abdominal
aortic aneurysm (AAA) and infective endocarditis (IE).
Methods: AAA has been obtained in 9 rats through a decellularized
xenograft (guinea pig) of the infrarenal aorta. Aortic IE has been induced in 6
rats by inserting a catheter through the aortic valve, and injecting a septic inoc-
ulum 2 days later. Tomoscintigraphies (SPECT) were acquired 2 hours after
intravenous injection of 99mTc-Fuco on a dedicated small-animal gamma
camera (γIMAGER-S, Biospace Lab, France), centered on the chest (IE) or
abdomen (AAA) during 45 minutes. After acquisition, animals were eutha-
nized and relevant samples were excised for quantitative autoradiography and
histology. Data are expressed as thrombus to background activity ratios. For
autoradiography, background activity was measured on remote myocardium
(IE) or thoracic aorta (AAA).
Results: A focal 99mTc-Fuco uptake has been detected on SPECT in all
animals. The uptake ratio was 3.6 [2.2-8.5] in AAA and 5.2 [2.7-9.1] in IE.
On autoradiography, the ratio was 9.1 [6.3-15.8] in AAA and in 17 [14-32] in
IE. Comparative analysis of autoradiography and histology slices showed that
99mTc-Fuco uptake was localized on the luminal layer of intraluminal
thrombus (AAA) and vegetations (IE model), and co-localized with P-selectin
immunostaining.
Conclusion: These preliminary data support the use of 99mTc-Fuco as a
relevant tool for in vivo detection of P-selectin expression by activated plate-
lets in arterial thrombus.
0414
Reliability of the SYNTAX score in daily practice. Results of an Inter-
and Intra-Observer Variability Study
Stéphane Zuily (1), Christophe Goetz (2), Julien Rosencher (1), Obay Oul-
mane (1), Zoheir Mami (1), Stéphane Manzo-Silberman (1), Nicolas Mar-
que (1), Philippe Allouch (1), Olivier Bical (3), Alain Pavie (4), Christian
Spaulding (1), Olivier Varenne (1)
(1) Cochin Hospital, Cardiology Department, Paris, France –
(2) INSERM, CIC-EC, CIE6, Department of Clinical Epidemiology and
Evaluation, Nancy, France – (3) Saint Joseph Hospital, Department of
Cardiac Surgery, Paris, France – (4) La Pitié-Salpêtrière Hospital, Insti-
tute of Cardiology, Paris, France
Introduction: The SYNTAX score (SYS) was developed to provide guid-
ance on optimal revascularization strategies for patients with multivessel and/
or left main coronary artery disease (CAD). In daily practice, discrepancies
between operators are common. We therefore assessed the inter- and intra-
observer variability of the SYS.
Methods: Twenty coronary angiograms of multivessel and/or left main
CAD were randomly chosen and evaluated by 8 blinded observers: 2 cardiac
surgeons and 6 interventional cardiologists (4 staff members, 2 senior fel-
lows, and 2 residents). Each operator estimated 1) a subjective score by clas-
sifying the angiograms in the three SYNTAX categories before calculating
the SYS and 2) the SYS using the SYS calculator. The inter- and intra-
observer reproducibility was assessed using intraclass correlation coeffi-
cients (ICC) and Cohen’s Kappa. Pearson’s chi square (X2) test was used to
compare the subjective score to the SYS and the received treatment to the
SYS strategy.
Results: The coronary angiograms of 18 men and 2 women with multi-
vessel CAD (n=16), left main CAD (n=1) or both (n=3) were evaluated. The
mean SYS was 24 +/-11 with significant differences between the observers
(p=0.02). There was a moderate inter- and intra-observer reproducibility
(ICC=0.67 [0.51-0.82] and ICC=0.69 [0.60-0.77] respectively). The differ-
ences between observers could be explained in part by a misuse of the SYS
calculator. Compared to the SYS strategy, the subjective score overestimated
the severity of lesions (X2 p<0.01), and applying the SYS strategy would have
led to different therapeutic choices (X2 p<0.01).
Conclusion: Inter- and intra-observer variability was noted when the SYS
was calculated by operators with different backgrounds and training. There-
fore use of the SYS by individual operators should be discouraged and a
multidisciplinary approach recommended when choosing between coronary
angioplasty and bypass surgery in patients with multivessel and/or left main
CAD.
Reliability assessment of the SYNTAX score
© Elsevier Masson SAS. All rights reserved.
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TOPIC 31 – Imaging, new echocardiogra-
phic techniques
0379
The 2D Strain Rate parameters have a prognostic value in right car-
diac failure patients assisted by Extracorporeal Membrane Oxygena-
tion (ECMO)
Nadia Aissaoui (1), Alain Combes (2), Emmanuel Guerot (3), Pascal
Leprince (4), Charles-Edouard Luyt (3), Jean Chastre (2), Benoît Diebold (1)
(1) HEGP, cardiologie, Paris, France – (2) ghps, réanimation médicale,
Paris, France – (3) HEGP, réanimation médicale, Paris, France –
(4) GHPS, Chirurgie cardiaque, Paris, France
Objectives: This study assessed 2DSR indices in predicting a successful
weaning from ECMO (Extracorporeal Membrane Oxygenation) in right ven-
tricular (RV) failure patients.
Background: Extracorporeal Membrane Oxygenation (ECMO) can be pro-
posed in refractory cardiogenic shock patients with right cardiac failure. The
assessment of the right ventricular (RV) function remains difficult and specific
criteria to predict which patients can be successfully weaned off ECMO are
lacking.
A recently introduced post processing of native echocardiographic
sequences 2 Dimensional Strain Rate Imaging (2DSRI), might be interesting
to detect precociously a RV recovery, but this point is not, so far, clearly
established.
Methods: Fifteen consecutive patients (6 males, 46±12 years old) with RV
dysfunction, received ECMO support for dilated cardiomyopathy (n=7), post-
transplantation (n=5) or fulminans myocarditis (n=3) cardiogenic shock. 
Clinical, haemodynamic and echocardiographic data were recorded daily.
RV parameters were specifically studied: right ventricular ejection fraction,
tissue Doppler tricuspid velocities and RV 2D Strain rate parameters (strain
(S), and strain rate (SR)). 
Results: Among the 15 patients receiving ECMO, 6 were ultimately
weaned from the device (the Weaned patients W) whereas 4 underwent heart
transplantation (n=2) or were bridged to ventricular-assist devices (n=2) and 5
died (The Nonweaned patients NW).
At the ECMO implantation and during the evolution, the two groups had
similar clinical (including illness severity) and haemodynamic characteristics.
Already in the first day, the RV 2DSR parameters were higher in the W (p
< 0.05): - 7.38% (± 4.72) and 0.70.s-1 (± 0.48) in W vs. – 2.69% (± 2.13) and
0.24 .s-1 (± 0.10) in NW, (for S and SR respectively).
Conclusions: The ECMO weaned patients have significantly higher RV S
and SR values already on the first day suggesting that these parameters may
help in their management. 
0488
Speckle tracking echocardiography analysis of chronic heart failure
patients and controls according to two software programs
Anne Bernard-Brunet (1), Erwan Donal (2), Christophe Thebault (2), Fré-
déric Schnell (2), Christophe Leclercq (2)
(1) CHRU Trousseau, EFMP, Tours, France – (2) CHRU Pontchaillou,
Rennes, France
 Background: Quantitative evaluation of left ventricular function is a
major step in echocardiographic examination. Speckle tracking is a novel
echocardiographic tool which allows strain analysis and therefore could be a
new method to assess left ventricular function. Different software programs
are available but we do not know whether they are similar. Our aim was to
describe strain analysis modalities according to two software programs. 
Methods: Twenty-five chronic heart failure patients (mean age=61±12
years old; mean LVEF=28±6%) and ten controls (mean age=21±2 years old;
mean LVEF=59±4%) were studied. Standard echocardiography was per-
formed using two different hardwares. All data were analysed off-line using
dedicated software package. Speckle tracking analyses were performed from
three apical views (4 chamber, 2 chamber, and long axis) and from parasternal
short-axis views at the level of the papillary muscles. Global longitudinal
strain from the three apical views, anterior septum peak radial strain and pos-
terior wall peak radial strain were measured.
Results: Variability between software results was higher with chronic heart
failure patients than with controls. Concerning heart failure patients, speckle
tracking analyses revealed quite good intraclass correlation coefficient for
global longitudinal strain measures (0.95 for A-4Ch, 0.75 for A-2Ch, and 0.83
for A-3Ch) between the two software programs. Intraclass correlation coeffi-
cient was better for controls (0.92 for A-4Ch, 0.91 for A-2Ch, and 0.99 for A-
3Ch). About radial strain analyses, intraclass correlation coefficient was low
for anterior septum peak radial strain (0.7) and rather bad for posterior wall
peak radial strain (0.4). 
Conclusion: This study demonstrated that longitudinal strain analyses using
two different speckle tracking software programs were quite similar, especially
for controls. But it was not so satisfying when considering radial strain. 
0208
Diastolic dynamics and timing of left ventricular strains and untwis-
ting mechanics during incremental exercise in healthy subjects: a
speckle tracking imaging study
Grégory Doucende (1), Iris Schuster-Beck (2), Thomas Rupp (1), Aliona
Startun (2), Michel Dauzat (2), Philippe Obert (1), Stéphane Nottin (1)
(1) Université d’Avignon, Faculté des sciences, Avignon, France –
(2) Centre Hospitalier Universitaire, Faculté de Médecine, Nimes, France
Background: Diastolic filling is the major limiting factor for the increase
in stroke volume during exercise. Dynamics and timing of diastolic strains and
torsional mechanics of the left ventricle (LV) and their relation to diastolic
filling have never been evaluated at various exercise intensities. 
Methods and Results: Twenty healthy sedentary subjects underwent a
progressive exercise test. Echocardiographic data were recorded at rest and at
20%, 30% and 40% of maximal aerobic power, and speckle tracking imaging
(STI) was used to analyze strains and torsional mechanics. Diastolic
untwisting velocity increased progressively with exercise intensity (-
116.2±46.7 to -182.9±53.5 deg.s-1, P<0.01), paralleling enhanced systolic tor-
sion (10.5±3.2 to 15.8±4.5 deg, P<0.001). The magnitude of increase was sig-
nificantly higher for diastolic untwisting compared to diastolic longitudinal
and circumferential strain rates (119±64 versus 65±44 and 57±24%, respecti-
vely), underlying its key role for diastolic filling. The timing of peak
untwisting (117±7 to 122±8%, NS) and the chronology of diastolic mechanical
events were unchanged during effort. Diastolic apical rotation and untwisting
were major determinants for mitral opening and IVRT, whereas basal diastolic
rotational velocity and longitudinal and circumferential strain rates were cor-
related to peak diastolic filling.
Conclusions: STI allows the assessment of LV diastolic strain and tor-
sional kinetics during incremental exercise in healthy subjects. It might be
useful to better understand mechanics and timing of diastolic adaptation to
exercise and to analyze diastolic dysfunction in various pathologic conditions.
0360
Comparison of quality and tolerance between micro and standard
transesophageal probe
Caroline Dussault, Laurens Mitchell-Heggs, Julien Nahum, Anne-Marie
Duval, Leslie Deal, Soulef Guendouz, Emilie Fougères, Delphine Hayat,
Martin Kloeckner, Jean-Luc Monin, Laurent Macron, Alexandre Bensaïd,
Pascal Guéret, Pascal Lim
GH Henri Mondor, Fédération de cardiologie, Créteil, France
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Aim: To compare the accuracy and tolerance of a micro (Philips, S8-3t,
Tip=5mm) and standard (Philips, X7-2t, Tip=10mm) transoesophageal
echocardiography (TEE) probe. 
Methods: Both micro and standard TEE were performed (in random order)
in 21 consecutive patients referred for TEE. A standard questionnaire was used
to evaluate tolerance (scale 10) of standard and micro TEE. Aorta structures,
inter-atrial septum and apical views (4C, 2C and 3C) from standard and micro
TEE were compared. 
Results: Micro TEE was better tolerated than standard TEE with less pain
(1.2 ± 2.0 vs. 3.0 ± 2.6 p<0.05) and discomfort (2.9 ± 2.1 vs. 4.5 ± 2.7
p=0.07). Image quality was similar for inter-atrial visualization (1.3 ± 0.5 vs.
1.1 ± 0.2) and 3C apical view (1.4 ± 0.6 vs. 1.1± 0.2) but was greater by stan-
dard TEE for 4C and 2C apical views. Close correlation was observed between
standard TEE and micro TEE for LVEF (r=0.963, p<0.05), ascending aorta
size measurements. However, aortic and mitral regurgitation observed in 15
patients by standard TEE was only identified in 4 of patients. 
Conclusion: Micro TEE provides is comparable to standard TEE for inter-
atrial and 3C apical view with a better tolerance than standard TEE. However,
low accuracy of BD Doppler seems strongly limit its use in clinical practice. 
0181
Decreased radial function is associated with subtle left ventricular
remodeling in type 2 diabetes mellitus
Laura Ernande (1), Cyrille Bergerot (1), Ernst Rietzschel (2), Marc De
Bruyzere (2), Michel Ovize (3), Laure Groisne (4), Philippe Moulin (4),
Thierry Gillebert (2), Geneviève Derumeaux (5)
(1) Laboratoire d’échocardiographie, Hôpital Louis Pradel, Lyon,
France – (2) Ghent University Hospital, Ghent, Belgique – (3) Unité
INSERM 886, Université Claude Bernard Lyon1, Lyon, France – (4) Ser-
vice d’endocrinologie, Hôpital Louis Pradel, Lyon, France – (5) Labora-
toire d’échocardiographie, Hôpital Louis Pradel et unité INSERM 886,
Lyon, France
Background: Previous studies have suggested that reduced longitudinal
myocardial function might be compensated by increased radial contractility
in type 2 diabetes mellitus (DM) patients. 
Aim: To evaluate left ventricular (LV) remodeling in type 2 DM according
to radial function assessed by STI.
Methods: 234 asymptomatic type 2 DM patients with no sign or history of
heart disease and normal conventional echo parameters were included. Mean
radial strain (SR) was assessed by STI from short-axis view at the midventric-
ular level.
 
Mean longitudinal strain (SL) was calculated from the apical 2- and
4-chamber views. The population was divided into 3 groups according to SR
value: group I=SR<45%(n=101), group II=SR between 45 and 60% (n=76) and
group III=SR>60% (n=57). Differences between groups were tested by
ANOVA. 
Results: Clinical, biological and echographic data are shown in table. Age,
body mass index (BMI), duration and severity of DM, systolic (sBP) and dias-
tolic (dBP) blood pressure, LV mass index (LVMi) and conventional systolic
parameters (LVEF: LV ejection fraction and FS: fractional shortening) were
similar between groups. However, a lower SR was associated with a significant
increase in LV end-diastolic (LVEDD) and end-systolic (LVESD) diameters
and a decreased SL.
Conclusion: An altered radial function might be an indicator of more
advanced diabetic cardiomyopathy with altered systolic function and begin-
ning of eccentric LV remodeling.
0361
3D vs. 2D Speckle Tracking for characterizing myocardial contractile
reserve
Delphine Hayat, Martin Kloeckner, Julien Nahum, Caroline Dussault, Pas-
cal Gueret, Pascal Lim
CHU Henri Mondor, Fédération de cardiologie, Créteil, France
Background: The aim of the study is to compare the accuracy of 3D and
2D strain for characterizing myocardial contractile reserve during stress
echocardiography.
Methods: The study included 14 patients (10 males, 65±16 years) with
ischemic left ventricular dysfunction (LVEF=39±8%). Longitudinal strain by
2D and 3D speckle tracking and 3D strain by 3D speckle tracking were com-
pared to contractile reserve during dobutamine stress echocardiography. 
Results: of 224 segments (16 segment model), 194 (87%) vs. 224 (100%)
were analyzable by 2D and 3D, respectively. Accuracy to identify abnormal
segments (n=153, 69%) at rest with 3D longitudinal strain (0.68, p<0.0001)
and 3D strain (AUC=0.65, p<0.0001) was better than 2D longitudinal strain
(0.61, p=0.009). Of abnormal segments, 54 (35%) segments exhibited a con-
tractile reserve (CR). Accuracy to identify CR was similar by 2D (AUC=0.66,
p=0.002) and 3D (AUC=0.66, p<0.0001) longitudinal strain but was superior
by 3D strain (AUC=0.68, p<0.0001).
Conclusion: 3D speckle tracking compared to 2D strain may provide a
better accuracy in characterizing myocardial contractility at rest and contractile
reserve under dobutamine. Further validation is required in a larger population
to confirm this hypothesis, especially in comparison to late contrast CMR.
0429
A New Semi-Automatic Analysis Software for Real Time 3D Echocar-
diography Left Ventricular Volumes and Function Assessment
Laurent Macron (1), Pascal Lim (1), Alexandre Bensaid (1), Julien
Nahum (1), Laurens Mitchell-Heggs (1), Jean-Luc Dubois-Randé (1),
Jean-Luc Monin (1), Jean-François Deux (2), Pascal Guéret (1)
(1) Hôpital Henri Mondor, cardiologie, Créteil, France – (2) Hôpital
Henri Mondor, radiologie, Créteil, France
Objective: to compare left ventricular volumes and ejection fraction (EF)
assessment by Real Time 3D Echocardiography (RT3DE) with a new semi-
automatic software (4DLVQ) that does not require manual tracing of endocar-
dial borders to the reference analysis tool TomTec and to Cardiac Magnetic
Resonance (CMR).
Methods: Sixty-six consecutive patients referred for CMR underwent
RT3DE and CMR on the same day. Of the 50 patients (59±18 years, 68%
men, 42% coronary artery disease, EF=49±14%, range 14 to 76%) with an
adequate RT3DE image quality, end-diastolic volume (EDV), end-systolic
volume (ESV) and EF computed using 4DLVQ were compared to TomTec
measurements and to CMR reference values. 
Results: Correlations with TomTec for EDV (161±59mL, r=0.96), ESV
(86±56mL, r=0.97) and EF (r=0.92) were excellent without significant bias for
all. Importantly, time analysis was significantly shorter with 4DLVQ than with
 Group I
(SR < 45%)
Group II
(SR: 45-60%)
Group III
(SR > 60%)
p
Age (years) 58.6±0.9 58.1±0.8 58.0±1.1 NS
Gender M/F 68/33 43/33 22/35 0.003
BMI (kg/m2) 29.3±0.5 29.6±0.5 28.6±0.6 NS
DM duration 
(years)
12.8±0.8 12.1±0.9 13.3±1.1 NS
HbA1C (%) 7.7±0.1 7.8±0.2 7.9±0.2 NS
sBP (mmHg) 131±1 135 ± 2 130±2 NS
dBP (mmHg) 75±1 77±1 75±2 NS
LVEDD (mm) 49.1±0.5 47.6±0.5 47.5±0.6 0.047
LVESD (mm) 29.2±0.4 27.8±0.5 27.4±0.5 0.019
LVMi (g/m2) 89.3±1.8 83.8±2.3 83.7±2.3 NS
LVEF (%) 67.4±0.6 68.0±0.7 68.7±0.7 NS
FS (%) 40.5±0.6 41.6±0.7 42.4±0.8 NS
SR (%) 34±1 52±1 69±1 <0.001
SL (%) -19±0.3 -20±0.3 -21±0.4 <0.001
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TomTec (133±22s. vs. 171±50s., p=0.03). However, despite excellent correla-
tions with CMR for EDV (r=0.93), ESD (r=0.95) and LVEF (r=0.90), 4DLVQ
underestimated EDV (-18±23mL) and ESV (-13±17mL) that resulted in a
small bias of 2% for EF assessment. RT3DE inter-observer variabilities for
EDV, ESV and EF were low with 4DLVQ (4.0±2.9%, 7.9±4.2% and
7.1±4.1% respectively) and TomTec (7.6±6.2, 6.6±4.3 and 6.1±4.6 respec-
tively) without significant difference between both.
Conclusion: 4DLVQ provides an accurate, reproducible and fast assess-
ment of left ventricular volumes and EF that could contribute to extend the use
of RT3DE in clinical practice. 
0430
Single versus Multi-beat Real Time 3D Echocardiography for Asses-
sing Left Ventricular Volumes and Ejection Fraction. A Comparison
Study with Cardiac Magnetic Resonance
Laurent Macron (1), Pascal Lim (1), Julien Nahum (1), Alexandre
Bensaid (1), Laurens Mitchell-Heggs (1), Jean-Luc Dubois-Randé (1),
Jean-Luc Monin (1), Jean-François Deux (2), Pascal Guéret (1)
(1) Hôpital henri mondor, cardiologie, Créteil, France – (2) Hôpital henri
mondor, radiologie, Créteil, France
Objective: RT3DE is superior to 2D echocardiography in assessing LV
volumes and EF but its feasibility is limited by multi-beat acquisition that
requires an optimal breath hold and a regular heart rhythm. We sought to eval-
uate the accuracy and feasibility of single and 2-beat Real Time 3D Echocar-
diography (RT3DE) for left ventricular (LV) volumes and ejection fraction
(EF) assessment.
Methods: Sixty-six consecutive patients referred for Cardiac Magnetic
Resonance (CMR) underwent RT3DE and CMR on the same day. Of the 50
patients (59±18 years, 68% men, 42% coronary artery disease,
LVEF=49±14%, range 14 to 76%) with an adequate RT3DE image quality,
accuracy for LV volumes and EF measurements of single and 2-beat modality
were compared to the conventional 4-beat acquisition and CMR. 
Results: Correlations with CMR for LV end diastolic volume
(EDV=161±59mL, r range: 0.93 to 0.94) and end systolic volume
(ESV=161±59mL, r range: 0.93 to 0.96) were excellent regardless of the
number of cardiac cycle used. However, because of the low temporal reso-
lution (7±2 volumes per second), single beat underestimated LVEF (bias, -
5±8%) with greater bias than 2-beat (bias, 1±6%, p<0.001) and 4-beat
(bias, 3±7%, p<0.001) modalities. Interestingly, 2-beat provided similar
accuracy than 4-beat for EDV (bias, -17±21mL vs. -15±23mL), ESV (bias,
-9±16mL vs. -12±17mL) and LVEF (bias, 1±6% vs. 3±7%) measurements,
but less stitched artifact was observed with 2- than 4-beat modality (3% vs.
30%). 
Conclusion: Single beat temporal resolution appears insufficient to provide
an accurate assessment of LV volumes and EF. In contrast, 2-beat acquisition
provides better image quality with similar accuracy than conventional multi-
beat modality.
0431
Impact of 2D Echocardiography Image Quality on Longitudinal Glo-
bal Strain by Speckle Tracking for Assessing Left Ventricular Systolic
Function
Laurent Macron (1), Pascal Lim (1), Julien Nahum (1), Alexandre
Bensaid (1), Laurens Mitchell-Heggs (1), Jean-Luc Dubois-Randé (1),
Jean-Luc Monin (1), Jean-François Deux (2), Pascal Guéret (1)
(1) Hôpital Henri Mondor, cardiologie, Créteil, France – (2) Hôpital
Henri Mondor, radiologie, Créteil, France
Objective: Left Ventricular (LV) systolic function assessment is mainly
based on Left Ventricular Ejection Fraction (LVEF) measurement by 2D
Echocardiography using the Simpson’s biplane method that requires a good
image quality (IQ). Global Longitudinal Strain (GLS) by 2D speckle tracking
imaging has been validated for quantifying LV systolic function. We sought to
evaluate in patients with a poor IQ (≥2 non-visualized segments) the feasi-
bility, accuracy and reproducibility of GLS for LV systolic function assess-
ment. 
Methods: Fifty-three patients (58±19 years, 60% men, 43% coronary
artery disease; good IQ, n=25; poor IQ, n=28) underwent 2DE and Cardiac
Magnetic Resonance (CMR). LV systolic function assessment using Sim-
pson’s biplane LVEF (EF-2D) and GLS was compared to LVEF by CMR
(49±16%, range 9 to 76%). In addition, Segmental Longitudinal Peak Strain
was compared to semi-quantitative regional wall motion assessment by CMR
in patients with poor IQ.
Results: GLS good correlated with LVEF by CMR regardless of IQ
(r=0.81 and 0.82 for good and poor IQ respectively). In contrast, EF-2D
was less correlated for poor IQ (r=0.76 vs. 0.89) and showed a two-fold
higher bias (bias 6±13% vs. 3±6%) with CMR. More important, reproduc-
ibility of EF-2D heavily depended on IQ (relative inter-observer variability
of 7±3% vs. 22±22% for good vs. poor IQ) while IQ did not impact on GLS
reproducibility (7±6% and 8±9% for good and poor IQ respectively). In
addition, Segmental Longitudinal Peak Strain allowed for an accurate
assessment of regional wall motion even in non-visualized but correctly
tracked segments. 
Conclusion: In contrast to EF-2D, image quality did not significantly
impact on feasibility, accuracy and reproducibility of GLS by 2D speckle
tracking imaging for LV systolic function assessment. GLS measurement
should be recommended in patients with poor image quality to assess LV sys-
tolic function.
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Longitudinal strain imaging in patients with ST-elevation myocardial
infarction. Relationships with magnetic resonance imaging
Rachid Marjane, Hafida Samet, Annie Trinh, Jérome Rischner, Hélène
Petit, Bogdan Radulescu, Laurence Jesel, Philippe Germain, Olivier
Morel, Pierre Bareiss, Patrick Ohlmann
Hôpitaux Universitaires de Strasbourg, Pôle cardiovasculaire, Stras-
bourg, France
Background: left ventricular ejection fraction (LVEF) is a major predictor
of mortality in coronary heart disease (CHD). In the setting of ST-elevation
myocardial infarction (STEMI), LVEF is indirectly representative of myocar-
dial infarct size. More recently, echocardiography (TEE) allows to investigate
left ventricular strain (2D speckle strain imaging), a new parameter which has
been shown to be more objective and in somehow indicative of LVEF. How-
ever, few data are available concerning the diagnostic value of 2D strain
imaging in STEMI. 
Objectives: here we investigate prospectively, the relationship existing
between 2D strain imaging parameters and LVEF as well with MRI evaluation
of infarct size and microvascular obstruction in a series of STEMI patients
undergoing primary PCI.
Methods: STEMI patients undergoing primary PCI within 6hours of symp-
toms onset were prospectively included. All received IIbIIIa antagonists. TEE
allowed to determine LVEF (Simpson method), wall motion score (WMS),
circumferential, longitudinal, radial and global longitudinal strain
(GLPSSavg). MRI allows estimating myocardial infarct size (late enhance-
ment) and microvascular obstruction (MO).
Results: 65 patients (56.2 ± 11.4 yo) were included. Mean LVEF was
53.6±11% and GLPSSavg was -14.85 ± 3.78 [-24;-6]. MRI infarct size was
19,6±16,1% and MO was 7.4±8.12%. GLPSSavg did not correlate with
LVEF, infarct size and MO. Even though LVEF correlated with peak troponin
I, infarct size and ST-segment regression GLPSSavg did not. However, longi-
tudinal strain imaging has a better the sensibility than wall motion score for
the localisation of the infarcted segment 66 vs 48% (p=0.033).
Conclusion: Whereas longitudinal stress imaging is of help for identifying
infarcted segments, our data do not favour the hypothesis of a correlation
between GLPSSavg and LVFE in patient with STEMI. This discrepancy with
NSTEMI and other CHD deserve further investigations.
© Elsevier Masson SAS. All rights reserved.
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0077
Human embryonic stem cell-derived cardiomyocytes do not alter car-
diac remodeling in a rat model of chronic myocardial infarction 
Sarah Fernandes (1), Anna Naumova (1), Joseph Gold (2), Charles Murry (1)
(1) University of washington, pathology, Seattle, Wa, Etats-Unis –
(2) Geron Corporation, Menlo Park, Etats-Unis
Human embryonic stem cell-derived cardiomyocytes (hESC-CM) are an
attractive potential therapy for heart failure patients. Our lab previously
showed that in an acute myocardial infarction model, hESC-CM injected with
a pro-survival cocktail (PSC) can survive in large number, halt ventricular
remodeling and preserve contractile function. In clinical practice, however,
end stage heart failure patients would benefit most from cell transplantation
therapy. We aimed to evaluate physiological effect of hESC-CM when trans-
planted into a chronic model of myocardial infarction.
Intramyocardial injection of 10x106 hESC-CM with PSC was performed on
nude Sprague Dawley rats, 4 weeks after myocardial infarction procedure. The
left ventricular function of hESC-CM injected rats was evaluated at 1, 2 and 3
months after the cell injection procedure and compared to 3 others control
groups (injected with Serum Free Media, PSC, or non cardiac human cells in
a PSC). We found that the hESC-CM survived to form large grafts in the
chronic infarcts. At 3 months, troponinT and βmyosin heavy chain immun-
ostaining revealed sarcomere organization of the injected human cells,
whereas BrdU labeling confirmed that hESC-CM are still proliferating at this
time point. Despite good engraftment and differentiation, neither echocardio-
graphy nor MRI analyses showed any significant difference in left ventricular
function between these 4 groups at any time point of the study.
Thus, when injected into a scar tissue of a chronic infarct model, hESC-CM
can engraft, survive and differentiate into maturing striated cardiomyocytes as
already observed in acute myocardial infarction studies. However, although
hESC-CM transplantation can attenuate the progression of heart failure in an
acute model, the same hESC-CM injection protocol is insufficient to restore
heart function or to alter adverse remodeling of a chronic myocardial infarc-
tion model.
0212
Expression and functionality of cardiac ionic channels and ionic
transporters in human embryonic stem cell-derived cardiovascular
progenitors 
Elodie Gouadon (1), Patrice Naud (2), Virginie Lambert (1), Michel
Pucéat (3), Jean-François Renaud (1), Sophie Demolombe (4), Catherine
Rücker-Martin (1)
(1) INSERM U999 -CCML -Université Paris Sud , Centre chirurgical
Marie Lannelongue, Le Plessis Robinson, France – (2) INSERM UMR
915 l’institut du thorax , IRT – UN , Nantes Cedex, France – (3) INSERM
Avenir Program Stem cells and cardiogenesis, Avenir Program Stem cells
and cardiogenesis, Evry, France – (4) CNRS UMR6097 , Institut de Phar-
macologie Moléculaire et Cellulaire, Valbonne, France
Identification from human pluripotent stem cells of early cardiovascular
progenitors, at the origin of the first cardiac lineage, would pave the way
toward cell therapy for cardiac degenerative diseases. Recently, M Puceat’s
team reported the identification and isolation, after a 4-day treatment with
BMP2, of an early population of cardiovascular progenitors derived from
human pluripotent stem cells expressing the differentiation marker SSEA1
(SSEA1+). This multipotential progeny features the capability to generate car-
diomyocytes as well as smooth muscle and endothelial cells. However, the
absence of data on the gene expression of ionic channels in these cells raises
the question about the effects of BMP2 on cardiac electrogenesis.
Using a high-throughput quantitative approach, we investigated the expres-
sion of 86 genes encoding ion-channel, transporter subunits and Ca2+-homeo-
stasis molecules in SSEA1+ and SSEA1- cells 48h after sorting. Using one-
way hierarchical clustering analysis, we identified 26/86 transcripts with an
up-regulated expression and 19 with a down-regulated expression in SSEA1+
compared to SSEA1- cells. Among important ion-channel/transporter subunits
KvLQT1, Herg, Cav1.2, Serca2, Serca3, CASQ2 and IP3R3 were up-regulated
while Kv1.5, Kv4.2, Kv4.3, KChip2, Cav3.2 were down-regulated. These
results are in concordance with the identification in 66% of cells of small L-
type Ca2+ currents (2.22±0.30 pA/pF) whereas no T-type Ca2+ currents were
detected,and the presence of depolarization-activated outward K+ currents
(6.79±1.10pA/pF). However, no hyperpolarization-activated inward currents
(IK1) were detected while Kir2.1 appeared up-regulated. SSEA1- cells were
used as negative controls. Although, the presence of Serca2, Kir3.4, TWIK1
and TASK1 validate an orientation of these progenitors towards cardiomyo-
cytes, the up-regulation of CASQ1, PMCA1 and PMCA4 suggest their capa-
bility to generate also endothelial and smooth muscle cells.
0070
Improvement of right ventricular function by cell therapy using car-
diac-committed human embryonic stem cells in a large animal model
of combined overload: first promising results
Virginie Lambert (1), André Capderou (2), Elodie Gouadon (2), Emma-
nuel Lebret (1), Catherine Rücker-Martin (2), Bertrand Stos (1), Nicolas
Raymond (1), Michel Pucéat (3), Alain Serraf (1), Jean-François Renaud
De La Faverie (2)
(1) Centre Chirurgical Marie-Lannelongue, Cardiologie et Chirurgie Car-
diaque Pédiatrique, Le Plessis-Robinson, France – (2) INSERM, Unité U-
999, Le Plessis-Robinson, France – (3) INSERM Avenir Program, Stem
cells and cardiogenesis, Evry, France
 Advances in cardiac surgery have improved short-term prognoses of
patients with congenital heart diseases but, at long-term, right ventricular (RV)
failure may occur, leading to morbidity and mortality. Cell therapy may be a
therapeutic option for cardiac repair. The ability of embryonic stem cells dif-
ferentiation towards a cardiomyogenic phenotype makes them attractive can-
didates. Our aim was to evaluate, in a large animal model, effects of human
cardiac progenitors transplantation on the RV function.
RV dysfunction was created in 6 piglets mimicking RV tract sequellae of
repaired tetralogy of Fallot leading, after 4 months, to a chronic combined RV
overload. 3 pigs received vehicle, 3 others received HUES-24 derived human
cardiac progenitors injected at multiple sites into the free wall of RV myocar-
dium. All pigs were immunosuppressed. Myocardial function was measured 3
months after cell transplantation by conductance catheter technique using max-
imal elastance (Emax) slope and ventricular energetics (stroke work, pression-
volume area). The risk of ventricular arrhythmia was evaluated by pro-
grammed ventricular stimulation at the end of the follow-up. Structural remod-
elling was assessed by histology.
All pigs survived, no complication occurred related to myocardial injec-
tions or immunosuppression. No ventricular arrhythmia was induced. In all
treated pigs, myocardial contractility was improved as assessed by an
increasing Emax slope relative to baseline (0.61±0.02 vs 0.40±0.01, p<0.001)
and to controls at the follow-up end (0.32±0.02, p<0.05). Stroke work was
similar in both groups, pression-volume area tended to increase in the treated
group suggesting that the total energy output was augmented. In treated pigs,
myocardial fibrosis appeared peritrabecular whereas peritrabecular and per-
imyocyte in controls.
Cell therapy in failed RV secondary to chronic overload is feasible,
improves RV myocardial contractility and allows a better adaptation to chronic
overload.
0353
Impact of 3D culture in hyaluronic acid gel on phenotypic plasticity of
mesenchymal stem cells and ability to repair expanding AAAs in rats 
Faiza Mohand Kaci, Mustapha Zidi, Eric Allaire
CNRS EAC 7054, Créteil, France
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Background: Abdominal aortic aneurysms (AAAs) are the chronic
wounds characterized by degradation of extracellular matrix and mesenchymal
cells rarefaction. We have shown previously that endovascular cell therapy
using mesenchymal stem cells (MSCs) promotes aneurysm repair. Capabilities
of MSC) to induce tissue healing may rely on their multilineage differentiation
potential. In vivo transfer of SMCs is made difficult because of poor survival,
when seeded in contact with aortic flow. For pre-clinical validation, we aimed
at developing SMC conditioning in three-dimensional culture (3D) using a
hyaluronic acid (HA) matrix. The aim of this study was to evaluate the impact
of encapsulation in a HA matrix on MSC phenotype, multipotency and ability
to participate to aneurismal healing. 
Methods: MSCs from male Fischer 344 rats were isolated by plastic adhe-
sion, and amplified to passage 4. MSCs were then cultured in parallel in 2D
and 3D. At different time points, MSC phenotype and function were assessed
by FACS, induction of differentiation. 
Results: Best MSC growth was obtained in gel reticulation conditions to
obtain a 20µm pore size. In 3D culture, MSC formed a cellular network. FACS
analysis showed similar patterns for most cell surface marker expression:
absence of hematopoietic (CD11b, CD34 et CD45) and endothelial (CD31 et
CD34) markers, expression of CD90 et CD73, characteristic of MSCs in 2D
culture. However, CD166 and CD105 were negative in 3D. MSC proliferation
was rapidly inhibited in 3D, in comparison to 2D on plastic dish or after
coating with a thin layer of HA in 2D (P=0.02). This suggested MSC quies-
cent in 3D culture. MSCs showed better osteogenic and adipogenic plasticity
in 3D than 2D culture. The injection of 2D cultured MSCs stabilized the diam-
eter of expanding AAAs in rats, in comparison to addition of culture medium
with no cell (P=0,005). Currently, we test the ability of 3D cultured MSCs to
stabilize AAAs. 
Conclusion: Our preliminary data indicate that the 3D HA hydrogel pre-
serves most of MSC properties. The 3D culture may allow to understand better
MSC stabilizing properties in aneurysms. 
0231
Focal non-viral gene transfection of ventricular cardiomyocytes with
HCN1-HCN2 channels generates ventricular pacemakers in a mouse
model of complete atrioventricular block
Cynthia Oré Cerpa (1), Jérôme Montnach (1), Agnès Hivonnait (1), Emilie
Goudeau (2), Bruno Pitard (1), Flavien Charpentier (1)
(1) INSERM UMR 1915, Nantes, France – (2) Incellart, Nantes, France
Our aim is to engineer bio-artificial cardiac pacemakers by in vivo non-
viral gene transfer. We have shown that focal injection of plasmids coding the
pacemaker channel Hcn2 and the β2-adrenoceptor (Adrb2) mixed with tetronic
614, a poloxamine block copolymer, could generate ventricular pacemakers in
mice in complete atrioventricular block (CAVB), that were 40% faster than
those in sham mice (non-coding plasmid).
The present study was designed to improve the efficiency of our pace-
makers in order to accelerate further the ventricular automatic rhythms. Based
on the differences between Hcn1 and Hcn2 isoforms, we engineered a
pcDNA3-plasmid coding a Hcn1-Hcn2 fusion protein. Plasmids coding Hcn1-
Hcn2 and Adrb2 mixed with tetronic 614 were injected focally in the left ven-
tricular free wall 7 days before CAVB obtained by radiofrequency ablation of
the AV node.
Hcn1-Hcn2 channel activated faster and at more positive voltages than
Hcn2 (half-activation at -61±3 mV and -75±4 mV, respectively). Five days
after CAVB induction, ventricular escape rhythms were faster in Hcn1-Hcn2/
Adrb2 mice (RR=231±13 ms; n=4) than in sham mice (RR=346±49 ms; n=4).
This difference persisted over time: 15 and 25 days after ablation, escape
rhythms were 57% and 37% faster respectively in Hcn1-Hcn2/Adrb2 (RR of
249±14 ms and 263±17 ms) than in sham mice (RR of 392±54 ms and 361±25
ms). These rhythms were also faster than in Hcn2/Adrb2 mice. Hcn1-Hcn2/
Adrb2 mice were characterized by abnormal QRS axes and longer QRS inter-
vals than sham mice (16±1 ms vs 11±1 ms at day 15) suggesting a left ven-
tricular origin in contrast to a septal origin in sham mice. The β-adrenergic
agonist isoproterenol (40 µg/kg ip) increased ventricular rhythms more in
Hcn1-Hcn2/Adrb2 mice (+43±3%) than in sham mice (+29±6%).
To conclude, non-viral in situ transfection of cardiomyocytes with Hcn1-
Hcn2 channels generate cardiac pacemakers beating faster than those gener-
ated by Hcn2 alone and regulated by sympathetic input.
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The ongoing MESAMI translational research program
Jérome Roncalli (1), Joffrey Pozzo (1), Philippe Bourin (2), Céline
Mias (3), Daniel Cussac (3), Olivier Lairez (1), Michel Galinier (1), Jean-
Noël Trochu (4), Patricia Lemarchand (4), Angelo Parini (3)
(1) CHU Rangueil, Pôle cardio-vasculaire et métabolique, Toulouse,
France – (2) Etablissement Français du Sang Midi-Pyrénées, Toulouse,
France – (3) INSERM U858, Toulouse, France – (4) Institut du Thorax,
Nantes, France
Background: Despite the improvement of pharmacological and surgical
therapies, the mortality related to ischemic heart failure remains high. During
the last years, bone marrow-mesenchymal stem cell (BM-MSC) therapy has
been proposed as a novel approach for the prevention and therapy of heart
failure. Intramyocardial injection allows concentrating grafted cells within the
injured zone. However, a major problem of intraparenchymal route of admin-
istration is the early death of most of grafted cells.
Purpose: The goal of the MESAMI program is to evaluate the effect of
intramyocardial administration of BM-MSC preconditioned or not with the
pineal hormone melatonin in ischemic cardiomyopathy.
Methods and Results: Our preclinical investigations have designed a pre-
conditioning strategy of BM-MSCs with the melatonin that significantly
increases survival and efficiency of grafted cells in animal models of myocar-
dial ischemia. Melatonin treatment significantly ameliorates the beneficial
effects of BM-MSC on the recovery of cardiac function. In the mean time, our
program started with a phase I clinical trial using the NOGA XP system to
guide injections into the myocardium in patients with severe ischemic cardi-
omyopathy and no option of revascularization. Based on our basic research
results, we are developing a multicenter phase II trial on the effects of
intramyocardial administration of melatonin-preconditioned BM-MSC in
patients with chronic ischemic cardiomyopathy. 
Conclusion: The ongoing MESAMI program is representative of a transla-
tional research program in France. 
0063
Blockade of aortic aneurysmal formation and expansion by local cell
therapy using mature endothelial cells
Grégory Franck, Jianping Dai, Stéphanie Michineau, Saravuth Ngo, Anne-
Marie Guinault, Eric Allaire, Marianne Gervais
CNRS EAC 7054, Creteil, France
Background: Destruction of the endothelium and its replacement by a
mural thrombus is a common structural feature of human abdominal aortic
aneurysms (AAA). Since endothelial dysfunction is a prerequisite to thrombo-
formation and since the thrombus participates in AAA evolution, we hypothe-
size that restoration of a functional endothelium by cell therapy would
stabilize AAA. Our goal was to study the impact of local seeding of mature
endothelial cells on AAA evolution in rats.
Methods and results: Rat aortic endothelial cell (RAEC) cultures were
established from male Fischer rat thoracic aortas. Preventive or stabilizing effect
of RAEC on AAA formation was evaluated in the xenograft model in rats. 5.106
RAEC (n=16) or 200µl of medium (control, n=14) were seeded endovascularly
either immediately (D0, prevention) or 14 days (D14, stabilization) after surgery,
i.e., on already-formed AAA. Animals were sacrificed 7 (prevention: D0+7; sta-
bilization: D14+7) or 28 (prevention: D0+28) days after cell therapy. In vivo,
local RAEC seeding prevents AAA formation (diameter increase at D0+7: 22±2
vs 35±3% and D0+28: 49±6 vs 81±6% in RAEC and control rats, respectively,
both p<0.05). This effect is associated with the preservation of medial elastin
content (41±4 vs 17±2% in RAEC and control rats, p<0.01), the formation of a
collagen, elastin and VSMC-rich neointima (number of VSMC: 6.103±4.102 vs
3.103±6.102 cells in RAEC and control rats, p<0.01), the decrease in inflamma-
tory cell infiltrate, MMP-dependant proteolysis and adventitial angiogenesis
(number of neovessels /mm2: 67±4 vs 123±7 in RAEC and control rats, p<0.05)
and the restoration of a luminal endothelium. Hence, local RAEC delivery sta-
bilizes already-formed AAA in rats (diameter increase at D14+7: 0.8±2.8 vs
13.1±3.5% in RAEC and control rats, p<0.05).
Conclusion: Endovascular cell therapy using mature endothelial cells pre-
vents AAA development and stabilizes already-formed AAA in rats.
© Elsevier Masson SAS. All rights reserved.
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TOPIC 33 – Valvular heart diseases, aortic
stenosis
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Clinical and echographic characteristics of a population of severe aor-
tic stenosis with preserved ejection fraction
Jérôme Adda (1), Christopher Mielot (2), Frédéric Cransac (1), Yvan Le
Dolley (2), Adrien Salem (2), Sébastien Ansaldi (2), Franck Thuny (2),
Jean-François Avierinos (2), Sébastien Renard (2), Catherine Sportouch-
Dukhan (1), Erwan Donal (3), Gilbert Habib (2)
(1) Hôpital Arnaud de Villeneuve, Cardiologie B, Montpellier, France –
(2) CHU La Timone, Cardiologie B, Marseille, France – (3) CHRU Pont-
chaillou, Cardiologie, Rennes, France
Background: Assessment of aortic stenosis (AS) can be challenging, espe-
cially in presence of a low flow and / or a low gradient. We sought to deter-
mine the incidence, characteristics, and left ventricular (LV) function of a
population of AS depending on gradient and flow.
Methods: We prospectively studied 234 patients with a severe AS, defined
by an aortic valve area (AVA) ≤ 0.6 cm2/m2, and LVEF ≥ 50%. We performed
2D-strain imaging and midwall fractional shortening (MWFS) to assess LV
systolic function. Global afterload was evaluated by valvulo-arterial imped-
ance (Zva). Four groups were defined depending on flow and gradient: low
flow was defined as a stroke volume index (SVi) ≤ 35 ml/m2, and low gradient
as a mean gradient (MG) ≤ 40 mmHg.
Results: Group 1 included 166 (70.9%) patients with normal flow and high
gradient. They were characterized by severe AS (AVA=0.43 ± 0.08 cm2/m2)
and normal Zva (4 ± 0.7 mmHg/ml/m2). Global longitudinal strain (GLS) was
-16.5 ± 3.5%. 
Group 2 included 24 Patients (10.3%) with low flow and high gradient.
They presented with the most severe AS (AVA=0.26 ± 0.05 cm2/m2), high Zva
(6.4 ± 1 mmHg/ml/m2) and lower systolic function assessed by 2D-strain
(GLS= -13.4 ± 2.7%) and MWFS.
Group 3 included 16 patients (6.8%) with low flow and low gradient. They
were older than the other patients. AS severity was intermediate between the
2 previous groups (AVA=0.40 ± 0.08 cm2/m2). They presented with high Zva
and preserved strain and MWFS. 
Group 4 included 28 patients (12%) with normal flow and low gradient.
They presented with the less severe form of AS (highest AVA 0.5 ± 0.07 cm2/
m2), normal Zva and systolic function. 
Conclusion: Patients with severe AS and preserved LV function can be
separated into 4 groups, depending on their stroke volume and transvalvular
gradient. These 4 groups present with very different characteristics, notably
strain and Zva. Further studies are required to evaluate the prognostic signifi-
cance of these findings.
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Balloon aortic valvuloplasty in unstable and critically ill patients: ana-
lysis of three strategies
Vincent Audigier, Gilles Rioufol, Guy Durand De Gevigney, Jean-Fran-
çois Obadia, Eric Bonnefoy-Cudraz, Nathan Mewton, Gerard Finet
Hôpital cardiologique Louis Pradel, département de cardiologie et car-
diologie interventionnelle, Lyon, France
Aim: Thanks to improved technology and the advent of transcatheter aortic
valve implantation (TAVI), balloon aortic valvuloplasty (BAV) has reappared
in the management of high risk patients with severe aortic stenosis in a critical
clinical state in three different therapeutic strategies: 1) palliative care [A], 2)
bridge to surgery [B], 3) bridge to TAVI [C]. Our main objective was to assess
the safety, the effiency and the pertinence of BAV.
Methods: Thirty six patients with severe aortic stenosis and prohibitive
surgical risk (logistic Euroscore >15% or severe commorbidities) underwent
39 BAV: 8 in strategy A, 20 in strategy B, 11 in strategy C; 3 patients under-
went a second BAV due to early restenosis.
Results: There was a significant improvement of the hemodynamic param-
eters after BAV: the peak to peak transaortic gradient was reduced by 56%
(47mmHg vs 30mmHg; p<0.001) and index valve area was increased by 48%
(0.35 vs 0.52 cm2/m2; p < 0.001). There was no severe procedural complica-
tion (no death due to procedure, no massive aortic insuffisiency, no tam-
ponade). Two patients (5.1%) needed a pacemaker implantation for
postprocedure atrioventricular block and 6 patients (15.4%) had moderate
bleeding of the femoral artery site. The mortality and follow up for the three
strategies are summarized in the table.
Conclusion: BAV is a safe and efficient transient therapeutic strategy for
patients with severe aortic stenosis with prohibitive surgical risk. BAV appears
to be more pertinent in bridge to surgery or brige to TAVI than in palliative
care. For patients in critical clinical state, BAV stabilizes the hemodynamic
status and allows the assessment of anatomical selection criteria for TAVI
0380
Immediate Results of Percutaneous Balloon Aortic Valvuloplasty with
the updated Technique in a Highly Experienced Center
Karim Bejar (1), Mathieu Godin (1), Bogdan Borz (1), Ali Farhat (1),
Akira Furuta (1), Jean Sébastien Mallet (1), Carlos Sanchez Giron (1),
Christophe Tron (1), Brahim Baala (2), Hélène Eltchaninoff (1), Alain
Cribier (1)
(1) CHU Rouen, Cardiologie, Rouen, France – (2) CHG Elbeuf, Elbeuf,
France
Management of aortic stenosis in elderly patients, especially when associ-
ated with complex comorbidities, has become an important issue. For these
higher surgical risk patients, the role of percutaneous balloon aortic valvulo-
plasty (BAV) remains discussed. Over the last years, improvements in tech-
niques and hardware have made the procedure more efficient, fast and safe.
We report the immediate results of BAV using an updated technique.
From January 2005 to December 2008, 323 patients underwent BAV in our
center: 44% were women and mean age was 80 ± 10 years. Mean Euroscore
was 18.3±12.6%. BAV is performed under local anesthesia using the percuta-
neous retrograde approach. Through a 10 sheath, 20, 23, or 25mm size bal-
loons are advanced to the native valve over an extra-stiff wire. The goal is to
increase the effective orifice area (EOA) by near 100% and decrease the mean
gradient to < 25mmHg. Rapid right ventricular pacing (180 to 220bpm) is sys-
tematically used during balloon inflation. Percutaneous closure of the femoral
approach is obtained with Angioseal / Perclose.
The indications for BAV were as follows: bridge to AVR in severely
depressed ventricular function (n=33), urgent BAV before non cardiac surgery
(n=37), urgent BAV for cardiogenic shock (n=49), bridge to transcatheter
valve implantation (TAVI) (n=121) and compassionate (n=83). EOA increased
from 0.68±0.24 to 1.12±0.39cm2 (p<0.001) and mean gradient decreased from
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 Stratégy A 
(n=8)
Stratégy B 
(n=20)
Stratégy C 
(n=11)
Age (mean, min-max) 80 (61-94) 73 (44-85) 81 (60-87)
Mean logistic Euroscore 
(%)
48 22.6 44.2
Death n (%) 6 (75) 8 (40) 5 (45)
Cardiovascular death n 
(%)
4 (50) 3 (15) 2 (18)
Time of occurrence 
(days, min-max)
12 (0-47) 66 (0-130) 155 (10-316)
Aortic valve replacement 
n (%)
- 14 (70) -
TAVI n (%) - - 2 (18)
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44±19 to 20±11mmHg (p<0.001). Early in-hospital mortality rate was 3.4%
(n=11). Twenty one patients (6.5%) had non fatal in-hospital complications:
surgical vascular complication (6 Pts; 1.8%), TIA or stroke (6 Pts; 1.8%),
acute aortic regurgitation ≥ grade3 (5 Pts; 1.5%) and complete A-V block (4
Pts; 1.2%). 
BAV has become much simpler and safer. This technique remains indi-
cated in various situations, with an emerging indication in highly symptomatic
/ life threatened patients on the waiting list for TAVI.
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Activation of the tissue factor – thrombin pathway in aortic valve
disease: potential role in valve mineralization
Joke Breyne (1), Francis Juthier (1), Delphine Corseaux (1), Sylvestre
Marechaux (1), Christophe Zawadzki (1), Emmanuelle Jeanpierre (1),
Pierre-Vladimir Ennezat (1), Hervé Le Marec (2), André Vincentelli (1),
Brigitte Jude (1), Thierry Le Tourneau (2)
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Background: We recently demonstrated in an experimental model the
expression of tissue factor (TF) in aortic valves. We hypothesized that TF
might play an important role in aortic valve stenosis through thrombin gener-
ation. Thrombin has been shown to cleave osteopontin (OSP), thereby
releasing the pro-inflammatory OSP N-half.Hence, the aim of the present
study was to evaluate the expression of TF, thrombin, OSP and OSP N-half in
calcified human aortic valves.
Methods: Fifty two calcified aortic valves were obtained from patients
undergoing valve replacement (31 men; age 70±10 years). TF, OSP, OSP N-
half and thrombin expression were measured using ELISA kits. Transcripts
were analyzed by RT-PCR. We finally examined TF expression and thrombin
generation in cultured valve interstitial cells.
Results: There was an overexpression in calcified regions as compared to
non calcified zones of TF (733.3±70.5 vs 429.4±73.2 pg/mg), OSP
(88.9±12.7 vs 15.0±3.3 ng/mg) and OSP N-half (0.41±0.06 vs 0.056±0.011
pmol/mg). Additionally, both TF and thrombin expression were associated
with OSP N-half (r=0.52;p<0.0001 and r=0.33;p=0.019, respectively). The
in vitro experiments on cultured valve interstitial cells confirmed these find-
ings.
Conclusions: Aortic leaflet TF and α-thrombin expression and their asso-
ciation with the thrombin-cleaved form of OSP, is a new and important feature
of human aortic valve stenosis. We hypothesize that TF may be involved in
the mineralization process of aortic valves by enhancing the generation of the
pro-inflammatory OSP N-half through thrombin induction. This new pathway
could provide novel treatment perspectives in aortic stenosis.
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Background: In the setting of low-flow/ low-gradient aortic stenosis
(LGAS), outcome data regarding patients with pseudo-severe AS are scarce
and the clinical relevance of this concept has been debated. 
Methods and Results: Outcome data from 84 consecutive patients with
LGAS who were followed under conservative treatment were analyzed. Based
on the results of Dobutamine echocardiography, patients were divided in
Group IA (true severe AS, n=37), Group IB (pseudo-severe AS, n=20) or
group II (no left ventricular contractile reserve, n=27). The 24-months mor-
tality rate was significantly lower in Group IB (35%, p=0.02 versus other
Groups), as compared to Group IA (62%) and Group II (74%). Accordingly,
follow-up duration was significantly longer in group IB (27 months [18-54],
p=0.002 versus other Groups) as compared to Group IA (15 months [3-42])
and Group II (7 months [5-16]). Cox proportional hazard models analysis
demonstrated that the Hazard Ratio for death in Group IB remained signifi-
cantly lower than in the other Groups, even after adjustment for currently
established risk factors in LGAS.
Conclusions: In contrast to previous studies, we found that 2-year mor-
tality in patients with pseudo-severe AS was fairly comparable to the expected
mortality rate among patients with primary cardiomyopathy and similar degree
of LV systolic dysfunction. Therefore, our results provide direct evidence that
the distinction between true severe and pseudo-severe AS is clinically relevant
the setting of LGAS, in order to select the best therapeutic option for each
individual patient.
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implantation. A simplified technique using local anesthesia and exclu-
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Background: Percutaneous aortic valve replacement (PAVR) emerged in
2002 as a therapeutic alternative for patients (Pts) with severe symptomatic
aortic stenosis (AS) who are poor candidates for surgical aortic valve replace-
ment. More than 10 000 Pts have been treated worldwide with the Edwards or
the Corevalve bioprosthesis. General anesthesia and TEE guidance are used in
the majority of centers.
Objective: To evaluate the early results and 30-day outcome of Pts with
severe AS treated by trans-femoral (TF) Edwards Sapien PAVR using a sim-
plified technique. 
Methods: 75 Pts with severe symptomatic AS were included in our center
from April, 2006 to December, 2009 as part of the REVIVE and PARTNER
multicentric trials and post-marketing SOURCE registry. All procedures were
performed under local anesthesia and sedation, without TEE guidance. Fem-
oral artery was cutdown and sutured surgically at the end of the procedure.
Implantation was performed under rapid pacing using calcifications on fluo-
roscopy for valve positioning. All Pts had clinical and echographic follow-up
at one-day, one week, and one month. 
Results: Mean age was 83 + 5.9 years and 54.8% were female. Logistic
Euroscore was 27.6 + 11.5%. A 23-mm or 26-mm valve was implanted in
45% and 52% of Pts respectively. Mean aortic valve area (AVA) increased
from 0.66 + 0.15 to 1.79 + 0.21 cm2 and mean gradient decreased from 41.7
+ 14.9 mm Hg to 9.8 + 2.6 mm Hg. There was no valve embolization. There
were 2 procedural deaths (2.6%): iliac artery rupture and aortic rupture during
predilatation. There was one stroke (1.3%) and grade 3 aortic regurgitation
was noted in 5.4% (4 Pts). One Pt had tamponade. Five Pts required perma-
nent pacing (7.2%). Overall 30-day mortality was 9.3%.
Conclusion: Edwards Sapien aortic valve implantation using surgical cut-
down under local anesthesia for TF approach and fluoroscopy guidance for
accurate valve positioning appears safe in our experience. The rate of severe
vascular complication is particularly low (1.3%) using surgical cutdown and
closure.
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Background: Percutaneous aortic valve replacement (PAVR) emerged in
2002 as a therapeutic alternative for patients (Pts) with severe symptomatic
aortic stenosis (AS) who are poor candidates for surgical aortic valve replace-
ment. More than 10 000 Pts have been treated worldwide with the Edwards or
the Corevalve bioprosthesis. 
Objective: To evaluate the mid-term outcome of Pts with severe AS
treated by Edwards Sapien PAVR using the trans-femoral (TF) and the trans-
apical (TA) approach. 
Methods: 105 Pts with severe symptomatic AS were included in our center
from April, 2006 to December, 2009 as part of the REVIVE and PARTNER
multicentric trials and post-marketing SOURCE registry. Implantation was
performed under rapid pacing using calcifications on fluoroscopy for valve
positioning. For TF approach, surgical cutdown was performed in all under
local anesthesia. All Pts had prospective clinical and echographic follow-up. 
Results: Mean age was 82.8 + 7.1 years and 46.7% were female. Logistic
Euroscore was 28.7 + 13.2%. Procedural success rate was 98.1%. TF and TA
approach were used in 72.4% and 27.6% respectively. A 23-mm or 26-mm
valve was implanted in 43% and 55% of Pts respectively. Mean aortic valve
area (AVA) increased from 0.68 + 0.16 to 1.79 + 0.22 cm2 at day 7 and mean
gradient decreased from 39.6 + 14.1 mm Hg to 9.8 + 3.4 mm Hg. These
parameters remained unchanged at 2 years (1.79 ± 0.16 cm2 and 10.1 ± 3.0
mmHg). Maximum follow-up is near 4 years and 39 Pts reached the 2 year
follow-up with good clinical status (NYHA class 1.4 ± 0.5 as compared to
3.1 ± 0.6 before PAVR). Overall 1 year survival is 81.9%.
Conclusion: PAVR using the Edwards-Sapien valve for Pts with non oper-
able severe AS via the TF and the TA approach shows good long term clinical
and echographic results.
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Preliminary results of feasibility of self- monitoring system of oral
anticoagulation in a French population with mechanical heart valve:
the 4A study STIC 2006
Raymond Roudaut, Aude Mignot, Christel Duprat
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Introduction: Vitamin K antagonists are associated with bleeding compli-
cations, which represent the most important of iatrogenic complications. The
4A study supported by the French Ministry of health was designed to evaluate
the medico and economical impact of INR self-monitoring systems in patients
who recently underwent mechanical heart valve, by comparing them with stan-
dard laboratory methods.
Methods: In this multicenter (24 centres) randomized prospective and open
study, patients were enrolled based on a single or multiple mechanical valve
replacement. Patients were randomly allocated to one of two groups: Group 1:
standard INR monitoring once a month in the laboratory. Group 2: home INR
self-monitoring once a week, with standard INR monitoring once a month.
Patients were seen at the department of cardiology at the 6th week and by the
liberal practice at 6th and 12th month. A follow-up screening for each patient
was carried out after 12 months. The ability for patient to realize INR self-
monitoring was evaluated each following visit. 
Preliminary results: A total of 890 patients were included in this study,
293 in group 1 and 597 in group 2. Demographic characterization was similar
in both groups. No significant difference was observed between the two
groups in term of prosthetic valves. Global follow-up in both groups was very
obtained in 95% of patients. Feasibility of INR self-monitoring was also good
with 94% of patients in group 2. Quality of life and degree of satisfaction of
patients with home INR self-monitoring was superior in group 2. 
Conclusion: This is the first French multicenter prospective study in a
large population which addressed the issue of the interest and safety of man-
agement of patients with prosthetic valves based on INR self-monitoring.
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Background: Transcatheter aortic valve implantation (TAVI) appears as
an alternative therapeutic for patients with symptomatic severe aortic stenosis,
and considered at high risk or inoperable by conventional surgery. The Core-
valve implantation seems to be associated with a higher level of conduction
disorders. The aim of this study was to determine the incidence and predictors
of severe atrioventricular conduction disorders requiring permanent pacemaker
implantation.
Methods: All patients undergoing TAVI in Henri Mondor hospital were
included in a prospective registry. Pre-implantation clinical, electrocardio-
graphic and echographic data were tested in uni and multivariate analysis to
determine those associated with a permanent pacing requirement.
Results: Between December 2007 and September 2009, 45 patients with
severe symptomatic aortic stenosis were recruited. Mean age was 84+/-7 years
.and mean logistic Euroscore was 27%. At baseline, twelve patients (26.6%)
had already pacemaker and were excluded. On the remaining thirty three
patients,15 (48%) had severe atrioventricular disorders requiring permanent
pacemaker Among them, 13 had complete atrioventricular block, one alterna-
tive block and one Mobitz 2 block. A new left bundle branch block appeared
in 11 (46%) patients; and QRS duration increased from 103 to 134 ms after
the procedure. Predictors for permanent pacemaker requirement were pre-
existing left axis deviation (p<0.002), pre-existing right bundle branch block
(p<0.007) and a too low Corevalve implantation (p<0.03)
Conclusion: The Corevalve implantation is associated with a high inci-
dence of severe atrioventricular disorders requiring a permanent pacemaker in
nearly 50% of cases. The knowledge of predictors would participate to
improve results of TAVI.

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TOPIC 34 – mitral valve diseases and
endocarditis
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Background: Percutaneous mitral commissurotomy (PMC) is a widely
used technique, but results have not been reported at 20 years.
Methods: Follow-up (FU) concerned 1024 consecutive patients (pts) who
underwent PMC between 1986 and 1995. Mean age was 49±14yrs; 787 pts
(77%) were in NYHA class III or IV, 408 (40%) were in atrial fibrillation, and
163 pts (16%) had a history of commissurotomy. Echocardiography showed
that 141 pts (14%) had pliable valves and mild subvalvular disease, 569 (55%)
had extensive subvalvular disease, while 314 (31%) had calcified valves. A
single balloon was used in 26 pts, a double balloon in 390, and the Inoue bal-
loon in 608. Good immediate results defined as valve area (VA) ≥1,5cm2
without mitral regurgitation >2/4, were obtained in 912 pts (89%). Procedural
mortality was 0.4% (4 patients).
Results: FU was completed in 854 pts (83%). During a median FU of 111
months, there were 143 deaths (87 of cardiac origin) and 417 interventions on
the mitral valve: 299 valve replacements (isolated or combined with other pro-
cedures), 33 valve repairs, and 85 repeat PMCs. 
Twenty-year overall survival was 75±2%. At 20 years, good functional
results, defined as survival without cardiovascular death, without operation
and in NYHA class I or II, were observed in 30±2% of all pts and in 33±2%
of the 912 patients with good immediate results.
A multivariate Cox model identified 8 predictors of good functional results
after good immediate results: young age (p<0.0001), female sex (p=0.009),
NYHA class I or II (p=0.001), sinus rhythm (p=0.005), no previous commis-
surotomy (p=0.005), favourable valve anatomy (p=0.0009), low mean gradient
(p<0.0001) after PMC, and large VA (p<0.0001) after PMC. 
Conclusion: After 20 years, 30% of patients still derive a functional ben-
efit of PMC in a large and varied population. The identification of predictive
factors of good functional results provides useful information for patient selec-
tion and follow-up. These findings emphasise the wide applicability of PMC. 
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Purpose: There is a paucity of data regarding consequences of mitral
stenosis (MS) on respiratory function and exercise capacity. In view of fre-
quent discrepancies between symptoms and anatomy in MS, identification of
determinants of aerobic capacity could be useful in the clinical-decision
making process. Our objective was to evaluate the role of cardiac and pulmo-
nary alterations on aerobic capacity in MS. 
Methods: Twenty-eight patients (53±7 y) with history of MS were pro-
spectively included. A comprehensive echocardiography was performed at rest
and during exercise. Right ventricular (RV) systolic function was assessed
with tricuspid lateral annulus S wave velocity (STric). Respiratory function
was assessed at rest with measure of transfer of carbon monoxide (DLCO).
We analyzed the two components of DLCO: membrane diffusion (DM) and
capillary volume (VCAP). Maximal oxygen uptake (VO2max) was determined
during cardio-pulmonary exercise test.
Results: Ten patients were examined before (native MS group) and 18
after corrective treatment (treated MS group). The mitral valve functional area
(MVA) was 1.3±0.3 cm2 in native MS group and 1.6±0.1 cm2 in treated MS
group. Overall, NYHA class was 1.8±0.3, VO2max 18±3 ml/kg/min, maximal
workload 85±13 Watts. There were no differences between groups in NYHA
class, maximal workload, VO2max, trans-mitral and trans-tricuspid gradients
and DLCO. DM and VCAP were impaired in patients with a history of MS.
In univariate analysis determinants of VO2max were gender (r=0.6, p=0.001),
DM (r=0.65, p=0.04), VCAP (r=0.69, p=0.001), exercise cardiac output
(r=0.52, p=0.03), and exercise STric (r=0.56, p=0.008). In multivariate anal-
ysis, independent determinants of VO2max were exercice STric (r=0.55,
p=0.005) and VCAP (r=0.46, p=0.01). 
Conclusion: DM and VCAP are impaired in MS. RV contractile reserve
and VCAP are the main determinants of aerobic capacity in MS. Theses
parameters could be used in the clinical-decision making process in MS.
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Objective: To identify predictors of operative mortality and long term sur-
vival after mitral valve repair in organic mitral regurgitation (MR) due to flail
leaflets and its long term results. 
Methods: Between 1991 and 2009, 335 consecutive patients with severe
MR due to flail leaflets had mitral valve repair. Mean age was 65+-10
years, 57% of patients were in class 3-4 NYHA, ejection fraction (EF) was
67%+/-9.
Results: Perioperative mortality was 2.6% and decreased between the first
and the second decade respectively from 4.8 to 1,1% (p=0.038). Late mortality
was 12.2% (excluding perioperative mortality).10 years overall survival was
77%+/-3. Predictors of perioperative mortality were presence of coronary dis-
ease, lower EF and dilated left ventricular end systolic diameter (LVESD).
Preoperative EF was independently associated with better survival. (HR: 0.9
CI: 0.8 to 0.99 p=0.02)). Predictors of overall mortality were older age, NHYA
3-4 functional class, presence of coronary disease, atrial fibrillation, lower EF
and elevated Charlson’s score and Euroscore. NYHA Class 1 – 2 (HR: 2.2 CI:
1.09 to 4.5 p=0.028), lower euroscore (HR: 1.16 CI:1.08 to 1.25 p=0.001) and
higher EF (HR: 1.03 CI:1.01 to 1.05 p=0.012)were independently associate
with better survival. 
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1 year after surgery 96% of patients were asymptomatic. LVEDD and EF
decreased (respectively from 61+/-6 mm to 53+/-6 mm, p=0.001 and from
67%+/-9 to 58+/-10, p=0.001), whereas LVESD was stable (37mm+/-1 to
36+/-6, p=0.154). 
10 years follow up was effective in 95% of patients. At 10 years, reoperation
rate was 6%; mitral regurgitation rate (> 2/4) was 18,4% and decreased from
23.5% during the first decade to 12.6% during the second decade( p=0.043) ; re-
hospitalization rate for heat failure was 10%, endocarditis rate was 3,6%; major
bleeding events was 3,6%, thromboembolic events was 8,6%.
Conclusion: Short and long term results of mitral valve repair in our center
are good (low peri-operative mortality and the low re-operation rate). Indepen-
dent predictors of overall mortality were preoperative class 3-4 NHYA, low
EF and comorbidities. 
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Characteristics and prognosis of patients with infective endocarditis
associated with spondylodiscitis
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Background: Association between spondylodiscitis (SP) and infective
endocarditis (IE) has not been well described. Therefore, characteristics and
prognosis of patients with an IE associated with a SP remain unknown.
Objectives: -To analyse clinical, echocardiographic and microbiological
characteristics and prognosis of IE associated with spondylodiscitis -To deter-
mine predictive factors of occurrence of SP in patients with IE.
Methods and results: 418 patients with definite IE according to the Duke
criteria were prospectively enrolled in our database. SP was found in 22
patients [S.bovis (59%), Enterococcus (18%), Streptococcus milleri (5%), Sta-
phylococcus aureus (9%), Staphylococcus coagulase negative (9%)]. We com-
pared patients with IE without associated SP (n=396) to 22 patients (5,3%)
with IE and SP. Aortic valve IE (77% v 54%; p=0.035), Streptococcus IE
(63% v 38%; p=0.017), Streptococcus bovis IE (59% v 16%; p<0,001) were
more frequently observed in patients with associated SP (n=22) whereas pros-
thetic valve IE (0 v 16%; p=0.034) and history of valvular heart disease (23%
v 48%; p=0.023) were less frequent. Delay between the onset of symptoms
and the diagnosis (70±55 days v 34±53 days; p=0.002) and mean time hospi-
talization (45±29 days v 34±22 days; p=0.029) were significantly longer in
patients with IE and SP. Two independent predictive factors of association
between SP and IE were found: S.bovis IE (OR 8.17 [3.2-20.8]; p<0.001) and
delay between the onset of symptoms before diagnosis (OR 1.006 [1.001-
1.012]; p=0.024). In hospital mortality and 1-year mortality were similar in the
2 groups.
Conclusion: SP was identified in 5% of IE and was more frequently found
in case of Streptococcus bovis IE. The occurence of SP does not affect hos-
pital mortality and 1-year mortality. These results suggest to perform an
echocardiography in cases of SP when blood cultures identified a Strepto-
coccus (especially S.bovis), a Staphylococcus or an Enterococcus.
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Introduction: The management of patients with mitral stenosis has been
modified by the development of percutaneous mitral commissurotomy (PMC)
whose safety and efficacy have been demonstrated in a number of studies. The
aim of our study is to report the experience of our team in PMC and to study
the immediate results of this technique. 
Materials and methods: Our study has compiled 90 cases of PMC per-
formed in Ibn Rochd center of cardiology from January 2008 to September
2009. All patients were evaluated clinically. Two-dimensional echocardio-
graphy was performed before and after the procedure, transoesophageal
echocardiographic was performed in all patients.We included all patients
admitted to the hospital with symptomatic mitral stenosis (mitral valve area
less than 1.5cm2), with a favorable valve anatomy, a mitral regurgitation ≤
grade II, and no image of intra-atrial thrombus in transoesophageal echocar-
diographic. 
Statistical analysis was performed on Epi-Info 6.0 fr. The Chi2 test was
used. A difference was considered statistically significant if p <0.05. 
Results: The mean age of our patients was 36.5 ± 9.4 years, with a
female predominance (82.5% vs 17.5%). Two patients were pregnant (gesta-
tional age was 25 weeks) . On admission, 64% of the patients were in
NYHA functional class II , the mean heart rate was 75.6 ± 13.2 bpm and
65% were in normal sinus rhythm. The mean area of the left atrium was 31.6
± 6.6 cm2, a right ventricular systolic dysfunction was observed in 17.2%.
Commissurotomy was performed using the Inoue technique in all patients.
PMC was successful in all patients, resulting in a significant increase in
mitral valve area from 1.02 ± 0.21 to 1.96 ± 0.17 cm2 (p=0.0002) and a sig-
nificant decrease in the mean mitral gradient from 15 ± 6.29 to 5.4 ± 3.12
mmHg (p <0.001). The Systolic pulmonary artery pressure has declined sig-
nificantly from 55.2 ± 20.7 to 32.5 ± 11.2 (p=0.0005). The appearance of
mitral regurgitation was observed in 6 patients and a worsening was
observed in 16 patients did not exceed grade II. One patient developed car-
diac tamponade. 
Conclusions: Since its introduction, PMC has become the procedure of
choice for isolated, uncomplicated mitral stenosis with favorable morphology.
In our series, the immediate results obtained joining the data of many series
reported in the literature. 
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rurgie Cardiovasculaire, Paris, France – (3) John Hopkins University,
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Background: Changes in mitral valve (MV) elasticity or distensibility
occur in disease and directly affect MV function, contributing to MV prolapse
(MVP) or flail vs restricted coaptation of stiffer leaflets in functional mitral
regurgitation (FMR) and MV stenosis (MS). Recent studies suggest MV dis-
Caractéristiques de la population
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tensibility may be modified to reduce MR, but distensibility has only been
measured in excised MVs. Our aim was to test the feasibility of obtaining a
noninvasive measure of MV distensibility in patients by measuring systolic
change in anterior leaflet length (ALL) or anterior leaflet strain; and to test the
hypothesis that these measures vary in diseases with known altered MV elas-
ticity. 
Methods: ALL was quantified in a long-axis view standardized by 3D
echo in 80 patients: 20 each with normal hearts, MVP, FMR and MS. Disten-
sibility was measured as end-systolic (ES) – end-diastolic (ED) total ALL nor-
malized to an ED reference; and alternatively as mid-leaflet strain measured
by tracking echo features. 
Results: ALL was greater in all disease groups vs normal (p<.001). The
maximum systolic increase in ALL relative to ED was 7.9 ± 7.4% in normals
vs >2-fold higher (16.5 ± 7.7.%) in MVP; it was 63-76% lower (2.9 ± 3.0%,
1.9 ± 3.1%) in FMR and MS, with comparable results for segmental AL strain
(Table). 
Conclusion: Noninvasive echocardiographic measures of MV distensibility
based on systolic changes in total length or segmental strain are feasible.
Results are consistent with excised valve biomechanics, showing increased
distensibility in MVP and decreased values in FMR and MS. Ultimately, these
techniques have the potential to monitor response to new therapies that aim to
improve MV biology and mechanics to reduce MR.
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MR provides best long-term results with least ventricular remodeling
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rurgie Cardiovasculaire, Paris, France
Background: In ischemic mitral regurgitation (IMR), leaflet tethering is
caused by post-MI LV and annular remodeling. Severing second-order mitral
chordae significantly decreases tethering and MR. We tested whether under-
sized ring annuloplasty can improve chordal cutting efficacy by reducing
annulus-related tethering. 
Methods: Posterolateral MI created chronic remodeling and MR in 28
sheep. At 3 months, sheep were randomized to sham surgery vs isolated annu-
loplasty undersized by 2 sizes vs isolated bileaflet chordal cutting vs at the
combined therapy (n=7 each). At baseline, chronic MI (3 months) and sacri-
fice (6.6 months) we measured LV volumes and ejection fraction (EF), wall
motion score index (WMSi), MR Regurgitation fraction (MRRF) and vena
contracta (VC), Mitral annulus area (MAA) and posterior leaflet (PL) restric-
tion angle (PL to MAA) by 2D and 3D echo. 
Results: All groups were comparable at baseline and chronic MI, with mild-
moderate MR (MRVC 4.6±1.0mm, MRRF 24±2.6%) and MA dilatation
(p<0.01). At sacrifice, LV end-systolic volume (ESV) increased by 108% in
controls vs 28% with ring + chordal cutting, less than with each intervention
alone (p<0.01). Also, MR progressed to moderate-severe in controls but
decreased to trace with ring + chordal cutting vs mild-moderate with ring alone
and trace-mild with chordal cutting alone (MRVC 5.9±1.1mm in controls,
2.0±0.7 with ring, 1.0±0.9 with chordal cutting, 0.5±0.08 with both, p<0.01).
Ring alone did not improve PL mobility, but chordal cutting did alone or with
ring (PL restriction angle 54±5° vs. 45±2.3° with ring, p=NS). In multivariate
analysis, LVESV and MAA most strongly predicted MR (r2=0.82, p<0.01). 
Conclusions: Comprehensive annular and subvalvular repair provides the
most effective long-term reduction of both chronic ischemic MR and LV
remodeling.Total anterior leaflet stretch
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TOPIC 35 – Valvular heart diseases 
and valvular surgery
0383
First results of the mobil unit for mechanical circulatory support
Sylvain Beurtheret (1), Pierre Mordant (1), Alain Combes (2), Stéphane
Aubert (1), Iradj Gandjbakhch (1), Alain Pavie (1), Pascal Leprince (1)
(1) Institut de cardiologie. Pitié, Chirurgie Thoracique et cardiovascu-
laire, Paris, France – (2) Institut de Cardiologie, Pitié, Service de réani-
mation Médicale, Paris, France
Background: Cardiogenic shock that resist to inotropic agents may ben-
efit from temporary circulatory support with Extra Corporeal Membrane
Oxygenation (ECMO). For patients hospitalized in intensive care units, a
dedicated surgical unit called Mobil Unit for Mechanical Circulatory Sup-
port can initiate this support. We have analysed in-hospital mortality and
prognostic factors of the Mobil Unit for Mechanical Circulatory Support of
our institution.
Methods: From May 2005 to December 2008, 69 patients hospitalized in
26 institutions in Paris area have been supported by an ECMO in the Mobil
Unit for Mechanical Circulatory Support program. Sex ratio was 2/1, mean
age was 46 years, and main diagnosis was myocardial infarction in 32 patients
(48%), acquired cardiopathy without underlying cardiac disease in 22 patients
(32%), and acute cardiac failure on chronic dilated myocardiopathy in 15
patients (20%). Circulatory support was indicated in case of inotropic support
failure, and consisted of arterio-veinous peripheral ECMO.
Results: All patients fulfilled cardiogenic shock criteria, including low
systolic and diastolic blood pressure and organ failure despite inotropic sup-
port. Twenty-six patients (38%) underwent cardiac arrest. Mean LV ejection
fraction was 21%. After ECMO initiation, 48 patients (70%) have been
transferred to our institution. Twenty-seven patients (39%) left the hospital
alive, after complete cardiac recovery (n=23, 33%) or after cardiac trans-
plantation (n=4, 6%). In-hospital mortality prognostic factors included age
(HR=1.04, p=0.02), myocardial infarction (HR=2.57, p=0.08), APTT
(RR=0.96, p=0.002), acute cardiopathy (RR=0.35, p=0.04) and diurese con-
servation (RR=0.07, p=0.001).
Conclusion: In-hospital mortality of patients admitted for inotropic-resis-
tant cardiogenic shock and managed by the Mobil Unit for Mechanical Circu-
latory Support was 61%. Better knowledge of the ECMO prognostic factors in
this setting may help to refine its indications.
0331
Alterations of wound healing properties of human fascial fibroblasts
in patients with abdominal aortic aneurysms
Maha David-Raoudi, Marianne Gervais-Taurel, Ibtissam Chabane, Eric
Allaire
CNRS EAC 7054, Centre de Recherches Chirurgicales, UFR de Médecine
Paris 12, Créteil, France
Background: Abdominal aortic aneurysms (AAAs) are associated to
higher incidence of incisional hernia (IH) after midline laparotomy, compared
to aortic occlusive disease (AOD). We made the hypothesis that IH represents
a model of defective healing in response to de novo tissue injury, and may
help identify early determinants of AAA formation. Our aim was to identify
functional alterations of abdominal wall fibroblasts associated to AAA on a
background of atherosclerosis. 
Methods: Fascial fibroblasts were isolated by migration from explants
of linea alba from patients undergoing surgery for AAA (n=6) or AOD
(n=6). Cells from the two groups were compared for their basal prolifera-
tion rate using BrdU incorporation, migration using both scratch wound
healing and Transwell assays, and apoptosis by detection of cytoplasmic
nucleosomes. 
Results: We found no difference in cell proliferation between AAA and
AOD patients. Assessment of repair in response to scratch wound healing in
confluent cell monolayer showed 40% less surface recolonized by fibroblasts
of AAA patients (p=0.032), suggesting less ability to spread in injured tissue
and extracellular matrix in AAA patients. In contrast, migration through small
pores as studied by Transwell showed no difference between the two groups.
Finely, nucleosomes determination in camptothecin treated cells demonstrated
a reduced apoptosis rate in AAA than in AOD fibroblasts (-30%, nucleosomes
factor was 3.9 for AAA and 5.5 for AOD), supporting reduced renewal in
AAA fibroblasts. 
Conclusion: Our results demonstrate functional differences relevant to
healing of fascial fibroblasts in AAA patients, e.g. in tissues distant from
aortic lesions and not directly altered by atherosclerosis. We are currently
studying linea alba structure in the groups of patients, the impact of circulating
factors in these cellular alterations, and large scale differential molecular
expression associated with these cellular functional differences. 
0089
Is it possible to avoid patient-prosthetic mismatch during valve repla-
cement?
Paul Menu, Pierre Corbi, Christophe Jayle, Géraldine Allain, Luc Chris-
tiaens
Hôpital Universitaire de Poitiers, chirurgie cardiaque, Poitiers, France
Background: The transvalvular gradient is essentially determined by two
factors, the effective orifice area and transvalvular flow. The effective orifice
area depends on the type of valve and also on the implantation technique and
the surgeon’s skill. The aim of this study was to determine the incidence of
patient-prosthetic mismatch (PPM) in relation to surgical sizing and place-
ment. Two placement techniques were evaluated for aortic valve replacement
(AVR) in an attempt to minimize PPM.
Methods: The PMM classification used defined severe PMM as AOEi
<0.6/cm2/m2. During the first step of AVR, blind probes 20, 21 or 22 mm in
size were used to measure the real annulus diameter. In the second step, the
surgeon selected the implant size and inserted the valve using the supraannular
(Group SAT, n=30) or intraannular implantation technique (Group IAT,
n=32). The placement technique was selected according to the surgeon’s pref-
erence. The effective orifice areas and indices and incidence of PMM were
evaluated 3 months after surgery in 62 patients undergoing isolated AVR
(mean age 74.7 ± 8.1 years; 40 men). The echocardiography examinations
were performed by the same echocardiographer.
Results: An interaction effect was observed between annulus size, implan-
tation technique and valve size: for valve 19 the valve size ratios were 10 in
the IAT group vs. 2 in the SAT group; for valve 21 the ratios were 22 in the
IAT group vs. 16 in the SAT group; and for valve 23 the ratio was 12 only in
the SAT group. Severe PPM was observed more frequently in patients under-
going IAT (6/32, 18%) than with SAT (2/30, 6%). PMM depended on the
body mass index, real orifice area and implantation technique.
Conclusion: Despite more than 30 years of clinical experience, the optimal
technique for AVR is unknown. However, supraannular placement seems to be
efficient to prevent severe PPM. There are no prospective studies on the rela-
tionship between annulus size and effective valve implant size. 
0135
FlnA mutations associated to myxomatous valular degeneresence
impede cellular migration.
Aurélie Lardeux, Florence Kyndt, Jean-Jacques Schott, Jean Merot
Institut du Thorax, INSERM U915, Nantes, France
Myxomatous Valvular Dystrophy (MVD) is a frequent cause of valvular
disease characterized by the thickening and lengthening of valve leaflets
causing regurgitation. We previously identified Filamin A (FlnA) as the first
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gene linked to nonsyndromic MVD but the pathophysiological mechanisms of
the disease remain to be elucidated. The purpose of this study is to identify the
effects of FlnA mutations (P637Q, G288R) associated to MVD on cell mor-
phology and the stability of FlnA protein. 
Stables cell lines expressing wild type (WT), FlnA-P637Q or G288R
mutants were established in the FlnA-deficient human melanoma cell line
(M2). Previous studies showed that FlnA deficiency determined blebs forma-
tion on M2 cells surface. Here, we showed that like WT-FlnA, mutant FlnA
suppressed blebs formation in M2 cells suggesting « normal » actin network
was rebuilt. On the other hand, cells expressing mutant FlnA exhibited smaller
lamellipodia and drastically reduced cell migration capabilities. In addition,
western blot experiments revealed reduced expression levels of FlnA-P637Q
or G288R compared to WT-FlnA suggesting reduced stability of mutant FlnA.
This point is now under study using metabolic pulse chase experiments and
biochemical analysis.
In conclusion, our experiments indicate that FlnA mutations associated
to MVD affect cellular migration. Although the link with exuberant myx-
omatous extracellular matrix remains to be determined this observation rep-
resents the first cellular phenotype associated to these specific FlnA
mutations. 

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TOPIC 36 – Rehabilitation, sports, cardio-
vascular prevention
0417
Influence of kind of exercise training on cardiac and ventilatory para-
meters in coronary heart disease patients continuous training versus
interval training
Pierre Bonnaud, Prisca Demaison
CHU Dupuytren, Cardiologie, Limoges, France
Cardiac rehabilitation, as well as cardiovascular risk factor correction, is
part of modern management after coronary heart disease. It has been proved
to enhance endurance performances and reduce mortality. However research is
still scarce about exercise training intensity and schedule.
Our prospective study randomized 53 stable coronary heart disease patients to
continuous training (26 patients) or to aerobic interval training (27 patients): 80%
versus peak workload at the ventilatory threshold respectively. We compared the
influence of this training on cardiac and ventilatory parameters after gas analysis
immediately after rehabilitation and six months after the cardiac event.
The results showed a significant decrease of LDL level (<1g/l) in both
groups and smoking cessation in 92.28% of cases after exercise training.
In our study, endurance training, whether interval or continuous, significantly
improved the respiratory parameters; maximal oxygen uptake (+15%), max-
imum workload (+28%), ventilatory threshold (higher in the contnuous group
and on average 11.65% over the normal range) and its workload (+25%).
There was no superiority of interval training over continuous training.
Interval training over the ventilatory threshold, but no higher than 90% of the
maximal oxygen uptake could lead to better results.
0334
Is a 3 week period of cardiac rehabilitation enough to improve endo-
thelial function? 
Philippe Castellant (1), Christelle Goanvec (2), Marie-Claire
Pouliquen (1), Olivier Simon (3), François Guerrero (2), Jean-Christophe
Cornily (1), Martine Gilard (1), Jacques Mansourati (1)
(1) CHU de Brest, Cardiologie, Brest, France – (2) UBO, Laboratoire
ORPHY, Brest, France – (3) Centre de réhadaptation Cardiovasculaire,
Roscoff, France
Endothelium is involved in different cardiovascular diseases as it has var-
ious regulating effects on vasomotion, tissue perfusion, haemostasis and
thrombosis. Exercise training is known to have beneficial effects on endothe-
lial function and consequently on heart failure, hypertension and atheroscle-
rosis. Cardiac rehabilitation is therefore particularly recommended after
cardiac surgery, myocardial infarction or in patients with heart failure. We
sought to evaluate the effect of a 3 weeks rehabilitation period on endothe-
lium-dependent vasomotion in cutaneous microcirculation. 
Methods: we assessed endothelium-dependent vasodilation in cutaneous
microcirculation in patients (pts) who underwent a program of cardiac rehabil-
itation after coronary artery bypass grafting (CABG) and/or valvular surgery,
or after a myocardial infarction. Reactive hyperaemia was measured in the
cutaneous microcirculation of the arm by Laser Doppler before and at the end
of the program. Peak VO2 was also determined before and after rehabilitation. 
Results: the study population included 22 pts (18 men, mean age
60.6±12.7 years). Indication of rehabilitation was: CABG in 6 pts, valvular
surgery in 4 pts CABG and valvular surgery in 2 pts and myocardial infarction
in 10 pts. Mean left ventricular ejection fraction was 57±12%. Mean body
mass index was 27.5±7.4 kg/m2. LDL cholesterol was 0.9±0.3g/L. 30% of
patients were smokers. Rehabilitation was not associated with a significant
improvement of perfusion in reactive hyperaemia: 40.5±23 perfusion units
(PU) before to 44.5±27 PU after rehabilitation,p=0,6. However, time to return
to baseline perfusion after hyperemia, improved significantly from 40.1±19 to
52± 18 sec, p=0.04. Peak VO2 improved from 19±3 to 21±6 ml/min/kg,
p=0.5). However no correlation was found between Peak VO2 improvement
and response to hyperaemia. 
Conclusion: a 3 week period of cardiac rehabilitation does not improve
significantly reactive hyperaemia measured in the cutaneous circulation by
Laser Doppler in our study population. Other parameters seem however to
improve. A longer period is probably needed for a significant improvement in
endothelial function which should lead to encourage patients to continue exer-
cise training after rehabilitation. 
0165
Moderate wine consumption and glycated haemoglobin level in diabe-
tic patients after an acute myocardial infarction: A prospective obser-
vational study
Pierre Sicard (1), Farnier Michel (2), Jack Ravisy (3), Charlotte Pernet-
Galay (4), Jean-Claude Beer (5), Hamid Makki (6), Anne-Cécile
Lagrost (7), Juliane Berchoud (8), Michel Vincent-Martin (9), Yves Lau-
rent (10), Luc Rochette (11), Yves Cottin (8), Marianne Zeller (12), Auré-
lie Gudjoncik (1, 8)
(1) LPPCE, IFR Sante-STIC, Dijon, France – (2) Le Point Médical, Dijon,
France – (3) Service de cardiologie, Clinique , Fontaine Les Dijon,
France – (4) CHU Montpellier, Dermatologie, Montpellier, France –
(5) Service de Cardiologie, CHU, Dijon, Dijon, France – (6) Service de car-
diologie, CH, Chatillon Sur Seine, France – (7) Service de Cardiologie,
CHU Dijon, Dijon, France – (8) Service de cardiologie, CHU Dijon, Dijon,
France – (9) Service de cardiologie, CH, Beaune, France – (10) Service de
Cardiologie, CH, Semur-En-Auxois, France – (11) LPPCE, IFR Santé-
STIC, Dijon, France – (12) LPPCE, IFR sante-stic, Dijon, France
Introduction: After acute myocardial infarction (AMI), glycemic control
is a major determinant of the prognosis. Light to moderate wine intake may
have beneficial effects on the evolution of cardiovascular diseases. The aim of
this prospective observational study was to investigate the association between
moderate wine consumption and glycated haemoglobin (HbA1c) level in dia-
betic patients who survived an AMI.
Methods: From the French regional RICO survey, 210 consecutive
patients with known diabetes and surviving an AMI were included between
the 1st January and the 31st December 2005. Demographic, clinical, and life-
style risk-factors, questionnaire-based wine consumption and HbA1c levels
were collected at one-year follow-up. 
Results: At follow-up, 48% of patients reported moderate wine consump-
tion (1-3 drink/day). Moderate drinkers were older than non or high-drinkers
(0 or >4 drink/day) (71(62-75) vs 67(55-74) year, p=0.026). In the moderate
drinkers group, HbA1c was lower than non or high-drinkers group (6.8(6.4-
7.4) vs 7.3(6.7-8.7)%, p=0.021). In univariate analyses, smoking, body mass
index, age were negatively associated with low HbA1c (<7.5%). In contrast,
physical activity, insulin therapy, oral diabetic drug and moderate wine intake
were positively associated with low HbA1c level. In multivariate analyses,
insulin therapy (OR(95%CI) (0.22(0.07-0.67)) and moderate wine intake
(OR(95%CI) (0.37(0.13-0.87)) were associated with low HbA1c.
Conclusion: Moderate wine intake was associated with low HbA1c level
in diabetic patients after AMI, an association not explained by confounding
factors. Our findings suggest that patients with high HbA1c may benefit more
from the favourable glycemic effect of a moderate wine consumption. Further
intervention studies are needed to confirm the long-term effect of moderate
wine intake in diabetic patient after an AMI.
0175
Effect of moderate wine consumption on high density lipoprotein-cho-
lesterol levels in high risk patients: A prospective observational study
Pierre Sicard (1), Michel Farnier (2), Gilles Dentan (3), Charlotte Pernet-
Galay (4), Jean-Claude Beer (5), Hamid Makki (6), Luc Janin-
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Manificat (7), Yves Laurent (8), Anne-Cécile Lagrost (9), Juliane Ber-
choud (10), Luc Rochette (11), Yves Cottin (10), Marianne Zeller (12),
Aurélie Gudjoncik (1, 8)
(1) LPPCE, IFR Sante-STIC, Dijon, France – (2) Service d’endocrinolo-
gie, Point Médical, Dijon, France – (3) Clinique de Fontaine, Cardiolo-
gie, Fontaine-Les-Dijon, France – (4) CHU Montpellier, Dermatologie,
Montpellier, France – (5) Service de Cardiologie, CHU, Dijon, Dijon,
France – (6) Service de cardiologie, CH, Chatillon Sur Seine, France –
(7) Centre Hospitalier, Cardiologie, Beaune, France – (8) Service de Car-
diologie, CH, Semur-En-Auxois, France – (9) Service de Cardiologie,
CHU Dijon, Dijon, France – (10) Service de cardiologie, CHU Dijon,
Dijon, France – (11) LPPCE, IFR Santé-STIC, Dijon, France –
(12) LPPCE, IFR sante-stic, Dijon, France
Introduction: Regular light to-moderate wine consumption, defined as 1-3
drinks/day, is associated with a lower risk of cardiovascular disease. More-
over, half of the cardiovascular benefit of wine consumption would be attrib-
utable to its High density lipoprotein-cholesterol (HDL-C) rising effect. The
aim of this prospective study was to investigate the association between mod-
erate wine consumption and HDL-C levels in patients who survived an acute
myocardial infarction (AMI).
Methods: From the French regional RICO survey, 920 consecutive
patients surviving an AMI were included between the 1st January and the 31st
december 2005. At one year follow-up, patients were asked to report their
wine consumption, using a questionnaire and examination of serum lipids was
performed. Associations of demographic, clinical, and lifestyle risk-factors
with HDL-C levels were assessed with multivariate analysis.
Results: Patient consuming 1-3 drink/day of wine had higher HDL-C
levels (respectively, 0.47(0.38-0.56) vs 0.43(0.35-0.53) mg/dL, (p=0.026)),
and lower CRP concentrations (2(1-5) vs 4(2-7) mg/L (p=0.01)), than non or
high-drinkers (0 or >4 drink/day). No difference was reported for triglycerides
or LDL-C levels in the two groups. In univariate analyses, CRP levels, dia-
betes, smoking and body mass index (BMI) were negatively associated with
high HDL-C (> 40 mg/dL in men and >50 mg/dL in women). In contrast,
female, physical activity and moderate wine intake were positively associated
with HDL-C. In multivariate analyses, BMI (OR(95%CI) (0.91(0.87-0.96)),
physical activity (OR(95%CI) (1.23(1.07-1.41)) and moderate wine intake
(OR(95%CI) (1.84(1.22-3.73)) were associated with high HDL-C. 
Conclusion: These data suggest that a moderate wine intake is associated
with elevated levels HDL-C levels. This association may participate to the
beneficial effect of moderate wine intake on cardiovascular disease. 
0455
Is a systematic screening of patients at high cardiovascular risk fol-
lowed by an appropriate care possible and effective? Prevarance Pro-
gram 
Thierry Denolle (1), Gérard Hamonic (1), Benoît Camberlein (1), Marie
Mérienne (1), Herve Le Neel (2), Rémy Bataillon (2), Florence Revault
D’Allonnes (1)
(1) Réseau rivarance, Dinard, France – (2) URML Bretagne, Rennes,
France
The Prevarance program consist, (1) after informing (by letters, newspa-
pers ...) the population of a district (25 000 person), (2) in identifying the CV
risk of men aged 50 to 54 and women aged 60 to 64 years and (3) in cases of
high cardiovascular risk (HRCV) (defined by at least 2 risk factors + age, or
HRCV diabetes, or CV or renal complications) and in providing a care both
specialised and free of charge assured by a multidisciplinary team. The profes-
sionals received a training in therapeutic education and benefited from the
assistance of a clinical research assistant. 
Results: 47 liberal professionals participated in the program (18/22 general
practitioners (GPs) assisted by 11 pharmacists, 15 nurses, 2 dieticians and 1
physical educator. The average time for care in the program was 510 days.
100% of MG have fulfilled the screening of at least 60% of their practice in 1
year. At inclusion: 685/945 patients targeted were screened (73%): 17%
smokers, 36% hypertensive treated or not, 8% diabetic, 7% heavy drinkers,
27% performing insufficient physical activity and 55% overweight. 171 (25%)
were HRCV: 62% and 19% in primary and secondary prevention and 19%
with diabetes at HRCV. 63/171 (37%) participated in the program. Significant
results in all HRCV patients, more marked in patients in the program:
increased rate of treated hypertensive patients (41 to 69%, p <0.01), of patients
who reached the LDL threshold recommended by the HAS (45 to 88%, p
<0.01) No significant differences were shown for BMI, smoking, physical
activity and alcohol consumption. In total, 32% of patients at HRCV were no
longer at end of the program. 
Conclusion: The program has shown (1) a CV risk screening is feasible by
100% of the GP (2) that 25% of the population is at HCVR (3) 37% of
screened patients agreed to participate in the program free of charge (4) a clin-
ical impact in terms of reducing overall CV risk is achievable in less than 1,5
years for 1 / 3 of HRCV patients.
0180
Exercise prevents deleterious effects of simulated urban carbon
monoxide air pollution on myocardial sensitivity to ischemia-reperfu-
sion
Charlotte Farah (1), Grégory Meyer (1), Lucas André (2), Sandrine Gay-
rard (1), Olivier Cazorla (2), Sylvain Richard (2), Philippe Obert (1), Sté-
phane Tanguy (1), Cyril Reboul (1)
(1) EA4278 Université d’Avignon, Pôle sportif et de recherche, Avignon,
France – (2) INSERM U637, Université de Montpellier 1, Montpellier,
France
Introduction: Carbon monoxide (CO) exposure was reported by our team
to exacerbate heart sensitivity to ischemia reperfusion. The aim of this work
was to evaluate the potential cardioprotective effect of moderate exercise in
the prevention of this phenomenon, notably by preventing the deleterious
effects of CO on myocardial antioxidant status and calcium homeostasy. 
Methods: Rats were randomly assigned to control groups with or without
exercise, or to CO groups, living in simulated urban CO pollution (30-100
ppm, 12h/day) with (CO-Ex) or without exercise (CO-Sed). On a first set of
rats, regional myocardial ischemia-reperfusion were realized on isolated per-
fused rat hearts. Myocardial function, coronary blood flow, LDH release and
infarct size were evaluated. On another set of rats, myocardial antioxidant
status and calcium handling were evaluated following the various environ-
mental exposures. 
Results and discussion: Moderate exercise mainly prevents CO-induced
myocardial phenotypical changes. Indeed, moderate exercise restores Ca2+
handling alteration in CO rats. In addition, it induces myocardial antioxidant
status recovery in CO-Ex rats when compared to CO-Sed rats. Importantly,
those phenotypical changes associated with moderate exercise training in CO
rats were associated with lower sensitivity of the myocardium to IR (lower inf-
arct size and decrease of reperfusion arrhythmias). 
To conclude, moderate exercise, by preventing CO-induced Ca2+ handling
and myocardial antioxidant status alterations, reduces heart vulnerability to IR. 
0227
Exercise-training restores endothelium-dependent vasorelaxation and
reverses endothelial NOsynthase uncoupling in Spontaneously Hyper-
tensive Rats
Sanéo Thioub (1), Christelle Goanvec (1), François Guerrero (1), Jean-
Christophe Cornilly (2), Jacques Mansourati (2)
(1) EA 4324 – ORPHY, Brest Cedex 3, France – (2) CHU Brest, Dépar-
tement de cardiologie, Brest, France
We sought to evaluate the effect of exercise training on eNOS coupling/
uncoupling in Spontaneously Hypertensive Rats (SHR). 
Male SHR and Wistar-Kyoto (WKY) rats were submitted to a treadmill
training protocol (20m/min, 60 min/day, 5 days/week, 9 weeks and 10°
incline). Systolic Blood Pressure (SBP) was measured before training, 6 h and
72 h after the last exercise bout. Dose-response curves to ACh (10-9 to 10-4
mol/L) alone or in the presence of either Nω-nitro-L-arginine methyl esther
(L-NAME, 5.10-5 mol/L) or tetrahydrobiopterin (BH4, 10-5 mol/L) were
studied in rings from femoral artery precontracted with PE (10-7 mol/L). 
Sedentary life-style and training exercise did not alter SBP in WKY. In
SHR, SBP increased significantly 6 h and 72 h (158 ± 6 vs 184 ± 4 mmHg
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and 184 ± 4 mmHg) post-sedentary life-style (p=0.0003). In trained SHR,
SBP was significantly reduced 6 h post-exercise as compared to reference
value (140 ± 3 vs 161 ± 3 mm Hg; p=0.002). SBP was also decreased 72 h
post-exercise as compared to post-sedentary life-style (166 ± 3 vs 184 ± 4
mm Hg; p=0.023). Results on femoral artery rings are summarized in the
table.
Training has acute and chronic hypotensive effects in SHR. Endothelial
dysfunction associated with hypertension involves eNOS uncoupling. Endot-
helium-dependent vasorelaxation is improved by exercise training in normo-
tensive rats. In hypertensive animals, exercise training restored ACh-induced
vasorelaxation by coupling eNOS. 
Emax (maximal relaxation) and EC50 (half-maximal effective dose) in
response to ACh alone or in presence of BH4. Percent relaxation=percent
reduction in force from PE. 
0223
Prevention of the cardiovascular risk by exercise training in rats
with chronic kidney disease treated with recombinant human
erythropoietin 
Fayçal Meziri (1), Saber Touati (1), Tlili Barhoumi (1), Marcos
Simoes (2), Alain Berthelot (2), Rhian M Touyz (3), Pascal Laurant (1)
(1) Université d’Avignon, EA 2426, Avignon, France – (2) Université de
Franche-Comté, Besançon, France – (3) Université d’Ottawa, Kidney
Research Centre, Ottawa, Canada
Chronic kidney disease (CKD) is associated with endothelial dysfunction
accompanied by pathogenetic factors which contribute to hypertension and
coronary artery disease, major causes of morbidity and mortality in patients
with renal failure. CKD also causes anemia, which is classically treated with
recombinant human erythropoietin (rHuEPO). However rHuEPO can induce
arterial hypertension (HTA) and aggravate cardiovascular morbidity.
Increasing evidence indicates that exercise has cardiovascular protective
properties. Here we questioned whether physical training in rats with CKD
and treated with rHuEPO may prevent development of hypertension and vas-
cular and renal injury. Rats with 5/6 renal mass ablation were submitted to
treadmill exercise for 30/60 min (5 times/week for 7 weeks). During the
same period, rats were treated (CKD-EPO) or not with rHuEPO (100 IU/kg,
twice a week, subcutaneous injection). Blood pressure was measured
weekly. Vasorelaxation of the aorta to acetylcholine was studied and
vasodilatory response to intravascular flow of isolated perfused and pressur-
ized mesenteric small arteries was assessed. Blood pressure increased signif-
icantly in CKD (171 mmHg) and CKD-EPO rats (170 mmHg) versus
controls (142 mmHg p<0.05). Exercise prevented, in part, development of
hypertension in CKD (150 mmHg) and CKD-EPO rats (155 mmHg). Aortic
vasodilatory responses were significantly impaired in CKD and CKD-EPO
rats versus sham. Exercise improved vasorelaxation in CKD, with lesser
effects in CKD-EPO-Ex rats. Impaired mesenteric vasodilatory responses in
the CKD groups were also significantly improved by exercise. Our data sug-
gest that exercise alone has a protective effect against hypertension and vas-
cular dysfunction, but when combined with EPO treatment, it seems to have
a deleterious effect in CKD rats. These findings highlight potentially dam-
aging cardiovascular and renal effects of combination exercise and EPO
treatment in chronic kidney disease. 
0205
Effect of exercise with and without diet modification on endothelial
function and oxidative stress in obese rats 
Sabeur Touati 
Université d’Avignon, Avignon, France
Obesity is a serious public health problem because it increases the risk of
chronic diseases such as type 2 diabetes mellitus and cardiovascular diseases.
Sedentary lifestyle and excess dietary fat are the most important modifiable risks
factors for obesity and metabolic abnormalities. This study tested the hypothesis
that exercise training can improves endothelial dysfunction, oxidative stress and
inflammation in obese rats without its being necessary to modify diet composi-
tion. Male Sprague-Dawley rats were placed on a high fat (HFD) or control diet
(CD) for 12 weeks. HFD rats were then divided into 4 groups: sedentary high
fat diet group (HFD-S), exercise trained (motor treadmill 5 days/week, 60 min/
day for 12 weeks) high fat diet group (HFD-Ex), modified diet (high fat to con-
trol diet) group (HF/CD-S) and exercise trained with modified diet group (HF/
CD-Ex). Body weight, blood pressure, plasma TNFα, IL-6 and TBARS levels,
NADPH oxidase activity and endothelium-dependent vasorelaxation in aorta
were measured. Body weight, blood pressure, NADPH oxidase activity, plasma
IL-6, TNFα and TBARS levels were significantly higher in HFD-S rats com-
pared to control group (p<0.05). Exercise and modified high-fat-to-normal diet
reduced adiposity and plasma inflammatory cytokines (p<0.05), exerted antihy-
pertensive effect, and improved aortic endothelium-dependent relaxation. The
lowering effect on blood pressure was more effective in the trained groups com-
pared to the HF/CD-S group (p<0.05). Moreover, exercise was also more effec-
tive to improve systemic oxidative stress by lowering plasma TBARS and to
correct the endothelium-dependent relaxation to acetylcholine than in the group
with diet modification alone (p<0.05). Both exercise and modified high-fat-to-
normal diet had the same effect in decreasing NADPH oxidase activity in vas-
culature. Our results demonstrated that exercise training seems a more effective
strategy than diet modification in decreasing blood pressure, improving endothe-
lial function and ameliorating systemic and vascular oxidative stress in obese
rats. Finally, it is concluded that exercise may be a potential non-pharmacolog-
ical treatment for multiple simultaneous cardiovascular risk factors.
0226
Role of beta-adrenergic pathway and calcium homeostasis in cardiac
dysfunction induced by prolonged strenuous exercise
Damien Vitiello (1), Julien Boissiere (2), Olivier Cazorla (3), Cyril
Reboul (1), Philippe Obert (1), Stéphane Nottin (1)
(1) EA-4278 LPPACE, Avignon, France – (2) STAPS Lille 2, Ronchin,
France – (3) Physiologie cardiovasculaire, INSERM U637, Montpellier,
France
Introduction: Mechanisms responsible for left ventricular (LV) dysfunc-
tion following a prolonged strenuous exercise (PSE) are not well understood.
We hypothesised that β-adrenergic pathway (β-AP) and changes in calcium
homeostasis (CH) could be involved in LV dysfunction following PSE.
Materials and methods: Rats were randomized into one control (CTL)
and one exercised (Ex) group. To induce LV dysfunction Ex rats were running
4H on a treadmill. We assessed β-AP from LV pressures evaluation (Millar®
transducer) during dose response to isoproterenol (ISO) both in-vivo and ex-
vivo (isolated perfused Langendorff heart model). We assessed CH in isolated
cardiomyocytes from subendocardium and subepicardium layers using Indo-1
AM and IonOptix acquisition software.
Results: After 4H of running, LV dysfunction was characterised by a
decrease in contractility (dP/dtmax: 4109 ± 289 versus 2917 ± 196 mmHg.s-1,
p<0.05) and relaxation (dP/dtmin: -2304 ± 169 versus -1644 ± 110 mmHg.s-1,
p<0.05). Both, in-vivo and ex-vivo LV pressures response to ISO was similar
in CTL and Ex groups. Isolated cardiomyocytes from subendocardium of Ex
rats had a higher Ca2+ intracellular concentration and a smaller reticulum sar-
coplasmic Ca2+ load than CTL rats. However, no changes were observed on
cardiomyocytes from subepicardium layer.
Conclusion: β-AP was not involved in LV dysfunction induced by 4H of
treadmill exercise. An alteration in CH was observed on cardiomyocytes of sub-
endocardium region, but not on those of subepicardium region, suggesting that
subendocardium layer was more sensitive to PSE. These data highlighted that
CH could be one mechanism responsible for LV dysfunction following PSE.
 
 ACh  ACh+BH4
 
 Emax (%)  EC50 (µM)  Emax (%)  EC50 (µM)
 SHR Sedentary 
(n=10) 
33.6 ± 7.83 1.45 ± 0.54 26.81 ± 4.23 0.12 ± 0.06 
 WKY sedentary 
(n=10)
 48.50 ± 8.73  0.08 ± 0.03 56.27 ± 21.50 0.25 ± 0.15
 SHR exercise 
(n=10)
 95.68 ± 16.83† 8.57 ± 8.40  33.01 ± 8.14  0.13 ± 0.06
 WKY exercise 
(n=10)
 86.87 ± 14.55‡ 0.04 ± 0.01  47.64 ± 5.65  0.13 ± 0.05
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Assessment of left and right ventricular functions in post-operative
Fallot pediatric patients by speckle tracking echocardiography:
reproducibility and comparison to Magnetic Resonance Imaging
Laurent Bonnemains (1), Bertrand Stos (2), Adela Rohnean (2), André
Capderou (2), Damien Bonnet (3), Daniel Sidi (3), Younes Boudjemline (3)
(1) CHU Brabois – Nancy – France, cardiologie infantile, Vandoeuvre
Les Nancy, France – (2) Centre chirurgical Marie Lannelongue, cardio-
logie pédiatrique, Le Plessis Robinson, France – (3) Necker enfants mala-
des, Paris, France
Two-dimensional (2D) speckle tracking echocardiography (STE) is a new
angle-independent ultrasound technique based on tracking of speckles within
the myocardium on grayscale images. This study was designed to assess the
feasibility and reproducibility of the technique within a paediatric population,
and to quantify the correlation between global strains and MRI computed ejec-
tion fraction.
Methods: 40 post-operative tetralogy of Fallot adolescents underwent a 2D
STE and a cardiac MRI. STE Global circumferential and longitudinal strains
of both ventricles were measured. Ejection fractions were measured by MRI
and compared to a new new functional tridimensionnal index (FI) based on
measured strains.
Results: The feasibility of STE and MRI analysis were similar (range= 83-
88%). Strain intra and interobserver variations were low (range=1.4-2.7%).
Strain rates had a low reproducibility (range=0.22-0.25s-1). FI and ejection
fraction were well correlated for the left (r=0.61, p=0.001,see=4.0,n=30) and
right (r=0.51,p=0.03,see=4.8,n=19) ventricles.
Conclusions: STE is a new echocardiographic technique providing repro-
ducible segmental and global myocardial function assessment. When those
data are integrated upon the perimeter of the ventricles they correctly represent
their length shortening. A simple combination of these shortening ratios allows
a correct left and right ventricular function assessment.
0489
Mid-term follow up after native aortic coarctation stenting
Jérôme Bouet (1), Béatrice Bonello (2), Issam Kammache (2), Mohamed El
Talawi (2), Virginie Fouilloux (3), Thomas Cuisset (4), Gilbert Habib (1),
Alain Fraisse (2)
(1) Hôpital de la timone, cardiologie Pr Habib, Marseille, France –
(2) cardiologie pediatrique, Marseille, France – (3) chirurgie cardiaque
pediatrique, Marseille, France – (4) cardiologie, Pr Bonnet, Marseille,
France
Backgroung: The feasibility of transcatheter primary stenting (TPS) to
treat native aortic coarctation (Coa) is well-demonstrated as an alternative of
surgical repair. However, information on mid-term follow-up remains scarce,
especially regarding the frequency of systemic hypertension and the integrity
of the aortic arch
Objectives: To retrospectively study the patient’s outcome after Coa
stenting, paying special attention to residual hypertension, aortic arch obstruc-
tion, aneurysm and dissection. 
Patients and Results: Since april 2002, 20 patients (8 female) with Coa
were treated by TPS at a median age and weight of 21 (7 to 52) years and 60
(27 to 94) kg, respectively. All the patients were symptomatic with upper limb
hypertension in 16 cases. Twenty stents were successfully implanted and the
mean peak systolic pressure gradient dropped from 31 (10 to 60) mmHg to 1,6
(0 to 15) mmHg. One major complication occurred in a patient who experi-
enced bilateral groin hematomas, with hypotension and anemia necessitating
transfusion. After a median follow-up of 2,9 (0,12 to 7,8 ) years, all the 20
patients are asymptomatic. Residual upper limb hypertension is present in 7
cases (35%), including 3 (15%) with mild residual upper-to-lower limbs gra-
dient (20mmHg). One patient was successfully redilated for in-stent restenosis.
By transthoracic echocardiography (n=20), spiral computed tomography (n=4),
and magnetic resonance imaging (n=5), there is no aortic aneurysm or dissec-
tion. 
Conclusion: TPS for Coa is successful with minimal morbidity. At mid-
term follow-up, residual hypertension is similar to that observed after surgical
repair, whereas aortic wall abnormalities were not encountered. Longer term
follow-up is mandatory to confirm this favorable outcome.
0188
Survival and follow-up after cardiac transplantation for congenital
heart diseases
Marie-Paule Guillaume (1), Thierry Timmermans (2), Olivier Van Caene-
ghem (2), Alain Poncelet (2), Olivier Gurné (2), Karlien Carbonez (1),
Thierry Sluysmans (1)
(1) UCL- Cliniques Universitaires Saint-Luc, Cardiologie Pédiatrique,
Bruxelles, Belgique – (2) Clinqiues Universitaires Saint-Luc, Bruxelles,
Belgique
Introduction: The number of patients with congenital heart disorder
requiring a cardiac transplant is limited. We report our experience concerning
survival and complications of congenital patients after cardiac transplantation
in our hospital. 
Method: From 1985 to January 2010, 19 patients (9 children and 10
adults) were transplanted (7 single ventricle, 5 left heart valvular disease (4
aortic and 1 mitral), 2 D-TGA after Senning or Mustard, 1 congenitally cor-
rected transposed great arteries, 2 Fallot, 1 truncus, 1 complete AV canal.
Median age at cardiac transplant was 20.8 years (min 7 years, max 64 year)
after a medium delay on the waiting list of 135 days (min 7 days – max 3
years). 
Results: Four patients died respectively after 1, 2, 6 days and 10 years post
transplant. The rate of survival was 84% at 10 years and 74% at 20 years of
follow-up. 
Complications were acute rejection (n=5) with 3 deaths at day 1, day 6 and
10 years post transplant, chronic renal insufficiency (14/15) with necessity of
dialysis in 3 patients, infections (14/15; septicaemia n=4, organ infection n=6,
local infection =7), hypertension (11/15), arrhythmia (2/15, pacemaker 1/15),
cerebral vascular accident (2/15), hyperlipidemia (14/15), dysthyroidia (5/15),
diabetes (1/15), hyperuricemia (1/15), osteoporosis (3/15). 
Conclusion: Survival and quality of life after cardiac transplant for con-
genital heart disease are globally good. Complications are nevertheless fre-
quent, particularly renal insufficiency.
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Assessment of left ventricular volumes and function by real-time
three-dimensional echocardiography in a pediatric population: a
Tomtec versus Qlab comparison
Sébastien Hascoët (1,2), Gilles Brierre (1,2), Philippe Acar (2), Guillaume
Caudron (1,2)
(1) CHU Rangueil, cardiologie, Toulouse, France – (2) Hôpital des
enfants, cardiologie pédiatrie, Toulouse, France
Background: Three-dimensional echocardiography (3DE) allows calcula-
tion of ventricular volumes without geometric assumption on the ventricular
shape. Real Time 3DE is validated to evaluate left ventricular (LV) volumes
and function in adults. Accuracy of the full volume reconstruction softwares
Tomtec and Qlab has not yet been studied in children. Our aim was to apply
3DE in a normal pediatric population and to compare the left ventricular vol-
umes measurements between these two analysing softwares.
Methods: Fifty pediatric patients (median age 9.5 years) without cardiop-
athy were included. 3DE was performed with the X4-2 or X7-2 matrix probe.
Off-line left ventricular volume analysis was performed with QLAB 6.0
(Semi-automated border detection with biplane projections) and Tomtec 4D
LV analysis (primarily manual tracking with triplane projections).
Results: Feasibility was 94% for Tomtec better than 80% for Qlab
(p=0.037). Analysis time was shorter with QLAB. (5+/-2 minutes versus 6+/-
3, p<0.05)
Measurements of stroke volume, end diastolic and end systolic left ventric-
ular volumes were strongly correlated (r>0.97; p<0.0001) with minimal bias.
Left Ventricular Ejection Fraction was well correlated (r=0.79; p<0.0001). No
significant difference was found between Qlab and Tomtec observer vari-
ability. Tomtec Intra observer and inter observer variability ranged respec-
tively from 5.7% to 13.4% and 13.1% to 33.2%. Qlab Intra observer and inter
observer variability ranged respectively from 4.6% to 12.2% and 8.9% to
14.7%. 
Conclusion: RT-3D echocardiography is a feasible and adequate method
for LV volume quantification in a normal pediatric population. Qlab seems
less feasible but analysis time is shorter. Further studies are needed to validate
the accuracy of the method to calculate enlarged LV volumes in patients with
congenital heart diseases. 
0490
Transcatheter closure of the majority of secundum atrial septal
defects with the adjunction of a modified, sizing balloon assisted tech-
nique 
Issam Kammache (1), Béatrice Bonello (1), Virginie Fouilloux (1), Sébas-
tien Ansaldi (2), Caroline Ovaert (1), Gilbert Habib (2), Loïc Mace (1),
Bernard Kreitmann (1), Alain Fraisse (1)
(1) Hôpital de la Timone-Marseille, Cardiologie pédiatrique , Marseille ,
France – (2) Hôpital de la Timone , Cardiologie adultes , Marseille,
France
Introduction and objectives: Atrial septal defects (ASD) are often closed
by interventional caheterization, under echocardiograophic guidance. How-
ever, the percentage of secundum ASDs that can be closed percutaneously
remains undetermined. In our institution, we use in dificult cases a Meditech
sizing balloon as a rim to secure position for the deployed device and prevent
prolapsing of the left disk in the right atrium. We sought to determine (1) the
amount of ASD that can be closed through interventional catheterization and
(2) the input of our modified sizing balloon technique (SBT) for transcatheter
closure. 
Patients and Methods: In 2009, 65 patients (37 female) were referred for
secundum ASD closure, at a median age and weight of 27.5(0.8 to 88) years
and 40.6 ( 5.6 to 97) kg, respectively. Twelve patients directly underwent sur-
gical closure because of referral cardiologist and/or patient’s choice (n=8), or
because their ASDs were unsuitable for transcatheter closure by echocardio-
graphy (n=4). Transcatheter closure was performed with Amplatzer device
occluder (ASO) or an Amplatzer cribriform in 53(81%) cases. In 28(53%)
children general anaesthesia and transesophageal echocardiography guidance
were used, whereas 25(47%) adults had their procedure under local anaes-
thesia and intracardiac echocardiography guidance. SBT was performed in 10
cases (20%). 
Results: Transcatheter closure was successful in 50 (94%) ases with a
median ASO size of 20 (10 to 40)mm in 47 patients. An Amplatzer Cribriform
was used in 3 cases for multiple ASDs. A 12 mm ASO could not be positioned
in a 5.6 kg infant, too small for SBT. Surgical closure was contraindicated for
poor general condition (former 26 weeks premature baby with severe bron-
chodysplasia). Transcatheter closure failed, even with SBT, in 2 cases. Sur-
gical closure was performed in one and is scheduled in the other. No major
complications occurred during or after transcatheter closure. Five patients
(10%) have a trivial residual shunt. Among the 57 patients referred for tran-
scatheter closure, 50 were successful (87%). 
Conclusion: Transcatheter closure of ASD using the Amplatzer occluder
device is successfully accomplished in the majority of the cases. The SBT is
a safe and useful technique for device positioning and delivery in patients with
large ASDs and deficient rims
